1	AAPS	NN	O	aap	dep	120	SENT_1	0/4
2	JAAPS	NN	O	jaap	dep	120	SENT_1	5/10
3	JThe	NN	O	jthe	dep	120	SENT_1	11/15
4	AAPS	NN	O	aap	dep	120	SENT_1	16/20
5	Journal1550-7416Springer	NN	O	journal1550-7416springer	dep	120	SENT_1	21/45
6	USBoston200581132844513916810	NN	O	usboston200581132844513916810	dep	120	SENT_1	46/75
7	.1208	CD	NUMBER	.1208	dep	120	SENT_1	75/80
8	/	:	O	/	dep	120	SENT_1	80/81
9	s12248-009-9168-2Research	JJ	O	s12248-009-9168-2research	dep	120	SENT_1	81/106
10	ArticleIntranasal	NNP	O	ArticleIntranasal	dep	120	SENT_1	107/124
11	Delivery	NN	O	delivery	dep	120	SENT_1	125/133
12	of	IN	O	of	dep	120	SENT_1	134/136
13	Influenza	NNP	O	Influenza	dep	120	SENT_1	137/146
14	Subunit	NN	O	subunit	dep	120	SENT_1	147/154
15	Vaccine	NNP	O	Vaccine	dep	120	SENT_1	155/162
16	Formulated	VBN	O	formulate	dep	120	SENT_1	163/173
17	with	IN	O	with	dep	120	SENT_1	174/178
18	GEM	NNP	ORGANIZATION	GEM	dep	120	SENT_1	179/182
19	Particles	NNPS	ORGANIZATION	Particles	dep	120	SENT_1	183/192
20	as	IN	O	as	dep	120	SENT_1	193/195
21	an	DT	O	a	dep	120	SENT_1	196/198
22	AdjuvantSalujaVinay+31-50-3633290+31-50-3632500v.saluja@rug.nlAmorijJean	JJ	O	adjuvantsalujavinay+31-50-3633290+31-50-3632500v.saluja@rug.nlamorijjean	dep	120	SENT_1	199/271
23	P.	NNP	PERSON	P.	dep	120	SENT_1	272/274
24	van	NNP	PERSON	van	dep	120	SENT_1	274/277
25	RoosmalenMaarten	NNP	PERSON	RoosmalenMaarten	dep	120	SENT_1	278/294
26	L.	NNP	PERSON	L.	dep	120	SENT_1	295/297
27	LeenhoutsKeesHuckriedeAnkeHinrichsWouter	NNP	PERSON	LeenhoutsKeesHuckriedeAnkeHinrichsWouter	dep	120	SENT_1	297/337
28	L.	NNP	PERSON	L.	dep	120	SENT_1	338/340
29	J.	NNP	PERSON	J.	dep	120	SENT_1	341/343
30	FrijlinkHenderik	NNP	PERSON	FrijlinkHenderik	dep	120	SENT_1	343/359
31	W.	NNP	ORGANIZATION	W.	dep	120	SENT_1	360/362
32	Department	NNP	ORGANIZATION	Department	dep	120	SENT_1	362/372
33	of	IN	ORGANIZATION	of	dep	120	SENT_1	373/375
34	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	dep	120	SENT_1	376/390
35	Technology	NNP	ORGANIZATION	Technology	dep	120	SENT_1	391/401
36	and	CC	O	and	dep	120	SENT_1	402/405
37	Biopharmacy	NNP	O	Biopharmacy	dep	120	SENT_1	406/417
38	,	,	O	,		-1	SENT_1	417/418
39	University	NNP	ORGANIZATION	University	dep	120	SENT_1	419/429
40	of	IN	ORGANIZATION	of	dep	120	SENT_1	430/432
41	Groningen	NNP	ORGANIZATION	Groningen	dep	120	SENT_1	433/442
42	,	,	O	,		-1	SENT_1	442/443
43	A.	NNP	PERSON	A.	dep	120	SENT_1	444/446
44	Deusinglaan	NNP	PERSON	Deusinglaan	dep	120	SENT_1	447/458
45	1	CD	NUMBER	1	dep	120	SENT_1	459/460
46	,	,	O	,		-1	SENT_1	460/461
47	9713	CD	NUMBER	9713	dep	120	SENT_1	462/466
48	AV	NNP	ORGANIZATION	AV	dep	120	SENT_1	467/469
49	Groningen	NNP	ORGANIZATION	Groningen	dep	120	SENT_1	470/479
50	,	,	O	,		-1	SENT_1	479/480
51	The	DT	LOCATION	the	dep	120	SENT_1	481/484
52	Netherlands	NNP	LOCATION	Netherlands	dep	120	SENT_1	485/496
53	Mucosis	NNP	ORGANIZATION	Mucosis	dep	120	SENT_1	497/504
54	BV	NN	ORGANIZATION	bv	dep	120	SENT_1	505/507
55	,	,	O	,		-1	SENT_1	507/508
56	Meditech	NNP	ORGANIZATION	Meditech	dep	120	SENT_1	509/517
57	Center	NNP	ORGANIZATION	Center	dep	120	SENT_1	518/524
58	,	,	O	,		-1	SENT_1	524/525
59	L.J.	NNP	PERSON	L.J.	dep	120	SENT_1	526/530
60	Zielstraweg	NNP	PERSON	Zielstraweg	dep	120	SENT_1	531/542
61	1	CD	NUMBER	1	dep	120	SENT_1	543/544
62	,	,	O	,		-1	SENT_1	544/545
63	9713	CD	NUMBER	9713	dep	120	SENT_1	546/550
64	GX	NNP	ORGANIZATION	GX	dep	120	SENT_1	551/553
65	Groningen	NNP	ORGANIZATION	Groningen	dep	120	SENT_1	554/563
66	,	,	O	,		-1	SENT_1	563/564
67	The	DT	O	the	dep	120	SENT_1	565/568
68	Netherlands	NNP	ORGANIZATION	Netherlands	dep	120	SENT_1	569/580
69	Department	NNP	ORGANIZATION	Department	dep	120	SENT_1	581/591
70	of	IN	ORGANIZATION	of	dep	120	SENT_1	592/594
71	Medical	NNP	ORGANIZATION	Medical	dep	120	SENT_1	595/602
72	Microbiology	NNP	ORGANIZATION	Microbiology	dep	120	SENT_1	603/615
73	,	,	O	,		-1	SENT_1	615/616
74	Molecular	JJ	O	molecular	dep	120	SENT_1	617/626
75	Virology	NNP	O	Virology	dep	120	SENT_1	627/635
76	Section	NNP	O	Section	dep	120	SENT_1	636/643
77	,	,	O	,		-1	SENT_1	643/644
78	University	NNP	ORGANIZATION	University	dep	120	SENT_1	645/655
79	Medical	NNP	ORGANIZATION	Medical	dep	120	SENT_1	656/663
80	Center	NNP	ORGANIZATION	Center	dep	120	SENT_1	664/670
81	Groningen	NNP	ORGANIZATION	Groningen	dep	120	SENT_1	671/680
82	,	,	O	,		-1	SENT_1	680/681
83	University	NNP	ORGANIZATION	University	dep	120	SENT_1	682/692
84	of	IN	ORGANIZATION	of	dep	120	SENT_1	693/695
85	Groningen	NNP	ORGANIZATION	Groningen	dep	120	SENT_1	696/705
86	,	,	O	,		-1	SENT_1	705/706
87	A.	NNP	PERSON	A.	dep	120	SENT_1	707/709
88	Deusinglaan	NNP	PERSON	Deusinglaan	dep	120	SENT_1	710/721
89	1	CD	NUMBER	1	dep	120	SENT_1	722/723
90	,	,	O	,		-1	SENT_1	723/724
91	9713	CD	NUMBER	9713	dep	120	SENT_1	725/729
92	AV	NNP	ORGANIZATION	AV	dep	120	SENT_1	730/732
93	Groningen	NNP	ORGANIZATION	Groningen	dep	120	SENT_1	733/742
94	,	,	O	,		-1	SENT_1	742/743
95	The	DT	O	the	dep	120	SENT_1	744/747
96	Netherlands	NNP	ORGANIZATION	Netherlands	dep	120	SENT_1	748/759
97	Research	NNP	ORGANIZATION	Research	dep	120	SENT_1	760/768
98	and	CC	ORGANIZATION	and	dep	120	SENT_1	769/772
99	Development	NNP	ORGANIZATION	Development	dep	120	SENT_1	773/784
100	Unit	NNP	ORGANIZATION	Unit	dep	120	SENT_1	785/789
101	,	,	O	,		-1	SENT_1	789/790
102	The	DT	O	the	dep	120	SENT_1	791/794
103	Netherlands	NNP	ORGANIZATION	Netherlands	dep	120	SENT_1	795/806
104	Vaccine	NNP	ORGANIZATION	Vaccine	dep	120	SENT_1	807/814
105	Institute	NNP	ORGANIZATION	Institute	dep	120	SENT_1	815/824
106	,	,	O	,		-1	SENT_1	824/825
107	Bilthoven	NNP	LOCATION	Bilthoven	dep	120	SENT_1	826/835
108	,	,	O	,		-1	SENT_1	835/836
109	The	DT	LOCATION	the	dep	120	SENT_1	837/840
110	Netherlands	NNP	LOCATION	Netherlands	dep	120	SENT_1	841/852
111	8120106201012210911611020097122009	CD	NUMBER	8120106201012210911611020097122009	dep	120	SENT_1	853/887
112	(	CD	NUMBER	(	dep	120	SENT_1	887/888
113	C	NN	O	c	dep	120	SENT_1	888/889
114	)	CD	NUMBER	)	dep	120	SENT_1	889/890
115	The	DT	O	the	dep	120	SENT_1	891/894
116	Author	NN	O	author	dep	120	SENT_1	895/901
117	(	NN	O	(	dep	120	SENT_1	901/902
118	s	VBZ	O	s	dep	120	SENT_1	902/903
119	)	CD	NUMBER	)	dep	120	SENT_1	903/904
120	2009	CD	DATE	2009		-1	SENT_1	905/909

1	Nasal	JJ	O	nasal	amod	2	SENT_2	926/931
2	administration	NN	O	administration	nsubj	6	SENT_2	932/946
3	of	IN	O	of		-1	SENT_2	947/949
4	influenza	NN	O	influenza	nn	5	SENT_2	950/959
5	vaccine	NN	O	vaccine	prep_of	2	SENT_2	960/967
6	has	VBZ	O	have		-1	SENT_2	968/971
7	the	DT	O	the	det	8	SENT_2	972/975
8	potential	JJ	O	potential	dobj	6	SENT_2	976/985
9	to	TO	O	to	aux	10	SENT_2	986/988
10	facilitate	VB	O	facilitate	dep	8	SENT_2	989/999
11	influenza	NN	O	influenza	nn	12	SENT_2	1000/1009
12	control	NN	O	control	dobj	10	SENT_2	1010/1017
13	and	CC	O	and		-1	SENT_2	1018/1021
14	prevention	NN	O	prevention	conj_and	12	SENT_2	1022/1032
15	.	.	O	.		-1	SENT_2	1032/1033

1	However	RB	O	however	advmod	15	SENT_3	1034/1041
2	,	,	O	,		-1	SENT_3	1041/1042
3	when	WRB	O	when	advmod	4	SENT_3	1043/1047
4	administered	VBN	O	administer	advcl	15	SENT_3	1048/1060
5	intranasally	RB	O	intranasally	advmod	4	SENT_3	1061/1073
6	(	CD	NUMBER	(	num	7	SENT_3	1074/1075
7	i.n.	NN	O	i.n.	dobj	4	SENT_3	1075/1079
8	)	JJ	O	)	amod	11	SENT_3	1079/1080
9	,	,	O	,		-1	SENT_3	1080/1081
10	commercially	RB	O	commercially	advmod	11	SENT_3	1082/1094
11	available	JJ	O	available	amod	7	SENT_3	1095/1104
12	inactivated	VBN	O	inactivate	partmod	7	SENT_3	1105/1116
13	vaccines	NNS	O	vaccine	nsubj	15	SENT_3	1117/1125
14	only	RB	O	only	advmod	15	SENT_3	1126/1130
15	generate	VBP	O	generate		-1	SENT_3	1131/1139
16	systemic	JJ	O	systemic	amod	20	SENT_3	1140/1148
17	and	CC	O	and		-1	SENT_3	1149/1152
18	mucosal	JJ	O	mucosal	conj_and	16	SENT_3	1153/1160
19	immune	JJ	O	immune	amod	20	SENT_3	1161/1167
20	responses	NNS	O	response	dobj	15	SENT_3	1168/1177
21	if	IN	O	if	mark	25	SENT_3	1178/1180
22	strong	JJ	O	strong	amod	23	SENT_3	1181/1187
23	adjuvants	NNS	O	adjuvant	nsubjpass	25	SENT_3	1188/1197
24	are	VBP	O	be	auxpass	25	SENT_3	1198/1201
25	used	VBN	O	use	dep	20	SENT_3	1202/1206
26	,	,	O	,		-1	SENT_3	1206/1207
27	which	WDT	O	which	nsubjpass	30	SENT_3	1208/1213
28	are	VBP	O	be	auxpass	30	SENT_3	1214/1217
29	often	RB	O	often	advmod	30	SENT_3	1218/1223
30	associated	VBN	O	associate	rcmod	20	SENT_3	1224/1234
31	with	IN	O	with		-1	SENT_3	1235/1239
32	safety	NN	O	safety	nn	33	SENT_3	1240/1246
33	problems	NNS	O	problem	prep_with	30	SENT_3	1247/1255
34	.	.	O	.		-1	SENT_3	1255/1256

1	We	PRP	O	we	nsubj	2	SENT_4	1257/1259
2	describe	VBP	O	describe		-1	SENT_4	1260/1268
3	the	DT	O	the	det	5	SENT_4	1269/1272
4	successful	JJ	O	successful	amod	5	SENT_4	1273/1283
5	use	NN	O	use	dobj	2	SENT_4	1284/1287
6	of	IN	O	of		-1	SENT_4	1288/1290
7	a	DT	O	a	det	12	SENT_4	1291/1292
8	safe	JJ	O	safe	amod	9	SENT_4	1293/1297
9	adjuvant	JJ	O	adjuvant	amod	12	SENT_4	1298/1306
10	Gram-positive	JJ	O	gram-positive	amod	12	SENT_4	1307/1320
11	enhancer	NN	O	enhancer	nn	12	SENT_4	1321/1329
12	matrix	NN	O	matrix	prep_of	5	SENT_4	1330/1336
13	(	JJ	O	(	amod	16	SENT_4	1337/1338
14	GEM	NN	O	gem	nn	16	SENT_4	1338/1341
15	)	NN	O	)	nn	16	SENT_4	1341/1342
16	particles	NNS	O	particle	dep	12	SENT_4	1343/1352
17	derived	VBN	O	derive	partmod	16	SENT_4	1353/1360
18	from	IN	O	from		-1	SENT_4	1361/1365
19	the	DT	O	the	det	20	SENT_4	1366/1369
20	food	NN	O	food	prep_from	17	SENT_4	1370/1374
21	-	:	O	-		-1	SENT_4	1374/1375
22	grade	NN	O	grade	nn	25	SENT_4	1376/1381
23	bacterium	NN	O	bacterium	nn	25	SENT_4	1382/1391
24	Lactococcus	NN	O	lactococcus	nn	25	SENT_4	1392/1403
25	lactis	NN	O	lacti	dep	16	SENT_4	1404/1410
26	for	IN	O	for		-1	SENT_4	1411/1414
27	i.n.	NN	O	i.n.	nn	28	SENT_4	1415/1419
28	vaccination	NN	O	vaccination	prep_for	25	SENT_4	1420/1431
29	with	IN	O	with		-1	SENT_4	1432/1436
30	subunit	NN	O	subunit	nn	32	SENT_4	1437/1444
31	influenza	NN	O	influenza	nn	32	SENT_4	1445/1454
32	vaccine	NN	O	vaccine	prep_with	28	SENT_4	1455/1462
33	in	IN	O	in		-1	SENT_4	1463/1465
34	mice	NNS	O	mouse	prep_in	32	SENT_4	1466/1470
35	.	.	O	.		-1	SENT_4	1470/1471

1	It	PRP	O	it	nsubjpass	3	SENT_5	1472/1474
2	is	VBZ	O	be	auxpass	3	SENT_5	1475/1477
3	shown	VBN	O	show		-1	SENT_5	1478/1483
4	that	IN	O	that	mark	14	SENT_5	1484/1488
5	simple	JJ	O	simple	amod	6	SENT_5	1489/1495
6	admixing	NN	O	admixing	nsubj	14	SENT_5	1496/1504
7	of	IN	O	of		-1	SENT_5	1505/1507
8	the	DT	O	the	det	9	SENT_5	1508/1511
9	vaccine	NN	O	vaccine	prep_of	6	SENT_5	1512/1519
10	with	IN	O	with		-1	SENT_5	1520/1524
11	the	DT	O	the	det	13	SENT_5	1525/1528
12	GEM	NN	O	gem	nn	13	SENT_5	1529/1532
13	particles	NNS	O	particle	prep_with	9	SENT_5	1533/1542
14	results	VBZ	O	result	ccomp	3	SENT_5	1543/1550
15	in	IN	O	in		-1	SENT_5	1551/1553
16	a	DT	O	a	det	20	SENT_5	1554/1555
17	strongly	RB	O	strongly	advmod	18	SENT_5	1556/1564
18	enhanced	VBN	O	enhance	amod	20	SENT_5	1565/1573
19	immune	JJ	O	immune	amod	20	SENT_5	1574/1580
20	response	NN	O	response	prep_in	14	SENT_5	1581/1589
21	.	.	O	.		-1	SENT_5	1589/1590

1	Already	RB	O	already	advmod	12	SENT_6	1591/1598
2	after	IN	O	after		-1	SENT_6	1599/1604
3	one	CD	NUMBER	one	num	4	SENT_6	1605/1608
4	booster	NN	O	booster	prep_after	12	SENT_6	1609/1616
5	,	,	O	,		-1	SENT_6	1616/1617
6	the	DT	O	the	det	7	SENT_6	1618/1621
7	i.n.	NN	O	i.n.	nsubj	12	SENT_6	1622/1626
8	delivered	VBN	O	deliver	partmod	7	SENT_6	1627/1636
9	GEM	NN	O	gem	nn	11	SENT_6	1637/1640
10	subunit	NN	O	subunit	nn	11	SENT_6	1641/1648
11	vaccine	NN	O	vaccine	dobj	8	SENT_6	1649/1656
12	resulted	VBD	O	result		-1	SENT_6	1657/1665
13	in	IN	O	in		-1	SENT_6	1666/1668
14	hemagglutination	NN	O	hemagglutination	nn	16	SENT_6	1669/1685
15	inhibition	NN	O	inhibition	nn	16	SENT_6	1686/1696
16	titers	NNS	O	titer	prep_in	12	SENT_6	1697/1703
17	in	IN	O	in		-1	SENT_6	1704/1706
18	serum	NN	O	serum	prep_in	16	SENT_6	1707/1712
19	at	IN	O	at		-1	SENT_6	1713/1715
20	a	DT	O	a	det	21	SENT_6	1716/1717
21	level	NN	O	level	prep_at	12	SENT_6	1718/1723
22	equal	JJ	O	equal	amod	21	SENT_6	1724/1729
23	to	TO	O	to		-1	SENT_6	1730/1732
24	the	DT	O	the	det	30	SENT_6	1733/1736
25	conventional	JJ	O	conventional	amod	30	SENT_6	1737/1749
26	intramuscular	JJ	O	intramuscular	amod	30	SENT_6	1750/1763
27	(	NN	O	(	nn	30	SENT_6	1764/1765
28	i.m.	NN	O	i.m.	nn	30	SENT_6	1765/1769
29	)	CD	NUMBER	)	num	30	SENT_6	1769/1770
30	route	NN	O	route	prep_to	22	SENT_6	1771/1776
31	.	.	O	.		-1	SENT_6	1776/1777

1	Moreover	RB	O	moreover	advmod	9	SENT_7	1778/1786
2	,	,	O	,		-1	SENT_7	1786/1787
3	i.n.	NN	O	i.n.	nn	4	SENT_7	1788/1792
4	immunization	NN	O	immunization	nsubj	9	SENT_7	1793/1805
5	with	IN	O	with		-1	SENT_7	1806/1810
6	GEM	NN	O	gem	nn	8	SENT_7	1811/1814
7	subunit	NN	O	subunit	nn	8	SENT_7	1815/1822
8	vaccine	NN	O	vaccine	prep_with	4	SENT_7	1823/1830
9	elicited	VBD	O	elicit		-1	SENT_7	1831/1839
10	superior	JJ	O	superior	amod	11	SENT_7	1840/1848
11	mucosal	JJ	O	mucosal	dobj	9	SENT_7	1849/1856
12	and	CC	O	and		-1	SENT_7	1857/1860
13	Th1	NN	O	th1	nn	16	SENT_7	1861/1864
14	skewed	JJ	O	skewed	amod	15	SENT_7	1865/1871
15	immune	JJ	O	immune	amod	16	SENT_7	1872/1878
16	responses	NNS	O	response	conj_and	11	SENT_7	1879/1888
17	compared	VBN	O	compare		-1	SENT_7	1889/1897
18	to	TO	O	to	prepc_compared_to	11	SENT_7	1898/1900
19	those	DT	O	those	pobj	11	SENT_7	1901/1906
20	induced	VBN	O	induce	partmod	19	SENT_7	1907/1914
21	by	IN	O	by		-1	SENT_7	1915/1917
22	i.m.	NN	O	i.m.	agent	20	SENT_7	1918/1922
23	and	CC	O	and		-1	SENT_7	1923/1926
24	i.n.	NN	O	i.n.	conj_and	22	SENT_7	1927/1931
25	administered	VBN	O	administer	partmod	22	SENT_7	1932/1944
26	subunit	NN	O	subunit	nn	27	SENT_7	1945/1952
27	vaccine	NN	O	vaccine	dobj	25	SENT_7	1953/1960
28	alone	RB	O	alone	advmod	25	SENT_7	1961/1966
29	.	.	O	.		-1	SENT_7	1966/1967

1	In	IN	O	in		-1	SENT_8	1968/1970
2	conclusion	NN	O	conclusion	prep_in	6	SENT_8	1971/1981
3	,	,	O	,		-1	SENT_8	1981/1982
4	GEM	NN	O	gem	nn	5	SENT_8	1983/1986
5	particles	NNS	O	particle	nsubj	6	SENT_8	1987/1996
6	act	VBP	O	act		-1	SENT_8	1997/2000
7	as	IN	O	as		-1	SENT_8	2001/2003
8	a	DT	O	a	det	14	SENT_8	2004/2005
9	potent	JJ	O	potent	amod	14	SENT_8	2006/2012
10	adjuvant	JJ	O	adjuvant	amod	14	SENT_8	2013/2021
11	for	IN	O	for		-1	SENT_8	2022/2025
12	i.n.	NN	O	i.n.	nn	13	SENT_8	2026/2030
13	influenza	NN	O	influenza	prep_for	10	SENT_8	2031/2040
14	immunization	NN	O	immunization	prep_as	6	SENT_8	2041/2053
15	.	.	O	.		-1	SENT_8	2053/2054

1	Key	NN	O	key	nn	2	SENT_9	2090/2093
2	words	NNS	O	word		-1	SENT_9	2094/2099

1	influenza	NN	O	influenza	nn	2	SENT_10	2116/2125
2	vaccineintranasal	NN	O	vaccineintranasal		-1	SENT_10	2126/2143
3	vaccineLactococcus	NN	O	vaccinelactococcus	nn	6	SENT_10	2144/2162
4	lactis	NN	O	lacti	nn	6	SENT_10	2163/2169
5	GEM	NN	O	gem	nn	6	SENT_10	2170/2173
6	particlesissue	NN	O	particlesissue	dep	2	SENT_10	2174/2188
7	-	:	O	-		-1	SENT_10	2188/2189
8	copyright-statement	NN	O	copyright-statement	dep	13	SENT_10	2190/2209
9	(	NN	O	(	dep	8	SENT_10	2209/2210
10	C	NN	O	c	dep	13	SENT_10	2210/2211
11	)	CD	NUMBER	)	num	10	SENT_10	2211/2212
12	American	NNP	O	American	nn	13	SENT_10	2213/2221
13	Association	NNP	O	Association	dep	17	SENT_10	2222/2233
14	of	IN	O	of		-1	SENT_10	2234/2236
15	Pharmaceutical	NNP	O	Pharmaceutical	nn	16	SENT_10	2237/2251
16	Scientists	NNS	O	scientist	prep_of	13	SENT_10	2252/2262
17	2010	CD	DATE	2010	dep	2	SENT_10	2263/2267

1	INTRODUCTION	NN	O	introduction		-1	SENT_11	2284/2296

1	Seasonal	JJ	O	seasonal	amod	2	SENT_12	2332/2340
2	influenza	NN	O	influenza	nsubj	5	SENT_12	2341/2350
3	is	VBZ	O	be	cop	5	SENT_12	2351/2353
4	still	RB	O	still	advmod	5	SENT_12	2354/2359
5	one	CD	NUMBER	one		-1	SENT_12	2360/2363
6	of	IN	O	of		-1	SENT_12	2364/2366
7	the	DT	O	the	det	9	SENT_12	2367/2370
8	major	JJ	O	major	amod	9	SENT_12	2371/2376
9	causes	NNS	O	cause	prep_of	5	SENT_12	2377/2383
10	for	IN	O	for		-1	SENT_12	2384/2387
11	mortality	NN	O	mortality	prep_for	9	SENT_12	2388/2397
12	and	CC	O	and		-1	SENT_12	2398/2401
13	morbidity	NN	O	morbidity	nn	15	SENT_12	2402/2411
14	worldwide	JJ	O	worldwide	amod	15	SENT_12	2412/2421
15	(	NN	O	(	conj_and	9	SENT_12	2422/2423
16	1	CD	NUMBER	1	num	17	SENT_12	2423/2424
17	)	NN	O	)	dep	15	SENT_12	2424/2425
18	.	.	O	.		-1	SENT_12	2425/2426

1	Annual	JJ	SET	annual	amod	2	SENT_13	2427/2433
2	vaccinations	NNS	O	vaccination	nsubj	7	SENT_13	2434/2446
3	are	VBP	O	be	cop	7	SENT_13	2447/2450
4	the	DT	O	the	det	7	SENT_13	2451/2454
5	most	RBS	O	most	advmod	6	SENT_13	2455/2459
6	effective	JJ	O	effective	amod	7	SENT_13	2460/2469
7	strategy	NN	O	strategy		-1	SENT_13	2470/2478
8	to	TO	O	to	aux	9	SENT_13	2479/2481
9	prevent	VB	O	prevent	infmod	7	SENT_13	2482/2489
10	and	CC	O	and		-1	SENT_13	2490/2493
11	control	VB	O	control	conj_and	9	SENT_13	2494/2501
12	influenza	NN	O	influenza	nn	13	SENT_13	2502/2511
13	infections	NNS	O	infection	dobj	9	SENT_13	2512/2522
14	(	VBP	O	(	rcmod	13	SENT_13	2523/2524
15	2,3	CD	NUMBER	2,3	number	16	SENT_13	2524/2527
16	)	CD	NUMBER	)	dobj	14	SENT_13	2527/2528
17	.	.	O	.		-1	SENT_13	2528/2529

1	Most	JJS	O	most	nsubjpass	8	SENT_14	2530/2534
2	of	IN	O	of		-1	SENT_14	2535/2537
3	the	DT	O	the	det	6	SENT_14	2538/2541
4	available	JJ	O	available	amod	6	SENT_14	2542/2551
5	influenza	NN	O	influenza	nn	6	SENT_14	2552/2561
6	vaccines	NNS	O	vaccine	prep_of	1	SENT_14	2562/2570
7	are	VBP	O	be	auxpass	8	SENT_14	2571/2574
8	administered	VBN	O	administer		-1	SENT_14	2575/2587
9	via	IN	O	via		-1	SENT_14	2588/2591
10	the	DT	O	the	det	12	SENT_14	2592/2595
11	intramuscular	JJ	O	intramuscular	amod	12	SENT_14	2596/2609
12	(	NN	O	(	prep_via	8	SENT_14	2610/2611
13	i.m.	NN	O	i.m.	dep	12	SENT_14	2611/2615
14	)	CD	NUMBER	)	num	13	SENT_14	2615/2616
15	or	CC	O	or		-1	SENT_14	2617/2619
16	subcutaneous	JJ	O	subcutaneous	conj_or	13	SENT_14	2620/2632
17	route	NN	O	route	advmod	8	SENT_14	2633/2638
18	.	.	O	.		-1	SENT_14	2638/2639

1	These	DT	O	these	det	3	SENT_15	2640/2645
2	parenteral	JJ	O	parenteral	amod	3	SENT_15	2646/2656
3	vaccines	NNS	O	vaccine	nsubj	4	SENT_15	2657/2665
4	induce	VBP	O	induce		-1	SENT_15	2666/2672
5	good	JJ	O	good	amod	8	SENT_15	2673/2677
6	systemic	JJ	O	systemic	amod	8	SENT_15	2678/2686
7	immune	JJ	O	immune	amod	8	SENT_15	2687/2693
8	response	NN	O	response	dobj	4	SENT_15	2694/2702
9	but	CC	O	but	prep	8	SENT_15	2703/2706
10	no	DT	O	no	det	16	SENT_15	2707/2709
11	mucosal	JJ	O	mucosal	amod	12	SENT_15	2710/2717
12	immune	JJ	O	immune	amod	16	SENT_15	2718/2724
13	response	NN	O	response	nn	16	SENT_15	2725/2733
14	(	NN	O	(	nn	16	SENT_15	2734/2735
15	3-5	CD	NUMBER	3-5	num	16	SENT_15	2735/2738
16	)	NN	O	)	dep	9	SENT_15	2738/2739
17	,	,	O	,		-1	SENT_15	2739/2740
18	which	WDT	O	which	nsubj	19	SENT_15	2741/2746
19	limits	VBZ	O	limit	rcmod	16	SENT_15	2747/2753
20	their	PRP$	O	they	poss	22	SENT_15	2754/2759
21	protective	JJ	O	protective	amod	22	SENT_15	2760/2770
22	efficacy	NN	O	efficacy	dobj	19	SENT_15	2771/2779
23	.	.	O	.		-1	SENT_15	2779/2780

1	In	IN	O	in		-1	SENT_16	2781/2783
2	contrast	NN	O	contrast	prep_in	17	SENT_16	2784/2792
3	,	,	O	,		-1	SENT_16	2792/2793
4	intranasal	JJ	O	intranasal	amod	6	SENT_16	2794/2804
5	(	NN	O	(	nn	6	SENT_16	2805/2806
6	i.n.	NN	O	i.n.	nsubj	17	SENT_16	2806/2810
7	)	JJ	O	)	amod	8	SENT_16	2810/2811
8	vaccines	NNS	O	vaccine	nsubj	10	SENT_16	2812/2820
9	may	MD	O	may	aux	10	SENT_16	2821/2824
10	induce	VB	O	induce	rcmod	6	SENT_16	2825/2831
11	both	DT	O	both	preconj	12	SENT_16	2832/2836
12	systemic	JJ	O	systemic	amod	16	SENT_16	2837/2845
13	and	CC	O	and		-1	SENT_16	2846/2849
14	mucosal	JJ	O	mucosal	conj_and	12	SENT_16	2850/2857
15	immune	JJ	O	immune	amod	16	SENT_16	2858/2864
16	responses	NNS	O	response	dobj	10	SENT_16	2865/2874
17	(	VBP	O	(		-1	SENT_16	2875/2876
18	6-9	CD	NUMBER	6-9	num	19	SENT_16	2876/2879
19	)	CD	NUMBER	)	dobj	17	SENT_16	2879/2880
20	.	.	O	.		-1	SENT_16	2880/2881

1	In	IN	O	in		-1	SENT_17	2882/2884
2	addition	NN	O	addition	prep_in	11	SENT_17	2885/2893
3	,	,	O	,		-1	SENT_17	2893/2894
4	i.n.	NN	O	i.n.	nn	5	SENT_17	2895/2899
5	delivery	NN	O	delivery	nsubj	11	SENT_17	2900/2908
6	of	IN	O	of		-1	SENT_17	2909/2911
7	the	DT	O	the	det	8	SENT_17	2912/2915
8	vaccine	NN	O	vaccine	prep_of	5	SENT_17	2916/2923
9	does	VBZ	O	do	aux	11	SENT_17	2924/2928
10	not	RB	O	not	neg	11	SENT_17	2929/2932
11	require	VB	O	require		-1	SENT_17	2933/2940
12	trained	JJ	O	trained	dep	13	SENT_17	2941/2948
13	health	NN	O	health	amod	15	SENT_17	2949/2955
14	care	NN	O	care	nn	15	SENT_17	2956/2960
15	personnel	NNS	O	personnel	dobj	11	SENT_17	2961/2970
16	for	IN	O	for		-1	SENT_17	2971/2974
17	the	DT	O	the	det	18	SENT_17	2975/2978
18	administration	NN	O	administration	prep_for	11	SENT_17	2979/2993
19	of	IN	O	of		-1	SENT_17	2994/2996
20	vaccine	NN	O	vaccine	prep_of	18	SENT_17	2997/3004
21	,	,	O	,		-1	SENT_17	3004/3005
22	is	VBZ	O	be	cop	23	SENT_17	3006/3008
23	suitable	JJ	O	suitable	conj_and	11	SENT_17	3009/3017
24	for	IN	O	for		-1	SENT_17	3018/3021
25	people	NNS	O	people	prep_for	23	SENT_17	3022/3028
26	with	IN	O	with		-1	SENT_17	3029/3033
27	needle	NN	O	needle	nn	28	SENT_17	3034/3040
28	phobia	NN	O	phobia	prep_with	25	SENT_17	3041/3047
29	,	,	O	,		-1	SENT_17	3047/3048
30	and	CC	O	and		-1	SENT_17	3049/3052
31	circumvents	VBZ	O	circumvent	conj_and	11	SENT_17	3053/3064
32	the	DT	O	the	det	33	SENT_17	3065/3068
33	problem	NN	O	problem	nsubj	37	SENT_17	3069/3076
34	of	IN	O	of		-1	SENT_17	3077/3079
35	needlestick	NN	O	needlestick	nn	36	SENT_17	3080/3091
36	injuries	NNS	O	injury	prep_of	33	SENT_17	3092/3100
37	(	VBP	O	(	ccomp	31	SENT_17	3101/3102
38	10	CD	NUMBER	10	number	39	SENT_17	3102/3104
39	)	CD	NUMBER	)	dobj	37	SENT_17	3104/3105
40	.	.	O	.		-1	SENT_17	3105/3106

1	A	DT	O	a	det	4	SENT_18	3142/3143
2	mucosal	JJ	O	mucosal	amod	4	SENT_18	3144/3151
3	immune	JJ	O	immune	amod	4	SENT_18	3152/3158
4	response	NN	O	response	nsubj	6	SENT_18	3159/3167
5	is	VBZ	O	be	cop	6	SENT_18	3168/3170
6	necessary	JJ	O	necessary		-1	SENT_18	3171/3180
7	for	IN	O	for		-1	SENT_18	3181/3184
8	the	DT	O	the	det	9	SENT_18	3185/3188
9	protection	NN	O	protection	prep_for	6	SENT_18	3189/3199
10	of	IN	O	of		-1	SENT_18	3200/3202
11	the	DT	O	the	det	14	SENT_18	3203/3206
12	upper	JJ	O	upper	amod	14	SENT_18	3207/3212
13	respiratory	JJ	O	respiratory	amod	14	SENT_18	3213/3224
14	tract	NN	O	tract	prep_of	9	SENT_18	3225/3230
15	,	,	O	,		-1	SENT_18	3230/3231
16	i.e.	FW	O	i.e.	dep	9	SENT_18	3232/3236
17	,	,	O	,		-1	SENT_18	3236/3237
18	the	DT	O	the	det	19	SENT_18	3238/3241
19	port	NN	O	port	appos	9	SENT_18	3242/3246
20	of	IN	O	of		-1	SENT_18	3247/3249
21	entry	NN	O	entry	prep_of	19	SENT_18	3250/3255
22	for	IN	O	for		-1	SENT_18	3256/3259
23	influenza	NN	O	influenza	nn	24	SENT_18	3260/3269
24	virus	NN	O	virus	prep_for	21	SENT_18	3270/3275
25	(	CD	NUMBER	(	number	26	SENT_18	3276/3277
26	6,11	CD	NUMBER	6,11	num	27	SENT_18	3277/3281
27	)	NN	O	)	dep	19	SENT_18	3281/3282
28	.	.	O	.		-1	SENT_18	3282/3283

1	The	DT	O	the	det	2	SENT_19	3284/3287
2	protection	NN	O	protection	nsubjpass	10	SENT_19	3288/3298
3	of	IN	O	of		-1	SENT_19	3299/3301
4	the	DT	O	the	det	7	SENT_19	3302/3305
5	upper	JJ	O	upper	amod	7	SENT_19	3306/3311
6	respiratory	JJ	O	respiratory	amod	7	SENT_19	3312/3323
7	tract	NN	O	tract	prep_of	2	SENT_19	3324/3329
8	is	VBZ	O	be	auxpass	10	SENT_19	3330/3332
9	mainly	RB	O	mainly	advmod	10	SENT_19	3333/3339
10	provided	VBN	O	provide		-1	SENT_19	3340/3348
11	by	IN	O	by		-1	SENT_19	3349/3351
12	sIgA	NN	O	siga	agent	10	SENT_19	3352/3356
13	(	CD	NUMBER	(	number	14	SENT_19	3357/3358
14	3,6,12	CD	NUMBER	3,6,12	num	15	SENT_19	3358/3364
15	)	NN	O	)	dep	10	SENT_19	3364/3365
16	.	.	O	.		-1	SENT_19	3365/3366

1	Moreover	RB	O	moreover	advmod	5	SENT_20	3367/3375
2	,	,	O	,		-1	SENT_20	3375/3376
3	sIgA	NN	O	siga	nsubjpass	5	SENT_20	3377/3381
4	is	VBZ	O	be	auxpass	5	SENT_20	3382/3384
5	known	VBN	O	know		-1	SENT_20	3385/3390
6	to	TO	O	to	aux	7	SENT_20	3391/3393
7	induce	VB	O	induce	xcomp	5	SENT_20	3394/3400
8	cross-protection	NN	O	cross-protection	dobj	7	SENT_20	3401/3417
9	against	IN	O	against		-1	SENT_20	3418/3425
10	variant	JJ	O	variant	amod	11	SENT_20	3426/3433
11	viruses	NNS	O	virus	prep_against	8	SENT_20	3434/3441
12	within	IN	O	within		-1	SENT_20	3442/3448
13	the	DT	O	the	det	15	SENT_20	3449/3452
14	same	JJ	O	same	amod	15	SENT_20	3453/3457
15	subtype	NN	O	subtype	prep_within	7	SENT_20	3458/3465
16	and	CC	O	and		-1	SENT_20	3466/3469
17	also	RB	O	also	advmod	5	SENT_20	3470/3474
18	increase	VBP	O	increase	conj_and	5	SENT_20	3475/3483
19	the	DT	O	the	det	20	SENT_20	3484/3487
20	protection	NN	O	protection	nsubj	26	SENT_20	3488/3498
21	during	IN	O	during		-1	SENT_20	3499/3505
22	epidemics	NNS	O	epidemic	prep_during	20	SENT_20	3506/3515
23	of	IN	O	of		-1	SENT_20	3516/3518
24	heterologous	JJ	O	heterologous	amod	25	SENT_20	3519/3531
25	viruses	NNS	O	virus	prep_of	22	SENT_20	3532/3539
26	(	VBP	O	(	ccomp	18	SENT_20	3540/3541
27	6,13-18	CD	NUMBER	6,13-18	num	28	SENT_20	3541/3548
28	)	CD	NUMBER	)	dobj	26	SENT_20	3548/3549
29	.	.	O	.		-1	SENT_20	3549/3550

1	Furthermore	RB	O	furthermore	advmod	5	SENT_21	3551/3562
2	,	,	O	,		-1	SENT_21	3562/3563
3	it	PRP	O	it	nsubjpass	5	SENT_21	3564/3566
4	is	VBZ	O	be	auxpass	5	SENT_21	3567/3569
5	reported	VBN	O	report		-1	SENT_21	3570/3578
6	that	IN	O	that	mark	11	SENT_21	3579/3583
7	the	DT	O	the	det	10	SENT_21	3584/3587
8	mucosal	JJ	O	mucosal	amod	10	SENT_21	3588/3595
9	immune	JJ	O	immune	amod	10	SENT_21	3596/3602
10	system	NN	O	system	nsubj	11	SENT_21	3603/3609
11	develops	VBZ	O	develop	ccomp	5	SENT_21	3610/3618
12	early	RB	O	early	advmod	11	SENT_21	3619/3624
13	in	IN	O	in		-1	SENT_21	3625/3627
14	life	NN	O	life	prep_in	11	SENT_21	3628/3632
15	and	CC	O	and		-1	SENT_21	3633/3636
16	is	VBZ	O	be	auxpass	18	SENT_21	3637/3639
17	not	RB	O	not	neg	18	SENT_21	3640/3643
18	affected	VBN	O	affect	conj_and	11	SENT_21	3644/3652
19	by	IN	O	by		-1	SENT_21	3653/3655
20	aging	VBG	O	age	agent	18	SENT_21	3656/3661
21	(	CD	NUMBER	(	number	22	SENT_21	3662/3663
22	19,20	CD	NUMBER	19,20	num	23	SENT_21	3663/3668
23	)	NN	O	)	dobj	20	SENT_21	3668/3669
24	.	.	O	.		-1	SENT_21	3669/3670

1	Therefore	RB	O	therefore	advmod	10	SENT_22	3671/3680
2	,	,	O	,		-1	SENT_22	3680/3681
3	a	DT	O	a	det	5	SENT_22	3682/3683
4	concomitant	JJ	O	concomitant	amod	5	SENT_22	3684/3695
5	advantage	NN	O	advantage	nsubj	10	SENT_22	3696/3705
6	of	IN	O	of		-1	SENT_22	3706/3708
7	i.n.	NN	O	i.n.	nn	9	SENT_22	3709/3713
8	influenza	NN	O	influenza	nn	9	SENT_22	3714/3723
9	immunization	NN	O	immunization	prep_of	5	SENT_22	3724/3736
10	is	VBZ	O	be		-1	SENT_22	3737/3739
11	that	IN	O	that	mark	15	SENT_22	3740/3744
12	it	PRP	O	it	nsubj	15	SENT_22	3745/3747
13	can	MD	O	can	aux	15	SENT_22	3748/3751
14	potentially	RB	O	potentially	advmod	15	SENT_22	3752/3763
15	provide	VB	O	provide	ccomp	10	SENT_22	3764/3771
16	effective	JJ	O	effective	amod	17	SENT_22	3772/3781
17	immunity	NN	O	immunity	dobj	15	SENT_22	3782/3790
18	in	IN	O	in		-1	SENT_22	3791/3793
19	all	DT	O	all	det	21	SENT_22	3794/3797
20	age	NN	O	age	nn	21	SENT_22	3798/3801
21	groups	NNS	O	group	prep_in	15	SENT_22	3802/3808
22	and	CC	O	and		-1	SENT_22	3809/3812
23	can	MD	O	can	aux	25	SENT_22	3813/3816
24	be	VB	O	be	auxpass	25	SENT_22	3817/3819
25	used	VBN	O	use	conj_and	15	SENT_22	3820/3824
26	for	IN	O	for		-1	SENT_22	3825/3828
27	mass	NN	O	mass	nn	28	SENT_22	3829/3833
28	vaccination	NN	O	vaccination	prep_for	25	SENT_22	3834/3845
29	.	.	O	.		-1	SENT_22	3845/3846

1	Currently	RB	DATE	currently	advmod	3	SENT_23	3882/3891
2	,	,	O	,		-1	SENT_23	3891/3892
3	live	VBP	O	live		-1	SENT_23	3893/3897
4	attenuated	VBN	O	attenuate	dep	3	SENT_23	3898/3908
5	influenza	NN	O	influenza	nn	7	SENT_23	3909/3918
6	virus	NN	O	virus	nn	7	SENT_23	3919/3924
7	vaccines	NNS	O	vaccine	nsubj	8	SENT_23	3925/3933
8	(	VBP	O	(	ccomp	4	SENT_23	3934/3935
9	LAIV	NN	O	laiv	nn	10	SENT_23	3935/3939
10	)	NN	O	)	nsubjpass	12	SENT_23	3939/3940
11	are	VBP	O	be	auxpass	12	SENT_23	3941/3944
12	marketed	VBN	O	market	ccomp	8	SENT_23	3945/3953
13	for	IN	O	for		-1	SENT_23	3954/3957
14	i.n.	NNP	O	i.n.	nn	15	SENT_23	3958/3962
15	administration	NN	O	administration	prep_for	12	SENT_23	3963/3977
16	.	.	O	.		-1	SENT_23	3977/3978

1	LAIV	NN	ORGANIZATION	laiv	nn	2	SENT_24	3979/3983
2	vaccines	NNS	O	vaccine	nsubj	4	SENT_24	3984/3992
3	have	VBP	O	have	aux	4	SENT_24	3993/3997
4	shown	VBN	O	show		-1	SENT_24	3998/4003
5	to	TO	O	to	aux	6	SENT_24	4004/4006
6	induce	VB	O	induce	xcomp	4	SENT_24	4007/4013
7	both	CC	O	both	preconj	8	SENT_24	4014/4018
8	systemic	JJ	O	systemic	amod	12	SENT_24	4019/4027
9	and	CC	O	and		-1	SENT_24	4028/4031
10	mucosal	JJ	O	mucosal	conj_and	8	SENT_24	4032/4039
11	immune	JJ	O	immune	amod	12	SENT_24	4040/4046
12	responses	NNS	O	response	dobj	6	SENT_24	4047/4056
13	.	.	O	.		-1	SENT_24	4056/4057

1	However	RB	O	however	advmod	6	SENT_25	4058/4065
2	,	,	O	,		-1	SENT_25	4065/4066
3	LAIV	NN	O	laiv	nn	4	SENT_25	4067/4071
4	vaccine	NN	O	vaccine	nsubjpass	6	SENT_25	4072/4079
5	is	VBZ	O	be	auxpass	6	SENT_25	4080/4082
6	licensed	VBN	O	license		-1	SENT_25	4083/4091
7	by	IN	O	by	prep	6	SENT_25	4092/4094
8	the	DT	O	the	det	12	SENT_25	4095/4098
9	Food	NNP	ORGANIZATION	Food	nn	12	SENT_25	4099/4103
10	and	CC	ORGANIZATION	and		-1	SENT_25	4104/4107
11	Drug	NNP	ORGANIZATION	Drug	conj_and	9	SENT_25	4108/4112
12	Administration	NNP	ORGANIZATION	Administration	pobj	7	SENT_25	4113/4127
13	only	RB	O	only	dep	7	SENT_25	4128/4132
14	for	IN	O	for	dep	7	SENT_25	4133/4136
15	persons	NNS	O	person	pobj	14	SENT_25	4137/4144
16	aged	JJ	O	aged	amod	15	SENT_25	4145/4149
17	2-49	CD	NUMBER	2-49	num	18	SENT_25	4150/4154
18	years	NNS	NUMBER	year	tmod	16	SENT_25	4155/4160
19	but	CC	O	but		-1	SENT_25	4161/4164
20	not	RB	O	not	conj_but	7	SENT_25	4165/4168
21	for	IN	O	for	dep	7	SENT_25	4169/4172
22	use	NN	O	use	pobj	21	SENT_25	4173/4176
23	in	IN	O	in		-1	SENT_25	4177/4179
24	high	JJ	O	high	prep_in	6	SENT_25	4180/4184
25	-	:	O	-		-1	SENT_25	4184/4185
26	risk	NN	O	risk	nn	27	SENT_25	4186/4190
27	populations	NNS	O	population	dep	24	SENT_25	4191/4202
28	(	CD	NUMBER	(	npadvmod	29	SENT_25	4203/4204
29	elderly	JJ	O	elderly	amod	27	SENT_25	4204/4211
30	,	,	O	,		-1	SENT_25	4211/4212
31	children	NNS	O	child	appos	27	SENT_25	4213/4221
32	,	,	O	,		-1	SENT_25	4221/4222
33	and	CC	O	and		-1	SENT_25	4223/4226
34	chronically	RB	O	chronically	advmod	35	SENT_25	4227/4238
35	ill	JJ	O	ill	amod	36	SENT_25	4239/4242
36	patients	NNS	O	patient	conj_and	27	SENT_25	4243/4251
37	)	IN	O	)		-1	SENT_25	4251/4252
38	(	CD	NUMBER	(	number	39	SENT_25	4253/4254
39	21,22	CD	NUMBER	21,22	num	40	SENT_25	4254/4259
40	)	NN	O	)	prep_)	6	SENT_25	4259/4260
41	.	.	O	.		-1	SENT_25	4260/4261

1	However	RB	O	however	advmod	10	SENT_26	4262/4269
2	,	,	O	,		-1	SENT_26	4269/4270
3	most	JJS	O	most	nsubjpass	10	SENT_26	4271/4275
4	of	IN	O	of		-1	SENT_26	4276/4278
5	the	DT	O	the	det	8	SENT_26	4279/4282
6	marketed	VBN	O	market	amod	8	SENT_26	4283/4291
7	influenza	NN	O	influenza	nn	8	SENT_26	4292/4301
8	vaccines	NNS	O	vaccine	prep_of	3	SENT_26	4302/4310
9	are	VBP	O	be	auxpass	10	SENT_26	4311/4314
10	inactivated	VBN	O	inactivate		-1	SENT_26	4315/4326
11	vaccines	NNS	O	vaccine	dobj	10	SENT_26	4327/4335
12	which	WDT	O	which	nsubjpass	15	SENT_26	4336/4341
13	can	MD	O	can	aux	15	SENT_26	4342/4345
14	be	VB	O	be	auxpass	15	SENT_26	4346/4348
15	administered	VBN	O	administer	rcmod	11	SENT_26	4349/4361
16	safely	RB	O	safely	advmod	15	SENT_26	4362/4368
17	via	IN	O	via		-1	SENT_26	4369/4372
18	i.n.	NNP	O	i.n.	nn	19	SENT_26	4373/4377
19	route	NN	O	route	prep_via	15	SENT_26	4378/4383
20	to	TO	O	to		-1	SENT_26	4384/4386
21	the	DT	O	the	det	23	SENT_26	4387/4390
22	whole	JJ	O	whole	amod	23	SENT_26	4391/4396
23	population	NN	O	population	prep_to	15	SENT_26	4397/4407
24	.	.	O	.		-1	SENT_26	4407/4408

1	A	DT	O	a	det	2	SENT_27	4409/4410
2	disadvantage	NN	O	disadvantage	nsubj	6	SENT_27	4411/4423
3	of	IN	O	of		-1	SENT_27	4424/4426
4	these	DT	O	these	det	5	SENT_27	4427/4432
5	vaccines	NNS	O	vaccine	prep_of	2	SENT_27	4433/4441
6	is	VBZ	O	be		-1	SENT_27	4442/4444
7	that	IN	O	that	mark	10	SENT_27	4445/4449
8	they	PRP	O	they	nsubj	10	SENT_27	4450/4454
9	have	VBP	O	have	aux	10	SENT_27	4455/4459
10	shown	VBN	O	show	ccomp	6	SENT_27	4460/4465
11	to	TO	O	to	aux	14	SENT_27	4466/4468
12	be	VB	O	be	cop	14	SENT_27	4469/4471
13	poorly	RB	O	poorly	advmod	14	SENT_27	4472/4478
14	immunogenic	JJ	O	immunogenic	xcomp	10	SENT_27	4479/4490
15	when	WRB	O	when	advmod	16	SENT_27	4491/4495
16	administered	VBN	O	administer	advcl	14	SENT_27	4496/4508
17	via	IN	O	via		-1	SENT_27	4509/4512
18	this	DT	O	this	det	22	SENT_27	4513/4517
19	route	NN	O	route	nn	22	SENT_27	4518/4523
20	(	NN	O	(	nn	22	SENT_27	4524/4525
21	4,13	CD	NUMBER	4,13	num	22	SENT_27	4525/4529
22	)	NN	O	)	prep_via	16	SENT_27	4529/4530
23	.	.	O	.		-1	SENT_27	4530/4531

1	To	TO	O	to	aux	2	SENT_28	4567/4569
2	increase	VB	O	increase	dep	6	SENT_28	4570/4578
3	the	DT	O	the	det	4	SENT_28	4579/4582
4	immunogenicity	NN	O	immunogenicity	dobj	2	SENT_28	4583/4597
5	,	,	O	,		-1	SENT_28	4597/4598
6	inactivated	VBD	O	inactivate		-1	SENT_28	4599/4610
7	influenza	NN	O	influenza	nn	8	SENT_28	4611/4620
8	vaccines	NNS	O	vaccine	nsubj	9	SENT_28	4621/4629
9	require	VBP	O	require	ccomp	6	SENT_28	4630/4637
10	adjuvants	NNS	O	adjuvant	nsubj	12	SENT_28	4638/4647
11	to	TO	O	to	aux	12	SENT_28	4648/4650
12	potentiate	VB	O	potentiate	xcomp	9	SENT_28	4651/4661
13	the	DT	O	the	det	15	SENT_28	4662/4665
14	immune	JJ	O	immune	amod	15	SENT_28	4666/4672
15	response	NN	O	response	dobj	12	SENT_28	4673/4681
16	when	WRB	O	when	advmod	17	SENT_28	4682/4686
17	administered	VBN	O	administer	advcl	12	SENT_28	4687/4699
18	via	IN	O	via		-1	SENT_28	4700/4703
19	the	DT	O	the	det	21	SENT_28	4704/4707
20	i.n.	NN	O	i.n.	nn	21	SENT_28	4708/4712
21	route	NN	O	route	prep_via	17	SENT_28	4713/4718
22	.	.	O	.		-1	SENT_28	4718/4719

1	Several	JJ	O	several	amod	2	SENT_29	4720/4727
2	adjuvants	NNS	O	adjuvant	nsubj	3	SENT_29	4728/4737
3	are	VBP	O	be	ccomp	19	SENT_29	4738/4741
4	currently	RB	DATE	currently	advmod	3	SENT_29	4742/4751
5	under	IN	O	under		-1	SENT_29	4752/4757
6	development	NN	O	development	prep_under	3	SENT_29	4758/4769
7	for	IN	O	for		-1	SENT_29	4770/4773
8	i.n.	NNP	O	i.n.	nn	9	SENT_29	4774/4778
9	immunizations	NNS	O	immunization	prep_for	6	SENT_29	4779/4792
10	like	IN	O	like	mark	13	SENT_29	4793/4797
11	virus-like	JJ	O	virus-like	amod	12	SENT_29	4798/4808
12	particles	NNS	O	particle	nsubj	13	SENT_29	4809/4818
13	(	VBP	O	(	advcl	3	SENT_29	4819/4820
14	23	CD	NUMBER	23	num	15	SENT_29	4820/4822
15	)	CD	NUMBER	)	dobj	13	SENT_29	4822/4823
16	,	,	O	,		-1	SENT_29	4823/4824
17	immunostimulating	JJ	O	immunostimulating	amod	18	SENT_29	4825/4842
18	complexes	NNS	O	complex	nsubj	19	SENT_29	4843/4852
19	(	VBP	O	(		-1	SENT_29	4853/4854
20	ISCOMS	NN	O	iscom	nsubj	37	SENT_29	4854/4860
21	)	CD	NUMBER	)	num	20	SENT_29	4860/4861
22	(	CD	NUMBER	(	number	23	SENT_29	4862/4863
23	23	CD	NUMBER	23	num	24	SENT_29	4863/4865
24	)	NN	O	)	dep	20	SENT_29	4865/4866
25	,	,	O	,		-1	SENT_29	4866/4867
26	lipids	NNS	O	lipid	conj_and	20	SENT_29	4868/4874
27	,	,	O	,		-1	SENT_29	4874/4875
28	nucleic	JJ	O	nucleic	amod	29	SENT_29	4876/4883
29	acids	NNS	O	acid	conj_and	20	SENT_29	4884/4889
30	(	CD	NUMBER	(	number	31	SENT_29	4890/4891
31	24	CD	NUMBER	24	num	32	SENT_29	4891/4893
32	)	NN	O	)	dep	29	SENT_29	4893/4894
33	,	,	O	,		-1	SENT_29	4894/4895
34	and	CC	O	and		-1	SENT_29	4896/4899
35	bacterial	JJ	O	bacterial	amod	36	SENT_29	4900/4909
36	components	NNS	O	component	conj_and	20	SENT_29	4910/4920
37	(	VBP	O	(	ccomp	19	SENT_29	4921/4922
38	25,26	CD	NUMBER	25,26	number	39	SENT_29	4922/4927
39	)	CD	NUMBER	)	dobj	37	SENT_29	4927/4928
40	.	.	O	.		-1	SENT_29	4928/4929

1	However	RB	O	however	advmod	12	SENT_30	4930/4937
2	,	,	O	,		-1	SENT_30	4937/4938
3	the	DT	O	the	det	4	SENT_30	4939/4942
4	development	NN	O	development	nsubjpass	12	SENT_30	4943/4954
5	of	IN	O	of		-1	SENT_30	4955/4957
6	many	JJ	O	many	prep_of	4	SENT_30	4958/4962
7	of	IN	O	of		-1	SENT_30	4963/4965
8	these	DT	O	these	det	10	SENT_30	4966/4971
9	adjuvants	NNS	O	adjuvant	nn	10	SENT_30	4972/4981
10	systems	NNS	O	system	prep_of	6	SENT_30	4982/4989
11	is	VBZ	O	be	auxpass	12	SENT_30	4990/4992
12	hampered	VBN	O	hamper		-1	SENT_30	4993/5001
13	by	IN	O	by		-1	SENT_30	5002/5004
14	safety	NN	O	safety	agent	12	SENT_30	5005/5011
15	and	CC	O	and		-1	SENT_30	5012/5015
16	regulatory	JJ	O	regulatory	amod	17	SENT_30	5016/5026
17	concerns	NNS	O	concern	nsubj	18	SENT_30	5027/5035
18	(	VBP	O	(	conj_and	12	SENT_30	5036/5037
19	27	CD	NUMBER	27	num	20	SENT_30	5037/5039
20	)	CD	NUMBER	)	dobj	18	SENT_30	5039/5040
21	.	.	O	.		-1	SENT_30	5040/5041

1	For	IN	O	for		-1	SENT_31	5042/5045
2	example	NN	O	example	prep_for	9	SENT_31	5046/5053
3	,	,	O	,		-1	SENT_31	5053/5054
4	potent	JJ	O	potent	amod	6	SENT_31	5055/5061
5	bacterial	JJ	O	bacterial	amod	6	SENT_31	5062/5071
6	adjuvants	NNS	O	adjuvant	nsubj	9	SENT_31	5072/5081
7	like	IN	O	like		-1	SENT_31	5082/5086
8	heat	NN	O	heat	prep_like	6	SENT_31	5087/5091
9	liable	JJ	O	liable		-1	SENT_31	5092/5098
10	toxin	NN	O	toxin	dobj	9	SENT_31	5099/5104
11	of	IN	O	of		-1	SENT_31	5105/5107
12	Escherichia	FW	PERSON	escherichia	nn	16	SENT_31	5108/5119
13	coli	FW	PERSON	coli	nn	16	SENT_31	5120/5124
14	(	FW	O	(	nn	16	SENT_31	5125/5126
15	LT	NN	O	lt	nn	16	SENT_31	5126/5128
16	)	NN	O	)	prep_of	10	SENT_31	5128/5129
17	have	VBP	O	have	aux	18	SENT_31	5130/5134
18	shown	VBN	O	show	rcmod	16	SENT_31	5135/5140
19	severe	JJ	O	severe	amod	21	SENT_31	5141/5147
20	side	JJ	O	side	amod	21	SENT_31	5148/5152
21	effects	NNS	O	effect	dobj	18	SENT_31	5153/5160
22	in	IN	O	in		-1	SENT_31	5161/5163
23	humans	NNS	O	human	prep_in	18	SENT_31	5164/5170
24	(	CD	NUMBER	(	number	25	SENT_31	5171/5172
25	28	CD	NUMBER	28	num	26	SENT_31	5172/5174
26	)	NN	O	)	dep	18	SENT_31	5174/5175
27	.	.	O	.		-1	SENT_31	5175/5176

1	Therefore	RB	O	therefore	advmod	7	SENT_32	5177/5186
2	,	,	O	,		-1	SENT_32	5186/5187
3	an	DT	O	a	det	4	SENT_32	5188/5190
4	adjuvant	JJ	O	adjuvant	nsubj	7	SENT_32	5191/5199
5	for	IN	O	for		-1	SENT_32	5200/5203
6	i.n.	NN	O	i.n.	prep_for	4	SENT_32	5204/5208
7	inactivated	VBD	O	inactivate		-1	SENT_32	5209/5220
8	influenza	NN	O	influenza	nn	9	SENT_32	5221/5230
9	vaccine	NN	O	vaccine	dobj	7	SENT_32	5231/5238
10	that	WDT	O	that	nsubj	12	SENT_32	5239/5243
11	is	VBZ	O	be	cop	12	SENT_32	5244/5246
12	potent	JJ	O	potent	rcmod	9	SENT_32	5247/5253
13	and	CC	O	and		-1	SENT_32	5254/5257
14	safe	JJ	O	safe	conj_and	12	SENT_32	5258/5262
15	for	IN	O	for	mark	20	SENT_32	5263/5266
16	human	JJ	O	human	amod	17	SENT_32	5267/5272
17	use	NN	O	use	nsubj	20	SENT_32	5273/5276
18	is	VBZ	O	be	aux	20	SENT_32	5277/5279
19	still	RB	O	still	advmod	20	SENT_32	5280/5285
20	lacking	VBG	O	lack	advcl	12	SENT_32	5286/5293
21	.	.	O	.		-1	SENT_32	5293/5294

1	The	DT	O	the	det	6	SENT_33	5330/5333
2	novel	JJ	O	novel	amod	6	SENT_33	5334/5339
3	adjuvant	JJ	O	adjuvant	amod	6	SENT_33	5340/5348
4	Gram-positive	JJ	O	gram-positive	amod	6	SENT_33	5349/5362
5	enhancer	NN	O	enhancer	nn	6	SENT_33	5363/5371
6	matrix	NN	O	matrix	nsubjpass	12	SENT_33	5372/5378
7	(	JJ	O	(	amod	10	SENT_33	5379/5380
8	GEM	NN	O	gem	nn	10	SENT_33	5380/5383
9	)	NN	O	)	nn	10	SENT_33	5383/5384
10	particles	NNS	O	particle	dep	6	SENT_33	5385/5394
11	are	VBP	O	be	auxpass	12	SENT_33	5395/5398
12	produced	VBN	O	produce		-1	SENT_33	5399/5407
13	from	IN	O	from		-1	SENT_33	5408/5412
14	the	DT	O	the	det	18	SENT_33	5413/5416
15	food-grade	JJ	O	food-grade	amod	18	SENT_33	5417/5427
16	bacterium	NN	O	bacterium	nn	18	SENT_33	5428/5437
17	Lactococcus	NN	O	lactococcus	nn	18	SENT_33	5438/5449
18	lactis	NN	O	lacti	prep_from	12	SENT_33	5450/5456
19	(	CD	NUMBER	(	number	20	SENT_33	5457/5458
20	29	CD	NUMBER	29	num	21	SENT_33	5458/5460
21	)	NN	O	)	dep	12	SENT_33	5460/5461
22	.	.	O	.		-1	SENT_33	5461/5462

1	L.	NNP	O	L.	nn	2	SENT_34	5463/5465
2	lactis	NN	O	lacti	nsubj	9	SENT_34	5466/5472
3	is	VBZ	O	be	cop	9	SENT_34	5473/5475
4	a	DT	O	a	det	9	SENT_34	5476/5477
5	nonpathogenic	JJ	O	nonpathogenic	amod	7	SENT_34	5478/5491
6	,	,	O	,		-1	SENT_34	5491/5492
7	noncolonizing	JJ	O	noncolonizing	amod	9	SENT_34	5493/5506
8	Gram-positive	JJ	O	gram-positive	amod	9	SENT_34	5507/5520
9	bacterium	NN	O	bacterium		-1	SENT_34	5521/5530
10	.	.	O	.		-1	SENT_34	5530/5531

1	Moreover	RB	O	moreover	advmod	6	SENT_35	5532/5540
2	,	,	O	,		-1	SENT_35	5540/5541
3	L.	NNP	O	L.	nn	4	SENT_35	5542/5544
4	lactis	NN	O	lacti	nsubjpass	6	SENT_35	5545/5551
5	is	VBZ	O	be	auxpass	6	SENT_35	5552/5554
6	approved	VBN	O	approve		-1	SENT_35	5555/5563
7	for	IN	O	for		-1	SENT_35	5564/5567
8	human	JJ	O	human	amod	9	SENT_35	5568/5573
9	use	NN	O	use	prep_for	6	SENT_35	5574/5577
10	by	IN	O	by		-1	SENT_35	5578/5580
11	regulatory	JJ	O	regulatory	amod	12	SENT_35	5581/5591
12	agencies	NNS	O	agency	agent	6	SENT_35	5592/5600
13	and	CC	O	and		-1	SENT_35	5601/5604
14	considered	VBN	O	consider	conj_and	6	SENT_35	5605/5615
15	as	IN	O	as		-1	SENT_35	5616/5618
16	a	DT	O	a	det	22	SENT_35	5619/5620
17	generally	RB	O	generally	advmod	18	SENT_35	5621/5630
18	recognized	VBN	O	recognize	amod	22	SENT_35	5631/5641
19	as	IN	O	as		-1	SENT_35	5642/5644
20	safe	JJ	O	safe	amod	21	SENT_35	5645/5649
21	(	CD	NUMBER	(	prep_as	18	SENT_35	5650/5651
22	GRAS	NNP	O	GRAS	prep_as	14	SENT_35	5651/5655
23	)	CD	NUMBER	)	num	24	SENT_35	5655/5656
24	organism	NN	O	organism	dobj	6	SENT_35	5657/5665
25	.	.	O	.		-1	SENT_35	5665/5666

1	The	DT	O	the	det	3	SENT_36	5667/5670
2	GEM	NN	O	gem	nn	3	SENT_36	5671/5674
3	particles	NNS	O	particle	nsubjpass	5	SENT_36	5675/5684
4	are	VBP	O	be	auxpass	5	SENT_36	5685/5688
5	produced	VBN	O	produce		-1	SENT_36	5689/5697
6	by	IN	O	by		-1	SENT_36	5698/5700
7	heating	VBG	O	heat	agent	5	SENT_36	5701/5708
8	the	DT	O	the	det	10	SENT_36	5709/5712
9	L.	NNP	O	L.	nn	10	SENT_36	5713/5715
10	lactis	NN	O	lacti	dobj	7	SENT_36	5716/5722
11	in	IN	O	in		-1	SENT_36	5723/5725
12	acid	NN	O	acid	prep_in	7	SENT_36	5726/5730
13	,	,	O	,		-1	SENT_36	5730/5731
14	followed	VBN	O	follow	partmod	12	SENT_36	5732/5740
15	by	IN	O	by		-1	SENT_36	5741/5743
16	washing	VBG	O	wash	agent	14	SENT_36	5744/5751
17	with	IN	O	with		-1	SENT_36	5752/5756
18	phosphate	NN	O	phosphate	nn	19	SENT_36	5757/5766
19	buffer	NN	O	buffer	prep_with	16	SENT_36	5767/5773
20	(	CD	NUMBER	(	num	22	SENT_36	5774/5775
21	30	CD	NUMBER	30	num	22	SENT_36	5775/5777
22	)	NN	O	)	dobj	16	SENT_36	5777/5778
23	.	.	O	.		-1	SENT_36	5778/5779

1	The	DT	O	the	det	3	SENT_37	5780/5783
2	resulting	VBG	O	result	amod	3	SENT_37	5784/5793
3	particles	NNS	O	particle	nsubj	5	SENT_37	5794/5803
4	are	VBP	O	be	cop	5	SENT_37	5804/5807
5	nonliving	JJ	O	nonliving		-1	SENT_37	5808/5817
6	,	,	O	,		-1	SENT_37	5817/5818
7	deprived	VBN	O	deprive	dep	5	SENT_37	5819/5827
8	of	IN	O	of		-1	SENT_37	5828/5830
9	intact	JJ	O	intact	amod	11	SENT_37	5831/5837
10	surface	NN	O	surface	nn	11	SENT_37	5838/5845
11	proteins	NNS	O	protein	prep_of	7	SENT_37	5846/5854
12	and	CC	O	and		-1	SENT_37	5855/5858
13	intracellular	JJ	O	intracellular	amod	14	SENT_37	5859/5872
14	content	NN	O	content	conj_and	11	SENT_37	5873/5880
15	.	.	O	.		-1	SENT_37	5880/5881

1	The	DT	O	the	det	5	SENT_38	5882/5885
2	thick	JJ	O	thick	amod	5	SENT_38	5886/5891
3	peptidoglycan	NN	O	peptidoglycan	nn	5	SENT_38	5892/5905
4	cell	NN	O	cell	nn	5	SENT_38	5906/5910
5	wall	NN	O	wall	nsubj	10	SENT_38	5911/5915
6	,	,	O	,		-1	SENT_38	5915/5916
7	however	RB	O	however	advmod	10	SENT_38	5917/5924
8	,	,	O	,		-1	SENT_38	5924/5925
9	remains	VBZ	O	remain	cop	10	SENT_38	5926/5933
10	intact	JJ	O	intact		-1	SENT_38	5934/5940
11	and	CC	O	and		-1	SENT_38	5941/5944
12	provides	VBZ	O	provide	conj_and	10	SENT_38	5945/5953
13	the	DT	O	the	det	15	SENT_38	5954/5957
14	structural	JJ	O	structural	amod	15	SENT_38	5958/5968
15	rigidity	NN	O	rigidity	dobj	12	SENT_38	5969/5977
16	to	TO	O	to	aux	17	SENT_38	5978/5980
17	constitute	VB	O	constitute	infmod	15	SENT_38	5981/5991
18	the	DT	O	the	det	21	SENT_38	5992/5995
19	bacterial-shaped	JJ	O	bacterial-shaped	amod	21	SENT_38	5996/6012
20	peptidoglycan	NN	O	peptidoglycan	nn	21	SENT_38	6013/6026
21	spheres	NNS	O	sphere	dobj	17	SENT_38	6027/6034
22	of	IN	O	of	dep	17	SENT_38	6035/6037
23	about	IN	O	about		-1	SENT_38	6038/6043
24	1	CD	NUMBER	1	num	25	SENT_38	6044/6045
25	m	NN	O	m	prep_about	17	SENT_38	6048/6049
26	in	IN	O	in		-1	SENT_38	6050/6052
27	size	NN	O	size	prep_in	25	SENT_38	6053/6057
28	,	,	O	,		-1	SENT_38	6057/6058
29	referred	VBN	O	refer	partmod	25	SENT_38	6059/6067
30	to	TO	O	to	xcomp	29	SENT_38	6068/6070
31	as	IN	O	as		-1	SENT_38	6071/6073
32	GEM	NN	O	gem	nn	33	SENT_38	6074/6077
33	particles	NNS	O	particle	prep_as	29	SENT_38	6078/6087
34	.	.	O	.		-1	SENT_38	6087/6088

1	The	DT	O	the	det	3	SENT_39	6089/6092
2	GEM	NN	O	gem	nn	3	SENT_39	6093/6096
3	particles	NNS	O	particle	nsubjpass	6	SENT_39	6097/6106
4	have	VBP	O	have	aux	6	SENT_39	6107/6111
5	been	VBN	O	be	auxpass	6	SENT_39	6112/6116
6	studied	VBN	O	study		-1	SENT_39	6117/6124
7	for	IN	O	for		-1	SENT_39	6125/6128
8	mucosal	JJ	O	mucosal	amod	9	SENT_39	6129/6136
9	vaccination	NN	O	vaccination	prep_for	6	SENT_39	6137/6148
10	of	IN	O	of		-1	SENT_39	6149/6151
11	malarial	JJ	O	malarial	amod	13	SENT_39	6152/6160
12	parasite	NN	O	parasite	nn	13	SENT_39	6161/6169
13	antigen	NN	O	antigen	prep_of	9	SENT_39	6170/6177
14	and	CC	O	and		-1	SENT_39	6178/6181
15	pneumococcal	JJ	O	pneumococcal	amod	16	SENT_39	6182/6194
16	antigens	NNS	O	antigen	nsubj	17	SENT_39	6195/6203
17	(	VBP	O	(	conj_and	6	SENT_39	6204/6205
18	31-33	CD	NUMBER	31-33	num	19	SENT_39	6205/6210
19	)	CD	NUMBER	)	dobj	17	SENT_39	6210/6211
20	.	.	O	.		-1	SENT_39	6211/6212

1	These	DT	O	these	det	2	SENT_40	6213/6218
2	studies	NNS	O	study	nsubj	3	SENT_40	6219/6226
3	demonstrated	VBD	O	demonstrate		-1	SENT_40	6227/6239
4	that	IN	O	that	mark	10	SENT_40	6240/6244
5	antigens	NNS	O	antigen	nsubj	10	SENT_40	6245/6253
6	displayed	VBN	O	display	partmod	5	SENT_40	6254/6263
7	on	IN	O	on		-1	SENT_40	6264/6266
8	GEM	NN	O	gem	nn	9	SENT_40	6267/6270
9	particles	NNS	O	particle	prep_on	6	SENT_40	6271/6280
10	induced	VBD	O	induce	ccomp	3	SENT_40	6281/6288
11	higher	JJR	O	higher	amod	13	SENT_40	6289/6295
12	immune	JJ	O	immune	amod	13	SENT_40	6296/6302
13	response	NN	O	response	dobj	10	SENT_40	6303/6311
14	than	IN	O	than		-1	SENT_40	6312/6316
15	antigen	NN	O	antigen	prep_than	10	SENT_40	6317/6324
16	alone	RB	O	alone	advmod	10	SENT_40	6325/6330
17	.	.	O	.		-1	SENT_40	6330/6331

1	Since	IN	O	since	mark	10	SENT_41	6332/6337
2	GEM	NN	O	gem	nn	3	SENT_41	6338/6341
3	particles	NNS	O	particle	nsubj	10	SENT_41	6342/6351
4	are	VBP	O	be	cop	10	SENT_41	6352/6355
5	a	DT	O	a	det	10	SENT_41	6356/6357
6	promising	JJ	O	promising	amod	10	SENT_41	6358/6367
7	adjuvant	JJ	O	adjuvant	amod	10	SENT_41	6368/6376
8	for	IN	O	for		-1	SENT_41	6377/6380
9	i.n.	NN	O	i.n.	prep_for	7	SENT_41	6381/6385
10	immunization	NN	O	immunization	advcl	17	SENT_41	6386/6398
11	,	,	O	,		-1	SENT_41	6398/6399
12	the	DT	O	the	det	13	SENT_41	6400/6403
13	aim	NN	O	aim	nsubj	17	SENT_41	6404/6407
14	of	IN	O	of		-1	SENT_41	6408/6410
15	this	DT	O	this	det	16	SENT_41	6411/6415
16	study	NN	O	study	prep_of	13	SENT_41	6416/6421
17	was	VBD	O	be		-1	SENT_41	6422/6425
18	to	TO	O	to	aux	19	SENT_41	6426/6428
19	investigate	VB	O	investigate	xcomp	17	SENT_41	6429/6440
20	the	DT	O	the	det	21	SENT_41	6441/6444
21	use	NN	O	use	dobj	19	SENT_41	6445/6448
22	of	IN	O	of		-1	SENT_41	6449/6451
23	GEM	NN	O	gem	nn	24	SENT_41	6452/6455
24	particles	NNS	O	particle	prep_of	21	SENT_41	6456/6465
25	as	IN	O	as		-1	SENT_41	6466/6468
26	adjuvant	JJ	O	adjuvant	amod	30	SENT_41	6469/6477
27	for	IN	O	for		-1	SENT_41	6478/6481
28	i.n.	NN	O	i.n.	nn	29	SENT_41	6482/6486
29	influenza	NN	O	influenza	prep_for	26	SENT_41	6487/6496
30	vaccination	NN	O	vaccination	prep_as	19	SENT_41	6497/6508
31	.	.	O	.		-1	SENT_41	6508/6509

1	In	IN	O	in		-1	SENT_42	6545/6547
2	this	DT	O	this	det	3	SENT_42	6548/6552
3	study	NN	O	study	prep_in	6	SENT_42	6553/6558
4	,	,	O	,		-1	SENT_42	6558/6559
5	we	PRP	O	we	nsubj	6	SENT_42	6560/6562
6	examined	VBD	O	examine		-1	SENT_42	6563/6571
7	the	DT	O	the	det	8	SENT_42	6572/6575
8	immunogenicity	NN	O	immunogenicity	dobj	6	SENT_42	6576/6590
9	in	IN	O	in		-1	SENT_42	6591/6593
10	Balb/c	NN	O	balb/c	nn	11	SENT_42	6594/6600
11	mice	NNS	O	mouse	prep_in	8	SENT_42	6601/6605
12	of	IN	O	of		-1	SENT_42	6606/6608
13	i.n.	NN	O	i.n.	prep_of	11	SENT_42	6609/6613
14	administered	VBN	O	administer	partmod	13	SENT_42	6614/6626
15	influenza	NN	O	influenza	nn	17	SENT_42	6627/6636
16	subunit	NN	O	subunit	nn	17	SENT_42	6637/6644
17	vaccine	NN	O	vaccine	dobj	14	SENT_42	6645/6652
18	mixed	VBN	O	mix	partmod	17	SENT_42	6653/6658
19	with	IN	O	with		-1	SENT_42	6659/6663
20	GEM	NN	O	gem	nn	21	SENT_42	6664/6667
21	particles	NNS	O	particle	prep_with	18	SENT_42	6668/6677
22	as	IN	O	as		-1	SENT_42	6678/6680
23	adjuvant	JJ	O	adjuvant	prep_as	18	SENT_42	6681/6689
24	.	.	O	.		-1	SENT_42	6689/6690

1	In	IN	O	in		-1	SENT_43	6691/6693
2	earlier	JJR	O	earlier	amod	3	SENT_43	6694/6701
3	studies	NNS	O	study	prep_in	7	SENT_43	6702/6709
4	,	,	O	,		-1	SENT_43	6709/6710
5	the	DT	O	the	det	6	SENT_43	6711/6714
6	antigens	NNS	O	antigen	nsubj	7	SENT_43	6715/6723
7	(	VBP	O	(		-1	SENT_43	6724/6725
8	pneumococcal	JJ	O	pneumococcal	amod	11	SENT_43	6725/6737
9	and	CC	O	and		-1	SENT_43	6738/6741
10	malarial	JJ	O	malarial	conj_and	8	SENT_43	6742/6750
11	)	NN	O	)	nsubjpass	14	SENT_43	6750/6751
12	were	VBD	O	be	auxpass	14	SENT_43	6752/6756
13	covalently	RB	O	covalently	advmod	14	SENT_43	6757/6767
14	bound	VBN	O	bind	ccomp	7	SENT_43	6768/6773
15	to	TO	O	to		-1	SENT_43	6774/6776
16	the	DT	O	the	det	17	SENT_43	6777/6780
17	GEM	NN	O	gem	prep_to	14	SENT_43	6781/6784
18	particles	NNS	O	particle	nsubj	19	SENT_43	6785/6794
19	(	VBP	O	(	rcmod	17	SENT_43	6795/6796
20	29-33	CD	NUMBER	29-33	num	21	SENT_43	6796/6801
21	)	CD	NUMBER	)	dobj	19	SENT_43	6801/6802
22	.	.	O	.		-1	SENT_43	6802/6803

1	In	IN	O	in		-1	SENT_44	6804/6806
2	contrast	NN	O	contrast	prep_in	13	SENT_44	6807/6815
3	,	,	O	,		-1	SENT_44	6815/6816
4	in	IN	O	in		-1	SENT_44	6817/6819
5	the	DT	O	the	det	7	SENT_44	6820/6823
6	present	JJ	DATE	present	amod	7	SENT_44	6824/6831
7	study	NN	O	study	prep_in	13	SENT_44	6832/6837
8	,	,	O	,		-1	SENT_44	6837/6838
9	the	DT	O	the	det	10	SENT_44	6839/6842
10	particles	NNS	O	particle	nsubjpass	13	SENT_44	6843/6852
11	were	VBD	O	be	auxpass	13	SENT_44	6853/6857
12	simply	RB	O	simply	advmod	13	SENT_44	6858/6864
13	mixed	VBN	O	mix		-1	SENT_44	6865/6870
14	with	IN	O	with		-1	SENT_44	6871/6875
15	the	DT	O	the	det	16	SENT_44	6876/6879
16	antigens	NNS	O	antigen	prep_with	13	SENT_44	6880/6888
17	.	.	O	.		-1	SENT_44	6888/6889

1	The	DT	O	the	det	3	SENT_45	6890/6893
2	immune	JJ	O	immune	amod	3	SENT_45	6894/6900
3	response	NN	O	response	nsubjpass	5	SENT_45	6901/6909
4	was	VBD	O	be	auxpass	5	SENT_45	6910/6913
5	compared	VBN	O	compare		-1	SENT_45	6914/6922
6	to	TO	O	to	aux	7	SENT_45	6923/6925
7	i.m.	VB	O	i.m.	xcomp	5	SENT_45	6926/6930
8	and	CC	O	and		-1	SENT_45	6931/6934
9	i.n.	VB	O	i.n.	conj_and	7	SENT_45	6935/6939
10	administered	VBN	O	administer	dep	9	SENT_45	6940/6952
11	subunit	NN	O	subunit	nn	13	SENT_45	6953/6960
12	influenza	NN	O	influenza	nn	13	SENT_45	6961/6970
13	vaccine	NN	O	vaccine	dobj	10	SENT_45	6971/6978
14	without	IN	O	without		-1	SENT_45	6979/6986
15	the	DT	O	the	det	16	SENT_45	6987/6990
16	adjuvant	JJ	O	adjuvant	prep_without	10	SENT_45	6991/6999
17	.	.	O	.		-1	SENT_45	6999/7000

1	MATERIALS	NNS	O	material		-1	SENT_46	7036/7045
2	AND	CC	O	and		-1	SENT_46	7046/7049
3	METHODS	NNS	O	method	conj_and	1	SENT_46	7050/7057

1	Influenza	NNP	O	Influenza	nn	4	SENT_47	7093/7102
2	monovalent	JJ	O	monovalent	amod	4	SENT_47	7103/7113
3	subunit	NN	O	subunit	nn	4	SENT_47	7114/7121
4	vaccine	NN	O	vaccine	nsubjpass	13	SENT_47	7122/7129
5	of	IN	O	of		-1	SENT_47	7130/7132
6	strain	NN	O	strain	nn	7	SENT_47	7133/7139
7	A/Wisconsin	NN	O	a/wisconsin	prep_of	4	SENT_47	7140/7151
8	(	CD	NUMBER	(	num	10	SENT_47	7152/7153
9	H3N2	NN	O	h3n2	nn	10	SENT_47	7153/7157
10	)	NN	O	)	dep	7	SENT_47	7157/7158
11	was	VBD	O	be	auxpass	13	SENT_47	7159/7162
12	kindly	RB	O	kindly	advmod	13	SENT_47	7163/7169
13	provided	VBN	O	provide		-1	SENT_47	7170/7178
14	by	IN	O	by		-1	SENT_47	7179/7181
15	Solvay	NNP	ORGANIZATION	Solvay	nn	18	SENT_47	7182/7188
16	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	18	SENT_47	7189/7204
17	(	NNP	O	(	nn	18	SENT_47	7205/7206
18	Weesp	NNP	PERSON	Weesp	agent	13	SENT_47	7206/7211
19	,	,	O	,		-1	SENT_47	7211/7212
20	The	DT	LOCATION	the	det	22	SENT_47	7213/7216
21	Netherlands	NNP	LOCATION	Netherlands	nn	22	SENT_47	7217/7228
22	)	NN	O	)	appos	18	SENT_47	7228/7229
23	.	.	O	.		-1	SENT_47	7229/7230

1	The	DT	O	the	det	2	SENT_48	7231/7234
2	concentration	NN	O	concentration	nsubjpass	13	SENT_48	7235/7248
3	of	IN	O	of		-1	SENT_48	7249/7251
4	the	DT	O	the	det	5	SENT_48	7252/7255
5	hemagglutinin	NN	O	hemagglutinin	prep_of	2	SENT_48	7256/7269
6	(	CD	NUMBER	(	num	7	SENT_48	7270/7271
7	HA	NNP	O	HA	dep	5	SENT_48	7271/7273
8	)	CD	NUMBER	)	num	7	SENT_48	7273/7274
9	in	IN	O	in		-1	SENT_48	7275/7277
10	the	DT	O	the	det	11	SENT_48	7278/7281
11	vaccine	NN	O	vaccine	prep_in	7	SENT_48	7282/7289
12	was	VBD	O	be	auxpass	13	SENT_48	7290/7293
13	determined	VBN	O	determine		-1	SENT_48	7294/7304
14	using	VBG	O	use	xcomp	13	SENT_48	7305/7310
15	the	DT	O	the	det	19	SENT_48	7311/7314
16	single	JJ	O	single	amod	19	SENT_48	7315/7321
17	radial	JJ	O	radial	amod	19	SENT_48	7322/7328
18	immunodiffusion	NN	O	immunodiffusion	nn	19	SENT_48	7329/7344
19	assay	NN	O	assay	dobj	14	SENT_48	7345/7350
20	.	.	O	.		-1	SENT_48	7350/7351

1	Gem	NN	O	gem	nn	2	SENT_49	7387/7390
2	Preparation	NN	O	preparation		-1	SENT_49	7391/7402

1	GEM	NN	O	gem	nn	2	SENT_50	7438/7441
2	particles	NNS	O	particle	nsubjpass	4	SENT_50	7442/7451
3	were	VBD	O	be	auxpass	4	SENT_50	7452/7456
4	prepared	VBN	O	prepare		-1	SENT_50	7457/7465
5	as	IN	O	as	mark	6	SENT_50	7466/7468
6	described	VBN	O	describe	advcl	4	SENT_50	7469/7478
7	earlier	JJR	O	earlier	advmod	6	SENT_50	7479/7486
8	(	CD	NUMBER	(	num	10	SENT_50	7487/7488
9	29	CD	NUMBER	29	num	10	SENT_50	7488/7490
10	)	NN	O	)	dobj	6	SENT_50	7490/7491
11	.	.	O	.		-1	SENT_50	7491/7492

1	In	IN	O	in		-1	SENT_51	7493/7495
2	brief	NN	O	brief	prep_in	16	SENT_51	7496/7501
3	,	,	O	,		-1	SENT_51	7501/7502
4	cells	NNS	O	cell	nsubjpass	16	SENT_51	7503/7508
5	of	IN	O	of		-1	SENT_51	7509/7511
6	an	DT	O	a	det	8	SENT_51	7512/7514
7	overnight	JJ	TIME	overnight	amod	8	SENT_51	7515/7524
8	culture	NN	O	culture	prep_of	4	SENT_51	7525/7532
9	of	IN	O	of		-1	SENT_51	7533/7535
10	L.	NNP	O	L.	nn	13	SENT_51	7536/7538
11	lactis	NN	O	lacti	nn	13	SENT_51	7539/7545
12	strain	NN	O	strain	nn	13	SENT_51	7546/7552
13	MG1363acmA	NN	O	mg1363acma	prep_of	8	SENT_51	7553/7563
14	1	CD	NUMBER	1	dep	13	SENT_51	7565/7566
15	were	VBD	O	be	auxpass	16	SENT_51	7567/7571
16	harvested	VBN	O	harvest		-1	SENT_51	7572/7581
17	and	CC	O	and		-1	SENT_51	7582/7585
18	washed	VBN	O	wash	conj_and	16	SENT_51	7586/7592
19	once	RB	DATE	once	advmod	16	SENT_51	7593/7597
20	with	IN	O	with		-1	SENT_51	7598/7602
21	sterile	JJ	O	sterile	amod	23	SENT_51	7603/7610
22	distilled	JJ	O	distilled	amod	23	SENT_51	7611/7620
23	water	NN	O	water	prep_with	16	SENT_51	7621/7626
24	.	.	O	.		-1	SENT_51	7626/7627

1	The	DT	O	the	det	2	SENT_52	7628/7631
2	cells	NNS	O	cell	nsubjpass	4	SENT_52	7632/7637
3	were	VBD	O	be	auxpass	4	SENT_52	7638/7642
4	resuspended	VBN	O	resuspend		-1	SENT_52	7643/7654
5	in	IN	O	in		-1	SENT_52	7655/7657
6	10	CD	PERCENT	10	number	7	SENT_52	7658/7660
7	%	NN	PERCENT	%	amod	9	SENT_52	7660/7661
8	trichloroacetic	JJ	O	trichloroacetic	amod	9	SENT_52	7662/7677
9	acid	NN	O	acid	prep_in	4	SENT_52	7678/7682
10	and	CC	O	and		-1	SENT_52	7683/7686
11	placed	VBN	O	place	conj_and	4	SENT_52	7687/7693
12	in	IN	O	in		-1	SENT_52	7694/7696
13	a	DT	O	a	det	16	SENT_52	7697/7698
14	hot	JJ	O	hot	amod	16	SENT_52	7699/7702
15	water	NN	O	water	nn	16	SENT_52	7703/7708
16	bath	NN	O	bath	prep_in	11	SENT_52	7709/7713
17	of	IN	O	of		-1	SENT_52	7714/7716
18	99	CD	NUMBER	99	num	19	SENT_52	7717/7719
19	C	NN	O	c	prep_of	16	SENT_52	7721/7722
20	for	IN	O	for		-1	SENT_52	7723/7726
21	30	CD	DURATION	30	num	22	SENT_52	7727/7729
22	min	NN	DURATION	min	prep_for	19	SENT_52	7730/7733
23	.	.	O	.		-1	SENT_52	7733/7734

1	The	DT	O	the	det	5	SENT_53	7735/7738
2	acid	NN	O	acid	nn	5	SENT_53	7739/7743
3	and	CC	O	and		-1	SENT_53	7744/7747
4	heat	NN	O	heat	conj_and	2	SENT_53	7748/7752
5	treatment	NN	O	treatment	nsubj	6	SENT_53	7753/7762
6	kills	VBZ	O	kill		-1	SENT_53	7763/7768
7	the	DT	O	the	det	8	SENT_53	7769/7772
8	bacteria	NNS	O	bacterium	dobj	6	SENT_53	7773/7781
9	and	CC	O	and		-1	SENT_53	7782/7785
10	generates	VBZ	O	generate	conj_and	6	SENT_53	7786/7795
11	the	DT	O	the	det	14	SENT_53	7796/7799
12	so-called	JJ	O	so-called	amod	14	SENT_53	7800/7809
13	GEM	NN	O	gem	nn	14	SENT_53	7810/7813
14	particles	NNS	O	particle	dobj	10	SENT_53	7814/7823
15	.	.	O	.		-1	SENT_53	7823/7824

1	After	IN	O	after		-1	SENT_54	7825/7830
2	acid	NN	O	acid	nn	5	SENT_54	7831/7835
3	and	CC	O	and		-1	SENT_54	7836/7839
4	heat	NN	O	heat	conj_and	2	SENT_54	7840/7844
5	treatment	NN	O	treatment	prep_after	11	SENT_54	7845/7854
6	,	,	O	,		-1	SENT_54	7854/7855
7	the	DT	O	the	det	9	SENT_54	7856/7859
8	GEM	NNP	O	GEM	nn	9	SENT_54	7860/7863
9	particles	NNS	O	particle	nsubj	11	SENT_54	7864/7873
10	were	VBD	O	be	cop	11	SENT_54	7874/7878
11	pelleted	JJ	O	pelleted		-1	SENT_54	7879/7887
12	and	CC	O	and		-1	SENT_54	7888/7891
13	washed	JJ	O	washed	conj_and	11	SENT_54	7892/7898
14	three	CD	NUMBER	three	num	15	SENT_54	7899/7904
15	times	NNS	O	time	npadvmod	11	SENT_54	7905/7910
16	in	IN	O	in		-1	SENT_54	7911/7913
17	phosphate	NN	O	phosphate	prep_in	11	SENT_54	7914/7923
18	buffered	VBN	O	buffer	partmod	17	SENT_54	7924/7932
19	saline	NN	O	saline	nn	21	SENT_54	7933/7939
20	(	CD	NUMBER	(	num	21	SENT_54	7940/7941
21	PBS	NNP	O	PBS	dobj	18	SENT_54	7941/7944
22	;	:	O	;		-1	SENT_54	7944/7945
23	Dulbecco	NNP	PERSON	Dulbecco	poss	25	SENT_54	7946/7954
24	's	POS	O	's		-1	SENT_54	7954/7956
25	phosphate	NN	O	phosphate	dep	21	SENT_54	7957/7966
26	buffered	VBN	O	buffer	dep	25	SENT_54	7967/7975
27	saline	NN	O	saline	dobj	26	SENT_54	7976/7982
28	without	IN	O	without		-1	SENT_54	7983/7990
29	CaCl2	NN	O	cacl2	nn	32	SENT_54	7991/7996
30	and	CC	O	and		-1	SENT_54	7997/8000
31	MgCl2	NN	O	mgcl2	conj_and	29	SENT_54	8001/8006
32	)	NN	O	)	prep_without	26	SENT_54	8006/8007
33	and	CC	O	and		-1	SENT_54	8008/8011
34	finally	RB	O	finally	advmod	35	SENT_54	8012/8019
35	resuspended	VBN	O	resuspend	conj_and	26	SENT_54	8020/8031
36	in	IN	O	in		-1	SENT_54	8032/8034
37	PBS	NNP	O	PBS	prep_in	35	SENT_54	8035/8038
38	and	CC	O	and		-1	SENT_54	8039/8042
39	stored	VBD	O	store	conj_and	11	SENT_54	8043/8049
40	at	IN	O	at	quantmod	41	SENT_54	8050/8052
41	20	CD	NUMBER	20	num	44	SENT_54	8056/8058
42	C.	NNP	O	C.	nn	44	SENT_54	8060/8062
43	One	CD	NUMBER	one	num	44	SENT_54	8063/8066
44	unit	NN	O	unit	nsubjpass	49	SENT_54	8067/8071
45	of	IN	O	of		-1	SENT_54	8072/8074
46	GEM	NN	O	gem	nn	47	SENT_54	8075/8078
47	particles	NNS	O	particle	prep_of	44	SENT_54	8079/8088
48	was	VBD	O	be	auxpass	49	SENT_54	8089/8092
49	defined	VBN	O	define	ccomp	39	SENT_54	8093/8100
50	as	IN	O	as		-1	SENT_54	8101/8103
51	approximately	RB	O	approximately	quantmod	53	SENT_54	8104/8117
52	2.5	CD	NUMBER	2.5	number	53	SENT_54	8118/8121
53	109	CD	NUMBER	109	num	55	SENT_54	8127/8130
54	nonliving	JJ	O	nonliving	amod	55	SENT_54	8131/8140
55	particles	NNS	O	particle	prep_as	49	SENT_54	8141/8150
56	.	.	O	.		-1	SENT_54	8150/8151

1	Immunization	NN	O	immunization		-1	SENT_55	8187/8199

1	Animal	NN	O	animal	nn	2	SENT_56	8235/8241
2	experiments	NNS	O	experiment	nsubjpass	4	SENT_56	8242/8253
3	were	VBD	O	be	auxpass	4	SENT_56	8254/8258
4	evaluated	VBN	O	evaluate		-1	SENT_56	8259/8268
5	and	CC	O	and		-1	SENT_56	8269/8272
6	approved	VBN	O	approve	conj_and	4	SENT_56	8273/8281
7	by	IN	O	by		-1	SENT_56	8282/8284
8	the	DT	O	the	det	9	SENT_56	8285/8288
9	Committee	NNP	ORGANIZATION	Committee	agent	4	SENT_56	8289/8298
10	for	IN	ORGANIZATION	for		-1	SENT_56	8299/8302
11	Animal	NNP	ORGANIZATION	Animal	nn	12	SENT_56	8303/8309
12	Experimentation	NN	ORGANIZATION	experimentation	prep_for	4	SENT_56	8310/8325
13	of	IN	ORGANIZATION	of		-1	SENT_56	8326/8328
14	the	DT	ORGANIZATION	the	det	15	SENT_56	8329/8332
15	University	NNP	ORGANIZATION	University	prep_of	12	SENT_56	8333/8343
16	of	IN	ORGANIZATION	of		-1	SENT_56	8344/8346
17	Groningen	NNP	ORGANIZATION	Groningen	prep_of	15	SENT_56	8347/8356
18	,	,	O	,		-1	SENT_56	8356/8357
19	The	DT	LOCATION	the	det	20	SENT_56	8358/8361
20	Netherlands	NNP	LOCATION	Netherlands	appos	17	SENT_56	8362/8373
21	according	VBG	O	accord		-1	SENT_56	8374/8383
22	to	TO	O	to	prepc_according_to	4	SENT_56	8384/8386
23	the	DT	O	the	det	24	SENT_56	8387/8390
24	guidelines	NNS	O	guideline	pobj	4	SENT_56	8391/8401
25	provided	VBN	O	provide	partmod	24	SENT_56	8402/8410
26	by	IN	O	by		-1	SENT_56	8411/8413
27	Dutch	JJ	O	dutch	amod	30	SENT_56	8414/8419
28	Animal	NNP	O	Animal	nn	30	SENT_56	8420/8426
29	Protection	NNP	O	Protection	nn	30	SENT_56	8427/8437
30	Act	NNP	O	Act	agent	25	SENT_56	8438/8441
31	.	.	O	.		-1	SENT_56	8441/8442

1	Balb/c	NN	O	balb/c	nn	2	SENT_57	8443/8449
2	mice	NNS	O	mouse	nsubj	3	SENT_57	8450/8454
3	(	VBP	O	(	ccomp	16	SENT_57	8455/8456
4	6-8	CD	NUMBER	6-8	num	5	SENT_57	8456/8459
5	weeks	NNS	NUMBER	week	dobj	3	SENT_57	8460/8465
6	)	CD	NUMBER	)	dep	7	SENT_57	8465/8466
7	purchased	VBN	O	purchase	amod	5	SENT_57	8467/8476
8	from	IN	O	from		-1	SENT_57	8477/8481
9	Harlan	NNP	LOCATION	Harlan	nn	11	SENT_57	8482/8488
10	,	,	O	,		-1	SENT_57	8488/8489
11	Zeist	NNP	O	Zeist	prep_from	7	SENT_57	8490/8495
12	,	,	O	,		-1	SENT_57	8495/8496
13	The	DT	LOCATION	the	det	14	SENT_57	8497/8500
14	Netherlands	NNPS	LOCATION	Netherlands	nsubjpass	16	SENT_57	8501/8512
15	were	VBD	O	be	auxpass	16	SENT_57	8513/8517
16	used	VBN	O	use		-1	SENT_57	8518/8522
17	for	IN	O	for		-1	SENT_57	8523/8526
18	all	DT	O	all	det	20	SENT_57	8527/8530
19	immunization	NN	O	immunization	nn	20	SENT_57	8531/8543
20	experiments	NNS	O	experiment	prep_for	16	SENT_57	8544/8555
21	.	.	O	.		-1	SENT_57	8555/8556

1	The	DT	O	the	det	2	SENT_58	8557/8560
2	mice	NNS	O	mouse	nsubjpass	4	SENT_58	8561/8565
3	were	VBD	O	be	auxpass	4	SENT_58	8566/8570
4	divided	VBN	O	divide		-1	SENT_58	8571/8578
5	in	IN	O	in		-1	SENT_58	8579/8581
6	three	CD	NUMBER	three	num	7	SENT_58	8582/8587
7	groups	NNS	O	group	prep_in	4	SENT_58	8588/8594
8	of	IN	O	of		-1	SENT_58	8595/8597
9	eight	CD	NUMBER	eight	prep_of	7	SENT_58	8598/8603
10	each	DT	O	each	dep	9	SENT_58	8604/8608
11	.	.	O	.		-1	SENT_58	8608/8609

1	All	DT	O	all	det	3	SENT_59	8610/8613
2	three	CD	NUMBER	three	num	3	SENT_59	8614/8619
3	groups	NNS	O	group	nsubjpass	7	SENT_59	8620/8626
4	of	IN	O	of		-1	SENT_59	8627/8629
5	animals	NNS	O	animal	prep_of	3	SENT_59	8630/8637
6	were	VBD	O	be	auxpass	7	SENT_59	8638/8642
7	immunized	VBN	O	immunize		-1	SENT_59	8643/8652
8	with	IN	O	with		-1	SENT_59	8653/8657
9	prime	JJ	O	prime	amod	10	SENT_59	8658/8663
10	vaccination	NN	O	vaccination	prep_with	7	SENT_59	8664/8675
11	on	IN	O	on		-1	SENT_59	8676/8678
12	day	NN	DURATION	day	prep_on	10	SENT_59	8679/8682
13	0	CD	NUMBER	0	num	12	SENT_59	8683/8684
14	and	CC	O	and		-1	SENT_59	8685/8688
15	two	CD	NUMBER	two	num	17	SENT_59	8689/8692
16	booster	NN	O	booster	nn	17	SENT_59	8693/8700
17	vaccinations	NNS	O	vaccination	conj_and	10	SENT_59	8701/8713
18	on	IN	O	on		-1	SENT_59	8714/8716
19	days	NNS	DURATION	day	prep_on	17	SENT_59	8717/8721
20	14	CD	NUMBER	14	num	19	SENT_59	8722/8724
21	and	CC	O	and		-1	SENT_59	8725/8728
22	28	CD	NUMBER	28	conj_and	19	SENT_59	8729/8731
23	with	IN	O	with		-1	SENT_59	8732/8736
24	5	CD	NUMBER	5	num	25	SENT_59	8737/8738
25	g	NN	O	g	prep_with	7	SENT_59	8741/8742
26	of	IN	O	of		-1	SENT_59	8743/8745
27	HA	NNP	O	HA	prep_of	25	SENT_59	8746/8748
28	.	.	O	.		-1	SENT_59	8748/8749

1	The	DT	O	the	det	4	SENT_60	8750/8753
2	influenza	NN	O	influenza	nn	4	SENT_60	8754/8763
3	subunit	NN	O	subunit	nn	4	SENT_60	8764/8771
4	vaccine	NN	O	vaccine	nsubjpass	10	SENT_60	8772/8779
5	and	CC	O	and		-1	SENT_60	8780/8783
6	the	DT	O	the	det	8	SENT_60	8784/8787
7	GEM	NN	O	gem	nn	8	SENT_60	8788/8791
8	particles	NNS	O	particle	conj_and	4	SENT_60	8792/8801
9	were	VBD	O	be	auxpass	10	SENT_60	8802/8806
10	admixed	VBN	O	admix		-1	SENT_60	8807/8814
11	just	RB	O	just	advmod	10	SENT_60	8815/8819
12	before	IN	O	before		-1	SENT_60	8820/8826
13	the	DT	O	the	det	14	SENT_60	8827/8830
14	immunization	NN	O	immunization	prep_before	10	SENT_60	8831/8843
15	.	.	O	.		-1	SENT_60	8843/8844

1	The	DT	O	the	det	3	SENT_61	8845/8848
2	test	NN	O	test	nn	3	SENT_61	8849/8853
3	group	NN	O	group	nsubjpass	5	SENT_61	8854/8859
4	was	VBD	O	be	auxpass	5	SENT_61	8860/8863
5	immunized	VBN	O	immunize	dep	19	SENT_61	8864/8873
6	intranasally	RB	O	intranasally	advmod	5	SENT_61	8874/8886
7	with	IN	O	with		-1	SENT_61	8887/8891
8	12	CD	NUMBER	12	num	9	SENT_61	8892/8894
9	l	NN	O	l	prep_with	5	SENT_61	8897/8898
10	of	IN	O	of		-1	SENT_61	8899/8901
11	GEM	NN	O	gem	nn	13	SENT_61	8902/8905
12	adjuvanted	JJ	O	adjuvanted	amod	13	SENT_61	8906/8916
13	vaccine	NN	O	vaccine	prep_of	9	SENT_61	8917/8924
14	(	CD	NUMBER	(	number	15	SENT_61	8925/8926
15	2.5	CD	NUMBER	2.5	dep	13	SENT_61	8926/8929
16	109	CD	NUMBER	109	num	18	SENT_61	8937/8940
17	GEM	NN	O	gem	nn	18	SENT_61	8941/8944
18	particles	NNS	O	particle	dep	15	SENT_61	8945/8954
19	(	VBP	O	(		-1	SENT_61	8955/8956
20	1	CD	NUMBER	1	dobj	19	SENT_61	8956/8957
21	U	NNP	O	U	nn	22	SENT_61	8958/8959
22	)	NNP	O	)	nsubjpass	24	SENT_61	8959/8960
23	were	VBD	O	be	auxpass	24	SENT_61	8961/8965
24	mixed	VBN	O	mix	rcmod	20	SENT_61	8966/8971
25	with	IN	O	with		-1	SENT_61	8972/8976
26	12	CD	NUMBER	12	num	27	SENT_61	8977/8979
27	l	NN	O	l	prep_with	24	SENT_61	8982/8983
28	of	IN	O	of		-1	SENT_61	8984/8986
29	5	CD	NUMBER	5	num	30	SENT_61	8987/8988
30	g	NN	O	g	prep_of	27	SENT_61	8991/8992
31	HA	NNP	O	HA	dep	33	SENT_61	8993/8995
32	)	CD	NUMBER	)	num	31	SENT_61	8995/8996
33	divided	VBN	O	divide	amod	30	SENT_61	8997/9004
34	over	IN	O	over	prep	33	SENT_61	9005/9009
35	both	CC	O	both	dep	34	SENT_61	9010/9014
36	the	DT	O	the	det	37	SENT_61	9015/9018
37	nostrils	NNS	O	nostril	conj	34	SENT_61	9019/9027
38	under	IN	O	under		-1	SENT_61	9028/9033
39	inhalation	NN	O	inhalation	nn	40	SENT_61	9034/9044
40	anesthesia	NN	O	anesthesia	prep_under	34	SENT_61	9045/9055
41	(	CD	NUMBER	(	num	43	SENT_61	9056/9057
42	isoflurane/O2	NN	O	isoflurane/o2	nn	43	SENT_61	9057/9070
43	)	NN	O	)	nsubj	19	SENT_61	9070/9071
44	.	.	O	.		-1	SENT_61	9071/9072

1	In	IN	O	in		-1	SENT_62	9073/9075
2	two	CD	NUMBER	two	num	4	SENT_62	9076/9079
3	control	NN	O	control	nn	4	SENT_62	9080/9087
4	groups	NNS	O	group	prep_in	9	SENT_62	9088/9094
5	,	,	O	,		-1	SENT_62	9094/9095
6	one	CD	NUMBER	one	num	7	SENT_62	9096/9099
7	group	NN	O	group	nsubjpass	9	SENT_62	9100/9105
8	was	VBD	O	be	auxpass	9	SENT_62	9106/9109
9	injected	VBN	O	inject	dep	32	SENT_62	9110/9118
10	with	IN	O	with		-1	SENT_62	9119/9123
11	an	DT	O	a	det	13	SENT_62	9124/9126
12	intramuscular	JJ	O	intramuscular	amod	13	SENT_62	9127/9140
13	injection	NN	O	injection	prep_with	9	SENT_62	9141/9150
14	of	IN	O	of		-1	SENT_62	9151/9153
15	50	CD	NUMBER	50	num	17	SENT_62	9154/9156
16	l	NN	O	l	nn	17	SENT_62	9159/9160
17	vaccine	NN	O	vaccine	prep_of	13	SENT_62	9161/9168
18	in	IN	O	in		-1	SENT_62	9169/9171
19	posterior	JJ	O	posterior	amod	21	SENT_62	9172/9181
20	thigh	NN	O	thigh	nn	21	SENT_62	9182/9187
21	muscles	NNS	O	muscle	prep_in	17	SENT_62	9188/9195
22	under	IN	O	under		-1	SENT_62	9196/9201
23	inhalation	NN	O	inhalation	nn	24	SENT_62	9202/9212
24	anaesthesia	NN	O	anaesthesia	prep_under	9	SENT_62	9213/9224
25	(	CD	NUMBER	(	num	27	SENT_62	9225/9226
26	isoflurane/O2	NN	O	isoflurane/o2	nn	27	SENT_62	9226/9239
27	)	NN	O	)	dep	24	SENT_62	9239/9240
28	and	CC	O	and		-1	SENT_62	9241/9244
29	second	JJ	ORDINAL	second	amod	30	SENT_62	9245/9251
30	group	NN	O	group	conj_and	24	SENT_62	9252/9257
31	was	VBD	O	be	auxpass	32	SENT_62	9258/9261
32	administered	VBN	O	administer		-1	SENT_62	9262/9274
33	12	CD	NUMBER	12	num	34	SENT_62	9275/9277
34	l	NN	O	l	dobj	32	SENT_62	9280/9281
35	of	IN	O	of		-1	SENT_62	9282/9284
36	vaccine	NN	O	vaccine	prep_of	34	SENT_62	9285/9292
37	intranasally	RB	O	intranasally	advmod	32	SENT_62	9293/9305
38	under	IN	O	under		-1	SENT_62	9306/9311
39	inhalation	NN	O	inhalation	nn	40	SENT_62	9312/9322
40	anaesthesia	NN	O	anaesthesia	prep_under	32	SENT_62	9323/9334
41	(	CD	NUMBER	(	num	43	SENT_62	9335/9336
42	isoflurane/O2	NN	O	isoflurane/o2	nn	43	SENT_62	9336/9349
43	)	NN	O	)	nsubjpass	32	SENT_62	9349/9350
44	.	.	O	.		-1	SENT_62	9350/9351

1	The	DT	O	the	det	2	SENT_63	9352/9355
2	mice	NNS	O	mouse	nsubjpass	4	SENT_63	9356/9360
3	were	VBD	O	be	auxpass	4	SENT_63	9361/9365
4	sacrificed	VBN	O	sacrifice		-1	SENT_63	9366/9376
5	2	CD	DATE	2	num	6	SENT_63	9377/9378
6	weeks	NNS	DATE	week	dobj	4	SENT_63	9379/9384
7	after	IN	DATE	after		-1	SENT_63	9385/9390
8	the	DT	DATE	the	det	11	SENT_63	9391/9394
9	second	JJ	DATE	second	amod	11	SENT_63	9395/9401
10	booster	NN	O	booster	nn	11	SENT_63	9402/9409
11	vaccination	NN	O	vaccination	prep_after	6	SENT_63	9410/9421
12	,	,	O	,		-1	SENT_63	9421/9422
13	i.e.	FW	O	i.e.	dep	6	SENT_63	9423/9427
14	,	,	O	,		-1	SENT_63	9427/9428
15	on	IN	O	on		-1	SENT_63	9429/9431
16	day	NN	DURATION	day	prep_on	6	SENT_63	9432/9435
17	42	CD	NUMBER	42	num	16	SENT_63	9436/9438
18	.	.	O	.		-1	SENT_63	9438/9439

1	After	IN	O	after	mark	5	SENT_64	9440/9445
2	the	DT	O	the	det	3	SENT_64	9446/9449
3	animals	NNS	O	animal	nsubjpass	5	SENT_64	9450/9457
4	were	VBD	O	be	auxpass	5	SENT_64	9458/9462
5	sacrificed	VBN	O	sacrifice	advcl	13	SENT_64	9463/9473
6	,	,	O	,		-1	SENT_64	9473/9474
7	the	DT	O	the	det	8	SENT_64	9475/9478
8	spleens	NNS	O	spleen	nsubjpass	13	SENT_64	9479/9486
9	of	IN	O	of		-1	SENT_64	9487/9489
10	the	DT	O	the	det	11	SENT_64	9490/9493
11	animals	NNS	O	animal	prep_of	8	SENT_64	9494/9501
12	were	VBD	O	be	auxpass	13	SENT_64	9502/9506
13	harvested	VBN	O	harvest		-1	SENT_64	9507/9516
14	and	CC	O	and		-1	SENT_64	9517/9520
15	subsequently	RB	O	subsequently	advmod	16	SENT_64	9521/9533
16	stored	VBN	O	store	conj_and	13	SENT_64	9534/9540
17	in	IN	O	in		-1	SENT_64	9541/9543
18	supplemented	VBN	O	supplement	prepc_in	16	SENT_64	9544/9556
19	Iscoves	NNP	O	Iscoves	poss	46	SENT_64	9557/9564
20	's	POS	O	's		-1	SENT_64	9564/9566
21	modified	VBN	O	modify	partmod	46	SENT_64	9567/9575
22	Dulbecco	NNP	PERSON	Dulbecco	poss	43	SENT_64	9576/9584
23	's	POS	O	's		-1	SENT_64	9584/9586
24	medium	NN	O	medium	nn	43	SENT_64	9587/9593
25	-	:	O	-		-1	SENT_64	9593/9594
26	glutamax	NN	O	glutamax	nn	27	SENT_64	9595/9603
27	medium	NN	O	medium	dep	43	SENT_64	9604/9610
28	with	IN	O	with		-1	SENT_64	9611/9615
29	5	CD	PERCENT	5	number	30	SENT_64	9616/9617
30	%	NN	PERCENT	%	amod	33	SENT_64	9617/9618
31	fetal	JJ	O	fetal	amod	33	SENT_64	9619/9624
32	calf	NN	O	calf	nn	33	SENT_64	9625/9629
33	serum	NN	O	serum	prep_with	27	SENT_64	9630/9635
34	,	,	O	,		-1	SENT_64	9635/9636
35	1	CD	PERCENT	1	num	36	SENT_64	9637/9638
36	%	NN	PERCENT	%	conj_and	27	SENT_64	9638/9639
37	penicillin/streptomycin	NN	O	penicillin/streptomycin	dep	36	SENT_64	9640/9663
38	,	,	O	,		-1	SENT_64	9663/9664
39	and	CC	O	and		-1	SENT_64	9665/9668
40	50	CD	NUMBER	50	num	41	SENT_64	9669/9671
41	M	NN	O	m	conj_and	27	SENT_64	9674/9675
42	-	:	O	-		-1	SENT_64	9678/9679
43	mercaptoethanol	NN	O	mercaptoethanol	dobj	21	SENT_64	9679/9694
44	at	IN	O	at		-1	SENT_64	9695/9697
45	4	CD	NUMBER	4	prep_at	21	SENT_64	9698/9699
46	C.	NN	O	c.	dep	18	SENT_64	9701/9703

1	Sera	NNP	O	Sera	nn	2	SENT_65	9739/9743
2	Collection	NNP	O	Collection		-1	SENT_65	9744/9754
3	and	CC	O	and		-1	SENT_65	9755/9758
4	Mucosal	JJ	O	mucosal	amod	5	SENT_65	9759/9766
5	Washes	NNS	O	wash	conj_and	2	SENT_65	9767/9773

1	Blood	NN	O	blood	nn	2	SENT_66	9809/9814
2	samples	NNS	O	sample	nsubjpass	4	SENT_66	9815/9822
3	were	VBD	O	be	auxpass	4	SENT_66	9823/9827
4	drawn	VBN	O	draw		-1	SENT_66	9828/9833
5	three	CD	NUMBER	three	num	6	SENT_66	9834/9839
6	times	NNS	O	time	dobj	4	SENT_66	9840/9845
7	during	IN	O	during		-1	SENT_66	9846/9852
8	the	DT	O	the	det	9	SENT_66	9853/9856
9	experiments	NNS	O	experiment	prep_during	6	SENT_66	9857/9868
10	,	,	O	,		-1	SENT_66	9868/9869
11	i.e.	FW	O	i.e.	dep	6	SENT_66	9870/9874
12	,	,	O	,		-1	SENT_66	9874/9875
13	on	IN	O	on		-1	SENT_66	9876/9878
14	day	NN	DURATION	day	prep_on	6	SENT_66	9879/9882
15	0	CD	NUMBER	0	num	14	SENT_66	9883/9884
16	and	CC	O	and		-1	SENT_66	9885/9888
17	28	CD	NUMBER	28	conj_and	14	SENT_66	9889/9891
18	by	IN	O	by		-1	SENT_66	9892/9894
19	orbital	JJ	O	orbital	amod	20	SENT_66	9895/9902
20	puncture	NN	O	puncture	agent	4	SENT_66	9903/9911
21	and	CC	O	and		-1	SENT_66	9912/9915
22	day	NN	DURATION	day	conj_and	20	SENT_66	9916/9919
23	42	CD	NUMBER	42	num	22	SENT_66	9920/9922
24	by	IN	O	by		-1	SENT_66	9923/9925
25	heart	NN	O	heart	nn	26	SENT_66	9926/9931
26	puncture	NN	O	puncture	agent	4	SENT_66	9932/9940
27	.	.	O	.		-1	SENT_66	9940/9941

1	Sera	NNP	O	Sera	nsubjpass	3	SENT_67	9942/9946
2	were	VBD	O	be	auxpass	3	SENT_67	9947/9951
3	obtained	VBN	O	obtain		-1	SENT_67	9952/9960
4	by	IN	O	by		-1	SENT_67	9961/9963
5	centrifugation	NN	O	centrifugation	agent	3	SENT_67	9964/9978
6	of	IN	O	of		-1	SENT_67	9979/9981
7	blood	NN	O	blood	prep_of	5	SENT_67	9982/9987
8	at	IN	O	at		-1	SENT_67	9988/9990
9	1,200	CD	NUMBER	1,200	num	10	SENT_67	9991/9996
10	g	NN	O	g	prep_at	3	SENT_67	9998/9999
11	for	IN	O	for		-1	SENT_67	10000/10003
12	5	CD	DURATION	5	num	13	SENT_67	10004/10005
13	min	NN	DURATION	min	prep_for	10	SENT_67	10006/10009
14	,	,	O	,		-1	SENT_67	10009/10010
15	and	CC	O	and		-1	SENT_67	10011/10014
16	the	DT	O	the	det	17	SENT_67	10015/10018
17	samples	NNS	O	sample	nsubjpass	20	SENT_67	10019/10026
18	were	VBD	O	be	auxpass	20	SENT_67	10027/10031
19	subsequently	RB	O	subsequently	advmod	20	SENT_67	10032/10044
20	stored	VBN	O	store	conj_and	3	SENT_67	10045/10051
21	at	IN	O	at		-1	SENT_67	10052/10054
22	20	CD	NUMBER	20	num	23	SENT_67	10058/10060
23	C	NN	O	c	prep_at	20	SENT_67	10062/10063
24	until	IN	O	until		-1	SENT_67	10064/10069
25	further	JJ	O	further	amod	26	SENT_67	10070/10077
26	analysis	NN	O	analysis	prep_until	20	SENT_67	10078/10086
27	.	.	O	.		-1	SENT_67	10086/10087

1	Nasal	JJ	O	nasal	amod	4	SENT_68	10123/10128
2	and	CC	O	and		-1	SENT_68	10129/10132
3	lung	NN	O	lung	conj_and	1	SENT_68	10133/10137
4	lavages	NNS	O	lavage	nsubjpass	6	SENT_68	10138/10145
5	were	VBD	O	be	auxpass	6	SENT_68	10146/10150
6	performed	VBN	O	perform		-1	SENT_68	10151/10160
7	as	IN	O	as	mark	8	SENT_68	10161/10163
8	described	VBN	O	describe	advcl	6	SENT_68	10164/10173
9	earlier	JJR	O	earlier	advmod	8	SENT_68	10174/10181
10	(	CD	NUMBER	(	num	12	SENT_68	10182/10183
11	34	CD	NUMBER	34	num	12	SENT_68	10183/10185
12	)	NN	O	)	dobj	8	SENT_68	10185/10186
13	.	.	O	.		-1	SENT_68	10186/10187

1	Briefly	RB	O	briefly	advmod	9	SENT_69	10188/10195
2	,	,	O	,		-1	SENT_69	10195/10196
3	the	DT	O	the	det	4	SENT_69	10197/10200
4	trachea	NN	O	trachea	nsubjpass	9	SENT_69	10201/10208
5	of	IN	O	of		-1	SENT_69	10209/10211
6	each	DT	O	each	det	7	SENT_69	10212/10216
7	mouse	NN	O	mouse	prep_of	4	SENT_69	10217/10222
8	was	VBD	O	be	auxpass	9	SENT_69	10223/10226
9	cannulated	VBN	O	cannulate		-1	SENT_69	10227/10237
10	and	CC	O	and		-1	SENT_69	10238/10241
11	connected	VBN	O	connect	conj_and	9	SENT_69	10242/10251
12	to	TO	O	to		-1	SENT_69	10252/10254
13	a	DT	O	a	det	15	SENT_69	10255/10256
14	1-ml	JJ	O	1-ml	amod	15	SENT_69	10257/10261
15	syringe	NN	O	syringe	prep_to	9	SENT_69	10262/10269
16	.	.	O	.		-1	SENT_69	10269/10270

1	Lung	NN	O	lung	nn	2	SENT_70	10271/10275
2	washes	NNS	O	wash	nsubjpass	4	SENT_70	10276/10282
3	were	VBD	O	be	auxpass	4	SENT_70	10283/10287
4	taken	VBN	O	take		-1	SENT_70	10288/10293
5	by	IN	O	by		-1	SENT_70	10294/10296
6	repeated	VBN	O	repeat	amod	7	SENT_70	10297/10305
7	flushing	NN	O	flushing	agent	4	SENT_70	10306/10314
8	of	IN	O	of		-1	SENT_70	10315/10317
9	lungs	NNS	O	lung	prep_of	7	SENT_70	10318/10323
10	with	IN	O	with		-1	SENT_70	10324/10328
11	1	CD	NUMBER	1	num	13	SENT_70	10329/10330
12	ml	NN	O	ml	nn	13	SENT_70	10331/10333
13	PBS	NNP	O	PBS	prep_with	9	SENT_70	10334/10337
14	(	CD	NUMBER	(	num	15	SENT_70	10338/10339
15	pH	NN	O	ph	dep	13	SENT_70	10339/10341
16	7	CD	NUMBER	7	num	17	SENT_70	10342/10343
17	)	NN	O	)	dep	15	SENT_70	10343/10344
18	.	.	O	.		-1	SENT_70	10344/10345

1	Nasal	JJ	O	nasal	amod	2	SENT_71	10346/10351
2	washes	NNS	O	wash	nsubjpass	4	SENT_71	10352/10358
3	were	VBD	O	be	auxpass	4	SENT_71	10359/10363
4	obtained	VBN	O	obtain		-1	SENT_71	10364/10372
5	by	IN	O	by		-1	SENT_71	10373/10375
6	flushing	VBG	O	flush	agent	4	SENT_71	10376/10384
7	the	DT	O	the	det	8	SENT_71	10385/10388
8	nasopharynx	NN	O	nasopharynx	dobj	6	SENT_71	10389/10400
9	with	IN	O	with		-1	SENT_71	10401/10405
10	1	CD	NUMBER	1	num	12	SENT_71	10406/10407
11	ml	NN	O	ml	nn	12	SENT_71	10408/10410
12	PBS	NNP	O	PBS	prep_with	6	SENT_71	10411/10414
13	.	.	O	.		-1	SENT_71	10414/10415

1	Subsequently	RB	O	subsequently	advmod	7	SENT_72	10416/10428
2	,	,	O	,		-1	SENT_72	10428/10429
3	the	DT	O	the	det	5	SENT_72	10430/10433
4	mucosal	JJ	O	mucosal	amod	5	SENT_72	10434/10441
5	washes	NNS	O	wash	nsubjpass	7	SENT_72	10442/10448
6	were	VBD	O	be	auxpass	7	SENT_72	10449/10453
7	admixed	VBN	O	admix		-1	SENT_72	10454/10461
8	with	IN	O	with		-1	SENT_72	10462/10466
9	10	CD	NUMBER	10	num	10	SENT_72	10467/10469
10	l	NN	O	l	prep_with	7	SENT_72	10472/10473
11	of	IN	O	of		-1	SENT_72	10474/10476
12	protease	NN	O	protease	nn	14	SENT_72	10477/10485
13	inhibitor	NN	O	inhibitor	nn	14	SENT_72	10486/10495
14	solution	NN	O	solution	prep_of	10	SENT_72	10496/10504
15	(	CD	NUMBER	(	num	17	SENT_72	10505/10506
16	one	CD	NUMBER	one	num	17	SENT_72	10506/10509
17	tablet	NN	O	tablet	dep	24	SENT_72	10510/10516
18	Complete	JJ	O	complete	amod	20	SENT_72	10517/10525
19	protease	NN	O	protease	nn	20	SENT_72	10528/10536
20	inhibitor	NN	O	inhibitor	dep	17	SENT_72	10537/10546
21	cocktail	NN	O	cocktail	dep	24	SENT_72	10547/10555
22	(	CD	NUMBER	(	num	21	SENT_72	10556/10557
23	Roche	NNP	PERSON	Roche	nn	24	SENT_72	10557/10562
24	diagnostics	NNS	O	diagnostic	dep	10	SENT_72	10563/10574
25	)	CD	NUMBER	)	dep	24	SENT_72	10574/10575
26	dissolved	VBN	O	dissolve	partmod	10	SENT_72	10576/10585
27	in	IN	O	in		-1	SENT_72	10586/10588
28	2	CD	NUMBER	2	num	29	SENT_72	10589/10590
29	ml	NN	O	ml	prep_in	26	SENT_72	10591/10593
30	PBS	NNP	O	PBS	tmod	26	SENT_72	10594/10597
31	)	CD	NUMBER	)	num	30	SENT_72	10597/10598
32	.	.	O	.		-1	SENT_72	10598/10599

1	ELISA	NN	PERSON	elisa		-1	SENT_73	10635/10640

1	The	DT	O	the	det	3	SENT_74	10676/10679
2	antibody	NN	O	antibody	nn	3	SENT_74	10680/10688
3	response	NN	O	response	nsubjpass	10	SENT_74	10689/10697
4	to	TO	O	to		-1	SENT_74	10698/10700
5	the	DT	O	the	det	8	SENT_74	10701/10704
6	influenza	NN	O	influenza	nn	8	SENT_74	10705/10714
7	subunit	NN	O	subunit	nn	8	SENT_74	10715/10722
8	antigen	NN	O	antigen	prep_to	3	SENT_74	10723/10730
9	was	VBD	O	be	auxpass	10	SENT_74	10731/10734
10	determined	VBN	O	determine		-1	SENT_74	10735/10745
11	using	VBG	O	use	xcomp	10	SENT_74	10746/10751
12	enzyme-linked	JJ	O	enzyme-linked	amod	14	SENT_74	10752/10765
13	immunosorbent	JJ	O	immunosorbent	amod	14	SENT_74	10766/10779
14	assays	NNS	O	assay	dobj	11	SENT_74	10780/10786
15	as	IN	O	as	mark	16	SENT_74	10787/10789
16	described	VBN	O	describe	advcl	11	SENT_74	10790/10799
17	previously	RB	DATE	previously	advmod	16	SENT_74	10800/10810
18	(	CD	NUMBER	(	num	20	SENT_74	10811/10812
19	34	CD	NUMBER	34	num	20	SENT_74	10812/10814
20	)	NN	O	)	dobj	16	SENT_74	10814/10815
21	.	.	O	.		-1	SENT_74	10815/10816

1	Briefly	RB	O	briefly	advmod	6	SENT_75	10817/10824
2	,	,	O	,		-1	SENT_75	10824/10825
3	the	DT	O	the	det	4	SENT_75	10826/10829
4	plates	NNS	O	plate	nsubjpass	6	SENT_75	10830/10836
5	were	VBD	O	be	auxpass	6	SENT_75	10837/10841
6	incubated	VBN	O	incubate		-1	SENT_75	10842/10851
7	with	IN	O	with		-1	SENT_75	10852/10856
8	200	CD	NUMBER	200	num	9	SENT_75	10857/10860
9	ng	NN	O	ng	prep_with	6	SENT_75	10861/10863
10	of	IN	O	of		-1	SENT_75	10864/10866
11	HA/well	NN	O	ha/well	prep_of	9	SENT_75	10867/10874
12	.	.	O	.		-1	SENT_75	10874/10875

1	After	IN	O	after		-1	SENT_76	10876/10881
2	overnight	JJ	TIME	overnight	amod	3	SENT_76	10882/10891
3	incubation	NN	O	incubation	prep_after	10	SENT_76	10892/10902
4	with	IN	O	with		-1	SENT_76	10903/10907
5	HA	NN	O	ha	prep_with	3	SENT_76	10908/10910
6	,	,	O	,		-1	SENT_76	10910/10911
7	the	DT	O	the	det	8	SENT_76	10912/10915
8	plates	NNS	O	plate	nsubjpass	10	SENT_76	10916/10922
9	were	VBD	O	be	auxpass	10	SENT_76	10923/10927
10	blocked	VBN	O	block		-1	SENT_76	10928/10935
11	with	IN	O	with		-1	SENT_76	10936/10940
12	3	CD	PERCENT	3	num	13	SENT_76	10941/10942
13	%	NN	PERCENT	%	npadvmod	14	SENT_76	10942/10943
14	bovine	JJ	O	bovine	amod	16	SENT_76	10944/10950
15	serum	NN	O	serum	nn	16	SENT_76	10951/10956
16	albumin	NN	O	albumin	prep_with	10	SENT_76	10957/10964
17	(	CD	NUMBER	(	num	18	SENT_76	10965/10966
18	BSA	NN	ORGANIZATION	bsa	dep	16	SENT_76	10966/10969
19	;	:	O	;		-1	SENT_76	10969/10970
20	Sigma-Aldrich	NNP	ORGANIZATION	Sigma-Aldrich	dep	16	SENT_76	10971/10984
21	,	,	O	,		-1	SENT_76	10984/10985
22	The	DT	LOCATION	the	det	24	SENT_76	10986/10989
23	Netherlands	NNP	LOCATION	Netherlands	nn	24	SENT_76	10990/11001
24	)	NN	O	)	appos	20	SENT_76	11001/11002
25	.	.	O	.		-1	SENT_76	11002/11003

1	Then	RB	O	then	advmod	27	SENT_77	11004/11008
2	,	,	O	,		-1	SENT_77	11008/11009
3	plates	NNS	O	plate	nsubjpass	5	SENT_77	11010/11016
4	were	VBD	O	be	auxpass	5	SENT_77	11017/11021
5	washed	VBN	O	wash	parataxis	27	SENT_77	11022/11028
6	and	CC	O	and		-1	SENT_77	11029/11032
7	incubated	VBN	O	incubate	conj_and	5	SENT_77	11033/11042
8	with	IN	O	with		-1	SENT_77	11043/11047
9	sera	NNS	O	serum	prep_with	5	SENT_77	11048/11052
10	and	CC	O	and		-1	SENT_77	11053/11056
11	mucosal	JJ	O	mucosal	amod	12	SENT_77	11057/11064
12	samples	NNS	O	sample	conj_and	9	SENT_77	11065/11072
13	in	IN	O	in		-1	SENT_77	11073/11075
14	serial	JJ	O	serial	amod	15	SENT_77	11076/11082
15	dilution	NN	O	dilution	prep_in	12	SENT_77	11083/11091
16	for	IN	O	for		-1	SENT_77	11092/11095
17	1.5	CD	NUMBER	1.5	num	18	SENT_77	11096/11099
18	h	NN	O	h	prep_for	15	SENT_77	11100/11101
19	at	IN	O	at		-1	SENT_77	11102/11104
20	37	CD	NUMBER	37	prep_at	18	SENT_77	11105/11107
21	C.	NNP	O	C.	nn	22	SENT_77	11109/11111
22	Next	NNP	O	Next	dep	12	SENT_77	11112/11116
23	,	,	O	,		-1	SENT_77	11116/11117
24	the	DT	O	the	det	25	SENT_77	11118/11121
25	plates	NNS	O	plate	nsubjpass	27	SENT_77	11122/11128
26	were	VBD	O	be	auxpass	27	SENT_77	11129/11133
27	washed	VBN	O	wash		-1	SENT_77	11134/11140
28	and	CC	O	and		-1	SENT_77	11141/11144
29	incubated	VBN	O	incubate	conj_and	27	SENT_77	11145/11154
30	with	IN	O	with		-1	SENT_77	11155/11159
31	horseradish	JJ	O	horseradish	amod	34	SENT_77	11160/11171
32	peroxidase-conjugated	JJ	O	peroxidase-conjugated	amod	34	SENT_77	11172/11193
33	goat	NN	O	goat	nn	34	SENT_77	11194/11198
34	antibodies	NNS	O	antibody	prep_with	27	SENT_77	11199/11209
35	directed	VBN	O	direct	partmod	34	SENT_77	11210/11218
36	against	IN	O	against		-1	SENT_77	11219/11226
37	mouse	NN	O	mouse	nn	38	SENT_77	11227/11232
38	IgG	NN	O	igg	prep_against	35	SENT_77	11233/11236
39	,	,	O	,		-1	SENT_77	11236/11237
40	IgG1	NN	O	igg1	conj_and	38	SENT_77	11238/11242
41	,	,	O	,		-1	SENT_77	11242/11243
42	IgG2a	NN	O	igg2a	conj_and	38	SENT_77	11244/11249
43	,	,	O	,		-1	SENT_77	11249/11250
44	IgG2b	NN	O	igg2b	conj_and	38	SENT_77	11251/11256
45	,	,	O	,		-1	SENT_77	11256/11257
46	and	CC	O	and		-1	SENT_77	11258/11261
47	IgA	NN	O	iga	conj_and	38	SENT_77	11262/11265
48	(	CD	NUMBER	(	num	47	SENT_77	11266/11267
49	Southern	NNP	ORGANIZATION	Southern	nn	56	SENT_77	11267/11275
50	Biotech	NNP	ORGANIZATION	Biotech	nn	56	SENT_77	11276/11283
51	,	,	O	,		-1	SENT_77	11283/11284
52	Birmingham	NNP	LOCATION	Birmingham	appos	56	SENT_77	11285/11295
53	,	,	O	,		-1	SENT_77	11295/11296
54	AL	NNP	O	AL	appos	56	SENT_77	11297/11299
55	,	,	O	,		-1	SENT_77	11299/11300
56	USA	NNP	LOCATION	USA	dep	47	SENT_77	11301/11304
57	)	CD	NUMBER	)	num	56	SENT_77	11304/11305
58	.	.	O	.		-1	SENT_77	11305/11306

1	Finally	RB	O	finally	advmod	25	SENT_78	11307/11314
2	,	,	O	,		-1	SENT_78	11314/11315
3	the	DT	O	the	det	5	SENT_78	11316/11319
4	substrate	NN	O	substrate	nn	5	SENT_78	11320/11329
5	solution	NN	O	solution	dep	10	SENT_78	11330/11338
6	(	CD	PERCENT	(	dep	5	SENT_78	11339/11340
7	0.02	CD	PERCENT	0.02	num	8	SENT_78	11340/11344
8	%	NN	PERCENT	%	dep	10	SENT_78	11344/11345
9	1,2-phenyllendiamine	NN	O	1,2-phenyllendiamine	nn	10	SENT_78	11346/11366
10	dihydrochloride	NN	O	dihydrochloride	dep	16	SENT_78	11367/11382
11	in	IN	O	in		-1	SENT_78	11383/11385
12	50	CD	NUMBER	50	num	15	SENT_78	11386/11388
13	mM	NN	O	mm	nn	15	SENT_78	11389/11391
14	phosphate	NN	O	phosphate	nn	15	SENT_78	11392/11401
15	buffer	NN	O	buffer	prep_in	10	SENT_78	11402/11408
16	pH	NN	O	ph	dep	25	SENT_78	11409/11411
17	5.6	CD	NUMBER	5.6	num	16	SENT_78	11412/11415
18	,	,	O	,		-1	SENT_78	11415/11416
19	containing	VBG	O	contain	dep	25	SENT_78	11417/11427
20	0.006	CD	PERCENT	0.006	num	21	SENT_78	11428/11433
21	%	NN	PERCENT	%	dobj	19	SENT_78	11433/11434
22	H2O2	NN	O	h2o2	nn	23	SENT_78	11435/11439
23	)	NN	O	)	nsubjpass	25	SENT_78	11439/11440
24	was	VBD	O	be	auxpass	25	SENT_78	11441/11444
25	added	VBN	O	add		-1	SENT_78	11445/11450
26	and	CC	O	and		-1	SENT_78	11451/11454
27	the	DT	O	the	det	28	SENT_78	11455/11458
28	plates	NNS	O	plate	nsubjpass	30	SENT_78	11459/11465
29	were	VBD	O	be	auxpass	30	SENT_78	11466/11470
30	incubated	VBN	O	incubate	conj_and	25	SENT_78	11471/11480
31	in	IN	O	in		-1	SENT_78	11481/11483
32	the	DT	O	the	det	33	SENT_78	11484/11487
33	dark	NN	O	dark	prep_in	30	SENT_78	11488/11492
34	for	IN	O	for		-1	SENT_78	11493/11496
35	30	CD	DURATION	30	num	36	SENT_78	11497/11499
36	min	NN	DURATION	min	prep_for	33	SENT_78	11500/11503
37	at	IN	O	at		-1	SENT_78	11504/11506
38	room	NN	O	room	nn	39	SENT_78	11507/11511
39	temperature	NN	O	temperature	prep_at	30	SENT_78	11512/11523
40	.	.	O	.		-1	SENT_78	11523/11524

1	The	DT	O	the	det	2	SENT_79	11525/11528
2	reaction	NN	O	reaction	nsubjpass	4	SENT_79	11529/11537
3	was	VBD	O	be	auxpass	4	SENT_79	11538/11541
4	stopped	VBN	O	stop		-1	SENT_79	11542/11549
5	by	IN	O	by		-1	SENT_79	11550/11552
6	addition	NN	O	addition	agent	4	SENT_79	11553/11561
7	of	IN	O	of		-1	SENT_79	11562/11564
8	2	CD	NUMBER	2	num	10	SENT_79	11565/11566
9	M	NN	O	m	nn	10	SENT_79	11567/11568
10	H2SO4	NN	O	h2so4	prep_of	6	SENT_79	11569/11574
11	,	,	O	,		-1	SENT_79	11574/11575
12	and	CC	O	and		-1	SENT_79	11576/11579
13	absorbance	NN	O	absorbance	nsubjpass	18	SENT_79	11580/11590
14	at	IN	O	at		-1	SENT_79	11591/11593
15	490	CD	NUMBER	490	num	16	SENT_79	11594/11597
16	nm	NN	O	nm	prep_at	13	SENT_79	11598/11600
17	was	VBD	O	be	auxpass	18	SENT_79	11601/11604
18	read	VBN	O	read	conj_and	4	SENT_79	11605/11609
19	with	IN	O	with		-1	SENT_79	11610/11614
20	a	DT	O	a	det	23	SENT_79	11615/11616
21	Benchmark	NNP	O	Benchmark	nn	23	SENT_79	11617/11626
22	Microplate	NNP	O	Microplate	nn	23	SENT_79	11627/11637
23	reader	NN	O	reader	prep_with	18	SENT_79	11638/11644
24	(	CD	NUMBER	(	num	23	SENT_79	11645/11646
25	BioRad	NNP	O	BioRad	nn	31	SENT_79	11646/11652
26	,	,	O	,		-1	SENT_79	11652/11653
27	Hercules	NNP	O	Hercules	appos	31	SENT_79	11654/11662
28	,	,	O	,		-1	SENT_79	11662/11663
29	CA	NNP	O	CA	appos	31	SENT_79	11664/11666
30	,	,	O	,		-1	SENT_79	11666/11667
31	USA	NNP	LOCATION	USA	dep	23	SENT_79	11668/11671
32	)	CD	NUMBER	)	num	31	SENT_79	11671/11672
33	.	.	O	.		-1	SENT_79	11672/11673

1	Titers	NNS	O	titer	nsubj	2	SENT_80	11674/11680
2	reported	VBD	O	report		-1	SENT_80	11681/11689
3	are	VBP	O	be	cop	5	SENT_80	11690/11693
4	the	DT	O	the	det	5	SENT_80	11694/11697
5	reciprocal	JJ	O	reciprocal	ccomp	2	SENT_80	11698/11708
6	of	IN	O	of		-1	SENT_80	11709/11711
7	the	DT	O	the	det	10	SENT_80	11712/11715
8	calculated	VBN	O	calculate	amod	10	SENT_80	11716/11726
9	sample	NN	O	sample	nn	10	SENT_80	11727/11733
10	dilution	NN	O	dilution	prep_of	5	SENT_80	11734/11742
11	corresponding	VBG	O	correspond	partmod	10	SENT_80	11743/11756
12	with	IN	O	with		-1	SENT_80	11757/11761
13	an	DT	O	a	det	14	SENT_80	11762/11764
14	A490	NN	O	a490	prep_with	11	SENT_80	11765/11769
15	0.2	CD	NUMBER	0.2	num	14	SENT_80	11778/11781
16	after	IN	O	after		-1	SENT_80	11782/11787
17	background	NN	O	background	nn	18	SENT_80	11788/11798
18	correction	NN	O	correction	prep_after	11	SENT_80	11799/11809
19	.	.	O	.		-1	SENT_80	11809/11810

1	Hemagglutination	NNP	O	Hemagglutination		-1	SENT_81	11846/11862
2	Inhibition	NN	O	inhibition	nn	3	SENT_81	11863/11873
3	Assay	NN	O	assay	dep	1	SENT_81	11874/11879

1	Hemagglutination	NN	O	hemagglutination	nn	2	SENT_82	11915/11931
2	inhibition	NN	O	inhibition	nsubj	12	SENT_82	11932/11942
3	(	CD	NUMBER	(	num	6	SENT_82	11943/11944
4	HI	NN	O	hus	nn	6	SENT_82	11944/11946
5	)	NN	O	)	nn	6	SENT_82	11946/11947
6	titers	NNS	O	titer	nsubjpass	10	SENT_82	11948/11954
7	in	IN	O	in		-1	SENT_82	11955/11957
8	serum	NN	O	serum	prep_in	6	SENT_82	11958/11963
9	were	VBD	O	be	auxpass	10	SENT_82	11964/11968
10	determined	VBN	O	determine	rcmod	2	SENT_82	11969/11979
11	as	IN	O	as	prep	10	SENT_82	11980/11982
12	described	VBN	O	describe		-1	SENT_82	11983/11992
13	previously	RB	DATE	previously	advmod	12	SENT_82	11993/12003
14	(	CD	NUMBER	(	num	16	SENT_82	12004/12005
15	34	CD	NUMBER	34	num	16	SENT_82	12005/12007
16	)	NN	O	)	dobj	12	SENT_82	12007/12008
17	.	.	O	.		-1	SENT_82	12008/12009

1	Briefly	RB	O	briefly	advmod	5	SENT_83	12010/12017
2	,	,	O	,		-1	SENT_83	12017/12018
3	serum	NN	O	serum	nsubjpass	5	SENT_83	12019/12024
4	was	VBD	O	be	auxpass	5	SENT_83	12025/12028
5	inactivated	VBN	O	inactivate		-1	SENT_83	12029/12040
6	at	IN	O	at		-1	SENT_83	12041/12043
7	56	CD	NUMBER	56	num	8	SENT_83	12044/12046
8	C	NN	O	c	prep_at	5	SENT_83	12048/12049
9	for	IN	O	for		-1	SENT_83	12050/12053
10	30	CD	DURATION	30	num	11	SENT_83	12054/12056
11	min	NN	DURATION	min	prep_for	8	SENT_83	12057/12060
12	.	.	O	.		-1	SENT_83	12060/12061

1	In	IN	O	in	mark	4	SENT_84	12062/12064
2	order	NN	O	order	dep	4	SENT_84	12065/12070
3	to	TO	O	to	aux	4	SENT_84	12071/12073
4	reduce	VB	O	reduce	advcl	13	SENT_84	12074/12080
5	nonspecific	JJ	O	nonspecific	amod	6	SENT_84	12081/12092
6	hemagglutination	NN	O	hemagglutination	dobj	4	SENT_84	12093/12109
7	,	,	O	,		-1	SENT_84	12109/12110
8	25	CD	PERCENT	25	num	9	SENT_84	12111/12113
9	%	NN	PERCENT	%	nsubjpass	13	SENT_84	12113/12114
10	kaolin	NN	O	kaolin	nn	11	SENT_84	12115/12121
11	suspension	NN	O	suspension	dep	9	SENT_84	12122/12132
12	was	VBD	O	be	auxpass	13	SENT_84	12133/12136
13	added	VBN	O	add		-1	SENT_84	12137/12142
14	to	TO	O	to	aux	15	SENT_84	12143/12145
15	inactivated	VBN	O	inactivate	xcomp	13	SENT_84	12146/12157
16	sera	NNS	O	serum	dobj	15	SENT_84	12158/12162
17	.	.	O	.		-1	SENT_84	12162/12163

1	After	IN	O	after		-1	SENT_85	12164/12169
2	centrifugation	NN	O	centrifugation	prep_after	13	SENT_85	12170/12184
3	at	IN	O	at		-1	SENT_85	12185/12187
4	1,200	CD	NUMBER	1,200	num	5	SENT_85	12188/12193
5	g	NN	O	g	prep_at	2	SENT_85	12195/12196
6	,	,	O	,		-1	SENT_85	12196/12197
7	50	CD	NUMBER	50	num	8	SENT_85	12198/12200
8	l	NN	O	l	nsubjpass	13	SENT_85	12203/12204
9	of	IN	O	of		-1	SENT_85	12205/12207
10	the	DT	O	the	det	11	SENT_85	12208/12211
11	supernatant	NN	O	supernatant	prep_of	8	SENT_85	12212/12223
12	was	VBD	O	be	auxpass	13	SENT_85	12224/12227
13	transferred	VBN	O	transfer		-1	SENT_85	12228/12239
14	in	IN	O	in		-1	SENT_85	12240/12242
15	duplicate	VB	O	duplicate	prep_in	13	SENT_85	12243/12252
16	to	TO	O	to		-1	SENT_85	12253/12255
17	96-well	JJ	O	96-well	amod	19	SENT_85	12256/12263
18	round-bottom	NN	O	round-bottom	nn	19	SENT_85	12264/12276
19	plate	NN	O	plate	prep_to	15	SENT_85	12277/12282
20	(	CD	NUMBER	(	num	23	SENT_85	12283/12284
21	Greiner	NNP	PERSON	Greiner	nn	23	SENT_85	12284/12291
22	,	,	O	,		-1	SENT_85	12291/12292
23	Alphen	NNP	PERSON	Alphen	dobj	15	SENT_85	12293/12299
24	a/d	VBD	PERSON	a/d	rcmod	23	SENT_85	12300/12303
25	Rijn	NNP	PERSON	Rijn	dobj	24	SENT_85	12304/12308
26	,	,	O	,		-1	SENT_85	12308/12309
27	The	DT	LOCATION	the	det	29	SENT_85	12310/12313
28	Netherlands	NNP	LOCATION	Netherlands	nn	29	SENT_85	12314/12325
29	)	NN	O	)	appos	25	SENT_85	12325/12326
30	and	CC	O	and		-1	SENT_85	12327/12330
31	serially	RB	O	serially	advmod	13	SENT_85	12331/12339
32	diluted	VBN	O	dilute	conj_and	13	SENT_85	12340/12347
33	twofold	RB	O	twofold	advmod	32	SENT_85	12348/12355
34	in	IN	O	in		-1	SENT_85	12356/12358
35	PBS	NNP	O	PBS	prep_in	32	SENT_85	12359/12362
36	.	.	O	.		-1	SENT_85	12362/12363

1	Then	RB	O	then	advmod	9	SENT_86	12364/12368
2	,	,	O	,		-1	SENT_86	12368/12369
3	four	CD	NUMBER	four	num	5	SENT_86	12370/12374
4	hemagglutination	NN	O	hemagglutination	nn	5	SENT_86	12375/12391
5	units	NNS	O	unit	nsubj	9	SENT_86	12392/12397
6	of	IN	O	of		-1	SENT_86	12398/12400
7	A/Wisconsin	NN	O	a/wisconsin	nn	8	SENT_86	12401/12412
8	influenza	NN	O	influenza	prep_of	5	SENT_86	12413/12422
9	inactivated	VBD	O	inactivate		-1	SENT_86	12423/12434
10	virus	NN	O	virus	nsubjpass	12	SENT_86	12435/12440
11	were	VBD	O	be	auxpass	12	SENT_86	12441/12445
12	added	VBN	O	add	ccomp	9	SENT_86	12446/12451
13	to	TO	O	to		-1	SENT_86	12452/12454
14	each	DT	O	each	prep_to	12	SENT_86	12455/12459
15	well	RB	O	well	advmod	12	SENT_86	12460/12464
16	,	,	O	,		-1	SENT_86	12464/12465
17	and	CC	O	and		-1	SENT_86	12466/12469
18	the	DT	O	the	det	19	SENT_86	12470/12473
19	plates	NNS	O	plate	nsubjpass	21	SENT_86	12474/12480
20	were	VBD	O	be	auxpass	21	SENT_86	12481/12485
21	incubated	VBN	O	incubate	conj_and	9	SENT_86	12486/12495
22	for	IN	O	for		-1	SENT_86	12496/12499
23	40	CD	DURATION	40	num	24	SENT_86	12500/12502
24	min	NN	DURATION	min	prep_for	21	SENT_86	12503/12506
25	at	IN	O	at		-1	SENT_86	12507/12509
26	room	NN	O	room	nn	27	SENT_86	12510/12514
27	temperature	NN	O	temperature	prep_at	24	SENT_86	12515/12526
28	.	.	O	.		-1	SENT_86	12526/12527

1	Finally	RB	O	finally	advmod	14	SENT_87	12528/12535
2	,	,	O	,		-1	SENT_87	12535/12536
3	50	CD	NUMBER	50	num	4	SENT_87	12537/12539
4	l	NN	O	l	nsubjpass	14	SENT_87	12542/12543
5	of	IN	O	of		-1	SENT_87	12544/12546
6	1	CD	PERCENT	1	num	9	SENT_87	12547/12548
7	%	NN	PERCENT	%	nn	9	SENT_87	12548/12549
8	guinea	NN	O	guinea	nn	9	SENT_87	12550/12556
9	pig	NN	O	pig	prep_of	4	SENT_87	12557/12560
10	red	JJ	O	red	amod	12	SENT_87	12561/12564
11	blood	NN	O	blood	nn	12	SENT_87	12565/12570
12	cells	NNS	O	cell	dep	9	SENT_87	12571/12576
13	was	VBD	O	be	auxpass	14	SENT_87	12577/12580
14	added	VBN	O	add		-1	SENT_87	12581/12586
15	to	TO	O	to		-1	SENT_87	12587/12589
16	each	DT	O	each	prep_to	14	SENT_87	12590/12594
17	well	RB	O	well	advmod	14	SENT_87	12595/12599
18	and	CC	O	and		-1	SENT_87	12600/12603
19	incubated	VBN	O	incubate	conj_and	14	SENT_87	12604/12613
20	for	IN	O	for		-1	SENT_87	12614/12617
21	2	CD	NUMBER	2	num	22	SENT_87	12618/12619
22	h	NN	O	h	prep_for	19	SENT_87	12620/12621
23	at	IN	O	at		-1	SENT_87	12622/12624
24	room	NN	O	room	nn	25	SENT_87	12625/12629
25	temperature	NN	O	temperature	prep_at	22	SENT_87	12630/12641
26	.	.	O	.		-1	SENT_87	12641/12642

1	The	DT	O	the	det	3	SENT_88	12643/12646
2	highest	JJS	O	highest	amod	3	SENT_88	12647/12654
3	dilution	NN	O	dilution	nsubjpass	9	SENT_88	12655/12663
4	capable	JJ	O	capable	amod	3	SENT_88	12664/12671
5	of	IN	O	of		-1	SENT_88	12672/12674
6	preventing	VBG	O	prevent	prepc_of	4	SENT_88	12675/12685
7	hemagglutination	NN	O	hemagglutination	dobj	6	SENT_88	12686/12702
8	was	VBD	O	be	auxpass	9	SENT_88	12703/12706
9	scored	VBN	O	score		-1	SENT_88	12707/12713
10	as	IN	O	as		-1	SENT_88	12714/12716
11	HI	NN	O	hus	nn	12	SENT_88	12717/12719
12	titer	NN	O	titer	prep_as	9	SENT_88	12720/12725
13	.	.	O	.		-1	SENT_88	12725/12726

1	ELISPOT	NN	O	elispot		-1	SENT_89	12762/12769

1	The	DT	O	the	det	3	SENT_90	12805/12808
2	Elispot	NN	O	elispot	nn	3	SENT_90	12809/12816
3	assay	NN	O	assay	nsubjpass	5	SENT_90	12817/12822
4	was	VBD	O	be	auxpass	5	SENT_90	12823/12826
5	performed	VBN	O	perform		-1	SENT_90	12827/12836
6	as	IN	O	as	mark	7	SENT_90	12837/12839
7	described	VBN	O	describe	advcl	5	SENT_90	12840/12849
8	earlier	JJR	O	earlier	advmod	7	SENT_90	12850/12857
9	(	CD	NUMBER	(	num	11	SENT_90	12858/12859
10	35	CD	NUMBER	35	num	11	SENT_90	12859/12861
11	)	NN	O	)	dobj	7	SENT_90	12861/12862
12	.	.	O	.		-1	SENT_90	12862/12863

1	Briefly	RB	O	briefly	advmod	10	SENT_91	12864/12871
2	,	,	O	,		-1	SENT_91	12871/12872
3	96-well	JJ	O	96-well	amod	4	SENT_91	12873/12880
4	microtiter	NN	O	microtiter	nsubj	5	SENT_91	12881/12891
5	plates	VBZ	O	plate	parataxis	10	SENT_91	12892/12898
6	(	NNP	O	(	nn	7	SENT_91	12899/12900
7	Greiner	NNP	PERSON	Greiner	dobj	5	SENT_91	12900/12907
8	,	,	O	,		-1	SENT_91	12907/12908
9	Alphen	NNP	PERSON	Alphen	nsubj	10	SENT_91	12909/12915
10	a/d	VBD	PERSON	a/d	ccomp	17	SENT_91	12916/12919
11	Rijn	NNP	PERSON	Rijn	dobj	10	SENT_91	12920/12924
12	,	,	O	,		-1	SENT_91	12924/12925
13	The	DT	LOCATION	the	det	15	SENT_91	12926/12929
14	Netherlands	NNP	LOCATION	Netherlands	nn	15	SENT_91	12930/12941
15	)	NN	O	)	nsubjpass	17	SENT_91	12941/12942
16	were	VBD	O	be	auxpass	17	SENT_91	12943/12947
17	incubated	VBN	O	incubate		-1	SENT_91	12948/12957
18	overnight	RB	TIME	overnight	advmod	17	SENT_91	12958/12967
19	at	IN	O	at		-1	SENT_91	12968/12970
20	4	CD	NUMBER	4	num	21	SENT_91	12971/12972
21	C	NN	O	c	prep_at	17	SENT_91	12974/12975
22	with	IN	O	with		-1	SENT_91	12976/12980
23	antimouse	JJ	O	antimouse	amod	24	SENT_91	12981/12990
24	interferon	NN	O	interferon	prep_with	21	SENT_91	12991/13001
25	-	:	O	-		-1	SENT_91	13001/13002
26	(	CD	NUMBER	(	num	27	SENT_91	13005/13006
27	IFN	NN	O	ifn	dep	24	SENT_91	13006/13009
28	-	:	O	-		-1	SENT_91	13009/13010
29	)	NN	O	)	dep	24	SENT_91	13012/13013
30	and	CC	O	and		-1	SENT_91	13014/13017
31	interleukin-4	NN	O	interleukin-4	conj_and	29	SENT_91	13018/13031
32	(	CD	NUMBER	(	num	33	SENT_91	13032/13033
33	IL-4	NN	O	il-4	dep	29	SENT_91	13033/13037
34	;	:	O	;		-1	SENT_91	13037/13038
35	BD	NNP	O	BD	nn	41	SENT_91	13039/13041
36	,	,	O	,		-1	SENT_91	13041/13042
37	Pharmingen	NNP	PERSON	Pharmingen	appos	41	SENT_91	13043/13053
38	,	,	O	,		-1	SENT_91	13053/13054
39	Erembodegem	NNP	O	Erembodegem	appos	41	SENT_91	13055/13066
40	,	,	O	,		-1	SENT_91	13066/13067
41	Belgium	NNP	LOCATION	Belgium	dep	24	SENT_91	13068/13075
42	)	CD	NUMBER	)	num	41	SENT_91	13075/13076
43	.	.	O	.		-1	SENT_91	13076/13077

1	After	IN	O	after		-1	SENT_92	13078/13083
2	washing	VBG	O	wash	prepc_after	18	SENT_92	13084/13091
3	the	DT	O	the	det	4	SENT_92	13092/13095
4	plates	NNS	O	plate	dobj	2	SENT_92	13096/13102
5	three	CD	NUMBER	three	num	6	SENT_92	13103/13108
6	times	NNS	O	time	npadvmod	2	SENT_92	13109/13114
7	with	IN	O	with		-1	SENT_92	13115/13119
8	PBS/Tween	NN	O	pbs/tween	nn	10	SENT_92	13120/13129
9	(	CD	NUMBER	(	num	10	SENT_92	13130/13131
10	Sigma-Aldrich	NNP	ORGANIZATION	Sigma-Aldrich	prep_with	2	SENT_92	13131/13144
11	,	,	O	,		-1	SENT_92	13144/13145
12	The	DT	LOCATION	the	det	14	SENT_92	13146/13149
13	Netherlands	NNP	LOCATION	Netherlands	nn	14	SENT_92	13150/13161
14	)	NN	O	)	appos	10	SENT_92	13161/13162
15	,	,	O	,		-1	SENT_92	13162/13163
16	they	PRP	O	they	nsubjpass	18	SENT_92	13164/13168
17	were	VBD	O	be	auxpass	18	SENT_92	13169/13173
18	blocked	VBN	O	block		-1	SENT_92	13174/13181
19	(	CD	NUMBER	(	num	20	SENT_92	13182/13183
20	PBS	NNP	O	PBS	dobj	18	SENT_92	13183/13186
21	+	CC	O	+		-1	SENT_92	13187/13188
22	4	CD	PERCENT	4	number	23	SENT_92	13189/13190
23	%	NN	PERCENT	%	amod	25	SENT_92	13190/13191
24	BSA	NN	O	bsa	nn	25	SENT_92	13192/13195
25	)	NN	O	)	conj_+	20	SENT_92	13195/13196
26	for	IN	O	for		-1	SENT_92	13197/13200
27	1	CD	NUMBER	1	num	28	SENT_92	13201/13202
28	h	NN	O	h	prep_for	25	SENT_92	13203/13204
29	at	IN	O	at		-1	SENT_92	13205/13207
30	37	CD	NUMBER	37	num	31	SENT_92	13208/13210
31	C	NN	O	c	prep_at	18	SENT_92	13212/13213
32	,	,	O	,		-1	SENT_92	13213/13214
33	and	CC	O	and		-1	SENT_92	13215/13218
34	spleen	NN	O	spleen	nn	35	SENT_92	13219/13225
35	cells	NNS	O	cell	nsubjpass	37	SENT_92	13226/13231
36	were	VBD	O	be	auxpass	37	SENT_92	13232/13236
37	added	VBN	O	add	conj_and	18	SENT_92	13237/13242
38	to	TO	O	to		-1	SENT_92	13243/13245
39	the	DT	O	the	det	40	SENT_92	13246/13249
40	plates	NNS	O	plate	prep_to	37	SENT_92	13250/13256
41	in	IN	O	in		-1	SENT_92	13257/13259
42	concentration	NN	O	concentration	prep_in	40	SENT_92	13260/13273
43	1	CD	NUMBER	1	number	44	SENT_92	13274/13275
44	106	CD	NUMBER	106	num	45	SENT_92	13283/13286
45	cells/well	NNS	O	cells/well	dep	42	SENT_92	13289/13299
46	with	IN	O	with		-1	SENT_92	13300/13304
47	or	CC	O	or		-1	SENT_92	13305/13307
48	without	IN	O	without		-1	SENT_92	13308/13315
49	subunit	NN	O	subunit	nn	50	SENT_92	13316/13323
50	vaccine	NN	O	vaccine	prep_with	37	SENT_92	13324/13331
51	as	IN	O	as		-1	SENT_92	13332/13334
52	a	DT	O	a	det	54	SENT_92	13335/13336
53	stimulation	NN	O	stimulation	nn	54	SENT_92	13337/13348
54	peptide	NN	O	peptide	prep_as	37	SENT_92	13349/13356
55	.	.	O	.		-1	SENT_92	13356/13357

1	After	IN	O	after		-1	SENT_93	13358/13363
2	incubation	NN	O	incubation	prep_after	15	SENT_93	13364/13374
3	overnight	JJ	TIME	overnight	amod	2	SENT_93	13375/13384
4	at	IN	O	at		-1	SENT_93	13385/13387
5	37	CD	NUMBER	37	num	6	SENT_93	13388/13390
6	C	NN	O	c	prep_at	2	SENT_93	13392/13393
7	,	,	O	,		-1	SENT_93	13393/13394
8	5	CD	PERCENT	5	number	9	SENT_93	13395/13396
9	%	NN	PERCENT	%	amod	10	SENT_93	13396/13397
10	CO2	NN	O	co2	appos	6	SENT_93	13398/13401
11	,	,	O	,		-1	SENT_93	13401/13402
12	the	DT	O	the	det	13	SENT_93	13403/13406
13	cells	NNS	O	cell	nsubjpass	15	SENT_93	13407/13412
14	were	VBD	O	be	auxpass	15	SENT_93	13413/13417
15	lysed	VBN	O	lyse		-1	SENT_93	13418/13423
16	with	IN	O	with		-1	SENT_93	13424/13428
17	cold	JJ	O	cold	amod	18	SENT_93	13429/13433
18	water	NN	O	water	prep_with	15	SENT_93	13434/13439
19	.	.	O	.		-1	SENT_93	13439/13440

1	Next	RB	O	next	advmod	6	SENT_94	13441/13445
2	,	,	O	,		-1	SENT_94	13445/13446
3	the	DT	O	the	det	4	SENT_94	13447/13450
4	plates	NNS	O	plate	nsubjpass	6	SENT_94	13451/13457
5	were	VBD	O	be	auxpass	6	SENT_94	13458/13462
6	washed	VBN	O	wash		-1	SENT_94	13463/13469
7	five	CD	NUMBER	five	num	8	SENT_94	13470/13474
8	times	NNS	O	time	tmod	6	SENT_94	13475/13480
9	with	IN	O	with		-1	SENT_94	13481/13485
10	PBS/Tween	NN	O	pbs/tween	prep_with	6	SENT_94	13486/13495
11	and	CC	O	and		-1	SENT_94	13496/13499
12	incubated	VBN	O	incubate	conj_and	6	SENT_94	13500/13509
13	with	IN	O	with		-1	SENT_94	13510/13514
14	biotinylated	VBN	O	biotinylate	prepc_with	12	SENT_94	13515/13527
15	antimouse	JJ	O	antimouse	amod	16	SENT_94	13528/13537
16	IFN	NN	O	ifn	dobj	14	SENT_94	13538/13541
17	-	:	O	-		-1	SENT_94	13541/13542
18	and	CC	O	and		-1	SENT_94	13545/13548
19	IL-4	NN	O	il-4	nn	20	SENT_94	13549/13553
20	antibodies	NNS	O	antibody	nsubj	21	SENT_94	13554/13564
21	(	VBP	O	(	conj_and	6	SENT_94	13565/13566
22	BD	NN	O	bd	nn	24	SENT_94	13566/13568
23	Pharmingen	NN	O	pharmingen	nn	24	SENT_94	13569/13579
24	)	NN	O	)	dobj	21	SENT_94	13579/13580
25	in	IN	O	in		-1	SENT_94	13581/13583
26	concentration	NN	O	concentration	prep_in	24	SENT_94	13584/13597
27	of	IN	O	of		-1	SENT_94	13598/13600
28	0.125	CD	NUMBER	0.125	num	29	SENT_94	13601/13606
29	g/ml	NN	O	g/ml	prep_of	26	SENT_94	13609/13613
30	in	IN	O	in		-1	SENT_94	13614/13616
31	PBS	NNP	O	PBS	prep_in	29	SENT_94	13617/13620
32	+	CC	O	+		-1	SENT_94	13621/13622
33	2	CD	PERCENT	2	number	34	SENT_94	13623/13624
34	%	NN	PERCENT	%	amod	35	SENT_94	13624/13625
35	BSA	NN	O	bsa	conj_+	24	SENT_94	13626/13629
36	.	.	O	.		-1	SENT_94	13629/13630

1	After	IN	O	after		-1	SENT_95	13631/13636
2	washing	VBG	O	wash	prepc_after	7	SENT_95	13637/13644
3	,	,	O	,		-1	SENT_95	13644/13645
4	the	DT	O	the	det	5	SENT_95	13646/13649
5	plates	NNS	O	plate	nsubjpass	7	SENT_95	13650/13656
6	were	VBD	O	be	auxpass	7	SENT_95	13657/13661
7	incubated	VBN	O	incubate	ccomp	39	SENT_95	13662/13671
8	with	IN	O	with		-1	SENT_95	13672/13676
9	streptavidin	NN	O	streptavidin	nn	15	SENT_95	13677/13689
10	alkaline	NN	O	alkaline	nn	15	SENT_95	13690/13698
11	phosphatase	NN	O	phosphatase	nn	15	SENT_95	13699/13710
12	(	CD	NUMBER	(	num	15	SENT_95	13711/13712
13	BD	NN	O	bd	nn	15	SENT_95	13712/13714
14	Pharmingen	NN	O	pharmingen	nn	15	SENT_95	13715/13725
15	)	NN	O	)	prep_with	7	SENT_95	13725/13726
16	for	IN	O	for		-1	SENT_95	13727/13730
17	1	CD	NUMBER	1	num	18	SENT_95	13731/13732
18	h	NN	O	h	prep_for	15	SENT_95	13733/13734
19	at	IN	O	at		-1	SENT_95	13735/13737
20	37	CD	NUMBER	37	num	21	SENT_95	13738/13740
21	C.	NNP	O	C.	prep_at	7	SENT_95	13742/13744
22	Finally	RB	O	finally	advmod	21	SENT_95	13745/13752
23	,	,	O	,		-1	SENT_95	13752/13753
24	after	IN	O	after		-1	SENT_95	13754/13759
25	washing	VBG	O	wash	prepc_after	7	SENT_95	13760/13767
26	three	CD	NUMBER	three	num	27	SENT_95	13768/13773
27	times	NNS	O	time	dobj	25	SENT_95	13774/13779
28	with	IN	O	with		-1	SENT_95	13780/13784
29	PBS/Tween	NN	O	pbs/tween	prep_with	25	SENT_95	13785/13794
30	and	CC	O	and		-1	SENT_95	13795/13798
31	two	CD	NUMBER	two	num	32	SENT_95	13799/13802
32	times	NNS	O	time	conj_and	29	SENT_95	13803/13808
33	with	IN	O	with		-1	SENT_95	13809/13813
34	PBS	NNP	ORGANIZATION	PBS	prep_with	25	SENT_95	13814/13817
35	,	,	O	,		-1	SENT_95	13817/13818
36	the	DT	O	the	det	37	SENT_95	13819/13822
37	spots	NNS	O	spot	nsubjpass	39	SENT_95	13823/13828
38	were	VBD	O	be	auxpass	39	SENT_95	13829/13833
39	developed	VBN	O	develop		-1	SENT_95	13834/13843
40	using	VBG	O	use	xcomp	39	SENT_95	13844/13849
41	the	DT	O	the	det	43	SENT_95	13850/13853
42	substrate	NN	O	substrate	nn	43	SENT_95	13854/13863
43	solution	NN	O	solution	dobj	40	SENT_95	13864/13872
44	consisting	VBG	O	consist	partmod	43	SENT_95	13873/13883
45	of	IN	O	of		-1	SENT_95	13884/13886
46	1	CD	NUMBER	1	num	48	SENT_95	13887/13888
47	mg/ml	NN	O	mg/ml	nn	48	SENT_95	13889/13894
48	5-bromo-4-chloro-3-indolylphosphate	NN	O	5-bromo-4-chloro-3-indolylphosphate	prep_of	44	SENT_95	13895/13930
49	,	,	O	,		-1	SENT_95	13930/13931
50	0.92	CD	PERCENT	0.92	number	51	SENT_95	13932/13936
51	%	NN	PERCENT	%	amod	53	SENT_95	13936/13937
52	(	CD	NUMBER	(	num	53	SENT_95	13938/13939
53	w/v	NN	O	w/v	conj_and	48	SENT_95	13939/13942
54	)	CD	NUMBER	)	num	55	SENT_95	13942/13943
55	2-amino-2-methyl-1-propanol	NN	O	2-amino-2-methyl-1-propanol	dep	53	SENT_95	13944/13971
56	,	,	O	,		-1	SENT_95	13971/13972
57	0.08	CD	NUMBER	0.08	num	59	SENT_95	13973/13977
58	l/ml	NN	O	l/ml	nn	59	SENT_95	13980/13984
59	TritonX-405	NN	O	tritonx-405	conj_and	48	SENT_95	13985/13996
60	,	,	O	,		-1	SENT_95	13996/13997
61	1	CD	NUMBER	1	num	63	SENT_95	13998/13999
62	M	NN	O	m	nn	63	SENT_95	14000/14001
63	MgCl2	NN	O	mgcl2	conj_and	48	SENT_95	14002/14007
64	,	,	O	,		-1	SENT_95	14007/14008
65	and	CC	O	and		-1	SENT_95	14009/14012
66	6	CD	NUMBER	6	num	68	SENT_95	14013/14014
67	mg/ml	NN	O	mg/ml	nn	68	SENT_95	14015/14020
68	agarose	NN	O	agarose	conj_and	48	SENT_95	14021/14028
69	.	.	O	.		-1	SENT_95	14028/14029

1	The	DT	O	the	det	2	SENT_96	14030/14033
2	spots	NNS	O	spot	nsubjpass	4	SENT_96	14034/14039
3	were	VBD	O	be	auxpass	4	SENT_96	14040/14044
4	counted	VBN	O	count		-1	SENT_96	14045/14052
5	using	VBG	O	use	xcomp	4	SENT_96	14053/14058
6	an	DT	O	a	det	8	SENT_96	14059/14061
7	Elispot	NN	O	elispot	nn	8	SENT_96	14062/14069
8	reader	NN	O	reader	dobj	5	SENT_96	14070/14076
9	(	CD	NUMBER	(	num	11	SENT_96	14077/14078
10	A.	NN	O	a.	nn	11	SENT_96	14078/14080
11	EL	NNP	O	EL	dep	8	SENT_96	14080/14082
12	.	.	O	.		-1	SENT_96	14082/14083

1	VIS	NN	O	vi	nn	3	SENT_97	14083/14086
2	Elispot	NN	O	elispot	nn	3	SENT_97	14087/14094
3	reader	NN	O	reader		-1	SENT_97	14095/14101
4	)	CD	NUMBER	)	dep	3	SENT_97	14101/14102
5	.	.	O	.		-1	SENT_97	14102/14103

1	Statistical	JJ	O	statistical	amod	2	SENT_98	14139/14150
2	Analysis	NN	O	analysis		-1	SENT_98	14151/14159

1	Statistical	JJ	O	statistical	amod	2	SENT_99	14195/14206
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_99	14207/14215
3	were	VBD	O	be	auxpass	4	SENT_99	14216/14220
4	performed	VBN	O	perform		-1	SENT_99	14221/14230
5	using	VBG	O	use	xcomp	4	SENT_99	14231/14236
6	Student	NN	O	student	poss	9	SENT_99	14237/14244
7	's	POS	O	's		-1	SENT_99	14244/14246
8	t	NN	O	t	nn	9	SENT_99	14247/14248
9	test	NN	O	test	npadvmod	12	SENT_99	14249/14253
10	with	IN	O	with		-1	SENT_99	14254/14258
11	p	NN	O	p	prep_with	9	SENT_99	14259/14260
12	<	JJR	O	<	acomp	5	SENT_99	14263/14264
13	0.05	CD	NUMBER	0.05	advmod	5	SENT_99	14267/14271
14	as	IN	O	as		-1	SENT_99	14272/14274
15	the	DT	O	the	det	17	SENT_99	14275/14278
16	minimal	JJ	O	minimal	amod	17	SENT_99	14279/14286
17	level	NN	O	level	prep_as	5	SENT_99	14287/14292
18	of	IN	O	of		-1	SENT_99	14293/14295
19	significance	NN	O	significance	prep_of	17	SENT_99	14296/14308
20	.	.	O	.		-1	SENT_99	14308/14309

1	The	DT	O	the	det	2	SENT_100	14310/14313
2	results	NNS	O	result	nsubjpass	4	SENT_100	14314/14321
3	are	VBP	O	be	auxpass	4	SENT_100	14322/14325
4	presented	VBN	O	present		-1	SENT_100	14326/14335
5	as	IN	O	as		-1	SENT_100	14336/14338
6	mean	JJ	O	mean	amod	8	SENT_100	14339/14343
7	standard	JJ	O	standard	amod	8	SENT_100	14349/14357
8	error	NN	O	error	prep_as	4	SENT_100	14358/14363
9	mean	VB	O	mean	ccomp	4	SENT_100	14364/14368
10	unless	IN	O	unless	mark	11	SENT_100	14369/14375
11	indicated	VBN	O	indicate	advcl	9	SENT_100	14376/14385
12	otherwise	RB	O	otherwise	advmod	11	SENT_100	14386/14395
13	.	.	O	.		-1	SENT_100	14395/14396

1	RESULTS	NNS	O	result		-1	SENT_101	14432/14439

1	Systemic	JJ	O	systemic	amod	3	SENT_102	14475/14483
2	Immune	JJ	O	immune	amod	3	SENT_102	14484/14490
3	Response	NN	O	response		-1	SENT_102	14491/14499

1	The	DT	O	the	det	3	SENT_103	14535/14538
2	protective	JJ	O	protective	amod	3	SENT_103	14539/14549
3	capacity	NN	O	capacity	nsubjpass	8	SENT_103	14550/14558
4	of	IN	O	of		-1	SENT_103	14559/14561
5	influenza	NN	O	influenza	nn	6	SENT_103	14562/14571
6	vaccines	NNS	O	vaccine	prep_of	3	SENT_103	14572/14580
7	was	VBD	O	be	auxpass	8	SENT_103	14581/14584
8	determined	VBN	O	determine		-1	SENT_103	14585/14595
9	by	IN	O	by		-1	SENT_103	14596/14598
10	measuring	VBG	O	measure	agent	8	SENT_103	14599/14608
11	HI	NN	O	hus	nn	12	SENT_103	14609/14611
12	titers	NNS	O	titer	dobj	10	SENT_103	14612/14618
13	.	.	O	.		-1	SENT_103	14618/14619

1	The	DT	O	the	det	3	SENT_104	14620/14623
2	HI	NN	O	hus	nn	3	SENT_104	14624/14626
3	titers	NNS	O	titer	nsubjpass	5	SENT_104	14627/14633
4	were	VBD	O	be	auxpass	5	SENT_104	14634/14638
5	determined	VBN	O	determine		-1	SENT_104	14639/14649
6	for	IN	O	for		-1	SENT_104	14650/14653
7	all	DT	O	all	det	8	SENT_104	14654/14657
8	mice	NNS	O	mouse	prep_for	5	SENT_104	14658/14662
9	after	IN	O	after		-1	SENT_104	14663/14668
10	the	DT	O	the	dep	11	SENT_104	14669/14672
11	first	JJ	ORDINAL	first	prep_after	5	SENT_104	14673/14678
12	and	CC	ORDINAL	and		-1	SENT_104	14679/14682
13	second	JJ	ORDINAL	second	amod	15	SENT_104	14683/14689
14	booster	NN	O	booster	nn	15	SENT_104	14690/14697
15	immunization	NN	O	immunization	conj_and	11	SENT_104	14698/14710
16	.	.	O	.		-1	SENT_104	14710/14711

1	Figure	NNP	O	Figure	nsubj	3	SENT_105	14712/14718
2	1	CD	NUMBER	1	num	1	SENT_105	14719/14720
3	shows	VBZ	O	show		-1	SENT_105	14721/14726
4	that	IN	O	that	mark	15	SENT_105	14727/14731
5	both	CC	O	both	preconj	8	SENT_105	14732/14736
6	the	DT	O	the	det	8	SENT_105	14737/14740
7	conventional	JJ	O	conventional	amod	8	SENT_105	14741/14753
8	i.m.	NN	O	i.m.	nsubj	15	SENT_105	14754/14758
9	and	CC	O	and		-1	SENT_105	14759/14762
10	the	DT	O	the	det	11	SENT_105	14763/14766
11	GEM	NN	O	gem	conj_and	8	SENT_105	14767/14770
12	adjuvanted	JJ	O	adjuvanted	amod	14	SENT_105	14771/14781
13	i.n.	NN	O	i.n.	nn	14	SENT_105	14782/14786
14	vaccines	NNS	O	vaccine	dep	11	SENT_105	14787/14795
15	reached	VBD	O	reach	ccomp	3	SENT_105	14796/14803
16	comparable	JJ	O	comparable	amod	18	SENT_105	14804/14814
17	HI	NN	O	hus	nn	18	SENT_105	14815/14817
18	titers	NNS	O	titer	dobj	15	SENT_105	14818/14824
19	above	IN	O	above		-1	SENT_105	14825/14830
20	2log6	NN	O	2log6	prep_above	15	SENT_105	14831/14836
21	after	IN	O	after		-1	SENT_105	14837/14842
22	the	DT	O	the	det	27	SENT_105	14843/14846
23	first	JJ	ORDINAL	first	amod	27	SENT_105	14847/14852
24	booster	NN	O	booster	nn	27	SENT_105	14853/14860
25	immunization	NN	O	immunization	nn	27	SENT_105	14861/14873
26	(	NN	O	(	nn	27	SENT_105	14874/14875
27	p	NN	O	p	prep_after	15	SENT_105	14875/14876
28	=	JJ	O	=	amod	27	SENT_105	14879/14880
29	0.2062	CD	NUMBER	0.2062	num	30	SENT_105	14883/14889
30	)	NN	O	)	dep	28	SENT_105	14889/14890
31	.	.	O	.		-1	SENT_105	14890/14891

1	These	DT	O	these	det	2	SENT_106	14892/14897
2	titers	NNS	O	titer	nsubj	3	SENT_106	14898/14904
3	increase	VBP	O	increase	dep	17	SENT_106	14905/14913
4	in	IN	O	in		-1	SENT_106	14914/14916
5	both	DT	O	both	det	6	SENT_106	14917/14921
6	cases	NNS	O	case	prep_in	3	SENT_106	14922/14927
7	to	TO	O	to		-1	SENT_106	14928/14930
8	values	NNS	O	value	prep_to	6	SENT_106	14931/14937
9	between	IN	O	between		-1	SENT_106	14938/14945
10	2log7	CD	NUMBER	2log7	prep_between	8	SENT_106	14946/14951
11	and	CC	NUMBER	and		-1	SENT_106	14952/14955
12	2log8	CD	NUMBER	2log8	conj_and	10	SENT_106	14956/14961
13	with	IN	O	with		-1	SENT_106	14962/14966
14	no	DT	O	no	det	16	SENT_106	14967/14969
15	significant	JJ	O	significant	amod	16	SENT_106	14970/14981
16	differences	NNS	O	difference	prep_with	3	SENT_106	14982/14993
17	(	VBP	O	(		-1	SENT_106	14994/14995
18	p	NN	O	p	nsubj	19	SENT_106	14995/14996
19	=	JJ	O	=	xcomp	17	SENT_106	14999/15000
20	0.7611	CD	NUMBER	0.7611	num	21	SENT_106	15001/15007
21	)	NN	O	)	nsubj	17	SENT_106	15007/15008
22	.	.	O	.		-1	SENT_106	15008/15009

1	I.n.	NNP	O	I.n.	nn	2	SENT_107	15010/15014
2	immunization	NN	O	immunization	nsubj	8	SENT_107	15015/15027
3	with	IN	O	with		-1	SENT_107	15028/15032
4	the	DT	O	the	det	6	SENT_107	15033/15036
5	subunit	NN	O	subunit	nn	6	SENT_107	15037/15044
6	vaccine	NN	O	vaccine	prep_with	2	SENT_107	15045/15052
7	alone	RB	O	alone	advmod	8	SENT_107	15053/15058
8	induced	VBD	O	induce		-1	SENT_107	15059/15066
9	low	JJ	O	low	amod	11	SENT_107	15067/15070
10	HI	NN	O	hus	nn	11	SENT_107	15071/15073
11	titers	NNS	O	titer	dobj	8	SENT_107	15074/15080
12	,	,	O	,		-1	SENT_107	15080/15081
13	even	RB	O	even	advmod	14	SENT_107	15082/15086
14	after	IN	O	after	dep	8	SENT_107	15087/15092
15	two	CD	NUMBER	two	num	17	SENT_107	15093/15096
16	booster	NN	O	booster	nn	17	SENT_107	15097/15104
17	immunizations	NNS	O	immunization	pobj	14	SENT_107	15105/15118
18	.	.	O	.		-1	SENT_107	15118/15119

1	Moreover	RB	O	moreover	advmod	9	SENT_108	15120/15128
2	,	,	O	,		-1	SENT_108	15128/15129
3	only	RB	O	only	quantmod	4	SENT_108	15130/15134
4	50	CD	PERCENT	50	num	5	SENT_108	15135/15137
5	%	NN	PERCENT	%	nsubj	9	SENT_108	15137/15138
6	of	IN	O	of		-1	SENT_108	15139/15141
7	the	DT	O	the	det	8	SENT_108	15142/15145
8	animals	NNS	O	animal	prep_of	5	SENT_108	15146/15153
9	responded	VBD	O	respond		-1	SENT_108	15154/15163
10	after	IN	O	after		-1	SENT_108	15164/15169
11	immunization	NN	O	immunization	prep_after	9	SENT_108	15170/15182
12	with	IN	O	with		-1	SENT_108	15183/15187
13	i.n.	NN	O	i.n.	nn	15	SENT_108	15188/15192
14	subunit	NN	O	subunit	nn	15	SENT_108	15193/15200
15	vaccine	NN	O	vaccine	prep_with	9	SENT_108	15201/15208
16	,	,	O	,		-1	SENT_108	15208/15209
17	while	IN	O	while	mark	20	SENT_108	15210/15215
18	all	DT	O	all	det	19	SENT_108	15216/15219
19	animals	NNS	O	animal	nsubj	20	SENT_108	15220/15227
20	responded	VBD	O	respond	advcl	9	SENT_108	15228/15237
21	in	IN	O	in		-1	SENT_108	15238/15240
22	the	DT	O	the	det	26	SENT_108	15241/15244
23	two	CD	NUMBER	two	num	26	SENT_108	15245/15248
24	other	JJ	O	other	amod	26	SENT_108	15249/15254
25	vaccine	NN	O	vaccine	nn	26	SENT_108	15255/15262
26	groups	NNS	O	group	prep_in	20	SENT_108	15263/15269
27	.	.	O	.		-1	SENT_108	15269/15270

1	Since	IN	O	since	mark	8	SENT_109	15271/15276
2	an	DT	O	a	det	4	SENT_109	15277/15279
3	HI	NN	O	hus	nn	4	SENT_109	15280/15282
4	titer	NN	O	titer	nsubjpass	8	SENT_109	15283/15288
5	above	IN	O	above		-1	SENT_109	15289/15294
6	2log5	NN	O	2log5	prep_above	4	SENT_109	15295/15300
7	is	VBZ	O	be	auxpass	8	SENT_109	15301/15303
8	considered	VBN	O	consider	advcl	17	SENT_109	15304/15314
9	to	TO	O	to	aux	11	SENT_109	15315/15317
10	be	VB	O	be	cop	11	SENT_109	15318/15320
11	protective	JJ	O	protective	xcomp	8	SENT_109	15321/15331
12	in	IN	O	in		-1	SENT_109	15332/15334
13	humans	NNS	O	human	prep_in	11	SENT_109	15335/15341
14	,	,	O	,		-1	SENT_109	15341/15342
15	these	DT	O	these	det	16	SENT_109	15343/15348
16	results	NNS	O	result	nsubj	17	SENT_109	15349/15356
17	indicate	VBP	O	indicate		-1	SENT_109	15357/15365
18	that	IN	O	that	mark	23	SENT_109	15366/15370
19	one	CD	NUMBER	one	num	21	SENT_109	15371/15374
20	single	JJ	O	single	amod	21	SENT_109	15375/15381
21	boost	NN	O	boost	nsubj	23	SENT_109	15382/15387
22	is	VBZ	O	be	cop	23	SENT_109	15388/15390
23	sufficient	JJ	O	sufficient	ccomp	17	SENT_109	15391/15401
24	for	IN	O	for	mark	27	SENT_109	15402/15405
25	i.n.	NNP	O	i.n.	nn	26	SENT_109	15406/15410
26	GEM	NNP	O	GEM	nsubj	27	SENT_109	15411/15414
27	adjuvanted	VBD	O	adjuvant	advcl	23	SENT_109	15415/15425
28	influenza	NN	O	influenza	nn	29	SENT_109	15426/15435
29	vaccines	NNS	O	vaccine	dobj	27	SENT_109	15436/15444
30	to	TO	O	to	aux	31	SENT_109	15445/15447
31	reach	VB	O	reach	xcomp	27	SENT_109	15448/15453
32	protective	JJ	O	protective	amod	33	SENT_109	15454/15464
33	immunity	NN	O	immunity	dobj	31	SENT_109	15465/15473
34	.	.	O	.		-1	SENT_109	15473/15474

1	Fig.	NN	O	fig.		-1	SENT_110	15475/15479
2	1	CD	NUMBER	1	num	1	SENT_110	15480/15481

1	Subunit	NN	O	subunit	nn	4	SENT_111	15498/15505
2	antigen-specific	JJ	O	antigen-specific	amod	4	SENT_111	15506/15522
3	HI	NN	O	hus	nn	4	SENT_111	15523/15525
4	titers	NNS	O	titer	nsubj	7	SENT_111	15526/15532
5	in	IN	O	in		-1	SENT_111	15533/15535
6	mice	NNS	O	mouse	prep_in	7	SENT_111	15536/15540
7	immunized	VBD	O	immunize		-1	SENT_111	15541/15550
8	three	CD	NUMBER	three	num	9	SENT_111	15551/15556
9	times	NNS	O	time	tmod	7	SENT_111	15557/15562
10	.	.	O	.		-1	SENT_111	15562/15563

1	a	DT	O	a	det	3	SENT_112	15564/15565
2	Comparative	JJ	O	comparative	amod	3	SENT_112	15566/15577
3	analysis	NN	O	analysis		-1	SENT_112	15578/15586
4	of	IN	O	of		-1	SENT_112	15587/15589
5	HI	NN	O	hus	nn	6	SENT_112	15590/15592
6	titers	NNS	O	titer	prep_of	3	SENT_112	15593/15599
7	in	IN	O	in		-1	SENT_112	15600/15602
8	different	JJ	O	different	amod	9	SENT_112	15603/15612
9	groups	NNS	O	group	prep_in	3	SENT_112	15613/15619
10	,	,	O	,		-1	SENT_112	15619/15620
11	i.e.	FW	O	i.e.	conj_and	9	SENT_112	15621/15625
12	,	,	O	,		-1	SENT_112	15625/15626
13	i.m.	NNP	O	i.m.	conj_and	9	SENT_112	15627/15631
14	,	,	O	,		-1	SENT_112	15631/15632
15	i.n.	NNP	O	i.n.	conj_and	9	SENT_112	15633/15637
16	,	,	O	,		-1	SENT_112	15637/15638
17	and	CC	O	and		-1	SENT_112	15639/15642
18	i.n.	NN	O	i.n.	conj_and	9	SENT_112	15643/15647
19	+	CC	O	+		-1	SENT_112	15648/15649
20	GEM	NN	O	gem	conj_+	18	SENT_112	15650/15653
21	at	IN	O	at		-1	SENT_112	15654/15656
22	0	CD	NUMBER	0	prep_at	20	SENT_112	15657/15658
23	,	,	O	,		-1	SENT_112	15658/15659
24	28	CD	NUMBER	28	conj_and	9	SENT_112	15660/15662
25	,	,	O	,		-1	SENT_112	15662/15663
26	and	CC	DURATION	and		-1	SENT_112	15664/15667
27	42	CD	DURATION	42	num	28	SENT_112	15668/15670
28	days	NNS	NUMBER	day	conj_and	9	SENT_112	15671/15675
29	after	IN	O	after		-1	SENT_112	15676/15681
30	the	DT	O	the	det	32	SENT_112	15682/15685
31	first	JJ	ORDINAL	first	amod	32	SENT_112	15686/15691
32	immunization	NN	O	immunization	prep_after	3	SENT_112	15692/15704
33	.	.	O	.		-1	SENT_112	15704/15705

1	b	NN	O	b	nn	3	SENT_113	15706/15707
2	Comparative	JJ	O	comparative	amod	3	SENT_113	15708/15719
3	analysis	NN	O	analysis		-1	SENT_113	15720/15728
4	of	IN	O	of		-1	SENT_113	15729/15731
5	HI	NN	O	hus	nn	6	SENT_113	15732/15734
6	titers	NNS	O	titer	prep_of	3	SENT_113	15735/15741
7	between	IN	O	between		-1	SENT_113	15742/15749
8	three	CD	NUMBER	three	num	9	SENT_113	15750/15755
9	groups	NNS	O	group	prep_between	3	SENT_113	15756/15762
10	,	,	O	,		-1	SENT_113	15762/15763
11	i.e.	FW	O	i.e.	conj_and	9	SENT_113	15764/15768
12	,	,	O	,		-1	SENT_113	15768/15769
13	i.m.	NNP	O	i.m.	conj_and	9	SENT_113	15770/15774
14	,	,	O	,		-1	SENT_113	15774/15775
15	i.n.	NNP	O	i.n.	conj_and	9	SENT_113	15776/15780
16	,	,	O	,		-1	SENT_113	15780/15781
17	and	CC	O	and		-1	SENT_113	15782/15785
18	i.n.	NN	O	i.n.	conj_and	9	SENT_113	15786/15790
19	+	CC	O	+		-1	SENT_113	15791/15792
20	GEM	NN	O	gem	conj_+	18	SENT_113	15793/15796
21	at	IN	O	at		-1	SENT_113	15797/15799
22	42	CD	DURATION	42	num	23	SENT_113	15800/15802
23	days	NNS	NUMBER	day	prep_at	20	SENT_113	15803/15807
24	after	IN	O	after		-1	SENT_113	15808/15813
25	first	JJ	ORDINAL	first	amod	26	SENT_113	15814/15819
26	immunization	NN	O	immunization	prep_after	23	SENT_113	15820/15832
27	.	.	O	.		-1	SENT_113	15832/15833

1	The	DT	O	the	det	2	SENT_114	15834/15837
2	numbers	NNS	O	number	nsubj	6	SENT_114	15838/15845
3	above	IN	O	above		-1	SENT_114	15846/15851
4	the	DT	O	the	det	5	SENT_114	15852/15855
5	columns	NNS	O	column	prep_above	2	SENT_114	15856/15863
6	indicate	VBP	O	indicate		-1	SENT_114	15864/15872
7	the	DT	O	the	det	8	SENT_114	15873/15876
8	number	NN	O	number	dobj	6	SENT_114	15877/15883
9	of	IN	O	of		-1	SENT_114	15884/15886
10	responders	NNS	O	responder	prep_of	8	SENT_114	15887/15897
11	per	IN	O	per		-1	SENT_114	15898/15901
12	group	NN	O	group	prep_per	10	SENT_114	15902/15907

1	As	IN	O	as	mark	2	SENT_115	15962/15964
2	expected	VBN	O	expect	advcl	10	SENT_115	15965/15973
3	,	,	O	,		-1	SENT_115	15973/15974
4	i.m.	VBN	O	i.m.	csubj	10	SENT_115	15975/15979
5	immunization	NN	O	immunization	dobj	4	SENT_115	15980/15992
6	with	IN	O	with		-1	SENT_115	15993/15997
7	conventional	JJ	O	conventional	amod	9	SENT_115	15998/16010
8	subunit	NN	O	subunit	nn	9	SENT_115	16011/16018
9	vaccine	NN	O	vaccine	prep_with	4	SENT_115	16019/16026
10	resulted	VBD	O	result		-1	SENT_115	16027/16035
11	in	IN	O	in		-1	SENT_115	16036/16038
12	robust	JJ	O	robust	amod	14	SENT_115	16039/16045
13	IgG	NN	O	igg	nn	14	SENT_115	16046/16049
14	responses	NNS	O	response	prep_in	10	SENT_115	16050/16059
15	while	IN	O	while	mark	22	SENT_115	16060/16065
16	this	DT	O	this	det	17	SENT_115	16066/16070
17	vaccine	NN	O	vaccine	nsubj	22	SENT_115	16071/16078
18	without	IN	O	without		-1	SENT_115	16079/16086
19	adjuvant	JJ	O	adjuvant	prep_without	17	SENT_115	16087/16095
20	was	VBD	O	be	cop	22	SENT_115	16096/16099
21	poorly	RB	O	poorly	advmod	22	SENT_115	16100/16106
22	immunogenic	JJ	O	immunogenic	advcl	10	SENT_115	16107/16118
23	when	WRB	O	when	advmod	24	SENT_115	16119/16123
24	administered	VBN	O	administer	advcl	22	SENT_115	16124/16136
25	via	IN	O	via		-1	SENT_115	16137/16140
26	the	DT	O	the	det	28	SENT_115	16141/16144
27	i.n.	NN	O	i.n.	nn	28	SENT_115	16145/16149
28	route	NN	O	route	prep_via	24	SENT_115	16150/16155
29	(	CD	NUMBER	(	number	30	SENT_115	16156/16157
30	26,36-38	CD	NUMBER	26,36-38	num	31	SENT_115	16157/16165
31	)	NN	O	)	dobj	24	SENT_115	16165/16166
32	.	.	O	.		-1	SENT_115	16166/16167

1	Figure	NN	O	figure	nsubj	3	SENT_116	16168/16174
2	2	CD	NUMBER	2	num	1	SENT_116	16175/16176
3	shows	VBZ	O	show		-1	SENT_116	16177/16182
4	the	DT	O	the	det	8	SENT_116	16183/16186
5	subunit	NN	O	subunit	nn	8	SENT_116	16187/16194
6	antigen-specific	JJ	O	antigen-specific	amod	8	SENT_116	16195/16211
7	IgG	NN	O	igg	nn	8	SENT_116	16212/16215
8	response	NN	O	response	dobj	3	SENT_116	16216/16224
9	after	IN	O	after		-1	SENT_116	16225/16230
10	two	CD	NUMBER	two	num	12	SENT_116	16231/16234
11	booster	NN	O	booster	nn	12	SENT_116	16235/16242
12	doses	NNS	O	dose	prep_after	3	SENT_116	16243/16248
13	.	.	O	.		-1	SENT_116	16248/16249

1	Even	RB	O	even	advmod	13	SENT_117	16250/16254
2	after	IN	O	after		-1	SENT_117	16255/16260
3	two	CD	NUMBER	two	num	5	SENT_117	16261/16264
4	booster	NN	O	booster	nn	5	SENT_117	16265/16272
5	doses	NNS	O	dose	prep_after	13	SENT_117	16273/16278
6	,	,	O	,		-1	SENT_117	16278/16279
7	i.n.	NN	O	i.n.	nn	8	SENT_117	16280/16284
8	immunization	NN	O	immunization	nsubj	13	SENT_117	16285/16297
9	with	IN	O	with		-1	SENT_117	16298/16302
10	subunit	NN	O	subunit	nn	11	SENT_117	16303/16310
11	vaccine	NN	O	vaccine	prep_with	8	SENT_117	16311/16318
12	alone	RB	O	alone	advmod	13	SENT_117	16319/16324
13	induced	VBD	O	induce		-1	SENT_117	16325/16332
14	lower	JJR	O	lower	iobj	13	SENT_117	16333/16338
15	(	CD	NUMBER	(	num	16	SENT_117	16339/16340
16	p	NN	O	p	npadvmod	17	SENT_117	16340/16341
17	<	JJR	O	<	amod	14	SENT_117	16344/16345
18	0.01	CD	NUMBER	0.01	num	21	SENT_117	16348/16352
19	)	NN	O	)	nn	21	SENT_117	16352/16353
20	IgG	NN	O	igg	nn	21	SENT_117	16354/16357
21	responses	NNS	O	response	dobj	13	SENT_117	16358/16367
22	than	IN	O	than		-1	SENT_117	16368/16372
23	i.n	JJ	O	i.n	prep_than	21	SENT_117	16373/16376
24	administered	VBN	O	administer	partmod	23	SENT_117	16377/16389
25	HA	NN	O	ha	dobj	24	SENT_117	16390/16392
26	+	CC	O	+		-1	SENT_117	16393/16394
27	GEM	NN	O	gem	conj_+	25	SENT_117	16395/16398
28	,	,	O	,		-1	SENT_117	16398/16399
29	clearly	RB	O	clearly	advmod	30	SENT_117	16400/16407
30	demonstrating	VBG	O	demonstrate	partmod	24	SENT_117	16408/16421
31	the	DT	O	the	det	33	SENT_117	16422/16425
32	adjuvant	JJ	O	adjuvant	amod	33	SENT_117	16426/16434
33	effect	NN	O	effect	dobj	30	SENT_117	16435/16441
34	of	IN	O	of		-1	SENT_117	16442/16444
35	the	DT	O	the	det	37	SENT_117	16445/16448
36	GEM	NN	O	gem	nn	37	SENT_117	16449/16452
37	particles	NNS	O	particle	prep_of	33	SENT_117	16453/16462
38	.	.	O	.		-1	SENT_117	16462/16463

1	While	IN	O	while	mark	9	SENT_118	16464/16469
2	the	DT	O	the	det	4	SENT_118	16470/16473
3	i.m.	NN	O	i.m.	nn	4	SENT_118	16474/16478
4	immunization	NN	O	immunization	nsubj	9	SENT_118	16479/16491
5	with	IN	O	with		-1	SENT_118	16492/16496
6	conventional	JJ	O	conventional	amod	8	SENT_118	16497/16509
7	subunit	NN	O	subunit	nn	8	SENT_118	16510/16517
8	vaccine	NN	O	vaccine	prep_with	4	SENT_118	16518/16525
9	resulted	VBD	O	result	advcl	41	SENT_118	16526/16534
10	in	IN	O	in		-1	SENT_118	16535/16537
11	a	DT	O	a	det	15	SENT_118	16538/16539
12	higher	JJR	O	higher	amod	15	SENT_118	16540/16546
13	response	NN	O	response	nn	15	SENT_118	16547/16555
14	(	NN	O	(	nn	15	SENT_118	16556/16557
15	p	NN	O	p	prep_in	9	SENT_118	16557/16558
16	=	JJ	O	=	amod	18	SENT_118	16561/16562
17	0.0101	CD	NUMBER	0.0101	tmod	16	SENT_118	16565/16571
18	)	NN	O	)	dobj	9	SENT_118	16571/16572
19	than	IN	O	than		-1	SENT_118	16573/16577
20	i.n.	JJ	O	i.n.	amod	21	SENT_118	16578/16582
21	immunization	NN	O	immunization	prep_than	9	SENT_118	16583/16595
22	with	IN	O	with		-1	SENT_118	16596/16600
23	HA	NN	O	ha	prep_with	9	SENT_118	16601/16603
24	+	CC	O	+		-1	SENT_118	16604/16605
25	GEM	NN	O	gem	conj_+	23	SENT_118	16606/16609
26	after	IN	O	after		-1	SENT_118	16610/16615
27	the	DT	O	the	det	30	SENT_118	16616/16619
28	first	JJ	ORDINAL	first	amod	30	SENT_118	16620/16625
29	booster	NN	O	booster	nn	30	SENT_118	16626/16633
30	dose	NN	O	dose	prep_after	9	SENT_118	16634/16638
31	,	,	O	,		-1	SENT_118	16638/16639
32	the	DT	O	the	det	34	SENT_118	16640/16643
33	IgG	NN	O	igg	nn	34	SENT_118	16644/16647
34	response	NN	O	response	nsubj	41	SENT_118	16648/16656
35	was	VBD	O	be	cop	41	SENT_118	16657/16660
36	comparable	JJ	O	comparable	amod	41	SENT_118	16661/16671
37	(	NN	O	(	nn	41	SENT_118	16672/16673
38	p	NN	O	p	nn	41	SENT_118	16673/16674
39	=	JJ	O	=	amod	41	SENT_118	16677/16678
40	0.4355	CD	NUMBER	0.4355	num	41	SENT_118	16681/16687
41	)	NN	O	)		-1	SENT_118	16687/16688
42	after	IN	O	after		-1	SENT_118	16689/16694
43	the	DT	O	the	det	46	SENT_118	16695/16698
44	second	JJ	ORDINAL	second	amod	46	SENT_118	16699/16705
45	booster	NN	O	booster	nn	46	SENT_118	16706/16713
46	immunization	NN	O	immunization	prep_after	41	SENT_118	16714/16726
47	.	.	O	.		-1	SENT_118	16726/16727

1	This	DT	O	this	nsubj	3	SENT_119	16728/16732
2	is	VBZ	O	be	cop	3	SENT_119	16733/16735
3	consistent	JJ	O	consistent		-1	SENT_119	16736/16746
4	with	IN	O	with	mark	7	SENT_119	16747/16751
5	earlier	JJR	O	earlier	amod	6	SENT_119	16752/16759
6	observations	NNS	O	observation	nsubj	7	SENT_119	16760/16772
7	(	VBP	O	(	advcl	3	SENT_119	16773/16774
8	25,36,39,40	CD	NUMBER	25,36,39,40	number	9	SENT_119	16774/16785
9	)	CD	NUMBER	)	num	10	SENT_119	16785/16786
10	reporting	NN	O	reporting	dobj	7	SENT_119	16787/16796
11	that	WDT	O	that	dobj	17	SENT_119	16797/16801
12	during	IN	O	during		-1	SENT_119	16802/16808
13	i.n.	NN	O	i.n.	nn	14	SENT_119	16809/16813
14	immunization	NN	O	immunization	prep_during	17	SENT_119	16814/16826
15	,	,	O	,		-1	SENT_119	16826/16827
16	there	EX	O	there	expl	17	SENT_119	16828/16833
17	is	VBZ	O	be	rcmod	10	SENT_119	16834/16836
18	a	DT	O	a	det	20	SENT_119	16837/16838
19	gradual	JJ	O	gradual	amod	20	SENT_119	16839/16846
20	increase	NN	O	increase	nsubj	17	SENT_119	16847/16855
21	in	IN	O	in		-1	SENT_119	16856/16858
22	IgG	NN	O	igg	nn	23	SENT_119	16859/16862
23	response	NN	O	response	prep_in	20	SENT_119	16863/16871
24	.	.	O	.		-1	SENT_119	16871/16872

1	Fig.	NN	O	fig.		-1	SENT_120	16873/16877
2	2	CD	NUMBER	2	num	1	SENT_120	16878/16879

1	Subunit	NN	O	subunit	nsubj	9	SENT_121	16896/16903
2	antigen-specific	JJ	O	antigen-specific	amod	4	SENT_121	16904/16920
3	total	JJ	O	total	amod	4	SENT_121	16921/16926
4	serum	NN	O	serum	dep	1	SENT_121	16927/16932
5	IgG	NN	O	igg	nn	6	SENT_121	16933/16936
6	titers	NNS	O	titer	dep	1	SENT_121	16937/16943
7	in	IN	O	in		-1	SENT_121	16944/16946
8	mice	NNS	O	mouse	prep_in	6	SENT_121	16947/16951
9	immunized	VBD	O	immunize		-1	SENT_121	16952/16961
10	three	CD	NUMBER	three	num	11	SENT_121	16962/16967
11	times	NNS	O	time	tmod	9	SENT_121	16968/16973
12	.	.	O	.		-1	SENT_121	16973/16974

1	a	DT	O	a	det	3	SENT_122	16975/16976
2	Comparative	JJ	O	comparative	amod	3	SENT_122	16977/16988
3	analysis	NN	O	analysis		-1	SENT_122	16989/16997
4	of	IN	O	of		-1	SENT_122	16998/17000
5	total	JJ	O	total	amod	8	SENT_122	17001/17006
6	serum	NN	O	serum	nn	8	SENT_122	17007/17012
7	IgG	NN	O	igg	nn	8	SENT_122	17013/17016
8	titers	NNS	O	titer	prep_of	3	SENT_122	17017/17023
9	in	IN	O	in		-1	SENT_122	17024/17026
10	different	JJ	O	different	amod	11	SENT_122	17027/17036
11	groups	NNS	O	group	prep_in	3	SENT_122	17037/17043
12	,	,	O	,		-1	SENT_122	17043/17044
13	i.e.	FW	O	i.e.	conj_and	11	SENT_122	17045/17049
14	,	,	O	,		-1	SENT_122	17049/17050
15	i.m.	NNP	O	i.m.	conj_and	11	SENT_122	17051/17055
16	,	,	O	,		-1	SENT_122	17055/17056
17	i.n.	NNP	O	i.n.	conj_and	11	SENT_122	17057/17061
18	,	,	O	,		-1	SENT_122	17061/17062
19	and	CC	O	and		-1	SENT_122	17063/17066
20	i.n.	NN	O	i.n.	conj_and	11	SENT_122	17067/17071
21	+	CC	O	+		-1	SENT_122	17072/17073
22	GEM	NN	O	gem	conj_+	20	SENT_122	17074/17077
23	at	IN	O	at		-1	SENT_122	17078/17080
24	0	CD	NUMBER	0	prep_at	22	SENT_122	17081/17082
25	,	,	O	,		-1	SENT_122	17082/17083
26	28	CD	NUMBER	28	conj_and	11	SENT_122	17084/17086
27	,	,	O	,		-1	SENT_122	17086/17087
28	and	CC	DURATION	and		-1	SENT_122	17088/17091
29	42	CD	DURATION	42	num	30	SENT_122	17092/17094
30	days	NNS	NUMBER	day	conj_and	11	SENT_122	17095/17099
31	after	IN	O	after		-1	SENT_122	17100/17105
32	the	DT	O	the	det	34	SENT_122	17106/17109
33	first	JJ	ORDINAL	first	amod	34	SENT_122	17110/17115
34	immunization	NN	O	immunization	prep_after	3	SENT_122	17116/17128
35	.	.	O	.		-1	SENT_122	17128/17129

1	b	NN	O	b	nn	3	SENT_123	17130/17131
2	Comparative	JJ	O	comparative	amod	3	SENT_123	17132/17143
3	analysis	NN	O	analysis		-1	SENT_123	17144/17152
4	of	IN	O	of		-1	SENT_123	17153/17155
5	total	JJ	O	total	amod	8	SENT_123	17156/17161
6	serum	NN	O	serum	nn	8	SENT_123	17162/17167
7	IgG	NN	O	igg	nn	8	SENT_123	17168/17171
8	titers	NNS	O	titer	prep_of	3	SENT_123	17172/17178
9	between	IN	O	between		-1	SENT_123	17179/17186
10	three	CD	NUMBER	three	num	11	SENT_123	17187/17192
11	groups	NNS	O	group	prep_between	3	SENT_123	17193/17199
12	,	,	O	,		-1	SENT_123	17199/17200
13	i.e.	FW	O	i.e.	conj_and	11	SENT_123	17201/17205
14	,	,	O	,		-1	SENT_123	17205/17206
15	i.m.	NNP	O	i.m.	conj_and	11	SENT_123	17207/17211
16	,	,	O	,		-1	SENT_123	17211/17212
17	i.n.	NNP	O	i.n.	conj_and	11	SENT_123	17213/17217
18	,	,	O	,		-1	SENT_123	17217/17218
19	and	CC	O	and		-1	SENT_123	17219/17222
20	i.n.	NN	O	i.n.	conj_and	11	SENT_123	17223/17227
21	+	CC	O	+		-1	SENT_123	17228/17229
22	GEM	NN	O	gem	conj_+	20	SENT_123	17230/17233
23	at	IN	O	at		-1	SENT_123	17234/17236
24	42	CD	DURATION	42	num	25	SENT_123	17237/17239
25	days	NNS	NUMBER	day	prep_at	22	SENT_123	17240/17244
26	after	IN	O	after		-1	SENT_123	17245/17250
27	first	JJ	ORDINAL	first	amod	28	SENT_123	17251/17256
28	immunization	NN	O	immunization	prep_after	25	SENT_123	17257/17269
29	.	.	O	.		-1	SENT_123	17269/17270

1	**	NN	O	**	nn	2	SENT_124	17271/17273
2	p	NN	O	p		-1	SENT_124	17273/17274
3	<	JJR	O	<	dep	2	SENT_124	17277/17278
4	0.01	CD	NUMBER	0.01	dep	2	SENT_124	17281/17285

1	Furthermore	RB	O	furthermore	advmod	10	SENT_125	17340/17351
2	,	,	O	,		-1	SENT_125	17351/17352
3	i.n.	NN	O	i.n.	nn	4	SENT_125	17353/17357
4	immunization	NN	O	immunization	nsubj	10	SENT_125	17358/17370
5	without	IN	O	without		-1	SENT_125	17371/17378
6	adjuvant	JJ	O	adjuvant	amod	9	SENT_125	17379/17387
7	and	CC	O	and		-1	SENT_125	17388/17391
8	i.m	JJ	O	i.m	conj_and	6	SENT_125	17392/17395
9	immunization	NN	O	immunization	prep_without	4	SENT_125	17396/17408
10	induced	VBD	O	induce		-1	SENT_125	17409/17416
11	low	JJ	O	low	amod	12	SENT_125	17417/17420
12	levels	NNS	O	level	nsubj	17	SENT_125	17421/17427
13	of	IN	O	of		-1	SENT_125	17428/17430
14	serum	NN	O	serum	nn	16	SENT_125	17431/17436
15	IgA	NN	O	iga	nn	16	SENT_125	17437/17440
16	titers	NNS	O	titer	prep_of	12	SENT_125	17441/17447
17	(	VBP	O	(	ccomp	10	SENT_125	17448/17449
18	Fig.	NN	O	fig.	nn	20	SENT_125	17449/17453
19	3	CD	NUMBER	3	num	20	SENT_125	17454/17455
20	)	NN	O	)	dobj	17	SENT_125	17455/17456
21	.	.	O	.		-1	SENT_125	17456/17457

1	Moreover	RB	O	moreover	advmod	14	SENT_126	17458/17466
2	,	,	O	,		-1	SENT_126	17466/17467
3	only	RB	O	only	quantmod	4	SENT_126	17468/17472
4	three	CD	NUMBER	three	nsubj	14	SENT_126	17473/17478
5	out	IN	O	out		-1	SENT_126	17479/17482
6	of	IN	O	of		-1	SENT_126	17483/17485
7	eight	CD	NUMBER	eight	prep_out_of	4	SENT_126	17486/17491
8	and	CC	O	and		-1	SENT_126	17492/17495
9	five	CD	NUMBER	five	conj_and	7	SENT_126	17496/17500
10	out	IN	O	out		-1	SENT_126	17501/17504
11	of	IN	O	of		-1	SENT_126	17505/17507
12	eight	CD	NUMBER	eight	num	13	SENT_126	17508/17513
13	animals	NNS	O	animal	prep_out_of	4	SENT_126	17514/17521
14	responded	VBD	O	respond		-1	SENT_126	17522/17531
15	after	IN	O	after		-1	SENT_126	17532/17537
16	i.n.	NNP	O	i.n.	prep_after	14	SENT_126	17538/17542
17	and	CC	O	and		-1	SENT_126	17543/17546
18	i.m.	NNP	O	i.m.	nn	19	SENT_126	17547/17551
19	immunization	NN	O	immunization	conj_and	16	SENT_126	17552/17564
20	with	IN	O	with		-1	SENT_126	17565/17569
21	subunit	NN	O	subunit	nn	22	SENT_126	17570/17577
22	vaccine	NN	O	vaccine	prep_with	19	SENT_126	17578/17585
23	,	,	O	,		-1	SENT_126	17585/17586
24	respectively	RB	O	respectively	advmod	14	SENT_126	17587/17599
25	.	.	O	.		-1	SENT_126	17599/17600

1	In	IN	O	in		-1	SENT_127	17601/17603
2	contrast	NN	O	contrast	prep_in	10	SENT_127	17604/17612
3	,	,	O	,		-1	SENT_127	17612/17613
4	i.n.	NN	O	i.n.	nn	5	SENT_127	17614/17618
5	immunization	NN	O	immunization	nsubj	10	SENT_127	17619/17631
6	with	IN	O	with		-1	SENT_127	17632/17636
7	HA	NN	O	ha	prep_with	5	SENT_127	17637/17639
8	+	CC	O	+		-1	SENT_127	17640/17641
9	GEM	NN	O	gem	conj_+	7	SENT_127	17642/17645
10	induced	VBD	O	induce		-1	SENT_127	17646/17653
11	higher	JJR	O	higher	iobj	10	SENT_127	17654/17660
12	(	CD	NUMBER	(	num	13	SENT_127	17661/17662
13	p	NN	O	p	npadvmod	14	SENT_127	17662/17663
14	<	JJR	O	<	amod	11	SENT_127	17666/17667
15	0.05	CD	NUMBER	0.05	num	19	SENT_127	17670/17674
16	)	NN	O	)	nn	19	SENT_127	17674/17675
17	serum	NN	O	serum	nn	19	SENT_127	17676/17681
18	IgA	NN	O	iga	nn	19	SENT_127	17682/17685
19	responses	NNS	O	response	dobj	10	SENT_127	17686/17695
20	than	IN	O	than		-1	SENT_127	17696/17700
21	the	DT	O	the	det	25	SENT_127	17701/17704
22	other	JJ	O	other	amod	25	SENT_127	17705/17710
23	two	CD	NUMBER	two	num	25	SENT_127	17711/17714
24	control	NN	O	control	nn	25	SENT_127	17715/17722
25	immunizations	NNS	O	immunization	prep_than	19	SENT_127	17723/17736
26	,	,	O	,		-1	SENT_127	17736/17737
27	and	CC	O	and		-1	SENT_127	17738/17741
28	all	DT	O	all	det	29	SENT_127	17742/17745
29	animals	NNS	O	animal	nsubj	30	SENT_127	17746/17753
30	responded	VBD	O	respond	conj_and	10	SENT_127	17754/17763
31	in	IN	O	in		-1	SENT_127	17764/17766
32	this	DT	O	this	det	33	SENT_127	17767/17771
33	group	NN	O	group	prep_in	30	SENT_127	17772/17777
34	.	.	O	.		-1	SENT_127	17777/17778

1	It	PRP	O	it	nsubj	3	SENT_128	17779/17781
2	is	VBZ	O	be	cop	3	SENT_128	17782/17784
3	evident	JJ	O	evident		-1	SENT_128	17785/17792
4	from	IN	O	from		-1	SENT_128	17793/17797
5	the	DT	O	the	det	6	SENT_128	17798/17801
6	results	NNS	O	result	prep_from	3	SENT_128	17802/17809
7	that	WDT	O	that	dobj	15	SENT_128	17810/17814
8	formulation	NN	O	formulation	nsubj	15	SENT_128	17815/17826
9	of	IN	O	of		-1	SENT_128	17827/17829
10	subunit	NN	O	subunit	nn	11	SENT_128	17830/17837
11	vaccine	NN	O	vaccine	prep_of	8	SENT_128	17838/17845
12	with	IN	O	with		-1	SENT_128	17846/17850
13	GEM	NN	O	gem	nn	14	SENT_128	17851/17854
14	particles	NNS	O	particle	prep_with	11	SENT_128	17855/17864
15	induced	VBD	O	induce	rcmod	6	SENT_128	17865/17872
16	a	DT	O	a	det	20	SENT_128	17873/17874
17	strong	JJ	O	strong	amod	20	SENT_128	17875/17881
18	systemic	JJ	O	systemic	amod	20	SENT_128	17882/17890
19	immune	JJ	O	immune	amod	20	SENT_128	17891/17897
20	response	NN	O	response	dobj	15	SENT_128	17898/17906
21	compared	VBN	O	compare		-1	SENT_128	17907/17915
22	to	TO	O	to	prepc_compared_to	15	SENT_128	17916/17918
23	both	DT	O	both	preconj	27	SENT_128	17919/17923
24	i.n.	NN	O	i.n.	nn	27	SENT_128	17924/17928
25	and	CC	O	and		-1	SENT_128	17929/17932
26	i.m.	NN	O	i.m.	conj_and	24	SENT_128	17933/17937
27	immunization	NN	O	immunization	pobj	15	SENT_128	17938/17950
28	with	IN	O	with		-1	SENT_128	17951/17955
29	subunit	NN	O	subunit	nn	30	SENT_128	17956/17963
30	vaccine	NN	O	vaccine	prep_with	27	SENT_128	17964/17971
31	alone	RB	O	alone	advmod	3	SENT_128	17972/17977
32	.	.	O	.		-1	SENT_128	17977/17978

1	Fig.	NN	O	fig.		-1	SENT_129	17979/17983
2	3	CD	NUMBER	3	num	1	SENT_129	17984/17985

1	Subunit	NN	O	subunit	nsubj	9	SENT_130	18002/18009
2	antigen-specific	JJ	O	antigen-specific	amod	4	SENT_130	18010/18026
3	total	JJ	O	total	amod	4	SENT_130	18027/18032
4	serum	NN	O	serum	dep	1	SENT_130	18033/18038
5	IgA	NN	O	iga	nn	6	SENT_130	18039/18042
6	titers	NNS	O	titer	dep	1	SENT_130	18043/18049
7	in	IN	O	in		-1	SENT_130	18050/18052
8	mice	NNS	O	mouse	prep_in	6	SENT_130	18053/18057
9	immunized	VBN	O	immunize		-1	SENT_130	18058/18067
10	i.m.	NNP	O	i.m.	dobj	9	SENT_130	18068/18072
11	,	,	O	,		-1	SENT_130	18072/18073
12	i.n.	NNP	O	i.n.	conj_and	10	SENT_130	18074/18078
13	,	,	O	,		-1	SENT_130	18078/18079
14	and	CC	O	and		-1	SENT_130	18080/18083
15	i.n.	NN	O	i.n.	conj_and	10	SENT_130	18084/18088
16	+	CC	O	+		-1	SENT_130	18089/18090
17	GEM	NN	O	gem	conj_+	15	SENT_130	18091/18094
18	.	.	O	.		-1	SENT_130	18094/18095

1	The	DT	O	the	det	2	SENT_131	18096/18099
2	numbers	NNS	O	number	nsubj	6	SENT_131	18100/18107
3	above	IN	O	above		-1	SENT_131	18108/18113
4	the	DT	O	the	det	5	SENT_131	18114/18117
5	columns	NNS	O	column	prep_above	2	SENT_131	18118/18125
6	indicate	VBP	O	indicate		-1	SENT_131	18126/18134
7	the	DT	O	the	det	8	SENT_131	18135/18138
8	number	NN	O	number	dobj	6	SENT_131	18139/18145
9	of	IN	O	of		-1	SENT_131	18146/18148
10	responders	NNS	O	responder	prep_of	8	SENT_131	18149/18159
11	per	IN	O	per		-1	SENT_131	18160/18163
12	group	NN	O	group	prep_per	10	SENT_131	18164/18169

1	Mucosal	JJ	O	mucosal	amod	3	SENT_132	18224/18231
2	Immune	JJ	O	immune	amod	3	SENT_132	18232/18238
3	Response	NN	O	response		-1	SENT_132	18239/18247

1	It	PRP	O	it	nsubjpass	4	SENT_133	18283/18285
2	has	VBZ	O	have	aux	4	SENT_133	18286/18289
3	been	VBN	O	be	auxpass	4	SENT_133	18290/18294
4	reported	VBN	O	report		-1	SENT_133	18295/18303
5	previously	RB	DATE	previously	advmod	4	SENT_133	18304/18314
6	that	IN	O	that	mark	10	SENT_133	18315/18319
7	i.n.	NN	O	i.n.	nn	8	SENT_133	18320/18324
8	immunization	NN	O	immunization	nsubj	10	SENT_133	18325/18337
9	may	MD	O	may	aux	10	SENT_133	18338/18341
10	induce	VB	O	induce	ccomp	4	SENT_133	18342/18348
11	local	JJ	O	local	amod	13	SENT_133	18349/18354
12	mucosal	JJ	O	mucosal	amod	13	SENT_133	18355/18362
13	immunity	NN	O	immunity	dobj	10	SENT_133	18363/18371
14	in	IN	O	in		-1	SENT_133	18372/18374
15	the	DT	O	the	det	17	SENT_133	18375/18378
16	respiratory	JJ	O	respiratory	amod	17	SENT_133	18379/18390
17	tract	NN	O	tract	prep_in	13	SENT_133	18391/18396
18	,	,	O	,		-1	SENT_133	18396/18397
19	i.e.	FW	O	i.e.	dep	13	SENT_133	18398/18402
20	,	,	O	,		-1	SENT_133	18402/18403
21	the	DT	O	the	det	22	SENT_133	18404/18407
22	port	NN	O	port	appos	13	SENT_133	18408/18412
23	of	IN	O	of		-1	SENT_133	18413/18415
24	entry	NN	O	entry	prep_of	22	SENT_133	18416/18421
25	of	IN	O	of		-1	SENT_133	18422/18424
26	influenza	NN	O	influenza	nn	27	SENT_133	18425/18434
27	virus	NN	O	virus	prep_of	24	SENT_133	18435/18440
28	(	CD	NUMBER	(	num	30	SENT_133	18441/18442
29	36,38-40	CD	NUMBER	36,38-40	num	30	SENT_133	18442/18450
30	)	NN	O	)	dep	22	SENT_133	18450/18451
31	.	.	O	.		-1	SENT_133	18451/18452

1	The	DT	O	the	det	2	SENT_134	18453/18456
2	activation	NN	O	activation	nsubj	7	SENT_134	18457/18467
3	of	IN	O	of		-1	SENT_134	18468/18470
4	the	DT	O	the	det	6	SENT_134	18471/18474
5	mucosal	JJ	O	mucosal	amod	6	SENT_134	18475/18482
6	immunity	NN	O	immunity	prep_of	2	SENT_134	18483/18491
7	primes	VBZ	O	prime		-1	SENT_134	18492/18498
8	the	DT	O	the	det	10	SENT_134	18499/18502
9	underlying	JJ	O	underlying	amod	10	SENT_134	18503/18513
10	B	NN	O	b	dobj	7	SENT_134	18514/18515
11	and	CC	O	and		-1	SENT_134	18516/18519
12	T	NN	O	t	nn	13	SENT_134	18520/18521
13	cells	NNS	O	cell	conj_and	10	SENT_134	18522/18527
14	and	CC	O	and		-1	SENT_134	18528/18531
15	results	NNS	O	result	conj_and	10	SENT_134	18532/18539
16	in	IN	O	in		-1	SENT_134	18540/18542
17	secretion	NN	O	secretion	prep_in	15	SENT_134	18543/18552
18	of	IN	O	of		-1	SENT_134	18553/18555
19	sIgA	NN	O	siga	prep_of	17	SENT_134	18556/18560
20	at	IN	O	at		-1	SENT_134	18561/18563
21	mucosal	JJ	O	mucosal	amod	22	SENT_134	18564/18571
22	sites	NNS	O	site	prep_at	7	SENT_134	18572/18577
23	.	.	O	.		-1	SENT_134	18577/18578

1	Consequently	RB	O	consequently	advmod	18	SENT_135	18579/18591
2	,	,	O	,		-1	SENT_135	18591/18592
3	the	DT	O	the	det	4	SENT_135	18593/18596
4	influenza	NN	O	influenza	nsubj	18	SENT_135	18597/18606
5	specific	JJ	O	specific	amod	7	SENT_135	18607/18615
6	sIgA	NN	O	siga	nn	7	SENT_135	18616/18620
7	titers	NNS	O	titer	nsubjpass	9	SENT_135	18621/18627
8	were	VBD	O	be	auxpass	9	SENT_135	18628/18632
9	determined	VBN	O	determine	rcmod	4	SENT_135	18633/18643
10	in	IN	O	in		-1	SENT_135	18644/18646
11	nasal	JJ	O	nasal	amod	14	SENT_135	18647/18652
12	and	CC	O	and		-1	SENT_135	18653/18656
13	lung	NN	O	lung	conj_and	11	SENT_135	18657/18661
14	lavages	NNS	O	lavage	prep_in	9	SENT_135	18662/18669
15	of	IN	O	of		-1	SENT_135	18670/18672
16	the	DT	O	the	det	17	SENT_135	18673/18676
17	mice	NNS	O	mouse	prep_of	14	SENT_135	18677/18681
18	(	VBP	O	(		-1	SENT_135	18682/18683
19	Fig.	NN	O	fig.	nn	21	SENT_135	18683/18687
20	4	CD	NUMBER	4	num	21	SENT_135	18688/18689
21	)	NN	O	)	dobj	18	SENT_135	18689/18690
22	.	.	O	.		-1	SENT_135	18690/18691

1	Fig.	NN	O	fig.		-1	SENT_136	18692/18696
2	4	CD	NUMBER	4	num	1	SENT_136	18697/18698

1	Subunit	NN	O	subunit		-1	SENT_137	18715/18722
2	antigen-specific	JJ	O	antigen-specific	amod	4	SENT_137	18723/18739
3	sIgA	NN	O	siga	nn	4	SENT_137	18740/18744
4	titers	NNS	O	titer	dep	1	SENT_137	18745/18751
5	in	IN	O	in		-1	SENT_137	18752/18754
6	nasal	JJ	O	nasal	amod	7	SENT_137	18755/18760
7	(	NN	O	(	prep_in	4	SENT_137	18761/18762
8	a	DT	O	a	det	9	SENT_137	18762/18763
9	)	NN	O	)	dep	15	SENT_137	18763/18764
10	and	CC	O	and		-1	SENT_137	18765/18768
11	lung	NN	O	lung	nn	12	SENT_137	18769/18773
12	lavages	NNS	O	lavage	conj_and	9	SENT_137	18774/18781
13	(	CD	NUMBER	(	num	14	SENT_137	18782/18783
14	b	NN	O	b	dep	15	SENT_137	18783/18784
15	)	NN	O	)	dep	4	SENT_137	18784/18785
16	of	IN	O	of		-1	SENT_137	18786/18788
17	mice	NNS	O	mouse	prep_of	15	SENT_137	18789/18793
18	immunized	VBN	O	immunize	partmod	1	SENT_137	18794/18803
19	i.m.	NNP	O	i.m.	dobj	18	SENT_137	18804/18808
20	,	,	O	,		-1	SENT_137	18808/18809
21	i.n.	NNP	O	i.n.	conj_and	19	SENT_137	18810/18814
22	,	,	O	,		-1	SENT_137	18814/18815
23	and	CC	O	and		-1	SENT_137	18816/18819
24	i.n.	NN	O	i.n.	conj_and	19	SENT_137	18820/18824
25	+	CC	O	+		-1	SENT_137	18825/18826
26	GEM	NN	O	gem	conj_+	24	SENT_137	18827/18830
27	.	.	O	.		-1	SENT_137	18830/18831

1	The	DT	O	the	det	2	SENT_138	18832/18835
2	numbers	NNS	O	number	nsubj	6	SENT_138	18836/18843
3	above	IN	O	above		-1	SENT_138	18844/18849
4	the	DT	O	the	det	5	SENT_138	18850/18853
5	columns	NNS	O	column	prep_above	2	SENT_138	18854/18861
6	indicate	VBP	O	indicate		-1	SENT_138	18862/18870
7	the	DT	O	the	det	8	SENT_138	18871/18874
8	number	NN	O	number	dobj	6	SENT_138	18875/18881
9	of	IN	O	of		-1	SENT_138	18882/18884
10	responders	NNS	O	responder	prep_of	8	SENT_138	18885/18895
11	per	IN	O	per		-1	SENT_138	18896/18899
12	group	NN	O	group	prep_per	10	SENT_138	18900/18905

1	I.m.	NNP	O	I.m.	nn	2	SENT_139	18960/18964
2	immunizations	NNS	O	immunization	nsubj	3	SENT_139	18965/18978
3	elicited	VBD	O	elicit		-1	SENT_139	18979/18987
4	sIgA	NN	O	siga	nn	5	SENT_139	18988/18992
5	levels	NNS	O	level	dobj	3	SENT_139	18993/18999
6	in	IN	O	in		-1	SENT_139	19000/19002
7	nasal	JJ	O	nasal	amod	10	SENT_139	19003/19008
8	and	CC	O	and		-1	SENT_139	19009/19012
9	lung	NN	O	lung	conj_and	7	SENT_139	19013/19017
10	lavages	NNS	O	lavage	prep_in	5	SENT_139	19018/19025
11	below	IN	O	below		-1	SENT_139	19026/19031
12	detection	NN	O	detection	nn	13	SENT_139	19032/19041
13	limits	NNS	O	limit	prep_below	3	SENT_139	19042/19048
14	in	IN	O	in		-1	SENT_139	19049/19051
15	most	JJS	O	most	prep_in	13	SENT_139	19052/19056
16	of	IN	O	of		-1	SENT_139	19057/19059
17	the	DT	O	the	det	18	SENT_139	19060/19063
18	mice	NNS	O	mouse	prep_of	15	SENT_139	19064/19068
19	(	RB	O	(	prep	3	SENT_139	19069/19070
20	only	RB	O	only	dep	19	SENT_139	19070/19074
21	one	CD	NUMBER	one	npadvmod	22	SENT_139	19075/19078
22	out	IN	O	out	dep	19	SENT_139	19079/19082
23	of	IN	O	of		-1	SENT_139	19083/19085
24	eight	CD	NUMBER	eight	num	25	SENT_139	19086/19091
25	mice	NNS	O	mouse	prep_of	3	SENT_139	19092/19096
26	showed	VBD	O	show	partmod	25	SENT_139	19097/19103
27	a	DT	O	a	det	28	SENT_139	19104/19105
28	response	NN	O	response	dobj	26	SENT_139	19106/19114
29	in	IN	O	in		-1	SENT_139	19115/19117
30	the	DT	O	the	det	33	SENT_139	19118/19121
31	nasal	JJ	O	nasal	amod	33	SENT_139	19122/19127
32	lavage	NN	O	lavage	nn	33	SENT_139	19128/19134
33	)	NN	O	)	prep_in	26	SENT_139	19134/19135
34	.	.	O	.		-1	SENT_139	19135/19136

1	Similarly	RB	O	similarly	advmod	10	SENT_140	19137/19146
2	,	,	O	,		-1	SENT_140	19146/19147
3	the	DT	O	the	det	5	SENT_140	19148/19151
4	i.n.	NNP	O	i.n.	nn	5	SENT_140	19152/19156
5	immunizations	NNS	O	immunization	nsubj	10	SENT_140	19157/19170
6	with	IN	O	with		-1	SENT_140	19171/19175
7	subunit	NN	O	subunit	nn	8	SENT_140	19176/19183
8	vaccine	NN	O	vaccine	prep_with	5	SENT_140	19184/19191
9	alone	RB	O	alone	advmod	10	SENT_140	19192/19197
10	gave	VBD	O	give		-1	SENT_140	19198/19202
11	low	JJ	O	low	amod	13	SENT_140	19203/19206
12	sIgA	NN	O	siga	nn	13	SENT_140	19207/19211
13	titers	NNS	O	titer	nsubj	19	SENT_140	19212/19218
14	in	IN	O	in		-1	SENT_140	19219/19221
15	lung	NN	O	lung	nn	18	SENT_140	19222/19226
16	and	CC	O	and		-1	SENT_140	19227/19230
17	nasal	JJ	O	nasal	conj_and	15	SENT_140	19231/19236
18	lavages	NNS	O	lavage	prep_in	13	SENT_140	19237/19244
19	(	VBD	O	(	ccomp	10	SENT_140	19245/19246
20	three	CD	NUMBER	three	dobj	19	SENT_140	19246/19251
21	out	IN	O	out		-1	SENT_140	19252/19255
22	of	IN	O	of		-1	SENT_140	19256/19258
23	eight	CD	NUMBER	eight	num	24	SENT_140	19259/19264
24	responders	NNS	O	responder	prep_out_of	19	SENT_140	19265/19275
25	)	CD	NUMBER	)	tmod	24	SENT_140	19275/19276
26	.	.	O	.		-1	SENT_140	19276/19277

1	In	IN	O	in		-1	SENT_141	19278/19280
2	contrast	NN	O	contrast	prep_in	10	SENT_141	19281/19289
3	,	,	O	,		-1	SENT_141	19289/19290
4	i.n.	NN	O	i.n.	nn	5	SENT_141	19291/19295
5	immunization	NN	O	immunization	nsubj	10	SENT_141	19296/19308
6	with	IN	O	with		-1	SENT_141	19309/19313
7	HA	NN	O	ha	prep_with	5	SENT_141	19314/19316
8	+	CC	O	+		-1	SENT_141	19317/19318
9	GEM	NN	O	gem	conj_+	7	SENT_141	19319/19322
10	induced	VBD	O	induce		-1	SENT_141	19323/19330
11	high	JJ	O	high	amod	13	SENT_141	19331/19335
12	sIgA	NN	O	siga	nn	13	SENT_141	19336/19340
13	titers	NNS	O	titer	dobj	10	SENT_141	19341/19347
14	in	IN	O	in		-1	SENT_141	19348/19350
15	nasal	JJ	O	nasal	amod	18	SENT_141	19351/19356
16	and	CC	O	and		-1	SENT_141	19357/19360
17	lung	NN	O	lung	conj_and	15	SENT_141	19361/19365
18	lavages	NNS	O	lavage	prep_in	10	SENT_141	19366/19373
19	of	IN	O	of		-1	SENT_141	19374/19376
20	all	DT	O	all	det	21	SENT_141	19377/19380
21	mice	NNS	O	mouse	prep_of	18	SENT_141	19381/19385
22	.	.	O	.		-1	SENT_141	19385/19386

1	In	IN	O	in		-1	SENT_142	19387/19389
2	conclusion	NN	O	conclusion	prep_in	10	SENT_142	19390/19400
3	,	,	O	,		-1	SENT_142	19400/19401
4	i.n.	NN	O	i.n.	nn	5	SENT_142	19402/19406
5	immunization	NN	O	immunization	nsubj	10	SENT_142	19407/19419
6	with	IN	O	with		-1	SENT_142	19420/19424
7	HA	NN	O	ha	prep_with	5	SENT_142	19425/19427
8	+	CC	O	+		-1	SENT_142	19428/19429
9	GEM	NN	O	gem	conj_+	7	SENT_142	19430/19433
10	induced	VBD	O	induce		-1	SENT_142	19434/19441
11	a	DT	O	a	det	15	SENT_142	19442/19443
12	strong	JJ	O	strong	amod	15	SENT_142	19444/19450
13	mucosal	JJ	O	mucosal	amod	15	SENT_142	19451/19458
14	immune	JJ	O	immune	amod	15	SENT_142	19459/19465
15	response	NN	O	response	dobj	10	SENT_142	19466/19474
16	at	IN	O	at		-1	SENT_142	19475/19477
17	both	CC	O	both	preconj	19	SENT_142	19478/19482
18	the	DT	O	the	det	19	SENT_142	19483/19486
19	upper	JJ	O	upper	prep_at	10	SENT_142	19487/19492
20	and	CC	O	and		-1	SENT_142	19493/19496
21	lower	JJR	O	lower	amod	23	SENT_142	19497/19502
22	respiratory	JJ	O	respiratory	amod	23	SENT_142	19503/19514
23	tract	NN	O	tract	conj_and	19	SENT_142	19515/19520
24	.	.	O	.		-1	SENT_142	19520/19521

1	Phenotype	NN	O	phenotype		-1	SENT_143	19557/19566
2	of	IN	O	of		-1	SENT_143	19567/19569
3	Immune	JJ	O	immune	amod	4	SENT_143	19570/19576
4	Response	NN	O	response	prep_of	1	SENT_143	19577/19585

1	In	IN	O	in	mark	4	SENT_144	19621/19623
2	order	NN	O	order	dep	4	SENT_144	19624/19629
3	to	TO	O	to	aux	4	SENT_144	19630/19632
4	evaluate	VB	O	evaluate	advcl	32	SENT_144	19633/19641
5	the	DT	O	the	det	6	SENT_144	19642/19645
6	phenotype	NN	O	phenotype	dobj	4	SENT_144	19646/19655
7	of	IN	O	of		-1	SENT_144	19656/19658
8	the	DT	O	the	det	9	SENT_144	19659/19662
9	response	NN	O	response	prep_of	6	SENT_144	19663/19671
10	,	,	O	,		-1	SENT_144	19671/19672
11	i.e.	FW	O	i.e.	appos	9	SENT_144	19673/19677
12	,	,	O	,		-1	SENT_144	19677/19678
13	the	DT	O	the	det	17	SENT_144	19679/19682
14	T-helper	NN	O	t-helper	nn	17	SENT_144	19683/19691
15	1/T-helper	NN	O	1/t-helper	nn	17	SENT_144	19692/19702
16	2	CD	NUMBER	2	num	17	SENT_144	19703/19704
17	ratio	NN	O	ratio	nsubjpass	32	SENT_144	19705/19710
18	(	CD	NUMBER	(	num	20	SENT_144	19711/19712
19	Th1/Th2	NN	O	th1/th2	nn	20	SENT_144	19712/19719
20	)	NN	O	)	dep	17	SENT_144	19719/19720
21	,	,	O	,		-1	SENT_144	19720/19721
22	IgG	NN	O	igg	nn	23	SENT_144	19722/19725
23	subtypes	NNS	O	subtype	conj_and	17	SENT_144	19726/19734
24	,	,	O	,		-1	SENT_144	19734/19735
25	and	CC	O	and		-1	SENT_144	19736/19739
26	IFN	NN	O	ifn	conj_and	23	SENT_144	19740/19743
27	-	:	O	-		-1	SENT_144	19743/19744
28	and	CC	O	and		-1	SENT_144	19747/19750
29	IL-4	NN	O	il-4	nn	30	SENT_144	19751/19755
30	responses	NNS	O	response	conj_and	17	SENT_144	19756/19765
31	were	VBD	O	be	auxpass	32	SENT_144	19766/19770
32	determined	VBN	O	determine		-1	SENT_144	19771/19781
33	.	.	O	.		-1	SENT_144	19781/19782

1	IgG	NN	O	igg	nn	2	SENT_145	19783/19786
2	subtype	NN	O	subtype	nsubj	8	SENT_145	19787/19794
3	profiling	VBG	O	profile	partmod	2	SENT_145	19795/19804
4	(	CD	NUMBER	(	num	5	SENT_145	19805/19806
5	Fig.	NN	O	fig.	dobj	3	SENT_145	19806/19810
6	5	CD	NUMBER	5	num	7	SENT_145	19811/19812
7	)	NN	O	)	dep	5	SENT_145	19812/19813
8	showed	VBD	O	show		-1	SENT_145	19814/19820
9	that	IN	O	that	mark	16	SENT_145	19821/19825
10	i.n.	NN	O	i.n.	nn	11	SENT_145	19826/19830
11	immunization	NN	O	immunization	nsubj	16	SENT_145	19831/19843
12	with	IN	O	with		-1	SENT_145	19844/19848
13	subunit	NN	O	subunit	nn	14	SENT_145	19849/19856
14	vaccine	NN	O	vaccine	prep_with	11	SENT_145	19857/19864
15	alone	RB	O	alone	advmod	16	SENT_145	19865/19870
16	induced	VBD	O	induce	ccomp	8	SENT_145	19871/19878
17	low	JJ	O	low	amod	18	SENT_145	19879/19882
18	IgG1	NN	O	igg1	dobj	16	SENT_145	19883/19887
19	,	,	O	,		-1	SENT_145	19887/19888
20	IgG2a	NN	O	igg2a	conj_and	18	SENT_145	19889/19894
21	,	,	O	,		-1	SENT_145	19894/19895
22	and	CC	O	and		-1	SENT_145	19896/19899
23	IgG2b	NN	O	igg2b	nn	24	SENT_145	19900/19905
24	responses	NNS	O	response	conj_and	18	SENT_145	19906/19915
25	.	.	O	.		-1	SENT_145	19915/19916

1	As	IN	O	as		-1	SENT_146	19917/19919
2	previously	RB	DATE	previously	advmod	3	SENT_146	19920/19930
3	reported	VBN	O	report	amod	4	SENT_146	19931/19939
4	(	NN	O	(	prep_as	13	SENT_146	19940/19941
5	34,35	CD	NUMBER	34,35	num	6	SENT_146	19941/19946
6	)	NN	O	)	nsubj	13	SENT_146	19946/19947
7	,	,	O	,		-1	SENT_146	19947/19948
8	i.m.	NN	O	i.m.	nn	9	SENT_146	19949/19953
9	immunization	NN	O	immunization	appos	6	SENT_146	19954/19966
10	with	IN	O	with		-1	SENT_146	19967/19971
11	subunit	NN	O	subunit	nn	12	SENT_146	19972/19979
12	vaccine	NN	O	vaccine	prep_with	9	SENT_146	19980/19987
13	induced	VBD	O	induce		-1	SENT_146	19988/19995
14	high	JJ	O	high	amod	16	SENT_146	19996/20000
15	IgG1	NN	O	igg1	nn	16	SENT_146	20001/20005
16	responses	NNS	O	response	dobj	13	SENT_146	20006/20015
17	but	CC	O	but	prep	16	SENT_146	20016/20019
18	little	JJ	O	little	amod	19	SENT_146	20020/20026
19	IgG2a	NN	O	igg2a	dep	17	SENT_146	20027/20032
20	and	CC	O	and		-1	SENT_146	20033/20036
21	IgG2b	NN	O	igg2b	conj_and	19	SENT_146	20037/20042
22	,	,	O	,		-1	SENT_146	20042/20043
23	indicating	VBG	O	indicate	partmod	13	SENT_146	20044/20054
24	an	DT	O	a	det	26	SENT_146	20055/20057
25	immune	JJ	O	immune	amod	26	SENT_146	20058/20064
26	response	NN	O	response	nsubj	27	SENT_146	20065/20073
27	biased	VBD	O	bias	ccomp	23	SENT_146	20074/20080
28	toward	IN	O	toward		-1	SENT_146	20081/20087
29	a	DT	O	a	det	31	SENT_146	20088/20089
30	Th2-type	JJ	O	th2-type	amod	31	SENT_146	20090/20098
31	response	NN	O	response	prep_toward	27	SENT_146	20099/20107
32	.	.	O	.		-1	SENT_146	20107/20108

1	In	IN	O	in		-1	SENT_147	20109/20111
2	comparison	NN	O	comparison	prep_in	13	SENT_147	20112/20122
3	to	TO	O	to	aux	4	SENT_147	20123/20125
4	i.m.	VB	O	i.m.	infmod	2	SENT_147	20126/20130
5	immunization	NN	O	immunization	dobj	4	SENT_147	20131/20143
6	,	,	O	,		-1	SENT_147	20143/20144
7	i.n.	NN	O	i.n.	nn	8	SENT_147	20145/20149
8	immunization	NN	O	immunization	nsubj	13	SENT_147	20150/20162
9	with	IN	O	with		-1	SENT_147	20163/20167
10	HA	NN	O	ha	prep_with	8	SENT_147	20168/20170
11	+	CC	O	+		-1	SENT_147	20171/20172
12	GEM	NN	O	gem	conj_+	10	SENT_147	20173/20176
13	induced	VBD	O	induce		-1	SENT_147	20177/20184
14	significant	JJ	O	significant	amod	18	SENT_147	20185/20196
15	higher	JJR	O	higher	amod	18	SENT_147	20197/20203
16	IgG2a	NN	O	igg2a	nn	18	SENT_147	20204/20209
17	(	NN	O	(	nn	18	SENT_147	20210/20211
18	p	NN	O	p	iobj	13	SENT_147	20211/20212
19	=	JJ	O	=	amod	18	SENT_147	20215/20216
20	0.042	CD	NUMBER	0.042	tmod	19	SENT_147	20219/20224
21	)	NN	O	)	nn	25	SENT_147	20224/20225
22	and	CC	O	and		-1	SENT_147	20226/20229
23	IgG2b	NN	O	igg2b	conj_and	21	SENT_147	20230/20235
24	(	NN	O	(	nn	25	SENT_147	20236/20237
25	p	NN	O	p	dobj	13	SENT_147	20237/20238
26	=	JJ	O	=	amod	28	SENT_147	20241/20242
27	0.030	CD	NUMBER	0.030	tmod	26	SENT_147	20245/20250
28	)	NN	O	)	dep	25	SENT_147	20250/20251
29	and	CC	O	and		-1	SENT_147	20252/20255
30	lower	JJR	O	lower	amod	33	SENT_147	20256/20261
31	IgG1	NN	O	igg1	nn	33	SENT_147	20262/20266
32	(	NN	O	(	nn	33	SENT_147	20267/20268
33	p	NN	O	p	conj_and	25	SENT_147	20268/20269
34	=	JJ	O	=	amod	37	SENT_147	20272/20273
35	0.0135	CD	NUMBER	0.0135	tmod	34	SENT_147	20276/20282
36	)	NN	O	)	nn	37	SENT_147	20282/20283
37	responses	NNS	O	response	dep	33	SENT_147	20284/20293
38	.	.	O	.		-1	SENT_147	20293/20294

1	These	DT	O	these	det	2	SENT_148	20295/20300
2	results	NNS	O	result	nsubj	3	SENT_148	20301/20308
3	indicate	VBP	O	indicate		-1	SENT_148	20309/20317
4	that	IN	O	that	mark	18	SENT_148	20318/20322
5	the	DT	O	the	det	7	SENT_148	20323/20326
6	antibody	NN	O	antibody	nn	7	SENT_148	20327/20335
7	responses	NNS	O	response	nsubj	18	SENT_148	20336/20345
8	generated	VBN	O	generate	partmod	7	SENT_148	20346/20355
9	by	IN	O	by		-1	SENT_148	20356/20358
10	i.n.	NNP	O	i.n.	nn	11	SENT_148	20359/20363
11	HA	NNP	O	HA	agent	8	SENT_148	20364/20366
12	+	CC	O	+		-1	SENT_148	20367/20368
13	GEM	NNP	O	GEM	nn	14	SENT_148	20369/20372
14	vaccine	NN	O	vaccine	conj_+	11	SENT_148	20373/20380
15	is	VBZ	O	be	cop	18	SENT_148	20381/20383
16	significantly	RB	O	significantly	advmod	18	SENT_148	20384/20397
17	more	RBR	O	more	advmod	18	SENT_148	20398/20402
18	skewed	JJ	O	skewed	ccomp	3	SENT_148	20403/20409
19	toward	IN	O	toward		-1	SENT_148	20410/20416
20	a	DT	O	a	det	22	SENT_148	20417/20418
21	Th1	NN	O	th1	nn	22	SENT_148	20419/20422
22	phenotype	NN	O	phenotype	prep_toward	18	SENT_148	20423/20432
23	than	IN	O	than		-1	SENT_148	20433/20437
24	the	DT	O	the	det	27	SENT_148	20438/20441
25	conventional	JJ	O	conventional	amod	27	SENT_148	20442/20454
26	i.m.	NN	O	i.m.	nn	27	SENT_148	20455/20459
27	vaccine	NN	O	vaccine	prep_than	22	SENT_148	20460/20467
28	.	.	O	.		-1	SENT_148	20467/20468

1	Fig.	NN	O	fig.		-1	SENT_149	20469/20473
2	5	CD	NUMBER	5	num	1	SENT_149	20474/20475

1	Subunit	NN	O	subunit		-1	SENT_150	20492/20499
2	antigen-specific	JJ	O	antigen-specific	amod	6	SENT_150	20500/20516
3	serum	NN	O	serum	nn	6	SENT_150	20517/20522
4	IgG	NN	O	igg	nn	6	SENT_150	20523/20526
5	subtype	NN	O	subtype	nn	6	SENT_150	20527/20534
6	titers	NNS	O	titer	dep	1	SENT_150	20535/20541
7	in	IN	O	in		-1	SENT_150	20542/20544
8	sera	NNS	O	serum	prep_in	6	SENT_150	20545/20549
9	of	IN	O	of		-1	SENT_150	20550/20552
10	mice	NNS	O	mouse	prep_of	8	SENT_150	20553/20557
11	immunized	VBN	O	immunize	partmod	1	SENT_150	20558/20567
12	i.m.	NNP	O	i.m.	dobj	11	SENT_150	20568/20572
13	,	,	O	,		-1	SENT_150	20572/20573
14	i.n.	NNP	O	i.n.	conj_and	12	SENT_150	20574/20578
15	,	,	O	,		-1	SENT_150	20578/20579
16	and	CC	O	and		-1	SENT_150	20580/20583
17	i.n.	NN	O	i.n.	conj_and	12	SENT_150	20584/20588
18	+	CC	O	+		-1	SENT_150	20589/20590
19	GEM	NN	O	gem	conj_+	17	SENT_150	20591/20594
20	.	.	O	.		-1	SENT_150	20594/20595

1	The	DT	O	the	det	2	SENT_151	20596/20599
2	IgG1	NN	O	igg1	nsubjpass	19	SENT_151	20600/20604
3	(	CD	NUMBER	(	num	2	SENT_151	20605/20606
4	a	DT	O	a	det	5	SENT_151	20606/20607
5	)	NN	O	)	dep	2	SENT_151	20607/20608
6	,	,	O	,		-1	SENT_151	20608/20609
7	IgG2a	NN	O	igg2a	nn	10	SENT_151	20610/20615
8	(	NN	O	(	nn	10	SENT_151	20616/20617
9	b	NN	O	b	nn	10	SENT_151	20617/20618
10	)	NN	O	)	conj_and	2	SENT_151	20618/20619
11	,	,	O	,		-1	SENT_151	20619/20620
12	and	CC	O	and		-1	SENT_151	20621/20624
13	IgG2b	NN	O	igg2b	nn	15	SENT_151	20625/20630
14	(	NN	O	(	nn	15	SENT_151	20631/20632
15	c	NN	O	c	conj_and	2	SENT_151	20632/20633
16	)	CD	NUMBER	)	num	17	SENT_151	20633/20634
17	titers	NNS	O	titer	dep	15	SENT_151	20635/20641
18	were	VBD	O	be	auxpass	19	SENT_151	20642/20646
19	determined	VBN	O	determine		-1	SENT_151	20647/20657
20	.	.	O	.		-1	SENT_151	20657/20658

1	*	NN	O	*	nn	2	SENT_152	20659/20660
2	p	NN	O	p		-1	SENT_152	20660/20661
3	<	JJR	O	<	dep	2	SENT_152	20664/20665
4	0.05	CD	NUMBER	0.05	dep	2	SENT_152	20668/20672

1	The	DT	O	the	det	2	SENT_153	20727/20730
2	type	NN	O	type	nsubj	11	SENT_153	20731/20735
3	of	IN	O	of		-1	SENT_153	20736/20738
4	immune	JJ	O	immune	amod	9	SENT_153	20739/20745
5	response	NN	O	response	nn	9	SENT_153	20746/20754
6	(	NN	O	(	nn	9	SENT_153	20755/20756
7	Fig.	NN	O	fig.	nn	9	SENT_153	20756/20760
8	6	CD	NUMBER	6	num	9	SENT_153	20761/20762
9	)	NN	O	)	prep_of	2	SENT_153	20762/20763
10	was	VBD	O	be	cop	11	SENT_153	20764/20767
11	further	JJ	O	further		-1	SENT_153	20768/20775
12	evaluated	VBN	O	evaluate	partmod	11	SENT_153	20776/20785
13	by	IN	O	by		-1	SENT_153	20786/20788
14	determining	VBG	O	determine	agent	12	SENT_153	20789/20800
15	antigen-specific	JJ	O	antigen-specific	amod	16	SENT_153	20801/20817
16	IFN	NN	ORGANIZATION	ifn	dobj	14	SENT_153	20818/20821
17	-	:	O	-		-1	SENT_153	20821/20822
18	-	:	O	-		-1	SENT_153	20824/20825
19	and	CC	O	and		-1	SENT_153	20826/20829
20	IL-4-producing	JJ	O	il-4-producing	amod	21	SENT_153	20830/20844
21	splenocytes	NNS	O	splenocyte	conj_and	11	SENT_153	20845/20856
22	of	IN	O	of	dep	21	SENT_153	20857/20859
23	the	DT	O	the	det	25	SENT_153	20860/20863
24	immunized	JJ	O	immunized	amod	25	SENT_153	20864/20873
25	mice	NNS	O	mouse	pobj	22	SENT_153	20874/20878
26	.	.	O	.		-1	SENT_153	20878/20879

1	I.m.	NNP	O	I.m.	nn	2	SENT_154	20880/20884
2	immunization	NN	O	immunization	nsubj	6	SENT_154	20885/20897
3	with	IN	O	with		-1	SENT_154	20898/20902
4	subunit	NN	O	subunit	nn	5	SENT_154	20903/20910
5	vaccine	NN	O	vaccine	prep_with	2	SENT_154	20911/20918
6	resulted	VBD	O	result		-1	SENT_154	20919/20927
7	in	IN	O	in		-1	SENT_154	20928/20930
8	a	DT	O	a	det	10	SENT_154	20931/20932
9	higher	JJR	O	higher	amod	10	SENT_154	20933/20939
10	number	NN	O	number	prep_in	6	SENT_154	20940/20946
11	of	IN	O	of		-1	SENT_154	20947/20949
12	IL-4-producing	JJ	O	il-4-producing	amod	13	SENT_154	20950/20964
13	cells	NNS	O	cell	prep_of	10	SENT_154	20965/20970
14	than	IN	O	than		-1	SENT_154	20971/20975
15	IFN	NN	O	ifn	prep_than	6	SENT_154	20976/20979
16	-	:	O	-		-1	SENT_154	20979/20980
17	-	:	O	-		-1	SENT_154	20982/20983
18	producing	VBG	O	produce	parataxis	6	SENT_154	20983/20992
19	cells	NNS	O	cell	dobj	18	SENT_154	20993/20998
20	,	,	O	,		-1	SENT_154	20998/20999
21	indicating	VBG	O	indicate	parataxis	18	SENT_154	21000/21010
22	again	RB	O	again	advmod	23	SENT_154	21011/21016
23	a	DT	O	a	dobj	21	SENT_154	21017/21018
24	predominated	VBN	O	predominate	partmod	23	SENT_154	21019/21031
25	Th2-type	JJ	O	th2-type	amod	26	SENT_154	21032/21040
26	response	NN	O	response	dobj	24	SENT_154	21041/21049
27	.	.	O	.		-1	SENT_154	21049/21050

1	I.n.	NNP	O	I.n.	nn	2	SENT_155	21051/21055
2	immunization	NN	O	immunization	dep	6	SENT_155	21056/21068
3	with	IN	O	with		-1	SENT_155	21069/21073
4	subunit	NN	O	subunit	nn	5	SENT_155	21074/21081
5	vaccine	NN	O	vaccine	prep_with	6	SENT_155	21082/21089
6	resulted	VBD	O	result		-1	SENT_155	21090/21098
7	in	IN	O	in		-1	SENT_155	21099/21101
8	lower	JJR	O	lower	amod	9	SENT_155	21102/21107
9	numbers	NNS	O	number	prep_in	6	SENT_155	21108/21115
10	of	IN	O	of		-1	SENT_155	21116/21118
11	IL-4-producing	JJ	O	il-4-producing	amod	12	SENT_155	21119/21133
12	cells	NNS	O	cell	prep_of	9	SENT_155	21134/21139
13	but	CC	O	but	prep	12	SENT_155	21140/21143
14	substantially	RB	O	substantially	advmod	15	SENT_155	21144/21157
15	higher	JJR	O	higher	amod	16	SENT_155	21158/21164
16	numbers	NNS	O	number	dep	13	SENT_155	21165/21172
17	of	IN	O	of		-1	SENT_155	21173/21175
18	IFN	NN	O	ifn	prep_of	12	SENT_155	21176/21179
19	-	:	O	-		-1	SENT_155	21179/21180
20	-	:	O	-		-1	SENT_155	21182/21183
21	producing	VBG	O	produce	parataxis	6	SENT_155	21183/21192
22	cells	NNS	O	cell	dobj	21	SENT_155	21193/21198
23	(	CD	NUMBER	(	num	26	SENT_155	21199/21200
24	Fig.	NN	O	fig.	nn	26	SENT_155	21200/21204
25	6	CD	NUMBER	6	num	26	SENT_155	21205/21206
26	)	NN	O	)	nsubj	6	SENT_155	21206/21207
27	,	,	O	,		-1	SENT_155	21207/21208
28	resulting	VBG	O	result	partmod	6	SENT_155	21209/21218
29	in	IN	O	in		-1	SENT_155	21219/21221
30	a	DT	O	a	det	33	SENT_155	21222/21223
31	balanced	JJ	O	balanced	amod	33	SENT_155	21224/21232
32	Th1/Th2	NN	O	th1/th2	nn	33	SENT_155	21233/21240
33	response	NN	O	response	prep_in	28	SENT_155	21241/21249
34	.	.	O	.		-1	SENT_155	21249/21250

1	The	DT	O	the	det	2	SENT_156	21251/21254
2	increase	NN	O	increase		-1	SENT_156	21255/21263
3	in	IN	O	in		-1	SENT_156	21264/21266
4	IFN	NN	ORGANIZATION	ifn	prep_in	2	SENT_156	21267/21270
5	-	:	O	-		-1	SENT_156	21270/21271
6	-	:	O	-		-1	SENT_156	21273/21274
7	producing	VBG	O	produce	amod	9	SENT_156	21274/21283
8	T	NN	O	t	nn	9	SENT_156	21284/21285
9	cells	NNS	O	cell	nsubj	15	SENT_156	21286/21291
10	was	VBD	O	be	cop	15	SENT_156	21292/21295
11	even	RB	O	even	advmod	15	SENT_156	21296/21300
12	significantly	RB	O	significantly	advmod	15	SENT_156	21301/21314
13	(	CD	NUMBER	(	num	14	SENT_156	21315/21316
14	p	NN	O	p	npadvmod	15	SENT_156	21316/21317
15	=	JJ	O	=	dep	2	SENT_156	21320/21321
16	0.0373	CD	NUMBER	0.0373	number	17	SENT_156	21322/21328
17	)	CD	NUMBER	)	dep	19	SENT_156	21328/21329
18	more	RBR	O	more	advmod	19	SENT_156	21330/21334
19	pronounced	JJ	O	pronounced	dep	15	SENT_156	21335/21345
20	after	IN	O	after		-1	SENT_156	21346/21351
21	i.n.	NN	O	i.n.	nn	22	SENT_156	21352/21356
22	immunization	NN	O	immunization	prep_after	15	SENT_156	21357/21369
23	with	IN	O	with		-1	SENT_156	21370/21374
24	HA	NN	O	ha	prep_with	15	SENT_156	21375/21377
25	+	CC	O	+		-1	SENT_156	21378/21379
26	GEM	NN	O	gem	conj_+	24	SENT_156	21380/21383
27	,	,	O	,		-1	SENT_156	21383/21384
28	indicating	VBG	O	indicate	xcomp	15	SENT_156	21385/21395
29	a	DT	O	a	det	30	SENT_156	21396/21397
30	shift	NN	O	shift	dobj	28	SENT_156	21398/21403
31	of	IN	O	of		-1	SENT_156	21404/21406
32	the	DT	O	the	det	34	SENT_156	21407/21410
33	immune	JJ	O	immune	amod	34	SENT_156	21411/21417
34	response	NN	O	response	prep_of	30	SENT_156	21418/21426
35	from	IN	O	from		-1	SENT_156	21427/21431
36	a	DT	O	a	det	38	SENT_156	21432/21433
37	balanced	JJ	O	balanced	amod	38	SENT_156	21434/21442
38	Th1/Th2	NN	O	th1/th2	prep_from	28	SENT_156	21443/21450
39	to	TO	O	to		-1	SENT_156	21451/21453
40	a	DT	O	a	det	43	SENT_156	21454/21455
41	predominant	JJ	O	predominant	amod	42	SENT_156	21456/21467
42	Th1-type	JJ	O	th1-type	amod	43	SENT_156	21468/21476
43	response	NN	O	response	prep_to	28	SENT_156	21477/21485
44	.	.	O	.		-1	SENT_156	21485/21486

1	Collectively	RB	O	collectively	advmod	5	SENT_157	21487/21499
2	,	,	O	,		-1	SENT_157	21499/21500
3	these	DT	O	these	det	4	SENT_157	21501/21506
4	results	NNS	O	result	nsubj	5	SENT_157	21507/21514
5	indicate	VBP	O	indicate		-1	SENT_157	21515/21523
6	that	IN	O	that	mark	12	SENT_157	21524/21528
7	the	DT	O	the	det	11	SENT_157	21529/21532
8	GEM-based	JJ	O	gem-based	amod	11	SENT_157	21533/21542
9	i.n.	NN	O	i.n.	nn	11	SENT_157	21543/21547
10	influenza	NN	O	influenza	nn	11	SENT_157	21548/21557
11	vaccine	NN	O	vaccine	nsubj	12	SENT_157	21558/21565
12	elicited	VBD	O	elicit	ccomp	5	SENT_157	21566/21574
13	a	DT	O	a	det	14	SENT_157	21575/21576
14	response	NN	O	response	nsubj	15	SENT_157	21577/21585
15	biased	VBD	O	bias	ccomp	12	SENT_157	21586/21592
16	toward	IN	O	toward		-1	SENT_157	21593/21599
17	a	DT	O	a	det	19	SENT_157	21600/21601
18	Th1	NN	O	th1	nn	19	SENT_157	21602/21605
19	phenotype	NN	O	phenotype	prep_toward	15	SENT_157	21606/21615
20	.	.	O	.		-1	SENT_157	21615/21616

1	Fig.	NN	O	fig.		-1	SENT_158	21617/21621
2	6	CD	NUMBER	6	num	1	SENT_158	21622/21623

1	The	DT	O	the	det	2	SENT_159	21640/21643
2	type	NN	O	type		-1	SENT_159	21644/21648
3	of	IN	O	of		-1	SENT_159	21649/21651
4	the	DT	O	the	det	6	SENT_159	21652/21655
5	immune	JJ	O	immune	amod	6	SENT_159	21656/21662
6	response	NN	O	response	prep_of	2	SENT_159	21663/21671
7	was	VBD	O	be	auxpass	8	SENT_159	21672/21675
8	determined	VBN	O	determine	rcmod	6	SENT_159	21676/21686
9	by	IN	O	by		-1	SENT_159	21687/21689
10	the	DT	O	the	det	13	SENT_159	21690/21693
11	cytokine	NN	O	cytokine	nn	13	SENT_159	21694/21702
12	release	NN	O	release	nn	13	SENT_159	21703/21710
13	profile	NN	O	profile	agent	8	SENT_159	21711/21718
14	,	,	O	,		-1	SENT_159	21718/21719
15	i.e.	FW	O	i.e.	dep	2	SENT_159	21720/21724
16	,	,	O	,		-1	SENT_159	21724/21725
17	IL-4	NN	O	il-4	nsubj	18	SENT_159	21726/21730
18	(	VBD	O	(	parataxis	2	SENT_159	21731/21732
19	a	DT	O	a	det	20	SENT_159	21732/21733
20	)	NN	O	)	dobj	18	SENT_159	21733/21734
21	and	CC	O	and		-1	SENT_159	21735/21738
22	IFN	NN	O	ifn	conj_and	20	SENT_159	21739/21742
23	-	:	O	-		-1	SENT_159	21742/21743
24	(	NN	O	(	nn	26	SENT_159	21746/21747
25	b	NN	O	b	nn	26	SENT_159	21747/21748
26	)	NN	O	)	dep	18	SENT_159	21748/21749
27	in	IN	O	in		-1	SENT_159	21750/21752
28	mice	NNS	O	mouse	prep_in	26	SENT_159	21753/21757
29	immunized	VBN	O	immunize	partmod	28	SENT_159	21758/21767
30	.	.	O	.		-1	SENT_159	21767/21768

1	i.m.	NNP	O	i.m.		-1	SENT_160	21769/21773
2	,	,	O	,		-1	SENT_160	21773/21774
3	i.n.	NNP	O	i.n.	conj_and	1	SENT_160	21775/21779
4	,	,	O	,		-1	SENT_160	21779/21780
5	and	CC	O	and		-1	SENT_160	21781/21784
6	i.n.	NN	O	i.n.	conj_and	1	SENT_160	21785/21789
7	+	CC	O	+		-1	SENT_160	21790/21791
8	GEM	NN	O	gem	conj_+	6	SENT_160	21792/21795
9	.	.	O	.		-1	SENT_160	21795/21796

1	*	NN	O	*	nn	2	SENT_161	21797/21798
2	p	NN	O	p		-1	SENT_161	21798/21799
3	<	JJR	O	<	dep	2	SENT_161	21802/21803
4	0.05	CD	NUMBER	0.05	dep	2	SENT_161	21806/21810

1	DISCUSSION	NN	O	discussion		-1	SENT_162	21865/21875

1	In	IN	O	in		-1	SENT_163	21911/21913
2	this	DT	O	this	det	3	SENT_163	21914/21918
3	study	NN	O	study	prep_in	6	SENT_163	21919/21924
4	,	,	O	,		-1	SENT_163	21924/21925
5	we	PRP	O	we	nsubj	6	SENT_163	21926/21928
6	demonstrated	VBD	O	demonstrate		-1	SENT_163	21929/21941
7	that	IN	O	that	mark	12	SENT_163	21942/21946
8	GEM	NN	O	gem	nn	9	SENT_163	21947/21950
9	particles	NNS	O	particle	nsubj	12	SENT_163	21951/21960
10	are	VBP	O	be	cop	12	SENT_163	21961/21964
11	promising	JJ	O	promising	amod	12	SENT_163	21965/21974
12	candidates	NNS	O	candidate	ccomp	6	SENT_163	21975/21985
13	as	IN	O	as		-1	SENT_163	21986/21988
14	an	DT	O	a	det	24	SENT_163	21989/21991
15	adjuvant	JJ	O	adjuvant	amod	24	SENT_163	21992/22000
16	for	IN	O	for		-1	SENT_163	22001/22004
17	the	DT	O	the	det	19	SENT_163	22005/22008
18	i.n.	NN	O	i.n.	nn	19	SENT_163	22009/22013
19	delivery	NN	O	delivery	prep_for	15	SENT_163	22014/22022
20	of	IN	O	of		-1	SENT_163	22023/22025
21	the	DT	O	the	det	22	SENT_163	22026/22029
22	influenza	NN	O	influenza	prep_of	19	SENT_163	22030/22039
23	subunit	NN	O	subunit	nn	24	SENT_163	22040/22047
24	vaccine	NN	O	vaccine	prep_as	12	SENT_163	22048/22055
25	.	.	O	.		-1	SENT_163	22055/22056

1	Our	PRP$	O	we	poss	2	SENT_164	22057/22060
2	results	NNS	O	result	nsubj	3	SENT_164	22061/22068
3	show	VBP	O	show	dep	38	SENT_164	22069/22073
4	that	IN	O	that	mark	23	SENT_164	22074/22078
5	intranasally	RB	O	intranasally	advmod	6	SENT_164	22079/22091
6	administered	VBN	O	administer	csubjpass	23	SENT_164	22092/22104
7	subunit	NN	O	subunit	nn	8	SENT_164	22105/22112
8	vaccine	NN	O	vaccine	dobj	6	SENT_164	22113/22120
9	adjuvanted	VBN	O	adjuvant	partmod	8	SENT_164	22121/22131
10	with	IN	O	with		-1	SENT_164	22132/22136
11	GEM	NN	O	gem	nn	12	SENT_164	22137/22140
12	particles	NNS	O	particle	prep_with	9	SENT_164	22141/22150
13	(	CD	NUMBER	(	dobj	9	SENT_164	22151/22152
14	which	WDT	O	which	nsubjpass	17	SENT_164	22152/22157
15	are	VBP	O	be	auxpass	17	SENT_164	22158/22161
16	simply	RB	O	simply	advmod	17	SENT_164	22162/22168
17	mixed	VBN	O	mix	rcmod	13	SENT_164	22169/22174
18	with	IN	O	with		-1	SENT_164	22175/22179
19	vaccine	NN	O	vaccine	nn	20	SENT_164	22180/22187
20	)	NN	O	)	prep_with	17	SENT_164	22187/22188
21	can	MD	O	can	aux	23	SENT_164	22189/22192
22	be	VB	O	be	auxpass	23	SENT_164	22193/22195
23	used	VBN	O	use	ccomp	3	SENT_164	22196/22200
24	in	IN	O	in		-1	SENT_164	22201/22203
25	a	DT	O	a	det	26	SENT_164	22204/22205
26	prime	JJ	O	prime	prep_in	23	SENT_164	22206/22211
27	-	:	O	-		-1	SENT_164	22211/22212
28	boost	VB	O	boost	dep	23	SENT_164	22213/22218
29	vaccination	NN	O	vaccination	nn	30	SENT_164	22219/22230
30	strategy	NN	O	strategy	dobj	28	SENT_164	22231/22239
31	to	TO	O	to	aux	32	SENT_164	22240/22242
32	induce	VB	O	induce	xcomp	28	SENT_164	22243/22249
33	protective	JJ	O	protective	amod	34	SENT_164	22250/22260
34	levels	NNS	O	level	dobj	32	SENT_164	22261/22267
35	of	IN	O	of		-1	SENT_164	22268/22270
36	HI	NN	O	hus	nn	37	SENT_164	22271/22273
37	titers	NNS	O	titer	prep_of	34	SENT_164	22274/22280
38	(	VBP	O	(		-1	SENT_164	22281/22282
39	>	JJR	O	>	acomp	38	SENT_164	22282/22283
40	2log5	CD	NUMBER	2log5	num	41	SENT_164	22283/22288
41	(	NN	O	(	nsubj	38	SENT_164	22289/22290
42	41	CD	NUMBER	41	number	43	SENT_164	22290/22292
43	)	CD	NUMBER	)	num	44	SENT_164	22292/22293
44	)	NN	O	)	dep	41	SENT_164	22293/22294
45	,	,	O	,		-1	SENT_164	22294/22295
46	which	WDT	O	which	nsubjpass	48	SENT_164	22296/22301
47	is	VBZ	O	be	auxpass	48	SENT_164	22302/22304
48	considered	VBN	O	consider	rcmod	44	SENT_164	22305/22315
49	to	TO	O	to	aux	53	SENT_164	22316/22318
50	be	VB	O	be	cop	53	SENT_164	22319/22321
51	an	DT	O	a	det	53	SENT_164	22322/22324
52	important	JJ	O	important	amod	53	SENT_164	22325/22334
53	correlate	NN	O	correlate	xcomp	48	SENT_164	22335/22344
54	of	IN	O	of		-1	SENT_164	22345/22347
55	protection	NN	O	protection	prep_of	53	SENT_164	22348/22358
56	.	.	O	.		-1	SENT_164	22358/22359

1	In	IN	O	in		-1	SENT_165	22360/22362
2	addition	NN	O	addition	prep_in	7	SENT_165	22363/22371
3	,	,	O	,		-1	SENT_165	22371/22372
4	the	DT	O	the	det	6	SENT_165	22373/22376
5	serum	NN	O	serum	nn	6	SENT_165	22377/22382
6	IgG	NN	O	igg	nsubj	7	SENT_165	22383/22386
7	results	VBZ	O	result		-1	SENT_165	22387/22394
8	clearly	RB	O	clearly	advmod	7	SENT_165	22395/22402
9	highlight	VB	O	highlight	dep	7	SENT_165	22403/22412
10	that	DT	O	that	det	12	SENT_165	22413/22417
11	GEM	NN	O	gem	nn	12	SENT_165	22418/22421
12	particles	NNS	O	particle	nsubj	13	SENT_165	22422/22431
13	enhance	VBP	O	enhance	ccomp	9	SENT_165	22432/22439
14	the	DT	O	the	det	15	SENT_165	22440/22443
15	immunogenicity	NN	O	immunogenicity	dobj	13	SENT_165	22444/22458
16	of	IN	O	of		-1	SENT_165	22459/22461
17	the	DT	O	the	det	18	SENT_165	22462/22465
18	i.n.	NN	O	i.n.	prep_of	15	SENT_165	22466/22470
19	administered	VBN	O	administer	partmod	18	SENT_165	22471/22483
20	influenza	NN	O	influenza	nn	22	SENT_165	22484/22493
21	subunit	NN	O	subunit	nn	22	SENT_165	22494/22501
22	vaccine	NN	O	vaccine	dobj	19	SENT_165	22502/22509
23	.	.	O	.		-1	SENT_165	22509/22510

1	In	IN	O	in		-1	SENT_166	22546/22548
2	addition	NN	O	addition		-1	SENT_166	22549/22557
3	to	TO	O	to		-1	SENT_166	22558/22560
4	substantial	JJ	O	substantial	amod	6	SENT_166	22561/22572
5	serum	NN	O	serum	nn	6	SENT_166	22573/22578
6	responses	NNS	O	response	prep_in_addition_to	13	SENT_166	22579/22588
7	,	,	O	,		-1	SENT_166	22588/22589
8	the	DT	O	the	det	9	SENT_166	22590/22593
9	GEM	NN	O	gem	nsubj	13	SENT_166	22594/22597
10	adjuvanted	JJ	O	adjuvanted	amod	12	SENT_166	22598/22608
11	i.n.	NN	O	i.n.	nn	12	SENT_166	22609/22613
12	vaccine	NN	O	vaccine	dep	9	SENT_166	22614/22621
13	elicited	VBD	O	elicit		-1	SENT_166	22622/22630
14	a	DT	O	a	det	18	SENT_166	22631/22632
15	strong	JJ	O	strong	amod	18	SENT_166	22633/22639
16	mucosal	JJ	O	mucosal	amod	18	SENT_166	22640/22647
17	immune	JJ	O	immune	amod	18	SENT_166	22648/22654
18	response	NN	O	response	dobj	13	SENT_166	22655/22663
19	,	,	O	,		-1	SENT_166	22663/22664
20	i.e.	FW	O	i.e.	appos	18	SENT_166	22665/22669
21	,	,	O	,		-1	SENT_166	22669/22670
22	secretion	NN	O	secretion	appos	18	SENT_166	22671/22680
23	of	IN	O	of		-1	SENT_166	22681/22683
24	the	DT	O	the	det	25	SENT_166	22684/22687
25	sIgA	NN	O	siga	prep_of	22	SENT_166	22688/22692
26	in	IN	O	in		-1	SENT_166	22693/22695
27	the	DT	O	the	det	29	SENT_166	22696/22699
28	respiratory	JJ	O	respiratory	amod	29	SENT_166	22700/22711
29	mucosa	NN	O	mucosa	prep_in	13	SENT_166	22712/22718
30	.	.	O	.		-1	SENT_166	22718/22719

1	These	DT	O	these	det	2	SENT_167	22720/22725
2	results	NNS	O	result	nsubj	4	SENT_167	22726/22733
3	are	VBP	O	be	cop	4	SENT_167	22734/22737
4	consistent	JJ	O	consistent		-1	SENT_167	22738/22748
5	with	IN	O	with		-1	SENT_167	22749/22753
6	earlier	JJR	O	earlier	amod	7	SENT_167	22754/22761
7	studies	NNS	O	study	prep_with	4	SENT_167	22762/22769
8	(	VBP	O	(	dep	7	SENT_167	22770/22771
9	31	CD	NUMBER	31	num	10	SENT_167	22771/22773
10	)	CD	NUMBER	)	dobj	8	SENT_167	22773/22774
11	in	IN	O	in		-1	SENT_167	22775/22777
12	which	WDT	O	which	prep_in	14	SENT_167	22778/22783
13	GEM	NN	O	gem	nsubj	14	SENT_167	22784/22787
14	bound	VBD	O	bind	rcmod	7	SENT_167	22788/22793
15	pneumococcal	JJ	O	pneumococcal	amod	17	SENT_167	22794/22806
16	i.n.	NN	O	i.n.	nn	17	SENT_167	22807/22811
17	vaccine	NN	O	vaccine	nsubj	18	SENT_167	22812/22819
18	induced	VBD	O	induce	ccomp	14	SENT_167	22820/22827
19	strong	JJ	O	strong	amod	21	SENT_167	22828/22834
20	mucosal	JJ	O	mucosal	amod	21	SENT_167	22835/22842
21	responses	NNS	O	response	dobj	18	SENT_167	22843/22852
22	.	.	O	.		-1	SENT_167	22852/22853

1	Induction	NN	O	induction	nsubj	10	SENT_168	22854/22863
2	of	IN	O	of		-1	SENT_168	22864/22866
3	significant	JJ	O	significant	amod	4	SENT_168	22867/22878
4	levels	NNS	O	level	prep_of	1	SENT_168	22879/22885
5	of	IN	O	of		-1	SENT_168	22886/22888
6	sIgA	NN	O	siga	prep_of	4	SENT_168	22889/22893
7	in	IN	O	in		-1	SENT_168	22894/22896
8	nasal	JJ	O	nasal	amod	9	SENT_168	22897/22902
9	mucosa	NN	O	mucosa	prep_in	6	SENT_168	22903/22909
10	shows	VBZ	O	show		-1	SENT_168	22910/22915
11	that	IN	O	that	mark	14	SENT_168	22916/22920
12	GEM	NN	O	gem	nn	13	SENT_168	22921/22924
13	particles	NNS	O	particle	nsubj	14	SENT_168	22925/22934
14	act	VBP	O	act	ccomp	10	SENT_168	22935/22938
15	as	IN	O	as		-1	SENT_168	22939/22941
16	immunopotentiators	NNS	O	immunopotentiator	prep_as	14	SENT_168	22942/22960
17	in	IN	O	in		-1	SENT_168	22961/22963
18	the	DT	O	the	det	20	SENT_168	22964/22967
19	nasal	JJ	O	nasal	amod	20	SENT_168	22968/22973
20	mucosa	NN	O	mucosa	prep_in	16	SENT_168	22974/22980
21	.	.	O	.		-1	SENT_168	22980/22981

1	The	DT	O	the	det	3	SENT_169	22982/22985
2	immune	JJ	O	immune	amod	3	SENT_169	22986/22992
3	system	NN	O	system	nsubj	8	SENT_169	22993/22999
4	of	IN	O	of		-1	SENT_169	23000/23002
5	the	DT	O	the	det	7	SENT_169	23003/23006
6	nasal	JJ	O	nasal	amod	7	SENT_169	23007/23012
7	mucosa	NN	O	mucosa	prep_of	3	SENT_169	23013/23019
8	consists	VBZ	O	consist		-1	SENT_169	23020/23028
9	of	IN	O	of		-1	SENT_169	23029/23031
10	the	DT	O	the	det	13	SENT_169	23032/23035
11	nasal-associated	JJ	O	nasal-associated	amod	13	SENT_169	23036/23052
12	lymphoid	JJ	O	lymphoid	amod	13	SENT_169	23053/23061
13	tissue	NN	O	tissue	prep_of	8	SENT_169	23062/23068
14	(	CD	NUMBER	(	num	15	SENT_169	23069/23070
15	NALT	NNP	O	NALT	dep	13	SENT_169	23070/23074
16	)	CD	NUMBER	)	num	15	SENT_169	23074/23075
17	.	.	O	.		-1	SENT_169	23075/23076

1	In	IN	O	in		-1	SENT_170	23077/23079
2	the	DT	O	the	det	3	SENT_170	23080/23083
3	NALT	NNP	ORGANIZATION	NALT	prep_in	8	SENT_170	23084/23088
4	,	,	O	,		-1	SENT_170	23088/23089
5	the	DT	O	the	det	6	SENT_170	23090/23093
6	antigens	NNS	O	antigen	nsubjpass	8	SENT_170	23094/23102
7	are	VBP	O	be	auxpass	8	SENT_170	23103/23106
8	taken	VBN	O	take		-1	SENT_170	23107/23112
9	up	RP	O	up	prt	8	SENT_170	23113/23115
10	by	IN	O	by		-1	SENT_170	23116/23118
11	the	DT	O	the	det	12	SENT_170	23119/23122
12	M-cells	NNS	O	m-cell	agent	8	SENT_170	23123/23130
13	and	CC	O	and		-1	SENT_170	23131/23134
14	then	RB	O	then	advmod	15	SENT_170	23135/23139
15	presented	VBN	O	present	conj_and	8	SENT_170	23140/23149
16	to	TO	O	to		-1	SENT_170	23150/23152
17	antigen-presenting	JJ	O	antigen-presenting	amod	18	SENT_170	23153/23171
18	cells	NNS	O	cell	prep_to	15	SENT_170	23172/23177
19	,	,	O	,		-1	SENT_170	23177/23178
20	which	WDT	O	which	nsubj	33	SENT_170	23179/23184
21	in	IN	O	in		-1	SENT_170	23185/23187
22	turn	NN	O	turn	nn	25	SENT_170	23188/23192
23	present	JJ	DATE	present	amod	25	SENT_170	23193/23200
24	antigen	NN	O	antigen	nn	25	SENT_170	23201/23208
25	fragments	NNS	O	fragment	prep_in	33	SENT_170	23209/23218
26	to	TO	O	to		-1	SENT_170	23219/23221
27	the	DT	O	the	det	29	SENT_170	23222/23225
28	underlying	JJ	O	underlying	amod	29	SENT_170	23226/23236
29	B	NN	O	b	prep_to	33	SENT_170	23237/23238
30	and	CC	O	and		-1	SENT_170	23239/23242
31	T	NN	O	t	nn	32	SENT_170	23243/23244
32	cells	NNS	O	cell	conj_and	29	SENT_170	23245/23250
33	(	VBP	O	(	rcmod	18	SENT_170	23251/23252
34	6,13,42,43	CD	NUMBER	6,13,42,43	number	35	SENT_170	23252/23262
35	)	CD	NUMBER	)	dobj	33	SENT_170	23262/23263
36	.	.	O	.		-1	SENT_170	23263/23264

1	This	DT	O	this	det	2	SENT_171	23265/23269
2	cascade	NN	O	cascade	nsubjpass	6	SENT_171	23270/23277
3	of	IN	O	of		-1	SENT_171	23278/23280
4	events	NNS	O	event	prep_of	2	SENT_171	23281/23287
5	is	VBZ	O	be	auxpass	6	SENT_171	23288/23290
6	required	VBN	O	require		-1	SENT_171	23291/23299
7	for	IN	O	for		-1	SENT_171	23300/23303
8	the	DT	O	the	det	14	SENT_171	23304/23307
9	initial	JJ	O	initial	amod	14	SENT_171	23308/23315
10	innate	JJ	O	innate	amod	14	SENT_171	23316/23322
11	and	CC	O	and		-1	SENT_171	23323/23326
12	adaptive	JJ	O	adaptive	conj_and	10	SENT_171	23327/23335
13	immune	JJ	O	immune	amod	14	SENT_171	23336/23342
14	response	NN	O	response	prep_for	6	SENT_171	23343/23351
15	against	IN	O	against		-1	SENT_171	23352/23359
16	the	DT	O	the	det	18	SENT_171	23360/23363
17	influenza	NN	O	influenza	nn	18	SENT_171	23364/23373
18	virus	NN	O	virus	prep_against	14	SENT_171	23374/23379
19	.	.	O	.		-1	SENT_171	23379/23380

1	The	DT	O	the	det	2	SENT_172	23381/23384
2	induction	NN	O	induction	nsubj	12	SENT_172	23385/23394
3	of	IN	O	of		-1	SENT_172	23395/23397
4	sIgA	NN	O	siga	nn	5	SENT_172	23398/23402
5	antibodies	NNS	O	antibody	prep_of	2	SENT_172	23403/23413
6	in	IN	O	in		-1	SENT_172	23414/23416
7	the	DT	O	the	det	8	SENT_172	23417/23420
8	NALT	NNP	ORGANIZATION	NALT	prep_in	5	SENT_172	23421/23425
9	might	MD	O	might	aux	12	SENT_172	23426/23431
10	be	VB	O	be	cop	12	SENT_172	23432/23434
11	the	DT	O	the	det	12	SENT_172	23435/23438
12	result	NN	O	result	dep	47	SENT_172	23439/23445
13	of	IN	O	of		-1	SENT_172	23446/23448
14	an	DT	O	a	det	15	SENT_172	23449/23451
15	interaction	NN	O	interaction	prep_of	12	SENT_172	23452/23463
16	with	IN	O	with		-1	SENT_172	23464/23468
17	Toll-like	JJ	O	toll-like	amod	20	SENT_172	23469/23478
18	receptor	NN	O	receptor	nn	20	SENT_172	23479/23487
19	(	NN	O	(	nn	20	SENT_172	23488/23489
20	TLR	NN	ORGANIZATION	tlr	prep_with	15	SENT_172	23489/23492
21	)	CD	NUMBER	)	num	22	SENT_172	23492/23493
22	-2	CD	NUMBER	-2	npadvmod	20	SENT_172	23493/23495
23	of	IN	O	of		-1	SENT_172	23496/23498
24	the	DT	O	the	det	25	SENT_172	23499/23502
25	peptidoglycan	NN	O	peptidoglycan	prep_of	20	SENT_172	23503/23516
26	present	JJ	DATE	present	amod	25	SENT_172	23517/23524
27	in	IN	O	in		-1	SENT_172	23525/23527
28	GEM	NNP	O	GEM	nn	29	SENT_172	23528/23531
29	particles	NNS	O	particle	prep_in	26	SENT_172	23532/23541
30	,	,	O	,		-1	SENT_172	23541/23542
31	as	IN	O	as	mark	34	SENT_172	23543/23545
32	it	PRP	O	it	nsubjpass	34	SENT_172	23546/23548
33	is	VBZ	O	be	auxpass	34	SENT_172	23549/23551
34	known	VBN	O	know	advcl	12	SENT_172	23552/23557
35	that	IN	O	that	mark	38	SENT_172	23558/23562
36	GEM	NN	O	gem	nn	37	SENT_172	23563/23566
37	particles	NNS	O	particle	nsubj	38	SENT_172	23567/23576
38	act	VBP	O	act	ccomp	34	SENT_172	23577/23580
39	as	IN	O	as		-1	SENT_172	23581/23583
40	a	DT	O	a	det	42	SENT_172	23584/23585
41	TLR-2	NN	O	tlr-2	nn	42	SENT_172	23586/23591
42	agonist	NN	O	agonist	prep_as	38	SENT_172	23592/23599
43	in	IN	O	in	prep	38	SENT_172	23600/23602
44	in	FW	O	in	nn	46	SENT_172	23603/23605
45	vitro	FW	O	vitro	dep	46	SENT_172	23606/23611
46	studies	NNS	O	study	advmod	47	SENT_172	23612/23619
47	(	VBP	O	(		-1	SENT_172	23620/23621
48	Pasetti	NNP	O	Pasetti	dobj	47	SENT_172	23621/23628
49	et	FW	O	et	nn	50	SENT_172	23629/23631
50	al.	FW	O	al.	nsubj	47	SENT_172	23632/23635
51	,	,	O	,		-1	SENT_172	23635/23636
52	manuscript	NN	O	manuscript	appos	50	SENT_172	23637/23647
53	in	IN	O	in		-1	SENT_172	23648/23650
54	communication	NN	O	communication	nn	55	SENT_172	23651/23664
55	)	NN	O	)	prep_in	52	SENT_172	23664/23665
56	.	.	O	.		-1	SENT_172	23665/23666

1	Furthermore	RB	O	furthermore	advmod	5	SENT_173	23667/23678
2	,	,	O	,		-1	SENT_173	23678/23679
3	it	PRP	O	it	nsubjpass	5	SENT_173	23680/23682
4	is	VBZ	O	be	auxpass	5	SENT_173	23683/23685
5	known	VBN	O	know		-1	SENT_173	23686/23691
6	that	IN	O	that	mark	10	SENT_173	23692/23696
7	GEM	NN	O	gem	nn	8	SENT_173	23697/23700
8	particles	NNS	O	particle	nsubj	10	SENT_173	23701/23710
9	can	MD	O	can	aux	10	SENT_173	23711/23714
10	activate	VB	O	activate	ccomp	5	SENT_173	23715/23723
11	the	DT	O	the	det	12	SENT_173	23724/23727
12	maturation	NN	O	maturation	dobj	10	SENT_173	23728/23738
13	of	IN	O	of		-1	SENT_173	23739/23741
14	the	DT	O	the	det	16	SENT_173	23742/23745
15	dendritic	JJ	O	dendritic	amod	16	SENT_173	23746/23755
16	cells	NNS	O	cell	prep_of	12	SENT_173	23756/23761
17	and	CC	O	and		-1	SENT_173	23762/23765
18	macrophages	NNS	O	macrophage	conj_and	16	SENT_173	23766/23777
19	in	FW	O	in	prep	16	SENT_173	23778/23780
20	vitro	FW	O	vitro	nn	21	SENT_173	23781/23786
21	(	FW	O	(	pobj	19	SENT_173	23787/23788
22	32	CD	NUMBER	32	num	23	SENT_173	23788/23790
23	)	NN	O	)	dep	21	SENT_173	23790/23791
24	.	.	O	.		-1	SENT_173	23791/23792

1	Thus	RB	O	thus	advmod	16	SENT_174	23793/23797
2	,	,	O	,		-1	SENT_174	23797/23798
3	both	CC	O	both	dep	5	SENT_174	23799/23803
4	the	DT	O	the	det	5	SENT_174	23804/23807
5	activation	NN	O	activation	nsubj	16	SENT_174	23808/23818
6	of	IN	O	of		-1	SENT_174	23819/23821
7	TLR-2	NN	O	tlr-2	prep_of	5	SENT_174	23822/23827
8	and	CC	O	and		-1	SENT_174	23828/23831
9	maturation	NN	O	maturation	conj_and	7	SENT_174	23832/23842
10	of	IN	O	of		-1	SENT_174	23843/23845
11	the	DT	O	the	det	13	SENT_174	23846/23849
12	dendritic	JJ	O	dendritic	amod	13	SENT_174	23850/23859
13	cells	NNS	O	cell	prep_of	5	SENT_174	23860/23865
14	might	MD	O	might	aux	16	SENT_174	23866/23871
15	have	VB	O	have	aux	16	SENT_174	23872/23876
16	contributed	VBN	O	contribute		-1	SENT_174	23877/23888
17	to	TO	O	to		-1	SENT_174	23889/23891
18	the	DT	O	the	det	22	SENT_174	23892/23895
19	stronger	JJR	O	stronger	dep	20	SENT_174	23896/23904
20	mucosal	JJ	O	mucosal	amod	22	SENT_174	23905/23912
21	immune	JJ	O	immune	amod	22	SENT_174	23913/23919
22	response	NN	O	response	prep_to	16	SENT_174	23920/23928
23	.	.	O	.		-1	SENT_174	23928/23929

1	Recently	RB	DATE	recently	advmod	6	SENT_175	23965/23973
2	,	,	O	,		-1	SENT_175	23973/23974
3	much	JJ	O	much	amod	4	SENT_175	23975/23979
4	emphasis	NN	O	emphasis	nsubjpass	6	SENT_175	23980/23988
5	is	VBZ	O	be	auxpass	6	SENT_175	23989/23991
6	put	VBN	O	put		-1	SENT_175	23992/23995
7	on	IN	O	on		-1	SENT_175	23996/23998
8	the	DT	O	the	det	9	SENT_175	23999/24002
9	phenotype	NN	O	phenotype	prep_on	6	SENT_175	24003/24012
10	of	IN	O	of		-1	SENT_175	24013/24015
11	the	DT	O	the	det	13	SENT_175	24016/24019
12	immune	JJ	O	immune	amod	13	SENT_175	24020/24026
13	response	NN	O	response	prep_of	9	SENT_175	24027/24035
14	,	,	O	,		-1	SENT_175	24035/24036
15	i.e.	FW	O	i.e.	conj_or	13	SENT_175	24037/24041
16	,	,	O	,		-1	SENT_175	24041/24042
17	Th1	NN	O	th1	conj_or	13	SENT_175	24043/24046
18	,	,	O	,		-1	SENT_175	24046/24047
19	Th2	NN	O	th2	conj_or	13	SENT_175	24048/24051
20	,	,	O	,		-1	SENT_175	24051/24052
21	or	CC	O	or		-1	SENT_175	24053/24055
22	balanced	JJ	O	balanced	amod	24	SENT_175	24056/24064
23	response	NN	O	response	nn	24	SENT_175	24065/24073
24	(	NN	O	(	conj_or	13	SENT_175	24074/24075
25	44-46	CD	NUMBER	44-46	num	26	SENT_175	24075/24080
26	)	NN	O	)	dep	24	SENT_175	24080/24081
27	.	.	O	.		-1	SENT_175	24081/24082

1	A	DT	O	a	det	3	SENT_176	24083/24084
2	Th1	NN	O	th1	nn	3	SENT_176	24085/24088
3	response	NN	O	response	nsubjpass	5	SENT_176	24089/24097
4	is	VBZ	O	be	auxpass	5	SENT_176	24098/24100
5	considered	VBN	O	consider		-1	SENT_176	24101/24111
6	to	TO	O	to	aux	8	SENT_176	24112/24114
7	be	VB	O	be	cop	8	SENT_176	24115/24117
8	superior	JJ	O	superior	xcomp	5	SENT_176	24118/24126
9	to	TO	O	to		-1	SENT_176	24127/24129
10	Th2	NN	O	th2	prep_to	8	SENT_176	24130/24133
11	or	CC	O	or		-1	SENT_176	24134/24136
12	a	DT	O	a	det	17	SENT_176	24137/24138
13	mixed	JJ	O	mixed	amod	17	SENT_176	24139/24144
14	response	NN	O	response	nn	17	SENT_176	24145/24153
15	(	NN	O	(	nn	17	SENT_176	24154/24155
16	47	CD	NUMBER	47	num	17	SENT_176	24155/24157
17	)	NN	O	)	conj_or	10	SENT_176	24157/24158
18	because	IN	O	because	mark	20	SENT_176	24159/24166
19	it	PRP	O	it	nsubj	20	SENT_176	24167/24169
20	(	NN	O	(	dep	17	SENT_176	24170/24171
21	1	CD	NUMBER	1	number	22	SENT_176	24171/24172
22	)	CD	NUMBER	)	num	23	SENT_176	24172/24173
23	results	NNS	O	result	dobj	20	SENT_176	24174/24181
24	in	IN	O	in		-1	SENT_176	24182/24184
25	better	JJR	O	better	amod	26	SENT_176	24185/24191
26	protection	NN	O	protection	prep_in	23	SENT_176	24192/24202
27	from	IN	O	from		-1	SENT_176	24203/24207
28	infection	NN	O	infection	prep_from	20	SENT_176	24208/24217
29	(	CD	NUMBER	(	num	28	SENT_176	24218/24219
30	16	CD	NUMBER	16	num	31	SENT_176	24219/24221
31	)	NN	O	)	tmod	8	SENT_176	24221/24222
32	and	CC	O	and		-1	SENT_176	24223/24226
33	(	NN	O	(	conj_and	31	SENT_176	24227/24228
34	2	CD	NUMBER	2	num	35	SENT_176	24228/24229
35	)	NN	O	)	nsubj	36	SENT_176	24229/24230
36	helps	VBZ	O	help	ccomp	8	SENT_176	24231/24236
37	in	IN	O	in		-1	SENT_176	24237/24239
38	virus	NN	O	virus	nn	39	SENT_176	24240/24245
39	neutralization	NN	O	neutralization	prep_in	36	SENT_176	24246/24260
40	by	IN	O	by		-1	SENT_176	24261/24263
41	secretion	NN	O	secretion	prep_by	36	SENT_176	24264/24273
42	of	IN	O	of		-1	SENT_176	24274/24276
43	INF	NN	O	inf	prep_of	41	SENT_176	24277/24280
44	-	:	O	-		-1	SENT_176	24280/24281
45	(	CD	NUMBER	(	number	46	SENT_176	24284/24285
46	48	CD	NUMBER	48	num	47	SENT_176	24285/24287
47	)	NN	O	)	dep	43	SENT_176	24287/24288
48	.	.	O	.		-1	SENT_176	24288/24289

1	Moreover	RB	O	moreover	advmod	7	SENT_177	24290/24298
2	,	,	O	,		-1	SENT_177	24298/24299
3	the	DT	O	the	det	5	SENT_177	24300/24303
4	natural	JJ	O	natural	amod	5	SENT_177	24304/24311
5	infection	NN	O	infection	nsubj	7	SENT_177	24312/24321
6	also	RB	O	also	advmod	7	SENT_177	24322/24326
7	induces	VBZ	O	induce		-1	SENT_177	24327/24334
8	a	DT	O	a	det	10	SENT_177	24335/24336
9	Th1	NN	O	th1	nn	10	SENT_177	24337/24340
10	type	NN	O	type	dobj	7	SENT_177	24341/24345
11	of	IN	O	of		-1	SENT_177	24346/24348
12	response	NN	O	response	prep_of	10	SENT_177	24349/24357
13	.	.	O	.		-1	SENT_177	24357/24358

1	However	RB	O	however	advmod	5	SENT_178	24359/24366
2	,	,	O	,		-1	SENT_178	24366/24367
3	subunit	NN	O	subunit	nn	4	SENT_178	24368/24375
4	vaccine	NN	O	vaccine	nsubj	5	SENT_178	24376/24383
5	administered	VBN	O	administer		-1	SENT_178	24384/24396
6	via	IN	O	via		-1	SENT_178	24397/24400
7	the	DT	O	the	det	9	SENT_178	24401/24404
8	i.n.	NN	O	i.n.	nn	9	SENT_178	24405/24409
9	route	NN	O	route	prep_via	5	SENT_178	24410/24415
10	and	CC	O	and		-1	SENT_178	24416/24419
11	many	JJ	O	many	conj_and	5	SENT_178	24420/24424
12	of	IN	O	of		-1	SENT_178	24425/24427
13	the	DT	O	the	det	15	SENT_178	24428/24431
14	nasal	JJ	O	nasal	amod	15	SENT_178	24432/24437
15	adjuvants	NNS	O	adjuvant	prep_of	11	SENT_178	24438/24447
16	like	IN	O	like		-1	SENT_178	24448/24452
17	chitosan	NN	O	chitosan	prep_like	11	SENT_178	24453/24461
18	(	CD	NUMBER	(	number	19	SENT_178	24462/24463
19	36,49	CD	NUMBER	36,49	num	20	SENT_178	24463/24468
20	)	NN	O	)	dep	17	SENT_178	24468/24469
21	,	,	O	,		-1	SENT_178	24469/24470
22	ISCOMS	NNP	O	ISCOMS	appos	17	SENT_178	24471/24477
23	(	CD	NUMBER	(	number	24	SENT_178	24478/24479
24	50	CD	NUMBER	50	num	25	SENT_178	24479/24481
25	)	NN	O	)	dep	22	SENT_178	24481/24482
26	,	,	O	,		-1	SENT_178	24482/24483
27	lipids	NNS	O	lipid	nsubj	28	SENT_178	24484/24490
28	(	VBP	O	(	dep	5	SENT_178	24491/24492
29	24,51	CD	NUMBER	24,51	number	30	SENT_178	24492/24497
30	)	CD	NUMBER	)	dobj	28	SENT_178	24497/24498
31	,	,	O	,		-1	SENT_178	24498/24499
32	and	CC	O	and		-1	SENT_178	24500/24503
33	LT	JJ	O	lt	amod	36	SENT_178	24504/24506
34	(	NN	O	(	nn	36	SENT_178	24507/24508
35	25	CD	NUMBER	25	num	36	SENT_178	24508/24510
36	)	NN	O	)	nsubj	37	SENT_178	24510/24511
37	induce	VBP	O	induce	conj_and	5	SENT_178	24512/24518
38	a	DT	O	a	det	41	SENT_178	24519/24520
39	mixed	JJ	O	mixed	amod	41	SENT_178	24521/24526
40	Th1/Th2-type	NN	O	th1/th2-type	nn	41	SENT_178	24527/24539
41	response	NN	O	response	dobj	37	SENT_178	24540/24548
42	.	.	O	.		-1	SENT_178	24548/24549

1	In	IN	O	in		-1	SENT_179	24550/24552
2	contrast	NN	O	contrast	prep_in	9	SENT_179	24553/24561
3	,	,	O	,		-1	SENT_179	24561/24562
4	the	DT	O	the	det	8	SENT_179	24563/24566
5	i.n.	NNP	O	i.n.	nn	8	SENT_179	24567/24571
6	GEM	NNP	O	GEM	nn	8	SENT_179	24572/24575
7	influenza	NN	O	influenza	nn	8	SENT_179	24576/24585
8	vaccine	NN	O	vaccine	nsubj	9	SENT_179	24586/24593
9	induced	VBD	O	induce		-1	SENT_179	24594/24601
10	a	DT	O	a	det	11	SENT_179	24602/24603
11	response	NN	O	response	nsubj	12	SENT_179	24604/24612
12	skewed	JJ	O	skewed	xcomp	9	SENT_179	24613/24619
13	toward	IN	O	toward		-1	SENT_179	24620/24626
14	Th1	NN	O	th1	nn	15	SENT_179	24627/24630
15	type	NN	O	type	prep_toward	12	SENT_179	24631/24635
16	.	.	O	.		-1	SENT_179	24635/24636

1	Thus	RB	O	thus	advmod	5	SENT_180	24637/24641
2	,	,	O	,		-1	SENT_180	24641/24642
3	GEM	NN	O	gem	nn	4	SENT_180	24643/24646
4	particles	NNS	O	particle	nsubj	5	SENT_180	24647/24656
5	modulate	VBP	O	modulate		-1	SENT_180	24657/24665
6	the	DT	O	the	det	7	SENT_180	24666/24669
7	response	NN	O	response	dobj	5	SENT_180	24670/24678
8	from	IN	O	from		-1	SENT_180	24679/24683
9	a	DT	O	a	det	10	SENT_180	24684/24685
10	balanced	JJ	O	balanced	prep_from	5	SENT_180	24686/24694
11	to	TO	O	to		-1	SENT_180	24695/24697
12	a	DT	O	a	det	14	SENT_180	24698/24699
13	Th1-skewed	JJ	O	th1-skewed	amod	14	SENT_180	24700/24710
14	response	NN	O	response	prep_to	10	SENT_180	24711/24719
15	.	.	O	.		-1	SENT_180	24719/24720

1	Furthermore	RB	O	furthermore	advmod	13	SENT_181	24756/24767
2	,	,	O	,		-1	SENT_181	24767/24768
3	the	DT	O	the	det	5	SENT_181	24769/24772
4	vaccine	NN	O	vaccine	nn	5	SENT_181	24773/24780
5	formulation	NN	O	formulation	nsubj	13	SENT_181	24781/24792
6	presented	VBN	O	present	partmod	5	SENT_181	24793/24802
7	in	IN	O	in		-1	SENT_181	24803/24805
8	this	DT	O	this	det	9	SENT_181	24806/24810
9	paper	NN	O	paper	prep_in	6	SENT_181	24811/24816
10	is	VBZ	O	be	cop	13	SENT_181	24817/24819
11	much	RB	O	much	advmod	13	SENT_181	24820/24824
12	more	RBR	O	more	advmod	13	SENT_181	24825/24829
13	convenient	JJ	O	convenient		-1	SENT_181	24830/24840
14	to	TO	O	to	aux	15	SENT_181	24841/24843
15	produce	VB	O	produce	xcomp	13	SENT_181	24844/24851
16	compared	VBN	O	compare		-1	SENT_181	24852/24860
17	to	TO	O	to	prepc_compared_to	15	SENT_181	24861/24863
18	most	JJS	O	most	pobj	15	SENT_181	24864/24868
19	of	IN	O	of		-1	SENT_181	24869/24871
20	the	DT	O	the	det	23	SENT_181	24872/24875
21	other	JJ	O	other	amod	23	SENT_181	24876/24881
22	adjuvant	JJ	O	adjuvant	amod	23	SENT_181	24882/24890
23	systems	NNS	O	system	prep_of	18	SENT_181	24891/24898
24	which	WDT	O	which	nsubj	25	SENT_181	24899/24904
25	have	VBP	O	have	rcmod	18	SENT_181	24905/24909
26	to	TO	O	to	aux	28	SENT_181	24910/24912
27	be	VB	O	be	auxpass	28	SENT_181	24913/24915
28	preformulated	VBN	O	preformulate	xcomp	25	SENT_181	24916/24929
29	(	CD	NUMBER	(	num	31	SENT_181	24930/24931
30	24,36,39,49-52	CD	NUMBER	24,36,39,49-52	num	31	SENT_181	24931/24945
31	)	NN	O	)	dobj	28	SENT_181	24945/24946
32	.	.	O	.		-1	SENT_181	24946/24947

1	The	DT	O	the	det	2	SENT_182	24948/24951
2	formulation	NN	O	formulation	nsubjpass	8	SENT_182	24952/24963
3	used	VBN	O	use	partmod	2	SENT_182	24964/24968
4	in	IN	O	in		-1	SENT_182	24969/24971
5	these	DT	O	these	det	6	SENT_182	24972/24977
6	experiments	NNS	O	experiment	prep_in	3	SENT_182	24978/24989
7	was	VBD	O	be	auxpass	8	SENT_182	24990/24993
8	prepared	VBN	O	prepare		-1	SENT_182	24994/25002
9	by	IN	O	by		-1	SENT_182	25003/25005
10	ad-mixing	JJ	O	ad-mixing	amod	13	SENT_182	25006/25015
11	the	DT	O	the	det	12	SENT_182	25016/25019
12	GEM	NN	O	gem	dep	10	SENT_182	25020/25023
13	particles	NNS	O	particle	agent	8	SENT_182	25024/25033
14	with	IN	O	with		-1	SENT_182	25034/25038
15	conventional	JJ	O	conventional	amod	17	SENT_182	25039/25051
16	subunit	NN	O	subunit	nn	17	SENT_182	25052/25059
17	vaccine	NN	O	vaccine	prep_with	13	SENT_182	25060/25067
18	.	.	O	.		-1	SENT_182	25067/25068

1	GEM	NN	O	gem	nn	2	SENT_183	25069/25072
2	particles	NNS	O	particle	nsubjpass	5	SENT_183	25073/25082
3	can	MD	O	can	aux	5	SENT_183	25083/25086
4	be	VB	O	be	auxpass	5	SENT_183	25087/25089
5	produced	VBN	O	produce		-1	SENT_183	25090/25098
6	in	IN	O	in		-1	SENT_183	25099/25101
7	large	JJ	O	large	amod	8	SENT_183	25102/25107
8	quantities	NNS	O	quantity	prep_in	5	SENT_183	25108/25118
9	under	IN	O	under		-1	SENT_183	25119/25124
10	sterile	JJ	O	sterile	amod	11	SENT_183	25125/25132
11	conditions	NNS	O	condition	prep_under	5	SENT_183	25133/25143
12	and	CC	O	and		-1	SENT_183	25144/25147
13	can	MD	O	can	aux	15	SENT_183	25148/25151
14	be	VB	O	be	auxpass	15	SENT_183	25152/25154
15	stored	VBN	O	store	conj_and	5	SENT_183	25155/25161
16	at	IN	O	at		-1	SENT_183	25162/25164
17	ambient	JJ	O	ambient	amod	18	SENT_183	25165/25172
18	temperature	NN	O	temperature	prep_at	15	SENT_183	25173/25184
19	for	IN	O	for		-1	SENT_183	25185/25188
20	long	JJ	O	long	amod	24	SENT_183	25189/25193
21	time	NN	O	time	nn	24	SENT_183	25194/25198
22	(	NN	O	(	nn	24	SENT_183	25199/25200
23	29	CD	NUMBER	29	num	24	SENT_183	25200/25202
24	)	NN	O	)	prep_for	18	SENT_183	25202/25203
25	.	.	O	.		-1	SENT_183	25203/25204

1	The	DT	O	the	det	2	SENT_184	25205/25208
2	ease	NN	O	ease	nsubj	7	SENT_184	25209/25213
3	of	IN	O	of		-1	SENT_184	25214/25216
4	formulation	NN	O	formulation	prep_of	2	SENT_184	25217/25228
5	and	CC	O	and		-1	SENT_184	25229/25232
6	administration	NN	O	administration	conj_and	4	SENT_184	25233/25247
7	makes	VBZ	O	make		-1	SENT_184	25248/25253
8	i.n.	NNP	O	i.n.	nn	12	SENT_184	25254/25258
9	GEM	NNP	O	GEM	nn	12	SENT_184	25259/25262
10	influenza	NN	O	influenza	nn	12	SENT_184	25263/25272
11	subunit	NN	O	subunit	nn	12	SENT_184	25273/25280
12	vaccine	NN	O	vaccine	nsubj	15	SENT_184	25281/25288
13	a	DT	O	a	det	15	SENT_184	25289/25290
14	promising	JJ	O	promising	amod	15	SENT_184	25291/25300
15	candidate	NN	O	candidate	xcomp	7	SENT_184	25301/25310
16	for	IN	O	for		-1	SENT_184	25311/25314
17	vaccination	NN	O	vaccination	prep_for	15	SENT_184	25315/25326
18	in	IN	O	in		-1	SENT_184	25327/25329
19	a	DT	O	a	det	20	SENT_184	25330/25331
20	pandemic	JJ	O	pandemic	prep_in	7	SENT_184	25332/25340
21	as	RB	O	as		-1	SENT_184	25341/25343
22	well	RB	O	well		-1	SENT_184	25344/25348
23	as	IN	O	as		-1	SENT_184	25349/25351
24	in	IN	O	in		-1	SENT_184	25352/25354
25	an	DT	O	a	det	27	SENT_184	25355/25357
26	epidemic	JJ	O	epidemic	amod	27	SENT_184	25358/25366
27	situation	NN	O	situation	conj_and	20	SENT_184	25367/25376
28	.	.	O	.		-1	SENT_184	25376/25377

1	A	DT	O	a	det	3	SENT_185	25413/25414
2	major	JJ	O	major	amod	3	SENT_185	25415/25420
3	hurdle	NN	O	hurdle	nsubj	10	SENT_185	25421/25427
4	in	IN	O	in		-1	SENT_185	25428/25430
5	the	DT	O	the	det	6	SENT_185	25431/25434
6	development	NN	O	development	prep_in	3	SENT_185	25435/25446
7	of	IN	O	of		-1	SENT_185	25447/25449
8	mucosal	JJ	O	mucosal	amod	9	SENT_185	25450/25457
9	adjuvants	NNS	O	adjuvant	prep_of	6	SENT_185	25458/25467
10	is	VBZ	O	be		-1	SENT_185	25468/25470
11	to	TO	O	to		-1	SENT_185	25471/25473
12	proof	NN	O	proof	nn	14	SENT_185	25474/25479
13	their	PRP$	O	they	poss	14	SENT_185	25480/25485
14	safety	NN	O	safety	prep_to	10	SENT_185	25486/25492
15	in	IN	O	in	mark	18	SENT_185	25493/25495
16	order	NN	O	order	dep	18	SENT_185	25496/25501
17	to	TO	O	to	aux	18	SENT_185	25502/25504
18	obtain	VB	O	obtain	advcl	10	SENT_185	25505/25511
19	approval	NN	O	approval	dobj	18	SENT_185	25512/25520
20	by	IN	O	by		-1	SENT_185	25521/25523
21	regulatory	JJ	O	regulatory	amod	22	SENT_185	25524/25534
22	agencies	NNS	O	agency	prep_by	18	SENT_185	25535/25543
23	.	.	O	.		-1	SENT_185	25543/25544

1	The	DT	O	the	det	3	SENT_186	25545/25548
2	GEM	NN	O	gem	nn	3	SENT_186	25549/25552
3	particles	NNS	O	particle	nsubj	9	SENT_186	25553/25562
4	used	VBN	O	use	partmod	3	SENT_186	25563/25567
5	in	IN	O	in		-1	SENT_186	25568/25570
6	this	DT	O	this	det	7	SENT_186	25571/25575
7	study	NN	O	study	prep_in	4	SENT_186	25576/25581
8	are	VBP	O	be	cop	9	SENT_186	25582/25585
9	safe	JJ	O	safe		-1	SENT_186	25586/25590
10	to	TO	O	to	aux	11	SENT_186	25591/25593
11	use	VB	O	use	xcomp	9	SENT_186	25594/25597
12	in	IN	O	in		-1	SENT_186	25598/25600
13	comparison	NN	O	comparison	prep_in	11	SENT_186	25601/25611
14	to	TO	O	to		-1	SENT_186	25612/25614
15	other	JJ	O	other	amod	16	SENT_186	25615/25620
16	adjuvants	NNS	O	adjuvant	prep_to	11	SENT_186	25621/25630
17	and	CC	O	and		-1	SENT_186	25631/25634
18	other	JJ	O	other	amod	22	SENT_186	25635/25640
19	lactic	JJ	O	lactic	amod	22	SENT_186	25641/25647
20	acid	NN	O	acid	nn	22	SENT_186	25648/25652
21	bacteria	NNS	O	bacterium	nn	22	SENT_186	25653/25661
22	systems	NNS	O	system	nsubj	23	SENT_186	25662/25669
23	evaluated	VBN	O	evaluate	conj_and	9	SENT_186	25670/25679
24	for	IN	O	for		-1	SENT_186	25680/25683
25	vaccination	NN	O	vaccination	prep_for	23	SENT_186	25684/25695
26	(	CD	NUMBER	(	number	27	SENT_186	25696/25697
27	27,53,54	CD	NUMBER	27,53,54	num	28	SENT_186	25697/25705
28	)	NN	O	)	dobj	23	SENT_186	25705/25706
29	.	.	O	.		-1	SENT_186	25706/25707

1	During	IN	O	during		-1	SENT_187	25708/25714
2	the	DT	O	the	det	3	SENT_187	25715/25718
3	production	NN	O	production	prep_during	12	SENT_187	25719/25729
4	of	IN	O	of		-1	SENT_187	25730/25732
5	GEM	NN	O	gem	nn	6	SENT_187	25733/25736
6	particles	NNS	O	particle	prep_of	3	SENT_187	25737/25746
7	,	,	O	,		-1	SENT_187	25746/25747
8	L.	FW	O	l.	nn	9	SENT_187	25748/25750
9	lactis	FW	O	lactis	nsubjpass	12	SENT_187	25751/25757
10	bacteria	NNS	O	bacterium	dep	9	SENT_187	25758/25766
11	are	VBP	O	be	auxpass	12	SENT_187	25767/25770
12	treated	VBN	O	treat		-1	SENT_187	25771/25778
13	with	IN	O	with		-1	SENT_187	25779/25783
14	acid	NN	O	acid	prep_with	12	SENT_187	25784/25788
15	,	,	O	,		-1	SENT_187	25788/25789
16	which	WDT	O	which	nsubj	17	SENT_187	25790/25795
17	results	VBZ	O	result	rcmod	14	SENT_187	25796/25803
18	in	IN	O	in		-1	SENT_187	25804/25806
19	loss	NN	O	loss	prep_in	17	SENT_187	25807/25811
20	of	IN	O	of		-1	SENT_187	25812/25814
21	genetic	JJ	O	genetic	amod	22	SENT_187	25815/25822
22	material	NN	O	material	prep_of	19	SENT_187	25823/25831
23	.	.	O	.		-1	SENT_187	25831/25832

1	The	DT	O	the	det	2	SENT_188	25833/25836
2	loss	NN	O	loss	nsubj	8	SENT_188	25837/25841
3	of	IN	O	of		-1	SENT_188	25842/25844
4	the	DT	O	the	det	6	SENT_188	25845/25848
5	genetic	JJ	O	genetic	amod	6	SENT_188	25849/25856
6	material	NN	O	material	prep_of	2	SENT_188	25857/25865
7	is	VBZ	O	be	cop	8	SENT_188	25866/25868
8	beneficial	JJ	O	beneficial		-1	SENT_188	25869/25879
9	as	IN	O	as	mark	25	SENT_188	25880/25882
10	the	DT	O	the	det	11	SENT_188	25883/25886
11	problem	NN	O	problem	nsubjpass	25	SENT_188	25887/25894
12	of	IN	O	of		-1	SENT_188	25895/25897
13	DNA	NN	O	dna	prep_of	11	SENT_188	25898/25901
14	shedding	VBG	O	shed	amod	13	SENT_188	25902/25910
15	and	CC	O	and		-1	SENT_188	25911/25914
16	infection	NN	O	infection	conj_and	13	SENT_188	25915/25924
17	in	IN	O	in		-1	SENT_188	25925/25927
18	the	DT	O	the	det	20	SENT_188	25928/25931
19	mucosal	JJ	O	mucosal	amod	20	SENT_188	25932/25939
20	layer	NN	O	layer	prep_in	16	SENT_188	25940/25945
21	by	IN	O	by		-1	SENT_188	25946/25948
22	the	DT	O	the	det	23	SENT_188	25949/25952
23	bacteria	NNS	O	bacterium	prep_by	20	SENT_188	25953/25961
24	is	VBZ	O	be	auxpass	25	SENT_188	25962/25964
25	avoided	VBN	O	avoid	advcl	8	SENT_188	25965/25972
26	(	CD	NUMBER	(	num	28	SENT_188	25973/25974
27	30	CD	NUMBER	30	num	28	SENT_188	25974/25976
28	)	NN	O	)	dobj	25	SENT_188	25976/25977
29	.	.	O	.		-1	SENT_188	25977/25978

1	Moreover	RB	O	moreover	advmod	7	SENT_189	25979/25987
2	,	,	O	,		-1	SENT_189	25987/25988
3	the	DT	O	the	det	5	SENT_189	25989/25992
4	GEM	NNP	O	GEM	nn	5	SENT_189	25993/25996
5	particles	NNS	O	particle	nsubjpass	7	SENT_189	25997/26006
6	are	VBP	O	be	auxpass	7	SENT_189	26007/26010
7	produced	VBN	O	produce		-1	SENT_189	26011/26019
8	from	IN	O	from		-1	SENT_189	26020/26024
9	a	DT	O	a	det	10	SENT_189	26025/26026
10	bacterium	NN	O	bacterium	prep_from	7	SENT_189	26027/26036
11	which	WDT	O	which	nsubjpass	13	SENT_189	26037/26042
12	is	VBZ	O	be	auxpass	13	SENT_189	26043/26045
13	used	VBN	O	use	rcmod	10	SENT_189	26046/26050
14	in	IN	O	in		-1	SENT_189	26051/26053
15	the	DT	O	the	det	16	SENT_189	26054/26057
16	production	NN	O	production	prep_in	13	SENT_189	26058/26068
17	of	IN	O	of		-1	SENT_189	26069/26071
18	dairy	NN	O	dairy	nn	19	SENT_189	26072/26077
19	products	NNS	O	product	prep_of	16	SENT_189	26078/26086
20	and	CC	O	and		-1	SENT_189	26087/26090
21	is	VBZ	O	be	auxpass	22	SENT_189	26091/26093
22	considered	VBN	O	consider	conj_and	7	SENT_189	26094/26104
23	a	DT	O	a	det	25	SENT_189	26105/26106
24	GRAS	NNP	O	GRAS	nn	25	SENT_189	26107/26111
25	organism	NN	O	organism	dobj	22	SENT_189	26112/26120
26	.	.	O	.		-1	SENT_189	26120/26121

1	Audouy	NNP	O	Audouy	nsubj	7	SENT_190	26122/26128
2	et	FW	O	et	dep	1	SENT_190	26129/26131
3	al.	FW	O	al.	nn	4	SENT_190	26132/26135
4	(	FW	O	(	dep	1	SENT_190	26136/26137
5	31	CD	NUMBER	31	num	6	SENT_190	26137/26139
6	)	NN	O	)	dep	4	SENT_190	26139/26140
7	reported	VBD	O	report		-1	SENT_190	26141/26149
8	that	IN	O	that	mark	12	SENT_190	26150/26154
9	GEMs	NNS	O	gem	nsubj	12	SENT_190	26155/26159
10	did	VBD	O	do	aux	12	SENT_190	26160/26163
11	not	RB	O	not	neg	12	SENT_190	26164/26167
12	induce	VB	O	induce	ccomp	7	SENT_190	26168/26174
13	detectable	JJ	O	detectable	amod	15	SENT_190	26175/26185
14	antibody	NN	O	antibody	nn	15	SENT_190	26186/26194
15	levels	NNS	O	level	dobj	12	SENT_190	26195/26201
16	to	TO	O	to		-1	SENT_190	26202/26204
17	particles	NNS	O	particle	prep_to	12	SENT_190	26205/26214
18	themselves	PRP	O	themselves	advmod	17	SENT_190	26215/26225
19	after	IN	O	after		-1	SENT_190	26226/26231
20	repeated	VBN	O	repeat	amod	22	SENT_190	26232/26240
21	intranasal	JJ	O	intranasal	amod	22	SENT_190	26241/26251
22	administrations	NNS	O	administration	prep_after	12	SENT_190	26252/26267
23	in	IN	O	in		-1	SENT_190	26268/26270
24	mice	NNS	O	mouse	prep_in	22	SENT_190	26271/26275
25	.	.	O	.		-1	SENT_190	26275/26276

1	In	IN	O	in		-1	SENT_191	26277/26279
2	addition	NN	O	addition	prep_in	9	SENT_191	26280/26288
3	,	,	O	,		-1	SENT_191	26288/26289
4	GEM	NN	O	gem	nn	5	SENT_191	26290/26293
5	particles	NNS	O	particle	nsubjpass	9	SENT_191	26294/26303
6	have	VBP	O	have	aux	9	SENT_191	26304/26308
7	already	RB	O	already	advmod	9	SENT_191	26309/26316
8	been	VBN	O	be	auxpass	9	SENT_191	26317/26321
9	tested	VBN	O	test	ccomp	33	SENT_191	26322/26328
10	intranasally	RB	O	intranasally	advmod	9	SENT_191	26329/26341
11	in	IN	O	in		-1	SENT_191	26342/26344
12	rabbits	NNS	O	rabbit	prep_in	9	SENT_191	26345/26352
13	in	IN	O	in		-1	SENT_191	26353/26355
14	a	DT	O	a	det	18	SENT_191	26356/26357
15	preclinical	JJ	O	preclinical	amod	18	SENT_191	26358/26369
16	GLP	NN	O	glp	nn	18	SENT_191	26370/26373
17	toxicity	NN	O	toxicity	nn	18	SENT_191	26374/26382
18	study	NN	O	study	prep_in	12	SENT_191	26383/26388
19	,	,	O	,		-1	SENT_191	26388/26389
20	and	CC	O	and		-1	SENT_191	26390/26393
21	no	DT	O	no	det	23	SENT_191	26394/26396
22	adverse	JJ	O	adverse	amod	23	SENT_191	26397/26404
23	events	NNS	O	event	nsubjpass	25	SENT_191	26405/26411
24	were	VBD	O	be	auxpass	25	SENT_191	26412/26416
25	reported	VBN	O	report	conj_and	9	SENT_191	26417/26425
26	(	NN	O	(	nn	27	SENT_191	26426/26427
27	Leenhouts	NNS	O	leenhout	dobj	25	SENT_191	26427/26436
28	et	FW	O	et	nn	29	SENT_191	26437/26439
29	al.	FW	O	al.	dep	27	SENT_191	26440/26443
30	,	,	O	,		-1	SENT_191	26443/26444
31	unpublished	JJ	O	unpublished	amod	32	SENT_191	26445/26456
32	results	NNS	O	result	nsubj	33	SENT_191	26457/26464
33	)	VBP	O	)		-1	SENT_191	26464/26465
34	.	.	O	.		-1	SENT_191	26465/26466

1	Therefore	RB	O	therefore	advmod	7	SENT_192	26467/26476
2	,	,	O	,		-1	SENT_192	26476/26477
3	GEM	NN	O	gem	nn	4	SENT_192	26478/26481
4	particles	NNS	O	particle	nsubjpass	7	SENT_192	26482/26491
5	can	MD	O	can	aux	7	SENT_192	26492/26495
6	be	VB	O	be	auxpass	7	SENT_192	26496/26498
7	considered	VBN	O	consider		-1	SENT_192	26499/26509
8	as	IN	O	as		-1	SENT_192	26510/26512
9	a	DT	O	a	det	11	SENT_192	26513/26514
10	safe	JJ	O	safe	amod	11	SENT_192	26515/26519
11	candidate	NN	O	candidate	prep_as	7	SENT_192	26520/26529
12	adjuvant	JJ	O	adjuvant	amod	11	SENT_192	26530/26538
13	for	IN	O	for		-1	SENT_192	26539/26542
14	mucosal	JJ	O	mucosal	amod	15	SENT_192	26543/26550
15	use	NN	O	use	prep_for	12	SENT_192	26551/26554
16	in	IN	O	in		-1	SENT_192	26555/26557
17	humans	NNS	O	human	prep_in	15	SENT_192	26558/26564
18	.	.	O	.		-1	SENT_192	26564/26565

1	CONCLUSION	NN	O	conclusion		-1	SENT_193	26601/26611

1	Our	PRP$	O	we	poss	2	SENT_194	26647/26650
2	data	NNS	O	datum	nsubj	3	SENT_194	26651/26655
3	show	VBP	O	show		-1	SENT_194	26656/26660
4	that	IN	O	that	mark	12	SENT_194	26661/26665
5	i.n.	NN	O	i.n.	nn	7	SENT_194	26666/26670
6	influenza	NN	O	influenza	nn	7	SENT_194	26671/26680
7	vaccine	NN	O	vaccine	nsubj	12	SENT_194	26681/26688
8	adjuvanted	VBN	O	adjuvant	partmod	7	SENT_194	26689/26699
9	with	IN	O	with		-1	SENT_194	26700/26704
10	GEM	NN	O	gem	nn	11	SENT_194	26705/26708
11	particles	NNS	O	particle	prep_with	8	SENT_194	26709/26718
12	induced	VBD	O	induce	ccomp	3	SENT_194	26719/26726
13	a	DT	O	a	det	16	SENT_194	26727/26728
14	comparable	JJ	O	comparable	amod	16	SENT_194	26729/26739
15	systemic	JJ	O	systemic	amod	16	SENT_194	26740/26748
16	immunity	NN	O	immunity	dobj	12	SENT_194	26749/26757
17	and	CC	O	and		-1	SENT_194	26758/26761
18	superior	JJ	O	superior	amod	22	SENT_194	26762/26770
19	mucosal	JJ	O	mucosal	amod	22	SENT_194	26771/26778
20	and	CC	O	and		-1	SENT_194	26779/26782
21	cell-mediated	JJ	O	cell-mediated	conj_and	19	SENT_194	26783/26796
22	immunity	NN	O	immunity	conj_and	16	SENT_194	26797/26805
23	compared	VBN	O	compare	partmod	22	SENT_194	26806/26814
24	to	TO	O	to	aux	25	SENT_194	26815/26817
25	i.m.	VB	O	i.m.	xcomp	23	SENT_194	26818/26822
26	immunization	NN	O	immunization	dobj	25	SENT_194	26823/26835
27	with	IN	O	with		-1	SENT_194	26836/26840
28	subunit	NN	O	subunit	nn	30	SENT_194	26841/26848
29	influenza	NN	O	influenza	nn	30	SENT_194	26849/26858
30	vaccine	NN	O	vaccine	prep_with	25	SENT_194	26859/26866
31	alone	RB	O	alone	advmod	25	SENT_194	26867/26872
32	.	.	O	.		-1	SENT_194	26872/26873

1	Importantly	RB	O	importantly	advmod	4	SENT_195	26874/26885
2	,	,	O	,		-1	SENT_195	26885/26886
3	it	PRP	O	it	nsubj	4	SENT_195	26887/26889
4	induced	VBD	O	induce		-1	SENT_195	26890/26897
5	higher	JJR	O	higher	amod	7	SENT_195	26898/26904
6	sIgA	NN	O	siga	nn	7	SENT_195	26905/26909
7	levels	NNS	O	level	dobj	4	SENT_195	26910/26916
8	which	WDT	O	which	nsubj	12	SENT_195	26917/26922
9	are	VBP	O	be	cop	12	SENT_195	26923/26926
10	a	DT	O	a	det	12	SENT_195	26927/26928
11	first	JJ	ORDINAL	first	amod	12	SENT_195	26929/26934
12	line	NN	O	line	rcmod	7	SENT_195	26935/26939
13	of	IN	O	of		-1	SENT_195	26940/26942
14	defense	NN	O	defense	prep_of	12	SENT_195	26943/26950
15	during	IN	O	during		-1	SENT_195	26951/26957
16	influenza	NN	O	influenza	nn	17	SENT_195	26958/26967
17	infection	NN	O	infection	prep_during	4	SENT_195	26968/26977
18	in	IN	O	in		-1	SENT_195	26978/26980
19	the	DT	O	the	det	22	SENT_195	26981/26984
20	upper	JJ	O	upper	amod	22	SENT_195	26985/26990
21	respiratory	JJ	O	respiratory	amod	22	SENT_195	26991/27002
22	tract	NN	O	tract	prep_in	4	SENT_195	27003/27008
23	.	.	O	.		-1	SENT_195	27008/27009

1	Moreover	RB	O	moreover	advmod	4	SENT_196	27010/27018
2	,	,	O	,		-1	SENT_196	27018/27019
3	it	PRP	O	it	nsubj	4	SENT_196	27020/27022
4	elicited	VBD	O	elicit		-1	SENT_196	27023/27031
5	a	DT	O	a	det	9	SENT_196	27032/27033
6	skewed	JJ	O	skewed	amod	7	SENT_196	27034/27040
7	Th1-type	JJ	O	th1-type	amod	9	SENT_196	27041/27049
8	immune	JJ	O	immune	amod	9	SENT_196	27050/27056
9	response	NN	O	response	dobj	4	SENT_196	27057/27065
10	which	WDT	O	which	nsubjpass	12	SENT_196	27066/27071
11	is	VBZ	O	be	auxpass	12	SENT_196	27072/27074
12	considered	VBN	O	consider	rcmod	9	SENT_196	27075/27085
13	to	TO	O	to	aux	14	SENT_196	27086/27088
14	provide	VB	O	provide	xcomp	12	SENT_196	27089/27096
15	superior	JJ	O	superior	amod	16	SENT_196	27097/27105
16	protection	NN	O	protection	dobj	14	SENT_196	27106/27116
17	.	.	O	.		-1	SENT_196	27116/27117

1	Overall	RB	O	overall	advmod	7	SENT_197	27118/27125
2	,	,	O	,		-1	SENT_197	27125/27126
3	GEM	NN	O	gem	nn	4	SENT_197	27127/27130
4	particles	NNS	O	particle	nsubjpass	7	SENT_197	27131/27140
5	can	MD	O	can	aux	7	SENT_197	27141/27144
6	be	VB	O	be	auxpass	7	SENT_197	27145/27147
7	regarded	VBN	O	regard		-1	SENT_197	27148/27156
8	as	IN	O	as		-1	SENT_197	27157/27159
9	a	DT	O	a	det	13	SENT_197	27160/27161
10	safe	JJ	O	safe	amod	13	SENT_197	27162/27166
11	and	CC	O	and		-1	SENT_197	27167/27170
12	potent	JJ	O	potent	conj_and	10	SENT_197	27171/27177
13	adjuvants	NNS	O	adjuvant	prep_as	7	SENT_197	27178/27187
14	for	IN	O	for		-1	SENT_197	27188/27191
15	i.n.	NN	O	i.n.	prep_for	13	SENT_197	27192/27196
16	delivered	VBN	O	deliver	partmod	15	SENT_197	27197/27206
17	influenza	NN	O	influenza	nn	19	SENT_197	27207/27216
18	subunit	NN	O	subunit	nn	19	SENT_197	27217/27224
19	vaccine	NN	O	vaccine	dobj	16	SENT_197	27225/27232
20	.	.	O	.		-1	SENT_197	27232/27233

1	We	PRP	O	we	nsubj	2	SENT_198	27269/27271
2	thank	VBP	O	thank		-1	SENT_198	27272/27277
3	Solvay	NNP	ORGANIZATION	Solvay	nn	4	SENT_198	27278/27284
4	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	dobj	2	SENT_198	27285/27300
5	for	IN	O	for		-1	SENT_198	27301/27304
6	providing	VBG	O	provide	prepc_for	4	SENT_198	27305/27314
7	the	DT	O	the	det	10	SENT_198	27315/27318
8	subunit	NN	O	subunit	nn	10	SENT_198	27319/27326
9	influenza	NN	O	influenza	nn	10	SENT_198	27327/27336
10	vaccine	NN	O	vaccine	dobj	6	SENT_198	27337/27344
11	.	.	O	.		-1	SENT_198	27344/27345

1	Open	NNP	O	Open		-1	SENT_199	27381/27385
2	Access	NN	O	access	dep	1	SENT_199	27386/27392

1	This	DT	O	this	det	2	SENT_200	27428/27432
2	article	NN	O	article	nsubjpass	4	SENT_200	27433/27440
3	is	VBZ	O	be	auxpass	4	SENT_200	27441/27443
4	distributed	VBN	O	distribute		-1	SENT_200	27444/27455
5	under	IN	O	under		-1	SENT_200	27456/27461
6	the	DT	O	the	det	7	SENT_200	27462/27465
7	terms	NNS	O	term	prep_under	4	SENT_200	27466/27471
8	of	IN	O	of		-1	SENT_200	27472/27474
9	the	DT	O	the	det	14	SENT_200	27475/27478
10	Creative	NNP	O	Creative	nn	14	SENT_200	27479/27487
11	Commons	NNPS	O	Commons	nn	14	SENT_200	27488/27495
12	Attribution	NNP	O	Attribution	nn	14	SENT_200	27496/27507
13	Noncommercial	NNP	O	Noncommercial	nn	14	SENT_200	27508/27521
14	License	NNP	O	License	prep_of	7	SENT_200	27522/27529
15	which	WDT	O	which	nsubj	16	SENT_200	27530/27535
16	permits	VBZ	O	permit	rcmod	14	SENT_200	27536/27543
17	any	DT	O	any	det	19	SENT_200	27544/27547
18	noncommercial	JJ	O	noncommercial	amod	19	SENT_200	27548/27561
19	use	NN	O	use	nsubj	29	SENT_200	27562/27565
20	,	,	O	,		-1	SENT_200	27565/27566
21	distribution	NN	O	distribution	appos	19	SENT_200	27567/27579
22	,	,	O	,		-1	SENT_200	27579/27580
23	and	CC	O	and		-1	SENT_200	27581/27584
24	reproduction	NN	O	reproduction	conj_and	21	SENT_200	27585/27597
25	in	IN	O	in		-1	SENT_200	27598/27600
26	any	DT	O	any	det	27	SENT_200	27601/27604
27	medium	NN	O	medium	prep_in	24	SENT_200	27605/27611
28	,	,	O	,		-1	SENT_200	27611/27612
29	provided	VBD	O	provide	ccomp	16	SENT_200	27613/27621
30	the	DT	O	the	det	32	SENT_200	27622/27625
31	original	JJ	O	original	amod	32	SENT_200	27626/27634
32	author	NN	O	author	iobj	29	SENT_200	27635/27641
33	(	CD	NUMBER	(	num	34	SENT_200	27641/27642
34	s	NNS	O	s	dobj	29	SENT_200	27642/27643
35	)	CD	NUMBER	)	nsubjpass	39	SENT_200	27643/27644
36	and	CC	O	and		-1	SENT_200	27645/27648
37	source	NN	O	source	conj_and	35	SENT_200	27649/27655
38	are	VBP	O	be	auxpass	39	SENT_200	27656/27659
39	credited	VBN	O	credit	rcmod	34	SENT_200	27660/27668
40	.	.	O	.		-1	SENT_200	27668/27669

1	References	NNS	O	reference		-1	SENT_201	27705/27715

1	1	LS	NUMBER	1		-1	SENT_202	27732/27733
2	.	.	O	.		-1	SENT_202	27733/27734

1	WHO	WP	O	who	dep	6	SENT_203	27734/27737
2	,	,	O	,		-1	SENT_203	27737/27738
3	influenza	NN	O	influenza	appos	1	SENT_203	27739/27748
4	,	,	O	,		-1	SENT_203	27748/27749
5	fact	NN	O	fact	nn	6	SENT_203	27750/27754
6	sheet	NN	O	sheet	dep	9	SENT_203	27755/27760
7	211	CD	NUMBER	211	dep	6	SENT_203	27761/27764
8	,	,	O	,		-1	SENT_203	27764/27765
9	revised	VBN	O	revise		-1	SENT_203	27766/27773
10	2003.2	CD	NUMBER	2003.2	dobj	9	SENT_203	27774/27780
11	.	.	O	.		-1	SENT_203	27780/27781

1	CouchRBKaselJAGlezenWPCateTRSixHRTaberLHInfluenza	NNP	O	CouchRBKaselJAGlezenWPCateTRSixHRTaberLHInfluenza		-1	SENT_204	27781/27830
2	:	:	O	:		-1	SENT_204	27830/27831
3	its	PRP$	O	its	poss	4	SENT_204	27832/27835
4	control	NN	O	control	dep	1	SENT_204	27836/27843
5	in	IN	O	in		-1	SENT_204	27844/27846
6	persons	NNS	O	person	prep_in	4	SENT_204	27847/27854
7	and	CC	O	and		-1	SENT_204	27855/27858
8	populationsJ	NN	O	populationsj	conj_and	6	SENT_204	27859/27871
9	Infect	VB	O	infect	dep	4	SENT_204	27872/27878
10	Dis198615334314039504373	NN	O	dis198615334314039504373	dobj	9	SENT_204	27879/27903
11	.	.	O	.		-1	SENT_204	27903/27904

1	CoxRJBrokstadKAOgraPInfluenza	NN	O	coxrjbrokstadkaograpinfluenza	nn	2	SENT_205	27904/27933
2	virus	NN	O	virus		-1	SENT_205	27934/27939
3	:	:	O	:		-1	SENT_205	27939/27940
4	immunity	NN	O	immunity	nn	7	SENT_205	27941/27949
5	and	CC	O	and		-1	SENT_205	27950/27953
6	vaccination	NN	O	vaccination	conj_and	4	SENT_205	27954/27965
7	strategies	NNS	O	strategy	dep	2	SENT_205	27966/27976
8	.	.	O	.		-1	SENT_205	27976/27977

1	Comparison	NN	O	comparison	nsubj	11	SENT_206	27978/27988
2	of	IN	O	of		-1	SENT_206	27989/27991
3	the	DT	O	the	det	5	SENT_206	27992/27995
4	immune	JJ	O	immune	amod	5	SENT_206	27996/28002
5	response	NN	O	response	prep_of	1	SENT_206	28003/28011
6	to	TO	O	to	aux	7	SENT_206	28012/28014
7	inactivated	VBN	O	inactivate	infmod	5	SENT_206	28015/28026
8	and	CC	O	and		-1	SENT_206	28027/28030
9	live	VB	O	live	conj_and	7	SENT_206	28031/28035
10	,	,	O	,		-1	SENT_206	28035/28036
11	attenuated	VBD	O	attenuate		-1	SENT_206	28037/28047
12	influenza	NN	O	influenza	nn	15	SENT_206	28048/28057
13	vaccinesScand	NN	O	vaccinesscand	nn	15	SENT_206	28058/28071
14	J	NN	O	j	nn	15	SENT_206	28072/28073
15	Immunol200459111510	NN	O	immunol200459111510	dep	11	SENT_206	28074/28093
16	.1111	CD	NUMBER	.1111	dep	15	SENT_206	28093/28098
17	/	:	O	/	punct	15	SENT_206	28098/28099
18	j.0300-947	CD	NUMBER	j.0300-947	num	19	SENT_206	28099/28109
19	5.2004.01382	CD	NUMBER	5.2004.01382	dep	15	SENT_206	28110/28122
20	.	.	O	.		-1	SENT_206	28122/28123

1	x147236164	NN	O	x147236164		-1	SENT_207	28123/28133
2	.	.	O	.		-1	SENT_207	28133/28134

1	AtmarRLKeitelWACateTRMunozFMRubenFCouchRBA	NN	O	atmarrlkeitelwacatetrmunozfmrubenfcouchrba	nn	2	SENT_208	28134/28176
2	dose	NN	O	dose		-1	SENT_208	28177/28181
3	-	:	O	-		-1	SENT_208	28181/28182
4	response	NN	O	response	nn	5	SENT_208	28183/28191
5	evaluation	NN	O	evaluation	dep	2	SENT_208	28192/28202
6	of	IN	O	of	prep	5	SENT_208	28203/28205
7	inactivated	VBN	O	inactivate	dep	6	SENT_208	28206/28217
8	influenza	NN	O	influenza	nn	9	SENT_208	28218/28227
9	vaccine	NN	O	vaccine	dobj	7	SENT_208	28228/28235
10	given	VBN	O	give	partmod	9	SENT_208	28236/28241
11	intranasally	RB	O	intranasally	advmod	10	SENT_208	28242/28254
12	and	CC	O	and		-1	SENT_208	28255/28258
13	intramuscularly	RB	O	intramuscularly	conj_and	7	SENT_208	28259/28274
14	to	TO	O	to		-1	SENT_208	28275/28277
15	healthy	JJ	O	healthy	amod	17	SENT_208	28278/28285
16	young	JJ	O	young	amod	17	SENT_208	28286/28291
17	adultsVaccine2007252953677310	NN	O	adultsvaccine2007252953677310	prep_to	13	SENT_208	28292/28321
18	.1016	CD	NUMBER	.1016	num	17	SENT_208	28321/28326
19	/	:	O	/	punct	21	SENT_208	28326/28327
20	j.	NN	O	j.	nn	21	SENT_208	28327/28329
21	vaccine	NN	O	vaccine	dep	17	SENT_208	28329/28336
22	.	.	O	.		-1	SENT_208	28336/28337

1	2007.05.002175599905	CD	NUMBER	2007.05.002175599905		-1	SENT_209	28338/28358
2	.	.	O	.		-1	SENT_209	28358/28359

1	CoxRJHaaheimLREricssonJCMadhunASBrokstadKAThe	NNP	O	CoxRJHaaheimLREricssonJCMadhunASBrokstadKAThe	amod	2	SENT_210	28359/28404
2	humoral	JJ	O	humoral	nsubj	6	SENT_210	28405/28412
3	and	CC	O	and		-1	SENT_210	28413/28416
4	cellular	JJ	O	cellular	amod	5	SENT_210	28417/28425
5	responses	NNS	O	response	conj_and	2	SENT_210	28426/28435
6	induced	VBD	O	induce		-1	SENT_210	28436/28443
7	locally	RB	O	locally	advmod	6	SENT_210	28444/28451
8	and	CC	O	and		-1	SENT_210	28452/28455
9	systemically	RB	O	systemically	conj_and	7	SENT_210	28456/28468
10	after	IN	O	after		-1	SENT_210	28469/28474
11	parenteral	JJ	O	parenteral	amod	13	SENT_210	28475/28485
12	influenza	NN	O	influenza	nn	13	SENT_210	28486/28495
13	vaccination	NN	O	vaccination	prep_after	6	SENT_210	28496/28507
14	in	IN	O	in		-1	SENT_210	28508/28510
15	manVaccine20062444-4665778010	NN	O	manvaccine20062444-4665778010	prep_in	13	SENT_210	28511/28540
16	.1016	CD	NUMBER	.1016	num	15	SENT_210	28540/28545
17	/	:	O	/	punct	19	SENT_210	28545/28546
18	j.	NN	O	j.	nn	19	SENT_210	28546/28548
19	vaccine	NN	O	vaccine	dep	6	SENT_210	28548/28555
20	.2006.05.0411684288	CD	NUMBER	.2006.05.0411684288	num	21	SENT_210	28555/28574
21	96	CD	NUMBER	96	dep	19	SENT_210	28575/28577
22	.	.	O	.		-1	SENT_210	28577/28578

1	TamuraSKurataTDefense	NN	O	tamuraskuratatdefense	nn	2	SENT_211	28578/28599
2	mechanisms	NNS	O	mechanism	nsubj	13	SENT_211	28600/28610
3	against	IN	O	against		-1	SENT_211	28611/28618
4	influenza	NN	O	influenza	nn	6	SENT_211	28619/28628
5	virus	NN	O	virus	nn	6	SENT_211	28629/28634
6	infection	NN	O	infection	prep_against	2	SENT_211	28635/28644
7	in	IN	O	in		-1	SENT_211	28645/28647
8	the	DT	O	the	det	12	SENT_211	28648/28651
9	respiratory	JJ	O	respiratory	amod	12	SENT_211	28652/28663
10	tract	NN	O	tract	nn	12	SENT_211	28664/28669
11	mucosaJpn	NN	O	mucosajpn	nn	12	SENT_211	28670/28679
12	J	NN	O	j	prep_in	6	SENT_211	28680/28681
13	Infect	VB	O	infect		-1	SENT_211	28682/28688
14	Dis200457623647156239477	NN	O	dis200457623647156239477	dobj	13	SENT_211	28689/28713
15	.	.	O	.		-1	SENT_211	28713/28714

1	YetterRALehrerSRamphalRSmallPAJrOutcome	NN	O	yetterralehrersramphalrsmallpajroutcome		-1	SENT_212	28714/28753
2	of	IN	O	of		-1	SENT_212	28754/28756
3	influenza	NN	O	influenza	nn	4	SENT_212	28757/28766
4	infection	NN	O	infection	prep_of	1	SENT_212	28767/28776
5	:	:	O	:		-1	SENT_212	28776/28777
6	effect	NN	O	effect	dep	1	SENT_212	28778/28784
7	of	IN	O	of		-1	SENT_212	28785/28787
8	site	NN	O	site	prep_of	6	SENT_212	28788/28792
9	of	IN	O	of		-1	SENT_212	28793/28795
10	initial	JJ	O	initial	amod	11	SENT_212	28796/28803
11	infection	NN	O	infection	prep_of	8	SENT_212	28804/28813
12	and	CC	O	and		-1	SENT_212	28814/28817
13	heterotypic	JJ	O	heterotypic	amod	15	SENT_212	28818/28829
14	immunityInfect	NN	O	immunityinfect	nn	15	SENT_212	28830/28844
15	Immun19802926546272164338	NN	O	immun19802926546272164338	conj_and	11	SENT_212	28845/28870
16	.	.	O	.		-1	SENT_212	28870/28871

1	ZeeYCOseboldJWDotsonWMAntibody	NN	O	zeeycoseboldjwdotsonwmantibody	nn	2	SENT_213	28871/28901
2	responses	NNS	O	response		-1	SENT_213	28902/28911
3	and	CC	O	and		-1	SENT_213	28912/28915
4	interferon	NN	O	interferon	nn	5	SENT_213	28916/28926
5	titers	NNS	O	titer	conj_and	2	SENT_213	28927/28933
6	in	IN	O	in		-1	SENT_213	28934/28936
7	the	DT	O	the	det	9	SENT_213	28937/28940
8	respiratory	JJ	O	respiratory	amod	9	SENT_213	28941/28952
9	tracts	NNS	O	tract	prep_in	2	SENT_213	28953/28959
10	of	IN	O	of		-1	SENT_213	28960/28962
11	mice	NNS	O	mouse	prep_of	9	SENT_213	28963/28967
12	after	IN	O	after		-1	SENT_213	28968/28973
13	aerosolized	JJ	O	aerosolized	amod	14	SENT_213	28974/28985
14	exposure	NN	O	exposure	prep_after	11	SENT_213	28986/28994
15	to	TO	O	to		-1	SENT_213	28995/28997
16	influenza	NN	O	influenza	nn	18	SENT_213	28998/29007
17	virusInfect	NN	O	virusinfect	nn	18	SENT_213	29008/29019
18	Immun197925120272252729	NN	O	immun197925120272252729	prep_to	2	SENT_213	29020/29043
19	.	.	O	.		-1	SENT_213	29044/29045

1	GreenbaumEEngelhardDLevyRSchlezingerMMoragAZakay-RonesZMucosal	JJ	O	greenbaumeengelharddlevyrschlezingermmoragazakay-roneszmucosal	amod	3	SENT_214	29045/29107
2	(	NN	O	(	nn	3	SENT_214	29108/29109
3	SIgA	NN	O	siga	nsubj	7	SENT_214	29109/29113
4	)	CD	NUMBER	)	dep	3	SENT_214	29113/29114
5	and	CC	O	and		-1	SENT_214	29115/29118
6	serum	NN	O	serum	conj_and	3	SENT_214	29119/29124
7	(	VBP	O	(		-1	SENT_214	29125/29126
8	IgG	NN	O	igg	nsubj	11	SENT_214	29126/29129
9	)	CD	NUMBER	)	num	11	SENT_214	29129/29130
10	immunologic	JJ	O	immunologic	amod	11	SENT_214	29131/29142
11	responses	NNS	O	response	xcomp	7	SENT_214	29143/29152
12	in	IN	O	in		-1	SENT_214	29153/29155
13	young	JJ	O	young	amod	14	SENT_214	29156/29161
14	adults	NNS	O	adult	prep_in	11	SENT_214	29162/29168
15	following	VBG	O	follow		-1	SENT_214	29169/29178
16	intranasal	JJ	O	intranasal	amod	17	SENT_214	29179/29189
17	administration	NN	O	administration	prep_following	14	SENT_214	29190/29204
18	of	IN	O	of		-1	SENT_214	29205/29207
19	one	CD	NUMBER	one	prep_of	17	SENT_214	29208/29211
20	or	CC	O	or		-1	SENT_214	29212/29214
21	two	CD	NUMBER	two	num	22	SENT_214	29215/29218
22	doses	NNS	O	dose	conj_or	17	SENT_214	29219/29224
23	of	IN	O	of		-1	SENT_214	29225/29227
24	inactivated	VBN	O	inactivate	prepc_of	22	SENT_214	29228/29239
25	,	,	O	,		-1	SENT_214	29239/29240
26	trivalent	JJ	O	trivalent	amod	28	SENT_214	29241/29250
27	anti-influenza	JJ	O	anti-influenza	amod	28	SENT_214	29251/29265
28	vaccineVaccine2004222025667710	NN	O	vaccinevaccine2004222025667710	dep	7	SENT_214	29266/29296
29	.1016	CD	NUMBER	.1016	dep	28	SENT_214	29296/29301
30	/	:	O	/	punct	28	SENT_214	29301/29302
31	j.	NN	O	j.	nn	32	SENT_214	29302/29304
32	vaccine	NN	O	vaccine	dep	28	SENT_214	29304/29311
33	.2003.12.0181519338210	CD	NUMBER	.2003.12.0181519338210	dep	32	SENT_214	29311/29333
34	.	.	O	.		-1	SENT_214	29334/29335

1	GiudiceELCampbellJDNeedle-free	JJ	O	giudiceelcampbelljdneedle-free	amod	5	SENT_215	29335/29365
2	vaccine	NN	O	vaccine	nn	5	SENT_215	29366/29373
3	deliveryAdv	NNP	O	deliveryAdv	nn	5	SENT_215	29374/29385
4	Drug	NNP	O	Drug	nn	5	SENT_215	29386/29390
5	Deliv	NNP	O	Deliv		-1	SENT_215	29391/29396
6	Rev2006581688910	NN	O	rev2006581688910	dep	5	SENT_215	29397/29413
7	.1016	CD	NUMBER	.1016	num	6	SENT_215	29413/29418
8	/	:	O	/	punct	10	SENT_215	29418/29419
9	j.	NN	O	j.	nn	10	SENT_215	29419/29421
10	addr	NN	O	addr	dep	6	SENT_215	29421/29425
11	.2005.12.0031656411111	NN	O	.2005.12.0031656411111	dep	6	SENT_215	29425/29447
12	.	.	O	.		-1	SENT_215	29447/29448

1	TaylorHPDimmockNJMechanism	NNP	O	TaylorHPDimmockNJMechanism	nsubj	11	SENT_216	29448/29474
2	of	IN	O	of		-1	SENT_216	29475/29477
3	neutralization	NN	O	neutralization	prep_of	1	SENT_216	29478/29492
4	of	IN	O	of		-1	SENT_216	29493/29495
5	influenza	NN	O	influenza	nn	6	SENT_216	29496/29505
6	virus	NN	O	virus	prep_of	3	SENT_216	29506/29511
7	by	IN	O	by		-1	SENT_216	29512/29514
8	secretory	JJ	O	secretory	amod	9	SENT_216	29515/29524
9	IgA	NN	O	iga	prep_by	6	SENT_216	29525/29528
10	is	VBZ	O	be	cop	11	SENT_216	29529/29531
11	different	JJ	O	different		-1	SENT_216	29532/29541
12	from	IN	O	from		-1	SENT_216	29542/29546
13	that	DT	O	that	prep_from	11	SENT_216	29547/29551
14	of	IN	O	of		-1	SENT_216	29552/29554
15	monomeric	JJ	O	monomeric	amod	16	SENT_216	29555/29564
16	IgA	NN	O	iga	prep_of	13	SENT_216	29565/29568
17	or	CC	O	or		-1	SENT_216	29569/29571
18	IgGJ	NN	O	iggj	nn	20	SENT_216	29572/29576
19	Exp	NN	O	exp	nn	20	SENT_216	29577/29580
20	Med1985161119820910	NN	O	med1985161119820910	conj_or	13	SENT_216	29581/29600
21	.1084	CD	NUMBER	.1084	dep	20	SENT_216	29600/29605
22	/	:	O	/	punct	23	SENT_216	29605/29606
23	jem	NN	O	jem	dep	21	SENT_216	29606/29609
24	.161.1.198298195312	CD	NUMBER	.161.1.198298195312	num	23	SENT_216	29609/29628
25	.	.	O	.		-1	SENT_216	29628/29629

1	R	NN	O	r	nn	2	SENT_217	29629/29630
2	enegarKBSmallPAJrBoykinsLGWrightPFRole	NN	O	enegarkbsmallpajrboykinslgwrightpfrole		-1	SENT_217	29631/29669
3	of	IN	O	of		-1	SENT_217	29670/29672
4	IgA	NN	O	iga	prep_of	2	SENT_217	29673/29676
5	versus	CC	O	versus	prep	2	SENT_217	29677/29683
6	IgG	NN	O	igg	dep	5	SENT_217	29684/29687
7	in	IN	O	in		-1	SENT_217	29688/29690
8	the	DT	O	the	det	9	SENT_217	29691/29694
9	control	NN	O	control	prep_in	2	SENT_217	29695/29702
10	of	IN	O	of		-1	SENT_217	29703/29705
11	influenza	NN	O	influenza	nn	13	SENT_217	29706/29715
12	viral	JJ	O	viral	amod	13	SENT_217	29716/29721
13	infection	NN	O	infection	prep_of	9	SENT_217	29722/29731
14	in	IN	O	in		-1	SENT_217	29732/29734
15	the	DT	O	the	det	19	SENT_217	29735/29738
16	murine	JJ	O	murine	amod	19	SENT_217	29739/29745
17	respiratory	JJ	O	respiratory	amod	19	SENT_217	29746/29757
18	tractJ	NN	O	tractj	nn	19	SENT_217	29758/29764
19	Immunol200417331978861526593213	NN	O	immunol200417331978861526593213	prep_in	13	SENT_217	29765/29796
20	.	.	O	.		-1	SENT_217	29796/29797

1	EylesJEWilliamsonEDAlparHOIntranasal	NNP	O	EylesJEWilliamsonEDAlparHOIntranasal	nn	2	SENT_218	29797/29833
2	administration	NN	O	administration		-1	SENT_218	29834/29848
3	of	IN	O	of		-1	SENT_218	29849/29851
4	influenza	NN	O	influenza	nn	5	SENT_218	29852/29861
5	vaccines	NNS	O	vaccine	prep_of	2	SENT_218	29862/29870
6	:	:	O	:		-1	SENT_218	29870/29871
7	current	JJ	DATE	current	amod	8	SENT_218	29872/29879
8	statusBioDrugs2000131355910	NN	O	statusbiodrugs2000131355910	dep	2	SENT_218	29880/29907
9	.2165	CD	NUMBER	.2165	dep	8	SENT_218	29907/29912
10	/	:	O	/	punct	11	SENT_218	29912/29913
11	00063030-200013010-000051803451214	CD	NUMBER	00063030-200013010-000051803451214	dep	9	SENT_218	29913/29947
12	.	.	O	.		-1	SENT_218	29948/29949

1	TamuraSFunatoHHirabayashiYSuzukiYNagamineTAizawaCCross-protection	NN	O	tamurasfunatohhirabayashiysuzukiynagaminetaizawaccross-protection	nsubj	9	SENT_219	29949/30014
2	against	IN	O	against		-1	SENT_219	30015/30022
3	influenza	NN	O	influenza	nn	6	SENT_219	30023/30032
4	A	NN	O	a	nn	6	SENT_219	30033/30034
5	virus	NN	O	virus	nn	6	SENT_219	30035/30040
6	infection	NN	O	infection	prep_against	1	SENT_219	30041/30050
7	by	IN	O	by	prep	6	SENT_219	30051/30053
8	passively	RB	O	passively	pcomp	7	SENT_219	30054/30063
9	transferred	VBN	O	transfer		-1	SENT_219	30064/30075
10	respiratory	JJ	O	respiratory	amod	13	SENT_219	30076/30087
11	tract	NN	O	tract	nn	13	SENT_219	30088/30093
12	IgA	NN	O	iga	nn	13	SENT_219	30094/30097
13	antibodies	NNS	O	antibody	dobj	9	SENT_219	30098/30108
14	to	TO	O	to		-1	SENT_219	30109/30111
15	different	JJ	O	different	amod	21	SENT_219	30112/30121
16	hemagglutinin	NN	O	hemagglutinin	nn	21	SENT_219	30122/30135
17	moleculesEur	NN	O	moleculeseur	nn	21	SENT_219	30136/30148
18	J	NN	O	j	nn	21	SENT_219	30149/30150
19	Immunol199121613374410	NN	O	immunol199121613374410	nn	21	SENT_219	30151/30173
20	.10	CD	NUMBER	.10	num	21	SENT_219	30173/30176
21	02/eji	NNS	O	02/eji	prep_to	9	SENT_219	30177/30183
22	.1830210602164611215	CD	NUMBER	.1830210602164611215	dep	21	SENT_219	30183/30203
23	.	.	O	.		-1	SENT_219	30203/30204

1	TamuraSIAsanumaHItoYHirabayashiYSuzukiYNagamineTSup	NN	O	tamurasiasanumahitoyhirabayashiysuzukiynagaminetsup	nn	2	SENT_220	30204/30255
2	erior	NN	O	erior		-1	SENT_220	30256/30261
3	cross-protective	JJ	O	cross-protective	amod	4	SENT_220	30262/30278
4	effect	NN	O	effect	dep	2	SENT_220	30279/30285
5	of	IN	O	of		-1	SENT_220	30286/30288
6	nasal	JJ	O	nasal	amod	7	SENT_220	30289/30294
7	vaccination	NN	O	vaccination	prep_of	4	SENT_220	30295/30306
8	to	TO	O	to		-1	SENT_220	30307/30309
9	subcutaneous	JJ	O	subcutaneous	amod	10	SENT_220	30310/30322
10	inoculation	NN	O	inoculation	prep_to	7	SENT_220	30323/30334
11	with	IN	O	with		-1	SENT_220	30335/30339
12	influenza	NN	O	influenza	nn	14	SENT_220	30340/30349
13	hemagglutinin	NN	O	hemagglutinin	nn	14	SENT_220	30350/30363
14	vaccineEur	NN	O	vaccineeur	prep_with	4	SENT_220	30364/30374
15	J	NN	O	j	prep	14	SENT_220	30375/30376
16	Immunol19922224778110	NN	O	immunol19922224778110	dep	15	SENT_220	30377/30398
17	.1002	CD	NUMBER	.1002	num	16	SENT_220	30398/30403
18	/	:	O	/	punct	2	SENT_220	30403/30404
19	eji	FW	O	eji	nn	20	SENT_220	30404/30407
20	.1830220228153738216	FW	NUMBER	.1830220228153738216	dep	2	SENT_220	30407/30427
21	.	.	O	.		-1	SENT_220	30427/30428

1	MoranTMParkHFernandez	NNP	O	MoranTMParkHFernandez		-1	SENT_221	30428/30449
2	-	:	O	-		-1	SENT_221	30449/30450
3	SesmaASchulmanJLTh2	NN	O	sesmaaschulmanjlth2	nn	4	SENT_221	30451/30470
4	responses	NNS	O	response	dep	1	SENT_221	30471/30480
5	to	TO	O	to	aux	6	SENT_221	30481/30483
6	inactivated	VBN	O	inactivate	infmod	4	SENT_221	30484/30495
7	influenza	NN	O	influenza	nn	8	SENT_221	30496/30505
8	virus	NN	O	virus	nsubjpass	11	SENT_221	30506/30511
9	can	MD	O	can	aux	11	SENT_221	30512/30515
10	Be	VB	O	be	auxpass	11	SENT_221	30516/30518
11	converted	VBN	O	convert	ccomp	6	SENT_221	30519/30528
12	to	TO	O	to		-1	SENT_221	30529/30531
13	Th1	NN	O	th1	nn	14	SENT_221	30532/30535
14	responses	NNS	O	response	prep_to	11	SENT_221	30536/30545
15	and	CC	O	and		-1	SENT_221	30546/30549
16	facilitate	VB	O	facilitate	conj_and	11	SENT_221	30550/30560
17	recovery	NN	O	recovery	dobj	16	SENT_221	30561/30569
18	from	IN	O	from		-1	SENT_221	30570/30574
19	heterosubtypic	JJ	O	heterosubtypic	amod	20	SENT_221	30575/30589
20	virus	NN	O	virus	prep_from	16	SENT_221	30590/30595
21	infectionJ	NNP	O	infectionJ	nsubj	22	SENT_221	30596/30606
22	Infect	VB	O	infect	rcmod	20	SENT_221	30607/30613
23	Dis199918035798510	NN	O	dis199918035798510	dobj	22	SENT_221	30614/30632
24	.1086	CD	NUMBER	.1086	num	23	SENT_221	30632/30637
25	/	:	O	/	punct	26	SENT_221	30637/30638
26	3149521043834217	CD	NUMBER	3149521043834217	dep	23	SENT_221	30638/30654
27	.	.	O	.		-1	SENT_221	30655/30656

1	LiewFYRussellSMAppleyardGBrandCMBealeJCross-protection	NNP	LOCATION	LiewFYRussellSMAppleyardGBrandCMBealeJCross-protection	nsubjpass	14	SENT_222	30656/30710
2	in	IN	O	in		-1	SENT_222	30711/30713
3	mice	NNS	O	mouse	prep_in	1	SENT_222	30714/30718
4	infected	VBN	O	infect	partmod	3	SENT_222	30719/30727
5	with	IN	O	with		-1	SENT_222	30728/30732
6	influenza	NN	O	influenza	nn	8	SENT_222	30733/30742
7	A	NN	O	a	nn	8	SENT_222	30743/30744
8	virus	NN	O	virus	prep_with	4	SENT_222	30745/30750
9	by	IN	O	by		-1	SENT_222	30751/30753
10	the	DT	O	the	det	12	SENT_222	30754/30757
11	respiratory	JJ	O	respiratory	amod	12	SENT_222	30758/30769
12	route	NN	O	route	agent	4	SENT_222	30770/30775
13	is	VBZ	O	be	auxpass	14	SENT_222	30776/30778
14	correlated	VBN	O	correlate		-1	SENT_222	30779/30789
15	with	IN	O	with		-1	SENT_222	30790/30794
16	local	JJ	O	local	amod	18	SENT_222	30795/30800
17	IgA	NN	O	iga	nn	18	SENT_222	30801/30804
18	antibody	NN	O	antibody	prep_with	14	SENT_222	30805/30813
19	rather	RB	O	rather		-1	SENT_222	30814/30820
20	than	IN	O	than		-1	SENT_222	30821/30825
21	serum	NN	O	serum	nn	22	SENT_222	30826/30831
22	antibody	NN	O	antibody	conj_negcc	18	SENT_222	30832/30840
23	or	CC	O	or		-1	SENT_222	30841/30843
24	cytotoxic	JJ	O	cytotoxic	amod	30	SENT_222	30844/30853
25	T	NN	O	t	nn	30	SENT_222	30854/30855
26	cell	NN	O	cell	nn	30	SENT_222	30856/30860
27	reactivityEur	NN	O	reactivityeur	nn	30	SENT_222	30861/30874
28	J	NN	O	j	nn	30	SENT_222	30875/30876
29	Immuno	NN	O	immuno	nn	30	SENT_222	30877/30883
30	l1984144350610	NN	O	l1984144350610	conj_or	18	SENT_222	30884/30898
31	.1002	CD	NUMBER	.1002	dep	30	SENT_222	30898/30903
32	/	:	O	/	punct	33	SENT_222	30903/30904
33	eji	FW	O	eji	dep	31	SENT_222	30904/30907
34	.1830140414660982418	CD	NUMBER	.1830140414660982418	dep	33	SENT_222	30907/30927
35	.	.	O	.		-1	SENT_222	30927/30928

1	TumpeyTMRenshawMClementsJDKatzJMMu	NN	O	tumpeytmrenshawmclementsjdkatzjmmu	nn	3	SENT_223	30928/30962
2	cosal	NN	O	cosal	nn	3	SENT_223	30963/30968
3	delivery	NN	O	delivery	nsubj	8	SENT_223	30969/30977
4	of	IN	O	of		-1	SENT_223	30978/30980
5	inactivated	VBN	O	inactivate	prepc_of	3	SENT_223	30981/30992
6	influenza	NN	O	influenza	nn	7	SENT_223	30993/31002
7	vaccine	NN	O	vaccine	dobj	5	SENT_223	31003/31010
8	induces	VBZ	O	induce		-1	SENT_223	31011/31018
9	B-cell-dependent	JJ	O	b-cell-dependent	amod	11	SENT_223	31019/31035
10	heterosubtypic	JJ	O	heterosubtypic	amod	11	SENT_223	31036/31050
11	cross-protection	NN	O	cross-protection	dobj	8	SENT_223	31051/31067
12	against	IN	O	against		-1	SENT_223	31068/31075
13	lethal	JJ	O	lethal	amod	14	SENT_223	31076/31082
14	influenza	NN	O	influenza	prep_against	11	SENT_223	31083/31092
15	A	DT	O	a	det	18	SENT_223	31093/31094
16	H5N1	NN	O	h5n1	nn	18	SENT_223	31095/31099
17	virus	NN	O	virus	nn	18	SENT_223	31100/31105
18	infectionJ	NN	O	infectionj	dep	14	SENT_223	31106/31116
19	Virol2001751151415010	NN	O	virol2001751151415010	dep	18	SENT_223	31117/31138
20	.1128	CD	NUMBER	.1128	num	19	SENT_223	31138/31143
21	/	:	O	/	punct	22	SENT_223	31143/31144
22	JVI.75.11.5141-5150	NN	DURATION	jvi.75.11.5141-5150	dep	19	SENT_223	31144/31163
23	.20011133389519	CD	NUMBER	.20011133389519	num	22	SENT_223	31163/31178
24	.	.	O	.		-1	SENT_223	31178/31179

1	McElhaneyJEThe	NNP	O	McElhaneyJEThe	nsubj	3	SENT_224	31179/31193
2	unmet	JJ	O	unmet	amod	3	SENT_224	31194/31199
3	need	NN	O	need		-1	SENT_224	31200/31204
4	in	IN	O	in		-1	SENT_224	31205/31207
5	the	DT	O	the	det	6	SENT_224	31208/31211
6	elderly	JJ	O	elderly	prep_in	3	SENT_224	31212/31219
7	:	:	O	:		-1	SENT_224	31219/31220
8	designing	VBG	O	design	dep	3	SENT_224	31221/31230
9	new	JJ	O	new	amod	11	SENT_224	31231/31234
10	influenza	NN	O	influenza	nn	11	SENT_224	31235/31244
11	vaccines	NNS	O	vaccine	dobj	8	SENT_224	31245/31253
12	for	IN	O	for		-1	SENT_224	31254/31257
13	older	JJR	O	older	amod	15	SENT_224	31258/31263
14	adultsVaccine200523Suppl	NN	O	adultsvaccine200523suppl	nn	15	SENT_224	31264/31288
15	1S102510	NN	O	1s102510	prep_for	8	SENT_224	31289/31297
16	.1016	CD	NUMBER	.1016	dep	15	SENT_224	31297/31302
17	/	:	O	/	punct	19	SENT_224	31302/31303
18	j.	NN	O	j.	nn	19	SENT_224	31303/31305
19	vaccine	NN	O	vaccine	dep	3	SENT_224	31305/31312
20	.2005.04.0191590806220	CD	NUMBER	.2005.04.0191590806220	dep	19	SENT_224	31312/31334
21	.	.	O	.		-1	SENT_224	31334/31335

1	SzewczukMRWadeAWAging	VBG	O	szewczukmrwadeawage		-1	SENT_225	31335/31356
2	and	CC	O	and	cc	6	SENT_225	31357/31360
3	the	DT	O	the	det	6	SENT_225	31361/31364
4	mucosal-associated	JJ	O	mucosal-associated	amod	6	SENT_225	31365/31383
5	lymphoid	JJ	O	lymphoid	amod	6	SENT_225	31384/31392
6	systemAnn	NN	O	systemann	dobj	1	SENT_225	31393/31402
7	N	NN	O	n	nn	10	SENT_225	31403/31404
8	Y	NN	O	y	nn	10	SENT_225	31405/31406
9	Acad	NNP	O	Acad	nn	10	SENT_225	31407/31411
10	Sci19834093334410	NNP	O	Sci19834093334410	dep	6	SENT_225	31412/31429
11	.1111	CD	NUMBER	.1111	num	10	SENT_225	31429/31434
12	/	:	O	/	punct	14	SENT_225	31434/31435
13	j.1749-6632	JJ	DURATION	j.1749-6632	amod	14	SENT_225	31435/31446
14	.1983	NN	NUMBER	.1983	dep	10	SENT_225	31446/31451
15	.	.	O	.		-1	SENT_225	31451/31452

1	tb26881	NN	O	tb26881		-1	SENT_226	31452/31459
2	.	.	O	.		-1	SENT_226	31459/31460

1	x634699321	NN	O	x634699321		-1	SENT_227	31460/31470
2	.	.	O	.		-1	SENT_227	31470/31471

1	Centers	NNPS	O	Centers		-1	SENT_228	31471/31478
2	for	IN	O	for		-1	SENT_228	31479/31482
3	Disease	NNP	O	Disease	nn	4	SENT_228	31483/31490
4	Control	NNP	O	Control	prep_for	1	SENT_228	31491/31498
5	and	CC	O	and		-1	SENT_228	31499/31502
6	Prevention	NNP	O	Prevention	conj_and	4	SENT_228	31503/31513
7	.	.	O	.		-1	SENT_228	31513/31514

1	Estimates	NNS	O	estimate		-1	SENT_229	31515/31524
2	of	IN	O	of		-1	SENT_229	31525/31527
3	influenza	NN	O	influenza	nn	7	SENT_229	31528/31537
4	vaccination	NN	O	vaccination	nn	7	SENT_229	31538/31549
5	target	NN	O	target	nn	7	SENT_229	31550/31556
6	population	NN	O	population	nn	7	SENT_229	31557/31567
7	sizes	NNS	O	size	prep_of	1	SENT_229	31568/31573
8	in	IN	O	in		-1	SENT_229	31574/31576
9	2006	CD	DATE	2006	prep_in	1	SENT_229	31577/31581
10	and	CC	O	and		-1	SENT_229	31582/31585
11	recent	JJ	O	recent	amod	14	SENT_229	31586/31592
12	vaccine	NN	O	vaccine	nn	14	SENT_229	31593/31600
13	uptake	NN	O	uptake	nn	14	SENT_229	31601/31607
14	levels	NNS	O	level	conj_and	9	SENT_229	31608/31614
15	.	.	O	.		-1	SENT_229	31614/31615

1	http://www.cdc.gov/flu/profess	NN	O	http://www.cdc.gov/flu/profess	nn	2	SENT_230	31616/31646
2	ionals/vaccination/pdf	NN	O	ionals/vaccination/pdf		-1	SENT_230	31647/31669
3	/	:	O	/	punct	2	SENT_230	31669/31670
4	targetpopchart	NN	O	targetpopchart	dep	2	SENT_230	31670/31684
5	.	.	O	.		-1	SENT_230	31684/31685

1	pdf	NN	O	pdf		-1	SENT_231	31685/31688
2	.22	CD	NUMBER	.22	dep	1	SENT_231	31688/31691
3	.	.	O	.		-1	SENT_231	31691/31692

1	BelsheRBAmbroseCSYiTSafety	NNP	PERSON	BelsheRBAmbroseCSYiTSafety	nsubj	6	SENT_232	31692/31718
2	and	CC	O	and		-1	SENT_232	31719/31722
3	efficacy	NN	O	efficacy	conj_and	1	SENT_232	31723/31731
4	of	IN	O	of		-1	SENT_232	31732/31734
5	live	JJ	O	live	prep_of	3	SENT_232	31735/31739
6	attenuated	VBN	O	attenuate		-1	SENT_232	31740/31750
7	influenza	NN	O	influenza	nn	8	SENT_232	31751/31760
8	vaccine	NN	O	vaccine	dobj	6	SENT_232	31761/31768
9	in	IN	O	in		-1	SENT_232	31769/31771
10	children	NNS	O	child	prep_in	6	SENT_232	31772/31780
11	2-7	CD	NUMBER	2-7	num	12	SENT_232	31781/31784
12	years	NNS	NUMBER	year	dep	6	SENT_232	31785/31790
13	of	IN	O	of		-1	SENT_232	31791/31793
14	ageVaccine200826Suppl	NN	O	agevaccine200826suppl	nn	15	SENT_232	31794/31815
15	4D10610	NN	O	4d10610	prep_of	6	SENT_232	31816/31823
16	.1016	CD	NUMBER	.1016	num	15	SENT_232	31823/31828
17	/	:	O	/	punct	19	SENT_232	31828/31829
18	j.	NN	O	j.	nn	19	SENT_232	31829/31831
19	vaccine	NN	O	vaccine	dep	6	SENT_232	31831/31838
20	.2008.06.0831861142223	CD	NUMBER	.2008.06.0831861142223	dep	19	SENT_232	31838/31860
21	.	.	O	.		-1	SENT_232	31860/31861

1	MatassovDCupoAGalarzaJMA	NN	O	matassovdcupoagalarzajma	nn	9	SENT_233	31861/31885
2	novel	JJ	O	novel	amod	9	SENT_233	31886/31891
3	intranasal	JJ	O	intranasal	amod	9	SENT_233	31892/31902
4	virus-like	JJ	O	virus-like	amod	9	SENT_233	31903/31913
5	particle	NN	O	particle	nn	9	SENT_233	31914/31922
6	(	CD	NUMBER	(	num	9	SENT_233	31923/31924
7	VLP	NN	O	vlp	nn	9	SENT_233	31924/31927
8	)	NN	O	)	nn	9	SENT_233	31927/31928
9	vaccine	NN	O	vaccine		-1	SENT_233	31929/31936
10	designed	VBN	O	design	partmod	9	SENT_233	31937/31945
11	to	TO	O	to	aux	12	SENT_233	31946/31948
12	protect	VB	O	protect	xcomp	10	SENT_233	31949/31956
13	against	IN	O	against		-1	SENT_233	31957/31964
14	the	DT	O	the	det	19	SENT_233	31965/31968
15	pandemic	JJ	O	pandemic	amod	19	SENT_233	31969/31977
16	1918	CD	DATE	1918	num	19	SENT_233	31978/31982
17	influenza	NN	O	influenza	nn	19	SENT_233	31983/31992
18	A	NN	O	a	nn	19	SENT_233	31993/31994
19	virus	NN	O	virus	prep_against	12	SENT_233	31995/32000
20	(	CD	NUMBER	(	num	21	SENT_233	32001/32002
21	H1N1	NN	O	h1n1	dobj	12	SENT_233	32002/32006
22	)	CD	NUMBER	)	num	24	SENT_233	32006/32007
23	Viral	JJ	O	viral	amod	24	SENT_233	32007/32012
24	Immunol20072034415210	NN	O	immunol20072034415210	dep	21	SENT_233	32013/32034
25	.1089	CD	NUMBER	.1089	dep	24	SENT_233	32034/32039
26	/	:	O	/	punct	27	SENT_233	32039/32040
27	vim	NN	O	vim	dep	25	SENT_233	32040/32043
28	.2007.00271793111424	CD	NUMBER	.2007.00271793111424	num	27	SENT_233	32043/32063
29	.	.	O	.		-1	SENT_233	32063/32064

1	JosephAItskovitz	NNP	PERSON	JosephAItskovitz		-1	SENT_234	32064/32080
2	-	:	O	-		-1	SENT_234	32080/32081
3	CooperNSamiraSFlastersteinOEliyahuHSimbergDA	NNP	O	CooperNSamiraSFlastersteinOEliyahuHSimbergDA	dep	1	SENT_234	32082/32126
4	new	JJ	O	new	amod	7	SENT_234	32127/32130
5	intranasal	JJ	O	intranasal	amod	7	SENT_234	32131/32141
6	influenza	NN	O	influenza	nn	7	SENT_234	32142/32151
7	vaccine	NN	O	vaccine	dep	3	SENT_234	32152/32159
8	based	VBN	O	base	partmod	3	SENT_234	32160/32165
9	on	IN	O	on		-1	SENT_234	32166/32168
10	a	DT	O	a	det	13	SENT_234	32169/32170
11	novel	JJ	O	novel	amod	13	SENT_234	32171/32176
12	polycationic	JJ	O	polycationic	amod	13	SENT_234	32177/32189
13	lipid	NN	O	lipid	prep_on	8	SENT_234	32190/32195
14	--	:	O	--		-1	SENT_234	32195/32197
15	ceramide	NN	O	ceramide	nn	16	SENT_234	32197/32205
16	carbamoyl-spermine	NN	O	carbamoyl-spermine	dep	1	SENT_234	32206/32224
17	(	CD	NUMBER	(	num	19	SENT_234	32225/32226
18	CCS	NN	O	cc	nn	19	SENT_234	32226/32229
19	)	NN	O	)	dep	16	SENT_234	32229/32230
20	.	.	O	.		-1	SENT_234	32230/32231

1	I.	NN	O	i.	nn	2	SENT_235	32232/32234
2	Immunogenicity	NN	O	immunogenicity		-1	SENT_235	32235/32249
3	and	CC	O	and		-1	SENT_235	32250/32253
4	efficacy	NN	O	efficacy	nn	5	SENT_235	32254/32262
5	studies	NNS	O	study	conj_and	2	SENT_235	32263/32270
6	in	IN	O	in		-1	SENT_235	32271/32273
7	miceVaccine200624183990400610	NN	O	micevaccine200624183990400610	prep_in	2	SENT_235	32274/32303
8	.1016	CD	NUMBER	.1016	num	7	SENT_235	32303/32308
9	/	:	O	/	punct	12	SENT_235	32308/32309
10	j.	NN	O	j.	nn	12	SENT_235	32309/32311
11	va	NN	O	va	nn	12	SENT_235	32311/32313
12	ccine	NN	O	ccine	dep	7	SENT_235	32314/32319
13	.2005.12.0171651635625	CD	NUMBER	.2005.12.0171651635625	dep	12	SENT_235	32319/32341
14	.	.	O	.		-1	SENT_235	32341/32342

1	HaanLVerweijWRHoltropMBrandsRvan	NNP	O	HaanLVerweijWRHoltropMBrandsRvan	nn	2	SENT_236	32342/32374
2	ScharrenburgGJPalacheAMNasal	NNP	O	ScharrenburgGJPalacheAMNasal	nsubj	20	SENT_236	32375/32403
3	or	CC	O	or		-1	SENT_236	32404/32406
4	intramuscular	JJ	O	intramuscular	amod	5	SENT_236	32407/32420
5	immunization	NN	O	immunization	conj_or	2	SENT_236	32421/32433
6	of	IN	O	of		-1	SENT_236	32434/32436
7	mice	NNS	O	mouse	prep_of	5	SENT_236	32437/32441
8	with	IN	O	with		-1	SENT_236	32442/32446
9	influenza	NN	O	influenza	nn	11	SENT_236	32447/32456
10	subunit	NN	O	subunit	nn	11	SENT_236	32457/32464
11	antigen	NN	O	antigen	prep_with	7	SENT_236	32465/32472
12	and	CC	O	and		-1	SENT_236	32473/32476
13	the	DT	O	the	det	15	SENT_236	32477/32480
14	B	NN	O	b	nn	15	SENT_236	32481/32482
15	subunit	NN	O	subunit	conj_and	7	SENT_236	32483/32490
16	of	IN	O	of		-1	SENT_236	32491/32493
17	Escherichia	FW	LOCATION	escherichia	nn	18	SENT_236	32494/32505
18	coli	FW	O	coli	prep_of	15	SENT_236	32506/32510
19	heat-labile	JJ	O	heat-labile	amod	20	SENT_236	32511/32522
20	toxin	NN	O	toxin		-1	SENT_236	32523/32528
21	induces	VBZ	O	induce	rcmod	20	SENT_236	32529/32536
22	IgA	NN	O	iga	dobj	21	SENT_236	32537/32540
23	-	:	O	-		-1	SENT_236	32540/32541
24	or	CC	O	or		-1	SENT_236	32542/32544
25	IgG-mediated	JJ	O	igg-mediated	amod	28	SENT_236	32545/32557
26	protective	JJ	O	protective	amod	28	SENT_236	32558/32568
27	mucosal	JJ	O	mucosal	amod	28	SENT_236	32569/32576
28	immunityVaccine20011920-22289890710	NN	O	immunityvaccine20011920-22289890710	conj_or	22	SENT_236	32577/32612
29	.1016	CD	NUMBER	.1016	dep	28	SENT_236	32612/32617
30	/	:	O	/	punct	31	SENT_236	32617/32618
31	S0264-410X	NN	O	s0264-410x	dep	20	SENT_236	32618/32628
32	(	CD	NUMBER	(	number	33	SENT_236	32628/32629
33	00	CD	NUMBER	00	dep	31	SENT_236	32629/32631
34	)	NN	O	)	dep	33	SENT_236	32631/32632
35	00556-91128220126	CD	NUMBER	00556-91128220126	num	34	SENT_236	32632/32649
36	.	.	O	.		-1	SENT_236	32650/32651

1	PlanteMJonesTAllardFTorossianKGauthierJSt-FelixNNasal	JJ	O	plantemjonestallardftorossiankgauthierjst-felixnnasal	amod	2	SENT_237	32651/32704
2	immunization	NN	O	immunization	nsubj	8	SENT_237	32705/32717
3	with	IN	O	with		-1	SENT_237	32718/32722
4	subunit	NN	O	subunit	nn	7	SENT_237	32723/32730
5	proteosome	NN	O	proteosome	nn	7	SENT_237	32731/32741
6	influenza	NN	O	influenza	nn	7	SENT_237	32742/32751
7	vaccines	NNS	O	vaccine	prep_with	2	SENT_237	32752/32760
8	induces	VBZ	O	induce		-1	SENT_237	32761/32768
9	serum	NN	O	serum	nn	10	SENT_237	32769/32774
10	HAI	NN	O	haus	dobj	8	SENT_237	32775/32778
11	,	,	O	,		-1	SENT_237	32778/32779
12	mucosal	JJ	O	mucosal	amod	13	SENT_237	32780/32787
13	IgA	NN	O	iga	conj_and	10	SENT_237	32788/32791
14	and	CC	O	and		-1	SENT_237	32792/32795
15	protection	NN	O	protection	conj_and	10	SENT_237	32796/32806
16	against	IN	O	against	prep	15	SENT_237	32807/32814
17	influenza	NN	O	influenza	nn	18	SENT_237	32815/32824
18	challengeVaccine2001201-22182510	NN	O	challengevaccine2001201-22182510	dep	16	SENT_237	32825/32857
19	.1016	CD	NUMBER	.1016	dep	18	SENT_237	32857/32862
20	/	:	O	/	punct	18	SENT_237	32862/32863
21	S0264-410X	NN	O	s0264-410x	dep	18	SENT_237	32863/32873
22	(	CD	NUMBER	(	number	23	SENT_237	32873/32874
23	01	CD	NUMBER	01	num	24	SENT_237	32875/32877
24	)	NN	O	)	dep	21	SENT_237	32877/32878
25	00268-71156776727	CD	NUMBER	00268-71156776727	dep	15	SENT_237	32878/32895
26	.	.	O	.		-1	SENT_237	32895/32896

1	FujihashiKKogaTvan	NNP	O	FujihashiKKogaTvan	nn	3	SENT_238	32896/32914
2	GinkelFWHagiwaraYMcGheeJRA	NNP	O	GinkelFWHagiwaraYMcGheeJRA	nn	3	SENT_238	32915/32941
3	dilemma	NN	O	dilemma		-1	SENT_238	32942/32949
4	for	IN	O	for		-1	SENT_238	32950/32953
5	mucosal	JJ	O	mucosal	amod	6	SENT_238	32954/32961
6	vaccination	NN	O	vaccination	prep_for	3	SENT_238	32962/32973
7	:	:	O	:		-1	SENT_238	32973/32974
8	efficacy	NN	O	efficacy	dep	3	SENT_238	32975/32983
9	versus	CC	O	versus	prep	8	SENT_238	32984/32990
10	toxicity	NN	O	toxicity	dep	9	SENT_238	32991/32999
11	using	VBG	O	use	partmod	10	SENT_238	33000/33005
12	enterotoxin-based	JJ	O	enterotoxin-based	amod	14	SENT_238	33006/33023
13	adjuvant	JJ	O	adjuvant	amod	14	SENT_238	33024/33032
14	sVaccine20022019-202431810	NN	O	svaccine20022019-202431810	dobj	11	SENT_238	33033/33059
15	.1016	CD	NUMBER	.1016	num	14	SENT_238	33059/33064
16	/	:	O	/	punct	17	SENT_238	33064/33065
17	S0264-410X	NN	O	s0264-410x	dep	14	SENT_238	33065/33075
18	(	CD	NUMBER	(	number	19	SENT_238	33075/33076
19	02	CD	NUMBER	02	dep	17	SENT_238	33076/33078
20	)	NN	O	)	nn	21	SENT_238	33078/33079
21	00155-X1205759728	NN	O	00155-x1205759728	dep	19	SENT_238	33079/33096
22	.	.	O	.		-1	SENT_238	33096/33097

1	MutschMZhouWRh	NN	O	mutschmzhouwrh	nn	2	SENT_239	33097/33111
2	odesPBoppMChenRTLinderTUse	NN	O	odespboppmchenrtlindertuse		-1	SENT_239	33112/33138
3	of	IN	O	of		-1	SENT_239	33139/33141
4	the	DT	O	the	det	23	SENT_239	33142/33145
5	inactivated	VBN	O	inactivate	dep	23	SENT_239	33146/33157
6	intranasal	JJ	O	intranasal	amod	8	SENT_239	33158/33168
7	influenza	NN	O	influenza	nn	8	SENT_239	33169/33178
8	vaccine	NN	O	vaccine	dobj	5	SENT_239	33179/33186
9	and	CC	O	and		-1	SENT_239	33187/33190
10	the	DT	O	the	det	11	SENT_239	33191/33194
11	risk	NN	O	risk	conj_and	8	SENT_239	33195/33199
12	of	IN	O	of	prep	11	SENT_239	33200/33202
13	Bell	NNP	PERSON	Bell	poss	15	SENT_239	33203/33207
14	's	POS	O	's		-1	SENT_239	33207/33209
15	palsy	NN	O	palsy	npadvmod	21	SENT_239	33210/33215
16	in	IN	O	in		-1	SENT_239	33216/33218
17	SwitzerlandN	NN	O	switzerlandn	nn	20	SENT_239	33219/33231
18	Engl	NN	O	engl	nn	20	SENT_239	33232/33236
19	J	NN	O	j	nn	20	SENT_239	33237/33238
20	Med2004350989690310	NN	O	med2004350989690310	prep_in	21	SENT_239	33239/33258
21	.1056	CD	NUMBER	.1056	dep	12	SENT_239	33258/33263
22	/	:	O	/	punct	21	SENT_239	33263/33264
23	NEJMoa0305951498548729	NN	O	nejmoa0305951498548729	prep_of	2	SENT_239	33264/33286
24	.	.	O	.		-1	SENT_239	33286/33287

1	Van	NNP	O	Van	nn	5	SENT_240	33287/33290
2	RoosmalenMLKanningaREl	NNP	O	RoosmalenMLKanningaREl	nn	5	SENT_240	33291/33313
3	KhattabiMNeefJAudouySBosmaTMucosal	NNP	O	KhattabiMNeefJAudouySBosmaTMucosal	nn	5	SENT_240	33314/33348
4	vaccine	NN	O	vaccine	nn	5	SENT_240	33349/33356
5	delivery	NN	O	delivery		-1	SENT_240	33357/33365
6	of	IN	O	of		-1	SENT_240	33366/33368
7	antigens	NNS	O	antigen	prep_of	5	SENT_240	33369/33377
8	tightly	RB	O	tightly	advmod	9	SENT_240	33378/33385
9	bound	VBN	O	bind	amod	7	SENT_240	33386/33391
10	to	TO	O	to		-1	SENT_240	33392/33394
11	an	DT	O	a	det	13	SENT_240	33395/33397
12	adjuvant	JJ	O	adjuvant	amod	13	SENT_240	33398/33406
13	particle	NN	O	particle	prep_to	5	SENT_240	33407/33415
14	made	VBN	O	make	partmod	5	SENT_240	33416/33420
15	from	IN	O	from		-1	SENT_240	33421/33425
16	food-grade	JJ	O	food-grade	amod	17	SENT_240	33426/33436
17	bacteriaMethods2006382144910	NN	O	bacteriamethods2006382144910	prep_from	14	SENT_240	33437/33465
18	.1016	CD	NUMBER	.1016	num	17	SENT_240	33465/33470
19	/	:	O	/	punct	21	SENT_240	33471/33472
20	j.	NN	O	j.	nn	21	SENT_240	33472/33474
21	ymeth	NN	O	ymeth	dep	17	SENT_240	33474/33479
22	.2005.09.0151641427230	CD	NUMBER	.2005.09.0151641427230	dep	21	SENT_240	33479/33501
23	.	.	O	.		-1	SENT_240	33501/33502

1	BosmaTKanningaRNeefJAudouySAvan	NNP	O	BosmaTKanningaRNeefJAudouySAvan	nn	2	SENT_241	33502/33533
2	RoosmalenMLSteenANovel	NNP	O	RoosmalenMLSteenANovel	nsubj	5	SENT_241	33534/33556
3	surface	NN	O	surface	nn	5	SENT_241	33557/33564
4	display	NN	O	display	nn	5	SENT_241	33565/33572
5	system	NN	O	system		-1	SENT_241	33573/33579
6	for	IN	O	for		-1	SENT_241	33580/33583
7	proteins	NNS	O	protein	prep_for	5	SENT_241	33584/33592
8	on	IN	O	on	prep	7	SENT_241	33593/33595
9	non-genetically	RB	O	non-genetically	pcomp	8	SENT_241	33596/33611
10	modified	VBN	O	modify	partmod	5	SENT_241	33612/33620
11	gram-positive	JJ	O	gram-positive	amod	14	SENT_241	33621/33634
12	bacteriaAppl	NN	O	bacteriaappl	nn	14	SENT_241	33635/33647
13	Environ	NN	O	environ	nn	14	SENT_241	33648/33655
14	Microbiol2006721880910	NN	O	microbiol2006721880910	dobj	10	SENT_241	33656/33678
15	.1128	CD	NUMBER	.1128	num	14	SENT_241	33678/33683
16	/	:	O	/	punct	17	SENT_241	33683/33684
17	AEM.72.1.880-889	CD	NUMBER	aem.72.1.880-889	dep	5	SENT_241	33684/33700
18	.20061639113031	CD	NUMBER	.20061639113031	dep	17	SENT_241	33700/33715
19	.	.	O	.		-1	SENT_241	33715/33716

1	AudouySAvan	NNP	O	AudouySAvan	nn	6	SENT_242	33716/33727
2	RoosmalenMLNeefJKanningaRPostEvan	NNP	O	RoosmalenMLNeefJKanningaRPostEvan	nn	6	SENT_242	33728/33761
3	DeemterMLactococcus	NNP	O	DeemterMLactococcus	nn	6	SENT_242	33762/33781
4	lactis	NN	O	lacti	nn	6	SENT_242	33782/33788
5	GEM	NN	O	gem	nn	6	SENT_242	33789/33792
6	particles	NNS	O	particle	nsubj	10	SENT_242	33793/33802
7	displaying	VBG	O	display	partmod	6	SENT_242	33803/33813
8	pneumococcal	JJ	O	pneumococcal	amod	9	SENT_242	33814/33826
9	antigens	NNS	O	antigen	dobj	7	SENT_242	33827/33835
10	induce	VBP	O	induce		-1	SENT_242	33836/33842
11	local	JJ	O	local	amod	15	SENT_242	33843/33848
12	and	CC	O	and		-1	SENT_242	33849/33852
13	systemic	JJ	O	systemic	conj_and	11	SENT_242	33853/33861
14	immune	JJ	O	immune	amod	15	SENT_242	33862/33868
15	responses	NNS	O	response	dobj	10	SENT_242	33869/33878
16	following	VBG	O	follow		-1	SENT_242	33879/33888
17	intranasal	JJ	O	intranasal	amod	18	SENT_242	33889/33899
18	immunizationVaccine2006242654344110	NN	O	immunizationvaccine2006242654344110	prep_following	15	SENT_242	33900/33935
19	.1016	CD	NUMBER	.1016	num	18	SENT_242	33935/33940
20	/	:	O	/	punct	22	SENT_242	33940/33941
21	j.	NN	O	j.	nn	22	SENT_242	33941/33943
22	vaccine	NN	O	vaccine	dep	18	SENT_242	33943/33950
23	.2006.0	CD	NUMBER	.2006.0	num	24	SENT_242	33950/33957
24	3.0541675706832	CD	NUMBER	3.0541675706832	dep	22	SENT_242	33958/33973
25	.	.	O	.		-1	SENT_242	33973/33974

1	AudouySAvan	NNP	O	AudouySAvan	nn	3	SENT_243	33974/33985
2	SelmSvan	NNP	O	SelmSvan	nn	3	SENT_243	33986/33994
3	RoosmalenMLPostEKanningaRNeefJDevelopment	NNP	O	RoosmalenMLPostEKanningaRNeefJDevelopment		-1	SENT_243	33995/34036
4	of	IN	O	of		-1	SENT_243	34037/34039
5	lactococcal	JJ	O	lactococcal	amod	8	SENT_243	34040/34051
6	GEM-based	JJ	O	gem-based	amod	8	SENT_243	34052/34061
7	pneumococcal	JJ	O	pneumococcal	amod	8	SENT_243	34062/34074
8	vaccinesVaccine20072513249750610	NN	O	vaccinesvaccine20072513249750610	prep_of	3	SENT_243	34075/34107
9	.1016	CD	NUMBER	.1016	dep	3	SENT_243	34107/34112
10	/	:	O	/	punct	12	SENT_243	34112/34113
11	j.	NN	O	j.	nn	12	SENT_243	34113/34115
12	vaccine	NN	O	vaccine	dep	9	SENT_243	34116/34123
13	.2006.09.0261708166033	CD	NUMBER	.2006.09.0261708166033	dep	9	SENT_243	34123/34145
14	.	.	O	.		-1	SENT_243	34145/34146

1	RamasamyRYasawardenaSZomerAVenemaGKokJLeenhoutsK	NN	O	ramasamyryasawardenaszomeravenemagkokjleenhoutsk	nn	2	SENT_244	34146/34194
2	Immunogenicity	NN	O	immunogenicity	nsubj	8	SENT_244	34195/34209
3	of	IN	O	of		-1	SENT_244	34210/34212
4	a	DT	O	a	det	7	SENT_244	34213/34214
5	malaria	NN	O	malaria	nn	7	SENT_244	34215/34222
6	parasite	NN	O	parasite	nn	7	SENT_244	34223/34231
7	antigen	NN	O	antigen	prep_of	2	SENT_244	34232/34239
8	displayed	VBN	O	display		-1	SENT_244	34240/34249
9	by	IN	O	by		-1	SENT_244	34250/34252
10	Lactococcus	NN	O	lactococcus	nn	11	SENT_244	34253/34264
11	lactis	NN	O	lacti	prep_by	8	SENT_244	34265/34271
12	in	IN	O	in		-1	SENT_244	34272/34274
13	oral	JJ	O	oral	amod	14	SENT_244	34275/34279
14	immunisationsVaccine200624183900810	NN	O	immunisationsvaccine200624183900810	prep_in	11	SENT_244	34280/34315
15	.1016	CD	NUMBER	.1016	num	14	SENT_244	34315/34320
16	/	:	O	/	punct	18	SENT_244	34320/34321
17	j.	NN	O	j.	nn	18	SENT_244	34321/34323
18	vaccine	NN	O	vaccine	dep	14	SENT_244	34323/34330
19	.2006.02.04016545511	CD	NUMBER	.2006.02.04016545511	num	20	SENT_244	34330/34350
20	34	CD	NUMBER	34	dep	18	SENT_244	34351/34353
21	.	.	O	.		-1	SENT_244	34353/34354

1	AmorijJPSalujaVPetersenAHHinrichsWLHuckriedeAFrijlinkHWPulmonary	JJ	O	amorijjpsalujavpetersenahhinrichswlhuckriedeafrijlinkhwpulmonary	amod	2	SENT_245	34354/34418
2	delivery	NN	O	delivery	nsubj	13	SENT_245	34419/34427
3	of	IN	O	of		-1	SENT_245	34428/34430
4	an	DT	O	a	det	8	SENT_245	34431/34433
5	inulin-stabilized	JJ	O	inulin-stabilized	amod	8	SENT_245	34434/34451
6	influenza	NN	O	influenza	nn	8	SENT_245	34452/34461
7	subunit	NN	O	subunit	nn	8	SENT_245	34462/34469
8	vaccine	NN	O	vaccine	prep_of	2	SENT_245	34470/34477
9	prepared	VBN	O	prepare	partmod	8	SENT_245	34478/34486
10	by	IN	O	by		-1	SENT_245	34487/34489
11	spray-freeze	JJ	O	spray-freeze	agent	9	SENT_245	34490/34502
12	drying	VBG	O	dry	partmod	11	SENT_245	34503/34509
13	induces	VBZ	O	induce		-1	SENT_245	34510/34517
14	systemic	JJ	O	systemic	amod	23	SENT_245	34518/34526
15	,	,	O	,		-1	SENT_245	34526/34527
16	mucosal	JJ	O	mucosal	amod	17	SENT_245	34528/34535
17	humoral	JJ	O	humoral	amod	23	SENT_245	34536/34543
18	as	RB	O	as		-1	SENT_245	34544/34546
19	well	RB	O	well		-1	SENT_245	34547/34551
20	as	IN	O	as		-1	SENT_245	34552/34554
21	cell-mediated	JJ	O	cell-mediated	amod	22	SENT_245	34555/34568
22	immune	JJ	O	immune	conj_and	17	SENT_245	34569/34575
23	responses	NNS	O	response	dobj	13	SENT_245	34576/34585
24	in	IN	O	in		-1	SENT_245	34586/34588
25	BALB/c	NN	O	balb/c	nn	26	SENT_245	34589/34595
26	miceVaccine2007255287071710	NN	O	micevaccine2007255287071710	prep_in	23	SENT_245	34596/34623
27	.1016	CD	NUMBER	.1016	num	26	SENT_245	34623/34628
28	/	:	O	/	punct	30	SENT_245	34628/34629
29	j.	NN	O	j.	nn	30	SENT_245	34629/34631
30	vaccine	NN	O	vaccine	dep	23	SENT_245	34631/34638
31	.2007.10.0351799	CD	NUMBER	.2007.10.0351799	num	32	SENT_245	34638/34654
32	699335	CD	NUMBER	699335	dep	30	SENT_245	34655/34661
33	.	.	O	.		-1	SENT_245	34661/34662

1	AmorijJPWestraTAHinrichsWLHuckriedeAFrijlinkHWTowards	NNPS	O	AmorijJPWestraTAHinrichsWLHuckriedeAFrijlinkHWTowards		-1	SENT_246	34662/34715
2	an	DT	O	a	det	5	SENT_246	34716/34718
3	oral	JJ	O	oral	amod	5	SENT_246	34719/34723
4	influenza	NN	O	influenza	nn	5	SENT_246	34724/34733
5	vaccine	NN	O	vaccine	dep	1	SENT_246	34734/34741
6	:	:	O	:		-1	SENT_246	34741/34742
7	comparison	NN	O	comparison	dep	1	SENT_246	34743/34753
8	between	IN	O	between		-1	SENT_246	34754/34761
9	intragastric	JJ	O	intragastric	amod	12	SENT_246	34762/34774
10	and	CC	O	and		-1	SENT_246	34775/34778
11	intracolonic	JJ	O	intracolonic	conj_and	9	SENT_246	34779/34791
12	delivery	NN	O	delivery	prep_between	7	SENT_246	34792/34800
13	of	IN	O	of		-1	SENT_246	34801/34803
14	influenza	NN	O	influenza	nn	16	SENT_246	34804/34813
15	subunit	NN	O	subunit	nn	16	SENT_246	34814/34821
16	vaccine	NN	O	vaccine	prep_of	7	SENT_246	34822/34829
17	in	IN	O	in		-1	SENT_246	34830/34832
18	a	DT	O	a	det	20	SENT_246	34833/34834
19	murine	JJ	O	murine	amod	20	SENT_246	34835/34841
20	modelVaccine2007261677610	NN	O	modelvaccine2007261677610	prep_in	16	SENT_246	34842/34867
21	.1016	CD	NUMBER	.1016	dep	20	SENT_246	34867/34872
22	/	:	O	/	punct	1	SENT_246	34872/34873
23	j.	NN	O	j.	nn	24	SENT_246	34873/34875
24	vaccine	NN	O	vaccine	dep	1	SENT_246	34875/34882
25	.2007.10.0451806131536	CD	NUMBER	.2007.10.0451806131536	dep	24	SENT_246	34882/34904
26	.	.	O	.		-1	SENT_246	34905/34906

1	AmidiMRomeijnSGVerhoefJCJungingerHEBungenerLHuckriedeAN-trimethyl	NN	O	amidimromeijnsgverhoefjcjungingerhebungenerlhuckriedean-trimethyl	nn	2	SENT_247	34906/34971
2	chitosan	NN	O	chitosan	nsubj	4	SENT_247	34972/34980
3	(	CD	NUMBER	(	num	4	SENT_247	34981/34982
4	TMC	NN	ORGANIZATION	tmc		-1	SENT_247	34982/34985
5	)	CD	NUMBER	)	num	6	SENT_247	34985/34986
6	nanoparticles	NNS	O	nanoparticle	dep	7	SENT_247	34987/35000
7	loaded	VBN	O	load	amod	4	SENT_247	35001/35007
8	with	IN	O	with		-1	SENT_247	35008/35012
9	influenza	NN	O	influenza	nn	11	SENT_247	35013/35022
10	subunit	NN	O	subunit	nn	11	SENT_247	35023/35030
11	antigen	NN	O	antigen	prep_with	7	SENT_247	35031/35038
12	for	IN	O	for		-1	SENT_247	35039/35042
13	intranasal	JJ	O	intranasal	amod	14	SENT_247	35043/35053
14	vaccination	NN	O	vaccination	prep_for	11	SENT_247	35054/35065
15	:	:	O	:		-1	SENT_247	35065/35066
16	biological	JJ	O	biological	amod	17	SENT_247	35067/35077
17	properties	NNS	O	property	dep	11	SENT_247	35078/35088
18	and	CC	O	and		-1	SENT_247	35089/35092
19	immunogenicity	NN	O	immunogenicity	conj_and	17	SENT_247	35093/35107
20	in	IN	O	in		-1	SENT_247	35108/35110
21	a	DT	O	a	det	23	SENT_247	35111/35112
22	mouse	NN	O	mouse	nn	23	SENT_247	35113/35118
23	modelVaccine2	NN	O	modelvaccine2	prep_in	19	SENT_247	35119/35132
24	0072511445310.1016	CD	NUMBER	0072511445310.1016	dep	19	SENT_247	35133/35151
25	/	:	O	/	punct	27	SENT_247	35151/35152
26	j.	NN	O	j.	nn	27	SENT_247	35152/35154
27	vaccine	NN	O	vaccine	dep	4	SENT_247	35154/35161
28	.2006.06.0861697324837	CD	NUMBER	.2006.06.0861697324837	dep	27	SENT_247	35161/35183
29	.	.	O	.		-1	SENT_247	35183/35184

1	SandersMTDeliyannisGPearseM	NN	O	sandersmtdeliyannisgpearsem	nn	5	SENT_248	35184/35211
2	JMcNamaraMKBrownLESingle	NN	O	jmcnamaramkbrownlesingle	nn	5	SENT_248	35212/35236
3	dose	NN	O	dose	nn	5	SENT_248	35237/35241
4	intranasal	JJ	O	intranasal	amod	5	SENT_248	35242/35252
5	immunization	NN	O	immunization	nsubj	16	SENT_248	35253/35265
6	with	IN	O	with		-1	SENT_248	35266/35270
7	ISCOMATRIX	NN	O	iscomatrix	nn	8	SENT_248	35271/35281
8	vaccines	NNS	O	vaccine	prep_with	5	SENT_248	35282/35290
9	to	TO	O	to	aux	10	SENT_248	35291/35293
10	elicit	VB	O	elicit	infmod	5	SENT_248	35294/35300
11	antibody-mediated	JJ	O	antibody-mediated	amod	12	SENT_248	35301/35318
12	clearance	NN	O	clearance	dobj	10	SENT_248	35319/35328
13	of	IN	O	of		-1	SENT_248	35329/35331
14	influenza	NN	O	influenza	nn	15	SENT_248	35332/35341
15	virus	NN	O	virus	prep_of	12	SENT_248	35342/35347
16	requires	VBZ	O	require		-1	SENT_248	35348/35356
17	delivery	NN	O	delivery	dobj	16	SENT_248	35357/35365
18	to	TO	O	to		-1	SENT_248	35366/35368
19	the	DT	O	the	det	22	SENT_248	35369/35372
20	lower	JJR	O	lower	amod	22	SENT_248	35373/35378
21	respiratory	JJ	O	respiratory	amod	22	SENT_248	35379/35390
22	tractVaccine2009271824758210	NN	O	tractvaccine2009271824758210	prep_to	23	SENT_248	35391/35419
23	.1016	CD	NUMBER	.1016	dep	16	SENT_248	35419/35424
24	/	:	O	/	punct	23	SENT_248	35424/35425
25	j.	NN	O	j.	nn	26	SENT_248	35425/35427
26	vaccine	NN	O	vaccine	dep	23	SENT_248	35427/35434
27	.2009.02.0541	CD	NUMBER	.2009.02.0541	num	28	SENT_248	35434/35447
28	936878938	CD	NUMBER	936878938	dep	26	SENT_248	35448/35457
29	.	.	O	.		-1	SENT_248	35457/35458

1	HagenaarsNMastrobattistaEGlansbeekHHeldensJvan	NNP	O	HagenaarsNMastrobattistaEGlansbeekHHeldensJvan	nn	3	SENT_249	35458/35504
2	den	NN	O	den	nn	3	SENT_249	35505/35508
3	BoschHSchijnsVHead-to-head	NNP	O	BoschHSchijnsVHead-to-head	nn	4	SENT_249	35509/35535
4	comparison	NN	O	comparison	nsubj	8	SENT_249	35536/35546
5	of	IN	O	of		-1	SENT_249	35547/35549
6	four	CD	NUMBER	four	prep_of	4	SENT_249	35550/35554
7	nonadjuvanted	JJ	O	nonadjuvanted	amod	6	SENT_249	35555/35568
8	inactivated	VBN	O	inactivate		-1	SENT_249	35569/35580
9	cell	NN	O	cell	nn	12	SENT_249	35581/35585
10	culture-derived	JJ	O	culture-derived	amod	12	SENT_249	35586/35601
11	influenza	NN	O	influenza	nn	12	SENT_249	35602/35611
12	vaccines	NNS	O	vaccine	dobj	8	SENT_249	35612/35620
13	:	:	O	:		-1	SENT_249	35620/35621
14	effect	NN	O	effect	dep	8	SENT_249	35622/35628
15	of	IN	O	of		-1	SENT_249	35629/35631
16	composition	NN	O	composition	prep_of	14	SENT_249	35632/35643
17	,	,	O	,		-1	SENT_249	35643/35644
18	spatial	JJ	O	spatial	amod	19	SENT_249	35645/35652
19	organization	NN	O	organization	conj_and	16	SENT_249	35653/35665
20	and	CC	O	and		-1	SENT_249	35666/35669
21	immunization	NN	O	immunization	nn	22	SENT_249	35670/35682
22	route	NN	O	route	conj_and	16	SENT_249	35683/35688
23	on	IN	O	on		-1	SENT_249	35689/35691
24	the	DT	O	the	det	25	SENT_249	35692/35695
25	immunogenicity	NN	O	immunogenicity	prep_on	14	SENT_249	35696/35710
26	in	IN	O	in		-1	SENT_249	35711/35713
27	a	DT	O	a	det	30	SENT_249	35714/35715
28	murine	JJ	O	murine	amod	30	SENT_249	35716/35722
29	challenge	NN	O	challenge	nn	30	SENT_249	35723/35732
30	modelVaccine2008265165556310	NN	O	modelvaccine2008265165556310	prep_in	14	SENT_249	35733/35761
31	.1016	CD	NUMBER	.1016	dep	30	SENT_249	35761/35766
32	/	:	O	/	punct	14	SENT_249	35766/35767
33	j.	NN	O	j.	nn	34	SENT_249	35767/35769
34	vaccine	NN	O	vaccine	dep	14	SENT_249	35769/35776
35	.2008.09.0571884885639	CD	NUMBER	.2008.09.0571884885639	dep	34	SENT_249	35776/35798
36	.	.	O	.		-1	SENT_249	35799/35800

1	CouckeDSchotsaertMLibertCPringelsEVervaetCForemanPSpray-dried	JJ	O	couckedschotsaertmlibertcpringelsevervaetcforemanpspray-dried	amod	2	SENT_250	35800/35861
2	powders	NNS	O	powder		-1	SENT_250	35862/35869
3	of	IN	O	of	dep	2	SENT_250	35870/35872
4	starch	NN	O	starch	pobj	3	SENT_250	35873/35879
5	and	CC	O	and		-1	SENT_250	35880/35883
6	crosslinked	VBN	O	crosslink	conj_and	3	SENT_250	35884/35895
7	poly	NN	O	poly	nn	8	SENT_250	35896/35900
8	(	NN	O	(	dobj	6	SENT_250	35900/35901
9	acrylic	JJ	O	acrylic	amod	10	SENT_250	35901/35908
10	acid	NN	O	acid	dep	2	SENT_250	35909/35913
11	)	RB	O	)	advmod	10	SENT_250	35913/35914
12	as	IN	O	as		-1	SENT_250	35915/35917
13	carriers	NNS	O	carrier	prep_as	10	SENT_250	35918/35926
14	for	IN	O	for		-1	SENT_250	35927/35930
15	nasal	JJ	O	nasal	amod	16	SENT_250	35931/35936
16	delivery	NN	O	delivery	prep_for	13	SENT_250	35937/35945
17	of	IN	O	of		-1	SENT_250	35946/35948
18	inactivated	VBN	O	inactivate	prepc_of	16	SENT_250	35949/35960
19	influenza	NN	O	influenza	nn	20	SENT_250	35961/35970
20	vaccineVaccine200927812798610	NN	O	vaccinevaccine200927812798610	dobj	18	SENT_250	35971/36000
21	.1016	CD	NUMBER	.1016	num	20	SENT_250	36000/36005
22	/	:	O	/	punct	24	SENT_250	36005/36006
23	j.	NN	O	j.	nn	24	SENT_250	36006/36008
24	vaccine	NN	O	vaccine	dep	13	SENT_250	36008/36015
25	.2008.12.0131911407540	CD	NUMBER	.2008.12.0131911407540	dep	24	SENT_250	36015/36037
26	.	.	O	.		-1	SENT_250	36037/36038

1	VerweijWRde	NNP	O	VerweijWRde	nn	3	SENT_251	36038/36049
2	HaanLHoltropMAgsteribbeEBrandsRvan	NNP	O	HaanLHoltropMAgsteribbeEBrandsRvan	nn	3	SENT_251	36050/36084
3	ScharrenburgGJMucosal	NNP	O	ScharrenburgGJMucosal		-1	SENT_251	36085/36106
4	immunoadjuvant	JJ	O	immunoadjuvant	amod	5	SENT_251	36107/36121
5	activity	NN	O	activity	dep	3	SENT_251	36122/36130
6	of	IN	O	of		-1	SENT_251	36131/36133
7	recombinant	JJ	O	recombinant	prep_of	5	SENT_251	36134/36145
8	Escherichia	FW	O	escherichia	nn	11	SENT_251	36146/36157
9	coli	FW	O	coli	nn	11	SENT_251	36158/36162
10	heat-labile	JJ	O	heat-labile	amod	11	SENT_251	36163/36174
11	enterotoxin	NN	O	enterotoxin	dep	3	SENT_251	36175/36186
12	and	CC	O	and		-1	SENT_251	36187/36190
13	its	PRP$	O	its	poss	15	SENT_251	36191/36194
14	B	NN	O	b	nn	15	SENT_251	36195/36196
15	subunit	NN	O	subunit	conj_and	11	SENT_251	36197/36204
16	:	:	O	:		-1	SENT_251	36204/36205
17	induction	NN	O	induction	dep	11	SENT_251	36206/36215
18	of	IN	O	of		-1	SENT_251	36216/36218
19	systemic	JJ	O	systemic	amod	20	SENT_251	36219/36227
20	IgG	NN	O	igg	prep_of	17	SENT_251	36228/36231
21	and	CC	O	and		-1	SENT_251	36232/36235
22	secretory	JJ	O	secretory	amod	24	SENT_251	36236/36245
23	IgA	NN	O	iga	nn	24	SENT_251	36246/36249
24	responses	NNS	O	response	conj_and	20	SENT_251	36250/36259
25	in	IN	O	in		-1	SENT_251	36260/36262
26	mice	NNS	O	mouse	prep_in	20	SENT_251	36263/36267
27	by	IN	O	by		-1	SENT_251	36268/36270
28	intranasal	JJ	O	intranasal	amod	29	SENT_251	36271/36281
29	immunization	NN	O	immunization	prep_by	26	SENT_251	36282/36294
30	with	IN	O	with	prep	26	SENT_251	36295/36299
31	influenza	NN	O	influenza	nn	33	SENT_251	36300/36309
32	virus	NN	O	virus	nn	33	SENT_251	36310/36315
33	surface	NN	O	surface	dep	30	SENT_251	36316/36323
34	antigenVaccine1998162020697610	NN	O	antigenvaccine1998162020697610	dep	33	SENT_251	36324/36354
35	.1016	CD	NUMBER	.1016	num	34	SENT_251	36354/36359
36	/	:	O	/	punct	33	SENT_251	36359/36360
37	S0264-410X	NN	O	s0264-410x	dep	33	SENT_251	36360/36370
38	(	CD	NUMBER	(	number	39	SENT_251	36370/36371
39	98	CD	NUMBER	98	num	40	SENT_251	36371/36373
40	)	NN	O	)	dep	37	SENT_251	36373/36374
41	00076-0979606641	CD	NUMBER	00076-0979606641	dep	17	SENT_251	36374/36390
42	.	.	O	.		-1	SENT_251	36390/36391

1	The	DT	O	the	det	3	SENT_252	36391/36394
2	European	JJ	O	european	amod	3	SENT_252	36395/36403
3	Agency	NNP	O	Agency		-1	SENT_252	36404/36410
4	for	IN	O	for		-1	SENT_252	36411/36414
5	the	DT	O	the	det	6	SENT_252	36415/36418
6	Evaluation	NN	ORGANIZATION	evaluation	prep_for	3	SENT_252	36419/36429
7	of	IN	ORGANIZATION	of		-1	SENT_252	36430/36432
8	Medicinal	NNP	ORGANIZATION	Medicinal	nn	9	SENT_252	36433/36442
9	Products	NNPS	ORGANIZATION	Products	prep_of	6	SENT_252	36443/36451
10	(	CD	NUMBER	(	dep	3	SENT_252	36452/36453
11	EMEA	NN	ORGANIZATION	emea	nn	13	SENT_252	36453/36457
12	)	CD	NUMBER	)	num	13	SENT_252	36457/36458
13	Committee	NNP	ORGANIZATION	Committee	dep	10	SENT_252	36459/36468
14	for	IN	ORGANIZATION	for		-1	SENT_252	36469/36472
15	Proprietary	NNP	ORGANIZATION	Proprietary	nn	17	SENT_252	36473/36484
16	Medicinal	NNP	ORGANIZATION	Medicinal	nn	17	SENT_252	36485/36494
17	Products	NNPS	ORGANIZATION	Products	prep_for	13	SENT_252	36495/36503
18	(	CD	NUMBER	(	num	20	SENT_252	36504/36505
19	CPMP	NN	ORGANIZATION	cpmp	nn	20	SENT_252	36505/36509
20	)	NN	O	)	dep	13	SENT_252	36509/36510
21	.	.	O	.		-1	SENT_252	36510/36511

1	Note	VB	O	note		-1	SENT_253	36512/36516
2	for	IN	O	for		-1	SENT_253	36517/36520
3	guidance	NN	O	guidance	prep_for	1	SENT_253	36521/36529
4	on	IN	O	on		-1	SENT_253	36530/36532
5	harmonization	NN	O	harmonization	prep_on	1	SENT_253	36533/36546
6	of	IN	O	of		-1	SENT_253	36547/36549
7	requirements	NNS	O	requirement	prep_of	5	SENT_253	36550/36562
8	for	IN	O	for		-1	SENT_253	36563/36566
9	influenza	NN	O	influenza	nn	10	SENT_253	36567/36576
10	vaccines	NNS	O	vaccine	prep_for	7	SENT_253	36577/36585
11	.	.	O	.		-1	SENT_253	36585/36586

1	CPMP/BWP/214	NN	O	cpmp/bwp/214		-1	SENT_254	36587/36599
2	/	:	O	/	punct	3	SENT_254	36599/36600
3	96	CD	NUMBER	96	dep	1	SENT_254	36600/36602
4	,	,	O	,		-1	SENT_254	36602/36603
5	London	NNP	LOCATION	London	nn	7	SENT_254	36604/36610
6	,	,	O	,		-1	SENT_254	36610/36611
7	March	NNP	DATE	March	appos	3	SENT_254	36612/36617
8	12	CD	DATE	12	num	7	SENT_254	36618/36620
9	,	,	O	,		-1	SENT_254	36620/36621
10	1997.42	CD	NUMBER	1997.42	num	7	SENT_254	36622/36629
11	.	.	O	.		-1	SENT_254	36629/36630

1	HolmgrenJCzerkinskyCMucosal	JJ	O	holmgrenjczerkinskycmucosal	amod	2	SENT_255	36630/36657
2	immunity	NN	O	immunity		-1	SENT_255	36658/36666
3	and	CC	O	and		-1	SENT_255	36667/36670
4	vaccinesNat	NN	O	vaccinesnat	nn	6	SENT_255	36671/36682
5	Med2005114	NN	O	med2005114	nn	6	SENT_255	36683/36693
6	SupplS455310	NN	O	suppls455310	conj_and	2	SENT_255	36694/36706
7	.1038	CD	NUMBER	.1038	dep	2	SENT_255	36706/36711
8	/	:	O	/	punct	9	SENT_255	36711/36712
9	nm12131581248943	CD	NUMBER	nm12131581248943	dep	7	SENT_255	36712/36728
10	.	.	O	.		-1	SENT_255	36728/36729

1	BienenstockJMcDermottMRBronchus	NNP	O	BienenstockJMcDermottMRBronchus	nsubj	6	SENT_256	36729/36760
2	-	:	O	-		-1	SENT_256	36760/36761
3	and	CC	O	and	cc	4	SENT_256	36762/36765
4	nasal	JJ	O	nasal	dep	1	SENT_256	36766/36771
5	-	:	O	-		-1	SENT_256	36771/36772
6	associated	VBN	O	associate		-1	SENT_256	36773/36783
7	lymphoid	JJ	O	lymphoid	amod	9	SENT_256	36784/36792
8	tissuesImmunol	NN	O	tissuesimmunol	nn	9	SENT_256	36793/36807
9	Rev2005206223110	NN	O	rev2005206223110	nsubj	10	SENT_256	36808/36824
10	.1111	CD	NUMBER	.1111	xcomp	6	SENT_256	36824/36829
11	/	:	O	/	punct	12	SENT_256	36829/36830
12	j.0105-2896	CD	DURATION	j.0105-2896	dep	10	SENT_256	36830/36841
13	.2005.0029	CD	NUMBER	.2005.0029	num	14	SENT_256	36841/36851
14	9	CD	NUMBER	9	dep	12	SENT_256	36852/36853
15	.	.	O	.		-1	SENT_256	36853/36854

1	x1604854044	NN	O	x1604854044		-1	SENT_257	36854/36865
2	.	.	O	.		-1	SENT_257	36865/36866

1	BungenerLGeeraedtsFTer	NNP	O	BungenerLGeeraedtsFTer	nn	2	SENT_258	36866/36888
2	VeerWMedemaJWilschutJHuckriedeAAlum	NNP	O	VeerWMedemaJWilschutJHuckriedeAAlum	nsubj	3	SENT_258	36889/36924
3	boosts	VBZ	O	boost		-1	SENT_258	36925/36931
4	TH2-type	JJ	O	th2-type	amod	6	SENT_258	36932/36940
5	antibody	NN	O	antibody	nn	6	SENT_258	36941/36949
6	responses	NNS	O	response	dobj	3	SENT_258	36950/36959
7	to	TO	O	to		-1	SENT_258	36960/36962
8	whole-inactivated	JJ	O	whole-inactivated	amod	11	SENT_258	36963/36980
9	virus	NN	O	virus	nn	11	SENT_258	36981/36986
10	influenza	NN	O	influenza	nn	11	SENT_258	36987/36996
11	vaccine	NN	O	vaccine	prep_to	3	SENT_258	36997/37004
12	in	IN	O	in		-1	SENT_258	37005/37007
13	mice	NNS	O	mouse	prep_in	11	SENT_258	37008/37012
14	but	CC	O	but		-1	SENT_258	37013/37016
15	does	VBZ	O	do	aux	17	SENT_258	37017/37021
16	not	RB	O	not	neg	17	SENT_258	37022/37025
17	confer	VB	O	confer	conj_but	3	SENT_258	37026/37032
18	superior	JJ	O	superior	amod	19	SENT_258	37033/37041
19	protectionVaccine200826192350910	NN	O	protectionvaccine200826192350910	dobj	17	SENT_258	37042/37074
20	.	.	O	.		-1	SENT_258	37074/37075

1	1016/j	NN	O	1016/j		-1	SENT_259	37076/37082
2	.	.	O	.		-1	SENT_259	37082/37083

1	vaccine	NN	O	vaccine		-1	SENT_260	37083/37090
2	.2008.02.0631840034045	CD	NUMBER	.2008.02.0631840034045	dep	1	SENT_260	37090/37112
3	.	.	O	.		-1	SENT_260	37112/37113

1	GeeraedtsFBungenerLPoolJter	NNP	O	GeeraedtsFBungenerLPoolJter	nn	2	SENT_261	37113/37140
2	VeerWWilschutJHuckriedeAWhole	NNP	O	VeerWWilschutJHuckriedeAWhole	nsubj	3	SENT_261	37141/37170
3	inactivated	VBD	O	inactivate		-1	SENT_261	37171/37182
4	virus	NN	O	virus	nn	6	SENT_261	37183/37188
5	influenza	NN	O	influenza	nn	6	SENT_261	37189/37198
6	vaccine	NN	O	vaccine	nsubj	8	SENT_261	37199/37206
7	is	VBZ	O	be	cop	8	SENT_261	37207/37209
8	superior	JJ	O	superior	ccomp	3	SENT_261	37210/37218
9	to	TO	O	to		-1	SENT_261	37219/37221
10	subunit	NN	O	subunit	nn	11	SENT_261	37222/37229
11	vaccine	NN	O	vaccine	prep_to	8	SENT_261	37230/37237
12	in	IN	O	in		-1	SENT_261	37238/37240
13	inducing	VBG	O	induce	prepc_in	11	SENT_261	37241/37249
14	immune	JJ	O	immune	amod	15	SENT_261	37250/37256
15	responses	NNS	O	response	dobj	13	SENT_261	37257/37266
16	and	CC	O	and		-1	SENT_261	37267/37270
17	secretion	NN	O	secretion	conj_and	15	SENT_261	37271/37280
18	of	IN	O	of	prep	15	SENT_261	37281/37283
19	proinflammatory	JJ	O	proinflammatory	amod	20	SENT_261	37284/37299
20	cytokines	NNS	O	cytokine	dep	25	SENT_261	37300/37309
21	by	IN	O	by		-1	SENT_261	37310/37312
22	DCsInfluenza	NN	O	dcsinfluenza	prep_by	20	SENT_261	37313/37325
23	Other	JJ	O	other	amod	24	SENT_261	37326/37331
24	Respi	NNP	O	Respi	dep	25	SENT_261	37332/37337
25	Viruses200822415110	NN	O	viruses200822415110	dep	29	SENT_261	37338/37357
26	.1111	CD	NUMBER	.1111	dep	25	SENT_261	37357/37362
27	/	:	O	/	punct	29	SENT_261	37362/37363
28	j.1750-2659	CD	DURATION	j.1750-2659	num	29	SENT_261	37363/37374
29	.2008.00038	CD	NUMBER	.2008.00038	dep	18	SENT_261	37374/37385
30	.	.	O	.		-1	SENT_261	37385/37386

1	x1945347146	NN	O	x1945347146		-1	SENT_262	37386/37397
2	.	.	O	.		-1	SENT_262	37397/37398

1	GuyBThe	NNP	O	GuyBThe		-1	SENT_263	37398/37405
2	perfect	JJ	O	perfect	amod	3	SENT_263	37406/37413
3	mix	NN	O	mix	dep	1	SENT_263	37414/37417
4	:	:	O	:		-1	SENT_263	37417/37418
5	recent	JJ	O	recent	amod	6	SENT_263	37419/37425
6	progress	NN	O	progress	dep	1	SENT_263	37426/37434
7	in	IN	O	in		-1	SENT_263	37435/37437
8	adjuvant	JJ	O	adjuvant	amod	11	SENT_263	37438/37446
9	researchNat	NN	O	researchnat	nn	11	SENT_263	37447/37458
10	Rev	NN	O	rev	nn	11	SENT_263	37459/37462
11	Microbiol2007575051710	NN	O	microbiol2007575051710	prep_in	6	SENT_263	37463/37485
12	.1038	CD	NUMBER	.1038	dep	11	SENT_263	37485/37490
13	/	:	O	/	punct	1	SENT_263	37490/37491
14	nrmicro16811755842647	CD	NUMBER	nrmicro16811755842647	dep	1	SENT_263	37491/37512
15	.	.	O	.		-1	SENT_263	37512/37513

1	HovdenAOCoxRJHaaheimLRWhole	NNP	O	HovdenAOCoxRJHaaheimLRWhole	nn	4	SENT_264	37513/37540
2	influenza	NN	O	influenza	nn	4	SENT_264	37541/37550
3	virus	NN	O	virus	nn	4	SENT_264	37551/37556
4	vaccine	NN	O	vaccine	nsubj	7	SENT_264	37557/37564
5	is	VBZ	O	be	cop	7	SENT_264	37565/37567
6	more	RBR	O	more	advmod	7	SENT_264	37568/37572
7	immunogenic	JJ	O	immunogenic		-1	SENT_264	37573/37584
8	than	IN	O	than		-1	SENT_264	37585/37589
9	split	JJ	O	split	amod	12	SENT_264	37590/37595
10	influenza	NN	O	influenza	nn	12	SENT_264	37596/37605
11	virus	NN	O	virus	nn	12	SENT_264	37606/37611
12	vaccine	NN	O	vaccine	prep_than	7	SENT_264	37612/37619
13	and	CC	O	and		-1	SENT_264	37620/37623
14	induces	VBZ	O	induce	conj_and	7	SENT_264	37624/37631
15	primarily	RB	O	primarily	advmod	14	SENT_264	37632/37641
16	an	DT	O	a	det	18	SENT_264	37642/37644
17	IgG2a	NN	O	igg2a	nn	18	SENT_264	37645/37650
18	response	NN	O	response	dobj	14	SENT_264	37651/37659
19	in	IN	O	in		-1	SENT_264	37660/37662
20	BALB/c	NN	O	balb/c	nn	22	SENT_264	37663/37669
21	miceScand	NN	O	micescand	nn	22	SENT_264	37670/37679
22	J	NN	O	j	prep_in	14	SENT_264	37680/37681
23	Immunol200562136	NN	O	immunol200562136	dobj	7	SENT_264	37682/37698
24	4410.1111	CD	NUMBER	4410.1111	num	23	SENT_264	37699/37708
25	/	:	O	/	punct	26	SENT_264	37708/37709
26	j.1365-3083	NN	DURATION	j.1365-3083	dep	23	SENT_264	37709/37720
27	.2005.01633	CD	NUMBER	.2005.01633	num	26	SENT_264	37720/37731
28	.	.	O	.		-1	SENT_264	37731/37732

1	x1609292148	NN	O	x1609292148		-1	SENT_265	37732/37743
2	.	.	O	.		-1	SENT_265	37743/37744

1	RimmelzwaanGFFouchierRAOsterhausA	NN	O	rimmelzwaangffouchierraosterhausa	nn	2	SENT_266	37744/37777
2	DInfluenza	NN	O	dinfluenza		-1	SENT_266	37778/37788
3	virus-specific	JJ	O	virus-specific	amod	6	SENT_266	37789/37803
4	cytotoxic	JJ	O	cytotoxic	amod	6	SENT_266	37804/37813
5	T	NN	O	t	nn	6	SENT_266	37814/37815
6	lymphocytes	NNS	O	lymphocyte	dep	2	SENT_266	37816/37827
7	:	:	O	:		-1	SENT_266	37827/37828
8	a	DT	O	a	det	9	SENT_266	37829/37830
9	correlate	NN	O	correlate	dep	2	SENT_266	37831/37840
10	of	IN	O	of		-1	SENT_266	37841/37843
11	protection	NN	O	protection	prep_of	9	SENT_266	37844/37854
12	and	CC	O	and		-1	SENT_266	37855/37858
13	a	DT	O	a	det	14	SENT_266	37859/37860
14	basis	NN	O	basis	conj_and	9	SENT_266	37861/37866
15	for	IN	O	for		-1	SENT_266	37867/37870
16	vaccine	NN	O	vaccine	nn	19	SENT_266	37871/37878
17	developmentCurr	NNP	O	developmentCurr	nn	19	SENT_266	37879/37894
18	Opin	NNP	O	Opin	nn	19	SENT_266	37895/37899
19	Biotechnol20071865293610	NNP	O	Biotechnol20071865293610	prep_for	14	SENT_266	37900/37924
20	.1016	CD	NUMBER	.1016	num	19	SENT_266	37924/37929
21	/	:	O	/	punct	2	SENT_266	37929/37930
22	j.c	NN	O	j.c	nn	23	SENT_266	37930/37933
23	opbio	NN	O	opbio	dep	2	SENT_266	37934/37939
24	.2007.11.0021808354849	CD	NUMBER	.2007.11.0021808354849	dep	23	SENT_266	37939/37961
25	.	.	O	.		-1	SENT_266	37961/37962

1	HagenaarsNMastrobattistaEVerheulRJMoorenIGlansbeek	NNP	O	HagenaarsNMastrobattistaEVerheulRJMoorenIGlansbeek	nn	2	SENT_267	37962/38012
2	HLHeldensJGPhysicochemical	NNP	O	HLHeldensJGPhysicochemical	nsubj	14	SENT_267	38013/38039
3	and	CC	O	and		-1	SENT_267	38040/38043
4	immunological	JJ	O	immunological	amod	5	SENT_267	38044/38057
5	characterization	NN	O	characterization	conj_and	2	SENT_267	38058/38074
6	of	IN	O	of		-1	SENT_267	38075/38077
7	N	NN	O	n	prep_of	5	SENT_267	38078/38079
8	,	,	O	,		-1	SENT_267	38079/38080
9	N	NN	O	n	appos	7	SENT_267	38081/38082
10	,	,	O	,		-1	SENT_267	38082/38083
11	N-trimethyl	NN	O	n-trimethyl	nsubj	14	SENT_267	38084/38095
12	chitosan-coated	JJ	O	chitosan-coated	amod	13	SENT_267	38096/38111
13	whole	JJ	O	whole	amod	11	SENT_267	38112/38117
14	inactivated	VBN	O	inactivate		-1	SENT_267	38118/38129
15	influenza	NN	O	influenza	nn	17	SENT_267	38130/38139
16	virus	NN	O	virus	nn	17	SENT_267	38140/38145
17	vaccine	NN	O	vaccine	dobj	14	SENT_267	38146/38153
18	for	IN	O	for		-1	SENT_267	38154/38157
19	intranasal	JJ	O	intranasal	amod	21	SENT_267	38158/38168
20	administrationPharm	NN	O	administrationpharm	nn	21	SENT_267	38169/38188
21	Res200926613536410	NN	O	res200926613536410	prep_for	17	SENT_267	38189/38207
22	.1007	CD	NUMBER	.1007	dep	21	SENT_267	38207/38212
23	/	:	O	/	punct	24	SENT_267	38212/38213
24	s11095-009-9845-y1922434450	NN	O	s11095-009-9845-y1922434450	dep	21	SENT_267	38213/38240
25	.	.	O	.		-1	SENT_267	38240/38241

1	HuKFLovgren	SYM	O	hukflovgren	dep	3	SENT_268	38241/38252
2	-	:	O	-		-1	SENT_268	38252/38253
3	BengtssonKMoreinBImmunostimulating	VBG	O	bengtssonkmoreinbimmunostimulate		-1	SENT_268	38254/38288
4	complexes	NNS	O	complex	dep	3	SENT_268	38289/38298
5	(	VBN	O	(	partmod	4	SENT_268	38299/38300
6	ISCOMs	NNS	O	iscom	dobj	5	SENT_268	38300/38306
7	)	CD	NUMBER	)	advmod	5	SENT_268	38306/38307
8	for	IN	O	for	prep	3	SENT_268	38308/38311
9	nasal	JJ	O	nasal	amod	12	SENT_268	38312/38317
10	vaccinationAdv	NNP	O	vaccinationAdv	nn	12	SENT_268	38318/38332
11	Drug	NNP	O	Drug	nn	12	SENT_268	38333/38337
12	Deliv	NNP	O	Deliv	dep	8	SENT_268	38338/38343
13	Rev2001511-31495910	NN	O	rev2001511-31495910	dep	12	SENT_268	38344/38363
14	.1016	CD	NUMBER	.1016	num	13	SENT_268	38363/38368
15	/	:	O	/	punct	12	SENT_268	38368/38369
16	S0169-409X	NN	O	s0169-409x	dep	12	SENT_268	38369/38379
17	(	CD	NUMBER	(	number	18	SENT_268	38379/38380
18	01	CD	NUMBER	01	num	20	SENT_268	38380/38382
19	)	NN	O	)	nn	20	SENT_268	38382/38383
20	00165-X1151678651	NN	O	00165-x1151678651	dep	16	SENT_268	38383/38400
21	.	.	O	.		-1	SENT_268	38401/38402

1	KoSYKoHJChangWSParkSHKweonMNKangCYalpha-Galactosylceramide	NN	O	kosykohjchangwsparkshkweonmnkangcyalpha-galactosylceramide	nsubj	3	SENT_269	38402/38460
2	can	MD	O	can	aux	3	SENT_269	38461/38464
3	act	VB	O	act		-1	SENT_269	38465/38468
4	as	IN	O	as	mark	9	SENT_269	38469/38471
5	a	DT	O	a	det	7	SENT_269	38472/38473
6	nasal	JJ	O	nasal	amod	7	SENT_269	38474/38479
7	vaccine	NN	O	vaccine	dep	9	SENT_269	38480/38487
8	adjuvant	JJ	O	adjuvant	dep	9	SENT_269	38488/38496
9	inducing	VBG	O	induce	advcl	3	SENT_269	38497/38505
10	protective	JJ	O	protective	amod	12	SENT_269	38506/38516
11	immune	JJ	O	immune	amod	12	SENT_269	38517/38523
12	responses	NNS	O	response	dobj	9	SENT_269	38524/38533
13	against	IN	O	against		-1	SENT_269	38534/38541
14	viral	JJ	O	viral	amod	15	SENT_269	38542/38547
15	infection	NN	O	infection	prep_against	9	SENT_269	38548/38557
16	and	CC	O	and		-1	SENT_269	38558/38561
17	tumorJ	NN	O	tumorj	nn	18	SENT_269	38562/38568
18	Immunol200517553309171611622352	NN	O	immunol200517553309171611622352	conj_and	15	SENT_269	38569/38600
19	.	.	O	.		-1	SENT_269	38600/38601

1	GarmiseRJStaatsHFHickeyAJNovel	NNP	O	GarmiseRJStaatsHFHickeyAJNovel	nn	4	SENT_270	38601/38631
2	dry	JJ	O	dry	amod	4	SENT_270	38632/38635
3	powder	NN	O	powder	nn	4	SENT_270	38636/38642
4	preparations	NNS	O	preparation	nsubj	7	SENT_270	38643/38655
5	of	IN	O	of		-1	SENT_270	38656/38658
6	whole	JJ	O	whole	prep_of	4	SENT_270	38659/38664
7	inactivated	VBN	O	inactivate		-1	SENT_270	38665/38676
8	influenza	NN	O	influenza	nn	9	SENT_270	38677/38686
9	virus	NN	O	virus	dobj	7	SENT_270	38687/38692
10	for	IN	O	for		-1	SENT_270	38693/38696
11	nasal	JJ	O	nasal	amod	13	SENT_270	38697/38702
12	vaccinationAAPS	NN	O	vaccinationaap	nn	13	SENT_270	38703/38718
13	PharmSciTech200784E8110	NN	O	pharmscitech200784e8110	prep_for	9	SENT_270	38719/38742
14	.1208	CD	NUMBER	.1208	dep	13	SENT_270	38742/38747
15	/	:	O	/	punct	16	SENT_270	38747/38748
16	pt08040811818154253	NN	O	pt08040811818154253	dep	13	SENT_270	38748/38767
17	.	.	O	.		-1	SENT_270	38768/38769

1	MercenierAMuller-AloufHGrangetteCLactic	JJ	PERSON	mercenieramuller-aloufhgrangetteclactic	amod	3	SENT_271	38769/38808
2	acid	NN	O	acid	nn	3	SENT_271	38809/38813
3	bacteria	NNS	O	bacterium		-1	SENT_271	38814/38822
4	as	IN	O	as		-1	SENT_271	38823/38825
5	live	JJ	O	live	amod	7	SENT_271	38826/38830
6	vaccinesCurr	NN	O	vaccinescurr	nn	7	SENT_271	38831/38843
7	Issues	NNS	O	issue	prep_as	3	SENT_271	38844/38850
8	Mol	NNP	O	Mol	nn	9	SENT_271	38851/38854
9	Biol20002117251146491654	NNP	O	Biol20002117251146491654	dep	7	SENT_271	38855/38879
10	.	.	O	.		-1	SENT_271	38879/38880

1	SeegersJFLactobacilli	NNP	PERSON	SeegersJFLactobacilli		-1	SENT_272	38880/38901
2	as	IN	O	as		-1	SENT_272	38902/38904
3	live	JJ	O	live	amod	6	SENT_272	38905/38909
4	vaccine	NN	O	vaccine	nn	6	SENT_272	38910/38917
5	delivery	NN	O	delivery	nn	6	SENT_272	38918/38926
6	vectors	NNS	O	vector	prep_as	1	SENT_272	38927/38934
7	:	:	O	:		-1	SENT_272	38934/38935
8	progress	NN	O	progress	nn	11	SENT_272	38936/38944
9	and	CC	O	and		-1	SENT_272	38945/38948
10	prospectsTrends	NNS	O	prospectstrend	conj_and	8	SENT_272	38949/38964
11	Biotechnol200220125081510	NN	O	biotechnol200220125081510	dep	1	SENT_272	38965/38990
12	.1016	CD	NUMBER	.1016	dep	11	SENT_272	38990/38995
13	/	:	O	/	punct	14	SENT_272	38995/38996
14	S0167-7799	NN	O	s0167-7799	dep	12	SENT_272	38996/39006
15	(	CD	NUMBER	(	number	16	SENT_272	39006/39007
16	02	CD	NUMBER	02	dep	14	SENT_272	39007/39009
17	)	NN	O	)	dep	16	SENT_272	39009/39010
18	02075-912443872	CD	NUMBER	02075-912443872	num	17	SENT_272	39010/39025

